<SEC-DOCUMENT>0001140361-17-030329.txt : 20170807
<SEC-HEADER>0001140361-17-030329.hdr.sgml : 20170807
<ACCEPTANCE-DATETIME>20170807143616
ACCESSION NUMBER:		0001140361-17-030329
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		53
CONFORMED PERIOD OF REPORT:	20170630
FILED AS OF DATE:		20170807
DATE AS OF CHANGE:		20170807

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			U S PHYSICAL THERAPY INC /NV
		CENTRAL INDEX KEY:			0000885978
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		IRS NUMBER:				760364866
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11151
		FILM NUMBER:		171011133

	BUSINESS ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
		BUSINESS PHONE:		7132977000

	MAIL ADDRESS:	
		STREET 1:		1300 WEST SAM HOUSTON PARKWAY
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77043
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>form10q.htm
<DESCRIPTION>10-Q
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Summit Financial Disclosure, LLC
    Document created using EDGARfilings PROfile 4.3.2.1
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-TOP: black 4px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 1px solid; COLOR: #ffffff; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">UNITED STATES</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="FONT-SIZE: 12pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">WASHINGTON, D.C. 20549</div>

<div style="FONT-SIZE: 18pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">FORM 10-Q</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">(MARK ONE)</div>

<div style="TEXT-ALIGN: justify">
<table id="zc1b882c11dee4c9687d45f341fa3f58f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 27pt; align: right">&#9746;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000; TEXT-ALIGN: center"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">FOR THE QUARTERLY PERIOD ENDED June 30, 2017</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">&#160;OR</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z71562cf94576404b8e3eba8b5c10a444" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 27pt; align: right">&#9744;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">FOR THE TRANSITION PERIOD FROM <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"><u>&#160; &#160; &#160; &#160; &#160;&#160; </u></font>TO _____</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">COMMISSION FILE NUMBER 1-11151</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; WIDTH: 20%; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>

<div style="FONT-SIZE: 24pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: center">U.S. PHYSICAL THERAPY, INC.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; WIDTH: 20%; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>

<div style="COLOR: #000000">&#160;</div>

<table id="za7b7dfe74e0d46ec957f819fc2e2b427" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 49.01%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">NEVADA</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 2%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 49%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">76-0364866</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 49.01%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">(STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 2%">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 49%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">(I.R.S. EMPLOYER IDENTIFICATION NO.)</div>
</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<table id="z2bb67b7126de45ab9856d5cba8f040a5" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 49.01%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">1300 WEST SAM HOUSTON PARKWAY SOUTH,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">SUITE 300, HOUSTON, TEXAS</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 2%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 49%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">77042</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 49.01%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 2%">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 49%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">(ZIP CODE)</div>
</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">REGISTRANT&#8217;S TELEPHONE NUMBER, INCLUDING AREA CODE: (713) 297-7000</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9746;</font>&#160; Yes&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9744;</font>&#160; No</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9746;</font> Yes&#160;&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9744;</font>&#160; No</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>

<div style="COLOR: #000000"><br>
</div>

<table id="zb7b5d62b37694a58b9c4056f6e13a3d3" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Large accelerated filer</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 50%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif; TEXT-ALIGN: left">&#9744;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Accelerated filer</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif; TEXT-ALIGN: left">&#9746;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Non-accelerated filer</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 50%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9744;</font> (Do not check if a smaller reporting company)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Smaller reporting company</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif; TEXT-ALIGN: left">&#9744;</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 50%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Emerging growth company</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif; TEXT-ALIGN: left">&#9744;</div>
</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 0.3pt; MARGIN-RIGHT: 0.3pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 13(a) of the Exchange Act. <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9744;</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 0.3pt; MARGIN-RIGHT: 0.3pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9744;</font> Yes&#160;&#160;&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Segoe UI Symbol', sans-serif">&#9746;</font>&#160; No</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">As of August 7, 2017, the number of shares outstanding (issued less treasury stock) of the registrant&#8217;s common stock, par value $.01 per share, was: 12,581,237.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">
<hr style="BORDER-TOP: black 1px solid; HEIGHT: 10px; BORDER-RIGHT: medium none; BORDER-BOTTOM: black 4px solid; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #ffffff; MARGIN-RIGHT: auto" align="center">
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; COLOR: #000000; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><font style="COLOR: #000000">PART I&#8212;</font><a name="FINANCIALINFORMATION"><!--Anchor--></a><font style="COLOR: #000000">FINANCIAL INFORMATION&#8212;UNAUDITED</font></div>

<div style="COLOR: #000000"><br>
</div>

<table id="z459b291262ac4e33a882e7d8fb4a6033" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Item 1.</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="#ITEM1.">Financial Statements.</a></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">3</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="#CONSOLIDATEDBALANCESHEETS">Consolidated Balance Sheets as of June 30, 2017 and December 31, 2016</a></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">3</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="#CONSOLIDATEDSTATEMENTSOFN">Consolidated Statements of Net Income for the three and six months ended June 30, 2017 and 2016</a></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">4</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="#CONSOLIDATEDSTATEMENTSOFC">Consolidated Statements of Cash Flows for the six months ended June 30, 2017, and 2016</a></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">5</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="#CONSOLIDATEDSTATEMENTOFSH">Consolidated Statement of Shareholders&#8217; Equity for the six months ended June 30, 2017</a></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">6</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="#NOTESTOCONSOLIDATEDFINANC">Notes to Consolidated Financial Statements</a></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">7</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Item 2.</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="#Item2.">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">24</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Item 3.</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="#ITEM3.">Quantitative and Qualitative Disclosure About Market Risk</a></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">35</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Item 4.</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="#ITEM4.">Controls and Procedures</a></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">35</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; BACKGROUND-COLOR: #ffffff" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; BACKGROUND-COLOR: #cceeff" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left">PART II&#8212;OTHER INFORMATION</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; BACKGROUND-COLOR: #ffffff" colspan="2">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">Item 1.</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff"><a href="#LEGALPROCEEDINGS.">Legal Proceedings</a></td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: center; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">37</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Item 6.</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="#ITEM6.">Exhibits</a></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">37</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="#SIGNATURES">Signatures</a></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">38</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 6%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 89%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Certifications</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 5%; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">2</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="TEXT-ALIGN: left">
<table id="z2923dcd024af41e38e0d6e6ed83be6fa" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 63pt; align: right"><a name="ITEM1."><!--Anchor--></a><font style="COLOR: #000000">ITEM 1.</font></td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold">FINANCIAL STATEMENTS.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center"><a name="CONSOLIDATEDBALANCESHEETS"><!--Anchor--></a><font style="COLOR: #000000">CONSOLIDATED BALANCE SHEETS</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(IN THOUSANDS, EXCEPT SHARE DATA)</div>

<div style="COLOR: #000000"><br>
</div>

<table id="zb57eca40f58345609faa86f9a820d323" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">December 31, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">ASSETS</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">(unaudited)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Current assets:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Cash and cash equivalents</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">20,242</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">20,047</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Patient accounts receivable, less allowance for doubtful accounts of $1,859&#160; and $1,792, respectively</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">46,770</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">38,840</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Accounts receivable - other</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">5,662</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,649</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Other current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">6,932</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,428</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Total current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">79,606</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">65,964</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Fixed assets:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Furniture and equipment</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">50,644</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">48,426</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Leasehold improvements</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">27,729</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">26,765</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Fixed assets, gross</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">78,373</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">75,191</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Less accumulated depreciation and amortization</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">58,200</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">56,018</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Fixed assets, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">20,173</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">19,173</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Goodwill</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">267,957</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">226,806</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Other identifiable intangible assets, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">48,321</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">38,060</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Other assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,268</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,228</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; TEXT-INDENT: -9pt">Total assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">417,325</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">351,231</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, USPH SHAREHOLDERS&#8217; EQUITY AND NON-CONTROLLING INTERESTS</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Current liabilities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Accounts payable - trade</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,613</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,634</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Accrued expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">31,235</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">21,756</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Current portion of notes payable</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,345</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,227</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Total current liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">35,193</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">24,617</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Notes payable, net of current portion</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,351</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,596</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Revolving line of credit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">69,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">46,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Mandatorily redeemable non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">83,643</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">69,190</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Deferred taxes</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">15,443</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">15,736</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Deferred rent</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,789</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,575</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Other long-term liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">829</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; TEXT-INDENT: -9pt">Total liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">209,419</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">162,543</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Redeemable non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">11,940</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Commitments and contingencies</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">U.S. Physical Therapy, Inc. ("USPH") shareholders&#8217; equity:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Common stock, $.01 par value, 20,000,000 shares authorized, 14,792,744 and 14,732,699 shares issued, respectively</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">147</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">147</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Additional paid-in capital</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">71,197</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">68,687</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Retained earnings</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">155,068</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">150,342</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Treasury stock at cost, 2,214,737 shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(31,628</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(31,628</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Total USPH shareholders&#8217; equity</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">194,784</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">187,548</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,182</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,140</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Total USPH shareholders' equity and non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">195,966</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">188,688</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; TEXT-INDENT: -9pt">Total liabilities, redeemable non-controlling interests, USPH shareholders' equity and non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">417,325</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">351,231</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: center">See notes to consolidated financial statements.</div>

<div style="COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">3</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center"><a name="CONSOLIDATEDSTATEMENTSOFN"><!--Anchor--></a><font style="COLOR: #000000">CONSOLIDATED STATEMENTS OF NET INCOME</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(IN THOUSANDS, EXCEPT PER SHARE DATA)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(unaudited)</div>

<div style="COLOR: #000000"><br>
</div>

<table id="zd4b1aa6d82754baa949938896f50328a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="6" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Three Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="6" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Six Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">(as restated)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">(as restated)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Net patient revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">97,657</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">88,433</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">191,311</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">173,482</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Other revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">6,594</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,997</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">10,505</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">3,856</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Net revenues</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">104,251</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">90,430</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">201,816</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">177,338</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Clinic operating costs:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Salaries and related costs</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">58,779</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">48,837</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">114,606</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">96,641</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Rent, clinic supplies, contract labor and other</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">20,033</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">17,546</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">40,120</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">35,053</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Provision for doubtful accounts</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">888</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">956</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,786</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,045</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Closure costs</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">17</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">32</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">23</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">45</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Total clinic operating costs</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">79,717</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">67,371</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">156,535</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">133,784</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Gross margin</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">24,534</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">23,059</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">45,281</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">43,554</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Corporate office costs</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">8,856</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">8,026</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">17,403</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">17,030</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Operating income</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">15,678</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">15,033</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">27,878</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">26,524</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #cceeff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Interest and other income, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">23</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">21</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">47</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">41</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Interest expense:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Mandatorily redeemable non-controlling interests - change in redemption value</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(3,923</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(1,931</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(6,592</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(4,122</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Mandatorily redeemable non-controlling interests - earnings allocable</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(1,787</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(1,330</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(3,081</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,217</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Debt and other</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(516</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(320</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(931</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(628</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Total interest expense</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(6,226</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(3,581</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(10,604</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(6,967</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Income before taxes</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">9,475</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">11,473</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">17,321</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">19,598</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Provision for income taxes</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">3,085</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">3,802</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,897</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">5,974</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Net income</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">6,390</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">7,671</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,424</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">13,624</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Less: net income attributable to non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(1,449</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(1,659</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,667</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(3,124</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Net income attributable to USPH shareholders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,941</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">6,012</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">9,757</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">10,500</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Basic and diluted earnings per share attributable to USPH shareholders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.39</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.48</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.78</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.84</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Shares used in computation - basic</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,579</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,511</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,553</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,480</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Shares used in computation - diluted</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,579</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,511</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,553</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,480</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Dividends declared per common share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.20</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.17</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.40</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.34</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: center">See notes to consolidated financial statements.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">4</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center"><a name="CONSOLIDATEDSTATEMENTSOFC"><!--Anchor--></a><font style="COLOR: #000000">CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(IN THOUSANDS)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(unaudited)</div>

<div style="COLOR: #000000"><br>
</div>

<table id="z824e8c050c2d48d68cc9de8ec22c375f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="6" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">Six Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">OPERATING ACTIVITIES</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">(as restated)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Net income including non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,424</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">13,624</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Depreciation and amortization</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,789</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,158</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Provision for doubtful accounts</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,786</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,045</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Loss on sale of fixed assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">65</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Equity-based awards compensation expense</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,345</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,484</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Deferred income tax</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(985</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,503</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Changes in operating assets and liabilities:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Increase in patient accounts receivable</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(4,006</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,449</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">(Increase) decrease in accounts receivable - other</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(3,406</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">53</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Increase in other assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,342</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,443</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Increase in accounts payable and accrued expenses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">5,043</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">6,603</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Increase in mandatorily redeemable non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">6,401</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,028</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Increase in other liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">77</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">447</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Net cash provided by operating activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">22,191</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">31,053</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">INVESTING ACTIVITIES</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Purchase of fixed assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(3,245</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(3,453</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Purchase of businesses, net of cash acquired</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(33,665</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(12,958</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Acquisitions of non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(250</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Proceeds on sale of fixed assets, net</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">62</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">42</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Net cash used in investing activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(36,848</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(16,619</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #cceeff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">FINANCING ACTIVITIES</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Distributions to non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,665</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,893</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Cash dividends paid to shareholders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,516</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(4,254</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Proceeds from revolving line of credit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">49,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">93,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Payments on revolving line of credit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(26,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(94,500</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Payments to settle mandatorily redeemable non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,230</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(1,136</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Principal payments on notes payable</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(777</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(533</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Tax benefit from equity-based awards</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">556</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Other</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">40</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Net cash used in financing activities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">14,852</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(9,759</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Net increase in cash and cash equivalents</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">195</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,675</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Cash and cash equivalents - beginning of period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">20,047</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">15,778</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Cash and cash equivalents - end of period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">20,242</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">20,453</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Cash paid during the period for:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Income taxes</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">7,516</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">5,513</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Interest</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">104</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">512</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Non-cash investing and financing transactions during the period:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Purchase of business - seller financing portion</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,650</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">500</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Acquisition of non-controlling interest - seller financing portion</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">388</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Payment to settle redeemable non-controlling interest - financing portion</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">126</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Sale of non-controlling interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">$</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">-</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(148</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: center">See notes to consolidated financial statements.</div>

<div style="COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">5</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center"><a name="CONSOLIDATEDSTATEMENTOFSH"><!--Anchor--></a><font style="COLOR: #000000">CONSOLIDATED STATEMENT OF SHAREHOLDERS&#8217; EQUITY</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(IN THOUSANDS)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(unaudited)</div>

<div style="COLOR: #000000"><br>
</div>

<table id="zc22415bfebb84390895e5906f6e439ab" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 28%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="26" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">U.S.Physical Therapy, Inc.</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 28%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 28%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="6" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Common Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Additional</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Retained</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="6" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Treasury Stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Total Shareholders&#8217;</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Non-Controlling</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 28%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Paid-In Capital</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Earnings</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Shares</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Equity</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Interests</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 28%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="26" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">(In thousands)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">Balance December 31, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">14,733</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">147</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">68,687</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">150,342</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,215</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(31,628</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">187,548</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,140</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">188,688</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 28%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">Issuance of restricted stock</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">60</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">Compensation expense - equity-based awards</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,345</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,345</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,345</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 28%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">165</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">165</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">165</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">Distribution to non-controlling interest partners</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,665</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,665</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 28%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">Contributions of non-controlling interest partners</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">40</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">40</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">Dividends declared to USPT shareholders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(5,031</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(5,031</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(5,031</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 28%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">Net income</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">9,757</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">9,757</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,667</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,424</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 28%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">Balance June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">14,793</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">147</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">71,197</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">155,068</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,215</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(31,628</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">194,784</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,182</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 5%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">195,966</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: center">See notes to consolidated financial statements.</div>

<div style="COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">6</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center"><a name="NOTESTOCONSOLIDATEDFINANC"><!--Anchor--></a><font style="COLOR: #000000">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">June 30, 2017</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: center">(unaudited)</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &#8220;Company&#8221;). All significant intercompany transactions and balances have been eliminated. The Company primarily operates through subsidiary clinic partnerships, in which the Company generally owns a 1% general partnership interest in all the Clinic Partnerships. Our limited partnership interests range from 49% to 99% in the Clinic Partnerships.&#160; The managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in the majority of the clinics (hereinafter referred to as &#8220;Clinic Partnerships&#8221;). To a lesser extent, the Company operates some clinics, through wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &#8220;Wholly-Owned Facilities&#8221;).</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and other referral sources by offering these therapists a competitive salary and incentives based on the profitability of the clinic that they manage. The Company also looks for therapists with whom to establish new, de novo clinics to be owned jointly by the Company and such therapists&#894; in these situations, the therapist is offered the opportunity to co-invest in the new clinic and also receives a competitive salary for managing the clinic. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior owners typically continue on as employees to manage the clinic operations, retaining a non-controlling ownership interest in the clinics and receiving a competitive salary for managing the clinic operations. In addition, we have developed satellite clinic facilities as part of existing Clinic Partnerships and Wholly-Owned facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned facilities operate more than one clinic location. In 2017, we intend to continue to acquire clinic practices and continue to focus on developing new clinics and on opening satellite clinics where appropriate along with increasing our patient volume through marketing and new programs.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">During the first six months of 2017 and the year ended 2016, the Company acquired an interest in the following clinic groups:</div>

<div style="COLOR: #000000"><br>
</div>

<table id="za02c7a6efff940dbb7cb05355440c7af" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 90%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 54%" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 12%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;Date</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">% Interest Acquired</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Number of Clinics</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 54%" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 12%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">June 2017 Acquisition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">June 30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">60</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">9</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">May 2017 Acquisition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">May 31</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">70</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">4</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">January 2017 Acquisition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">January 1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">70</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">17</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 54%; BACKGROUND-COLOR: #cceeff" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">February 2016 Acquisition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">February 29</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">55</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">8</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">November 2016 Acquisition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">November 30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">60</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">12</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">In addition to the above clinic groups, in March 2017, the Company acquired a 55% interest in a company which is a leading provider of workforce performance solutions. Services provided include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers including a number of Fortune 500 companies. Other clients include large insurers and their contractors. Also, during the second quarter, the Company purchased the assets and business of a physical therapy clinic and consolidated its business with an existing clinic.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">As of June 30, 2017, the Company operated 566 clinics in 41 states.&#160; The Company also manages physical therapy facilities for third parties, primarily physicians, with 27 third-party facilities under management as of June 30, 2017.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The results of operations of the acquired clinics have been included in the Company&#8217;s consolidated financial statements since the date of their respective acquisition.&#160; The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">7</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-RIGHT: 0.1pt">The accompanying unaudited consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions for Form 10-Q. However, the statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. Management believes this report contains all necessary adjustments (consisting only of normal recurring adjustments) to present fairly, in all material respects, the Company&#8217;s financial position, results of operations and cash flows for the interim periods presented. For further information regarding the Company&#8217;s accounting policies, please read the audited financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company believes, and the Chief Executive Officer, Chief Financial Officer and Corporate Controller have certified, that the financial statements included in this report present fairly, in all material respects, the Company&#8217;s financial position, results of operations and cash flows for the interim periods presented.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Operating results for the six months ended June 30, 2017 are not necessarily indicative of the results the Company expects for the entire year.&#160; Please also review the Risk Factors section included in our Annual Report on Form 10-K for the year ended December 31, 2016.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">Clinic Partnerships</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by the managing therapist, directly or indirectly, are recorded within the balance sheets and income statements as non-controlling interests.&#160; For acquired Clinic Partnerships with mandatorily redeemable non-controlling interests, the earnings and liabilities attributable to the non-controlling interest are recorded within the statements of net income line items: Interest expense &#8211; mandatorily redeemable non-controlling interests &#8211; earnings allocable and in the balance sheet line item: Mandatorily redeemable non-controlling interests.&#160; For acquired Clinic Partnerships with redeemable non-controlling interests, the earnings attributable to the redeemable non-controlling interest are recorded within the statements of net income line item &#8211; net income attributable to non-controlling interest and the equity interests are recorded on the balance sheet as redeemable non-controlling interests.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">Wholly-Owned Facilities</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing due to the profit sharing therapists. The amount is expensed as compensation and included in clinic operating costs &#8211; salaries and related costs. The respective liability is included in current liabilities &#8211; accrued expenses on the balance sheets.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Restatement of Prior Financial Statements</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">As disclosed in our Current Report on Form 8-K filed March 16, 2017, and further described in our Annual Report on Form 10-K for the year ended December 31, 2016 filed on June 7, 2017, prior to issuing the 2016 annual financial statements, the Company determined it had previously incorrectly accounted for the non-controlling interests in the Company&#8217;s subsidiary clinic partnerships that were mandatorily redeemable. Management and the Company&#8217;s board of directors concluded this error was material to previously issued annual and quarterly consolidated financial statements.&#160; Additional information regarding the restatement is available in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016. Financial information in this Form 10-Q related to all periods prior to the quarter ended December 31, 2016 has been amended where necessary to reflect the restatement. Therefore, this Form 10-Q should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016.</div>

<div style="COLOR: #000000">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Significant Accounting Policies</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Cash Equivalents</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company maintains its cash and cash equivalents at financial institutions.&#160; The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a concentration of credit risk related on deposits in excess of FDIC insurance coverage. Management believes that the risk is not significant.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">8</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Long-Lived Assets</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the assets. Estimated useful lives for furniture and equipment range from three to eight years and for software purchased from three to seven years. Leasehold improvements are amortized over the shorter of the lease term or estimated useful lives of the assets, which is generally three to five years.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances which indicate that the amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Goodwill</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009, from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective January 1, 2009, if the purchase price of a non-controlling interest related to non-acquired Clinic Partnerships by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The carrying value of goodwill and other identifiable intangible assets with indefinite lives are tested for impairment annually and upon the occurrence of certain events, and are written down to fair value if considered impaired. The Company evaluates goodwill for impairment on at least an annual basis (in its third quarter) by comparing the fair value of its reporting units to the carrying value of each reporting unit including related goodwill. The Company&#8217;s business is primarily made up of various clinics within partnerships. The partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test. In the second quarter of 2017, there were six regions.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The estimated fair value of a reporting unit is determined using two factors: (i) earnings prior to taxes, depreciation and amortization for the reporting unit multiplied by a price/earnings ratio used in the industry and (ii) a discounted cash flow analysis. A weight is assigned to each factor and the sum of each weight times the factor is considered the estimated fair value. For 2016, the factors (i.e., price/earnings ratio, discount rate and residual capitalization rate) were updated to reflect current market conditions. The evaluation of goodwill in 2016 did not result in any goodwill amounts that were deemed impaired.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company has not identified any triggering events occurring after the testing date that would impact the impairment testing results obtained. Factors which could result in future impairment charges include but are not limited to:</div>

<div style="TEXT-ALIGN: left">
<table id="z9ccbe7f21b444c4e8fa3eebb6525adb5" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">cost, risks and uncertainties associated with the Company&#8217;s recent restatement of its prior financial statements due to the correction of its accounting methodology for redeemable noncontrolling partnership interests, and including any pending and future claims or proceedings relating to such matters&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z8df0e23b02c145059c597bf1f698daf0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">changes as the result of government enacted national healthcare reform&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z73b4d84344324ff98bf107eeb1764665" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification or enrollment status&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z56d7c1a84df94c15bdb111dd40bd78ee" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z33ce4c5383464041be76fcbf1dd32c1b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">business and regulatory conditions including federal and state regulation&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="ze4eb2ca36fd14eb280ab980b4cb46b65" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">governmental and other third party payor inspections, reviews, investigations and audits&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="ze2657c37e5194b77bc5f9f3e22718614" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information and associated fines and penalties for failure to comply&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z178f60bebf4c4e7b994c33537dda5960" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">legal actions, which could subject us to increased operating costs and uninsured liabilities&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z53f57fe740534506b0f5345ac02b8da2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z67902bdf24de4bde9746c7ac57be3a6b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">revenue and earnings expectations&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z07ca3973da4849e5a8a39c2d8d1edb17" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">general economic conditions&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z4ec2b0c68c804667a533c70a9ab4e5f9" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">availability and cost of qualified physical and occupational therapists&#894;</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">9</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="TEXT-ALIGN: left">
<table id="z66560cc92bf24fdd809958341d7a1513" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">personnel productivity and retaining key personnel&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zb3061bfe31ed402c8caf21cb35a9410b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain operations and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z9fb3cd6b0c8d4b02956e656e66426484" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">acquisitions, purchases of non-controlling interests (minority interests) and the successful integration of the operations of the acquired business&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zc0b1444166404552b9a5070c4e3f39d8" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">maintaining necessary insurance coverage&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zcb2677684e644f7a9d570650939a708d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">availability, terms, and use of capital&#894; and</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z757d9514a9b74b46a0ddf1c7652c3edf" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">weather and other seasonal factors.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Mandatorily Redeemable Non-Controlling Interests</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">The non-controlling interests that are reflected as mandatorily redeemable non-controlling interests in the consolidated financial statements consist of those owners who have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase the non-controlling interest of those owners at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&#160; The redemption rights are triggered at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically three to five years, as defined in the limited partnership agreement.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">On the date the Company acquires a controlling interest in a partnership and the limited partnership agreement contains mandatory redemption rights, the fair value of the non-controlling interest is recorded in the long-term liabilities section of the consolidated balance sheet under the caption &#8211; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">Mandatorily redeemable non-controlling interests</font>.&#160; Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to its then current redemption value, based on the predetermined formula defined in the respective limited partnership agreement.&#160; The Company reflects any adjustment in the redemption value and any earnings attributable to the mandatorily redeemable non-controlling interest in its consolidated statements of net income by recording the adjustments and earnings to other income and expense in the captions - <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">Interest expense &#8211; mandatorily redeemable non-controlling interests &#8211; change in redemption value and Interest expense &#8211; mandatorily redeemable non-controlling interests &#8211; earnings allocable</font>.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Redeemable Non-Controlling Interests</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">The non-controlling interests that are reflected as redeemable non-controlling interests in the consolidated financial statements consist of those owners who have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase the non-controlling interest of those owners, if certain conditions are met and the owners request the purchase.&#160; The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&#160; The redemption rights can be triggered by the owner at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically three to five years, as defined in the limited partnership agreement.&#160; The redemption rights are not automatic (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">On the date the Company acquires a controlling interest in a partnership and the limited partnership agreement contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#8211; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">Redeemable non-controlling interests</font>.&#160; Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial value, based on the predetermined formula defined in the respective limited partnership agreement.&#160; Hence, the value of the non-controlling interest is not adjusted below its initial value.&#160; The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the statements of net income.&#160; Although the adjustments are not reflected in the statements of net income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation.&#160; The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the income statement.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">10</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Non-Controlling Interests</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company recognizes non-controlling interests as equity in the consolidated financial statements separate from the parent entity&#8217;s equity. Changes in a parent entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling interest on the deconsolidation date.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">When the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall, as applicable, is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Revenue Recognition</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Revenues are recognized in the period in which services are rendered. Net patient revenues (patient revenues less estimated contractual adjustments) are reported at the estimated net realizable amounts from third-party payors, patients and others for services rendered. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off experience.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company determines allowances for doubtful accounts based on the specific agings and payor classifications at each clinic. The provision for doubtful accounts is included in clinic operating costs in the statement of net income. Net accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for doubtful accounts, includes only those amounts the Company estimates to be collectible.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Medicare Reimbursement</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&#8216;&#8216;MPFS&#8217;&#8217;). The MPFS rates have historically been subject to an automatic annual update based on a formula, called the sustainable growth rate (&#8216;&#8216;SGR&#8217;&#8217;) formula. The use of the SGR formula would have resulted in calculated automatic reductions in rates in every year since 2002&#894; however, for each year through September 30, 2015, Centers for Medicare &amp; Medicaid Services (&#8216;&#8216;CMS&#8217;&#8217;) or Congress has taken action to prevent the implementation of SGR formula reductions. On April 16, 2015, the Medicare Access and CHIP Reauthorization Act of 2015 (&#8216;&#8216;MACRA&#8217;&#8217;) was signed into law, eliminating the SGR formula and the associated annual automatic rate reductions.&#160; The MACRA promotes the development of new payment models that focus on quality and outcomes.&#160; As a result of MACRA and CMS&#8217; adjustment to the applicable conversion factor, the net fee schedule payment rates were increased for 2017 by 0.24%.&#160; For 2018 and 2019, a 0.5% increase will be applied each year to the fee schedule payment rates, unless further adjusted by CMS.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years, and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extends the 2% reductions to Medicare payments through fiscal year 2025.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 0.2pt; MARGIN-RIGHT: 0.2pt">As a result of the Balanced Budget Act of 1997, the formula for determining the total amount paid by Medicare in any one year for outpatient physical therapy, occupational therapy, and/or speech/language pathology services provided to any Medicare beneficiary (i.e., the &#8216;&#8216;Therapy Cap&#8217;&#8217; or &#8216;&#8216;Limit&#8217;&#8217;) was established. Based on the statutory definitions which constrained how the Therapy Cap would be applied, there is one Limit for Physical Therapy and Speech Language Pathology Services combined, and one Limit for Occupational Therapy. For 2017, the annual Limit on outpatient therapy services is $1,980 for Physical and Speech Language Pathology Services combined and $1,980 for Occupational Therapy Services. Historically, these Therapy Caps applied to outpatient therapy services provided in all settings, except for services provided in departments of hospitals. However, the Protecting Access to Medicare Act of 2014, and prior legislation, extended the Therapy Caps to services furnished in hospital outpatient department settings. The application of these annual limits to hospital outpatient department settings will sunset on December 31, 2017 unless Congress extends it.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">11</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">In the Deficit Reduction Act of 2005, Congress implemented an exceptions process to the annual Limit for therapy expenses for therapy services above the annual Limit. Therapy services above the annual Limit that are medically necessary satisfy an exception to the annual Limit and such claims are payable by the Medicare program. The MACRA extended the exceptions process for outpatient therapy caps through December 31, 2017. Unless Congress extends the exceptions process further, the exceptions no longer will be available in those outpatient therapy setting where the annual Limits are applicable. For any claim above the annual Limit, the claim must contain a modifier indicating that the services are medically necessary and justified by appropriate documentation in the medical record.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Furthermore, under the Middle Class Tax Relief and Job Creation Act of 2012 (&#8216;&#8216;MCTRA&#8217;&#8217;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services&#894; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">CMS adopted a multiple procedure payment reduction (&#8216;&#8216;MPPR&#8217;&#8217;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value Unit (&#8216;&#8216;RVU&#8217;&#8217;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by 50%. In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&#8217;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge, CMS has rejected claims if the required data is not included in the claim.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Physician Quality Reporting System, or &#8216;&#8216;PQRS,&#8217;&#8217; is a CMS reporting program that uses a combination of incentive payments and payment reductions to promote reporting of quality information by &#8216;&#8216;eligible professionals.&#8217;&#8217; Although physical therapists, occupational therapists and qualified speech-language therapists were generally able to participate in the PQRS program, therapy professionals for whose services we bill through our certified rehabilitation agencies cannot participate because the Medicare claims processing systems currently cannot accommodate institutional providers such as certified rehabilitation agencies. Eligible professionals, such as those of our therapy professionals for whose services we bill using their individual Medicare provider numbers, who do not satisfactorily report data on quality measures will be subject to a 2% reduction in their Medicare payment in 2016 and 2017. As required under the MACRA, the PQRS program has been replaced with the Merit-Based Incentive Payment System (MIPS) on January 1, 2017. Physical therapists and occupational therapists are not required to participate in the MIPS program until January 1, 2019 or later, as determined by CMS.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. The Company believes that it is in compliance in all material respects with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the Company&#8217;s financial statements as of June 30, 2017. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the six months ended June 30, 2017, net revenue from Medicare accounts for approximately $45.8 million.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Management Contract Revenues</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Management contract revenues are derived from contractual arrangements whereby the Company manages a clinic for third party owners. The Company does not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized when services are performed. Costs, typically salaries for the Company&#8217;s employees, are recorded when incurred. Management contract revenues are included in &#8220;other revenues&#8221; in the accompanying Consolidated Statements of Net Income.</div>

<div style="COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">12</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Contractual Allowances</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#8217;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&#8217;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#8217;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, the historical difference between net revenues and corresponding cash collections has generally reflected a difference within approximately 1% of net revenues. Additionally, analysis of subsequent period&#8217;s contractual write-offs on a payor basis reflects a difference within approximately 1% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% at June 30, 2017.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Income Taxes</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company did not have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the six months ended June 30, 2017. The Company will book any interest or penalties, if required, in interest and/or other income/expense as appropriate.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Fair Value of Financial Instruments</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement approximates its fair value. The interest rate on the Amended Credit Agreement, which is tied to the Eurodollar Rate, is set at various short-term intervals, as detailed in the Amended Credit Agreement.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Segment Reporting</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by chief operating decision makers in deciding how to allocate resources and in assessing performance. The Company identifies operating segments based on management responsibility and believes it meets the criteria for aggregating its operating segments into a single reporting segment.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">13</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Use of Estimates</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">In preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, purchase accounting, goodwill impairment, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Self-Insurance Program</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company utilizes a self-insurance plan for its employee group health insurance coverage administered by a third party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through June 30, 2017.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Restricted Stock</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock granted to employees, other than officers, lapse in equal annual installments on the following four anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the first year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The restricted stock issued is included in basic and diluted shares for the earnings per share computation.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Recently Adopted Accounting Guidance</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">In March 2016, the FASB issued guidance to simplify some provisions in stock compensation accounting.&#160; The guidance amends how excess tax benefits and a company&#8217;s payments to cover tax bills for the recipients&#8217; shares should be classified.&#160; Prior to this guidance, excess tax benefits were recorded in additional paid-in capital, but will now become a component of the income tax provision/benefit in the period in which they occur.&#160; This guidance allows companies to estimate the number of stock awards expected to vest and revises the withholding requirements for classifying stock awards as equity.&#160; For public business entities, this guidance is effective for fiscal years starting after December 15, 2016, including interim periods within those fiscal years but early adoption is allowed.&#160; The Company adopted this accounting treatment in the fourth quarter of 2016 and retrospectively adjusted each quarter period in 2016.&#160; The adoption increased earnings, by decreasing the tax provision, by $0.5 million for the three months ended March 31, 2016.&#160;&#160; The election to record forfeitures in the period they occur is consistent with the Company&#8217;s past approach, due to the immateriality of past forfeitures, and the Company believes the effect to be immaterial on the consolidated financial statements.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Recently Issued Accounting Guidance</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">In January 2017, the FASB issued ASU 2017-04, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">Simplifying the Test for Goodwill Impairment (Topic 350),</font> which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment change. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods within those years, beginning after December 15, 2019. The Company is currently evaluating the impact of adopting this ASU on our consolidated financial statements and do not expect adoption to have a material impact.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">In February 2016, the FASB issued amended accounting guidance (ASU 2016-02 - <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">Leases</font>) which replaced most existing lease accounting guidance under U. S. generally accepted accounting principles. Among other changes, the amended guidance requires that a right-to-use asset, which is an asset that represents the lessee&#8217;s right to use, and a lease liability, which is a lessee&#8217;s obligation to make lease payments arising for a lease measured on a discounted basis, be recognized on the balance sheet by lessees for those leases with a term of greater than 12 months. The amended guidance is effective for reporting periods beginning after December 15, 2018&#894; however, early adoption is permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Since the Company leases all but one of its clinic facilities, it has been evaluating various lease management systems to capture the necessary information and the impact that this amended accounting guidance will have on its consolidated financial statements. The Company believes the adoption of this guidance will significantly affect total assets and liabilities in the consolidated balance sheet.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">14</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">In May 2014, March 2016, April 2016, and December 2016, the FASB issued ASU 2014-09, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">Revenue from Contracts with Customers</font>, ASU 2016-08, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">Revenue from Contracts with Customers, Principal versus Agent Considerations</font>, ASU 2016-10, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing</font>, ASU 2016-12, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients</font>, and ASU 2016-20, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customer</font> (collectively &#8220;the standards&#8221;), respectively, which supersede most of the current revenue recognition requirements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. New disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers are also required. The original standards were effective for fiscal years beginning after December 15, 2016; however, in July 2015, the FASB approved a one-year deferral of these standards, with a new effective date for fiscal years beginning after December 15, 2017. The standards require the selection of a retrospective or cumulative effect transition method. The Company does not anticipate a material adjustment upon adoption of these standards.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Subsequent Event</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company has evaluated events occurring after the balance sheet date for possible disclosure as a subsequent event through the date that these consolidated financial statements were issued. No disclosure was required.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">2. ACQUISITIONS OF BUSINESSES</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">On January 1, 2017, the Company acquired a 70% interest in a seventeen-clinic physical therapy practice.&#160; The purchase price for the 70% interest was $10.7 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, in January 2018 and 2019.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">On March 23, 2017, (effective March 1, 2017 for accounting purposes) the Company acquired a 55% interest&#160;in a company </font>which is a leading provider of workforce performance solutions. Services provided include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers including a number of Fortune 500 companies. Other clients include large insurers and their contractors.<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'"> The purchase price for the 55% interest was $6.2 million in cash and $0.4 million in a seller note that is payable, principal plus accrued interest, in September 2018.</font></div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">On May 31, 2017 the Company acquired 70% interest in a four-clinic physical therapy practice. The purchase price for the 70% interest was $2.3 million in cash and $250,000 in a seller note that is payable in two principal installments totaling $125,000 each, plus accrued interest, in May 2018 and 2019.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">On June 30, 2017, the Company acquired a 60% interest in a nine-clinic physical therapy practice.&#160; The purchase price for the 60% interest was $15.8 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, in June 2018 and 2019.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">Also, in 2017, we purchased the assets and business of a physical therapy clinic for $100,000 and consolidated its business with an existing clinic.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">15</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The purchase price for the 2017 acquisitions has been preliminarily allocated as follows (in thousands):</div>

<div style="COLOR: #000000"><br>
</div>

<table id="z4c9c2cabcc5f4004a07a19b14c20973f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Cash paid, net of cash acquired</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">33,665</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Seller notes</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,650</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Total consideration</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">35,315</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Estimated fair value of net tangible assets acquired:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Total current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">5,868</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Total non-current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,790</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Total liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(1,919</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Net tangible assets acquired</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">5,739</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Referral relationships</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,693</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Non-compete</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,790</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Tradename</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">5,118</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Goodwill</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">40,197</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(11,940</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(10,282</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; MARGIN-LEFT: 9pt; WIDTH: 88%; BACKGROUND-COLOR: #cceeff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">35,315</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">On November 30, 2016, the Company acquired a 60% interest in a 12 clinic physical therapy practice. The purchase price for the 60% interest was $11.0 million in cash and $0.5 million in a seller note that is payable in two principal installments of $250,000 each, plus accrued interest, in November 2017 and 2018. On February 29, 2016, the Company acquired a 55% interest in an eight-clinic physical therapy practice. The purchase price for the 55% interest was $13.2 million in cash and $0.5 million in a seller note that is payable in two principal installments of $250,000 each, plus accrued interest, one of which was paid in February 2017 and one of which is due in February 2018. During 2016, two subsidiaries of the Company each acquired a single clinic therapy practice for an aggregate purchase price of $75,000.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The purchase prices for the 2016 acquisitions have been preliminarily allocated as follows (in thousands):</div>

<div style="COLOR: #000000"><br>
</div>

<table id="zbedcb58fedd64bf9be5a91f5c1ec4fbc" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Cash paid, net of cash acquired</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">23,623</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Seller notes</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Total consideration</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">24,623</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Estimated fair value of net tangible assets acquired:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Total current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,763</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Total non-current assets</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">839</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Total liabilities</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(1,039</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 27pt; TEXT-INDENT: -9pt">Net tangible assets acquired</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,563</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Referral relationships</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,919</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Non-compete</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">847</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Tradename</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">3,802</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Goodwill</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">32,371</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(18,879</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; MARGIN-LEFT: 9pt; WIDTH: 88%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">24,623</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">For the acquisition that occurred in the first quarter of 2016, the purchase price plus the fair value of the non-controlling interests was allocated to the fair value of certain assets acquired (patient accounts receivable, equipment, prepaid expenses and deposits, tradename, non-compete agreements and referral relationships) and liabilities assumed (accounts payable and accrued employee salary and benefits) based on the fair values at the acquisition date, with the amount exceeding the fair values being recorded as goodwill. For the acquisition that occurred after June 30, 2016, the purchase price plus the fair value of the non-controlling interests was allocated to the fair value of certain assets acquired (patient accounts receivable, equipment, prepaid expenses and deposits, tradename, non-compete agreements and referral relationships) and liabilities assumed (accounts payable and accrued employee salary and benefits) based on the preliminary estimates of the fair values at the acquisition date, with the amount exceeding the estimated fair values being recorded as goodwill. The Company is in the process of completing its formal valuation analysis. Thus, the final allocation of the purchase price will differ from the preliminary estimates used based on additional information obtained. Changes in the estimated valuation of the tangible and intangible assets acquired and the completion by the Company of the identification of any unrecorded pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in adjustments to goodwill.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">For the above acquisitions, total current assets primarily represent patient accounts receivable.&#160; Total non-current assets are fixed assets, primarily equipment, used in the practices.&#160; The estimated values assigned to the referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives.&#160; For referral relationships, the range of the estimated lives was 12 to 13 years, and for non-compete agreements the estimated lives was six years. The values assigned to tradenames and goodwill is tested annually for impairment.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">16</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The consideration for each transaction was agreed upon through arm&#8217;s length negotiations. Funding for the cash portion of the purchase price for the 2017 and 2016 acquisitions was derived from proceeds under the Amended Credit Agreement.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 0.2pt; MARGIN-RIGHT: 0.2pt">The results of operations of these acquisitions have been included in the Company&#8217;s consolidated financial statements since acquired.&#160; Unaudited proforma consolidated financial information for acquisitions occurring in 2017 and 2016 have not been included as the results were not material to current operations.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">3. MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Prior to the second quarter of 2017, when the Company acquired a majority interest (the &#8220;Acquisition&#8221;) in a physical therapy clinic business (referred to as &#8220;Therapy Practice&#8221;), these Acquisitions occurred in a series of steps which are described below.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: left">
<table id="z4d665776441344809c7d2f9cf07596dd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &#8220;Seller Entity&#8221;). The Seller Entity is owned by one or more individuals (the &#8220;Selling Shareholders&#8221;) most of whom are physical therapists that work in the Therapy Practice and provide physical therapy services to patients.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zbceacd6a6c514b2b9ba41720596f4ce2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">In conjunction with the Acquisition, the Seller Entity contributes the Therapy Practice into a newly-formed limited partnership (&#8220;NewCo&#8221;), in exchange for one hundred percent (100%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a wholly-owned subsidiary of the Seller Entity.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zc50e38ee9d7e45c493d8a040a553c59e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Company enters into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Seller Entity a majority (ranges from 50% to 90%) of the limited partnership interest and, in all cases, 100% of the general partnership interest in NewCo. The Company does not purchase 100% of the limited partnership interest because the Selling Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in the form of cash at closing and a small two-year note in lieu of an escrow (the &#8220;Purchase Price&#8221;). The Purchase Agreement does not contain any future earn-out or other contingent consideration that is payable to the Seller Entity or the Selling Shareholders.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z697236a31b154eb387756ade6e3de744" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">4.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Company and the Seller Entity also execute a partnership agreement (the &#8220;Partnership Agreement&#8221;) for NewCo that sets forth the rights and obligations of the limited and general partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z42021cfca90b4cabb2c422397449f376" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">5.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited partnership interest in NewCo (&#8220;Seller Entity Interest&#8221;).</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z75523186006a42d2a4a4f3934b34e62a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">6.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">In most cases, some or all of the Selling Shareholders enter into an employment agreement (the&#160; &#8220;Employment Agreement&#8221;) with NewCo with an initial term that ranges from three to five years (the &#8220;Employment Term&#8221;), with automatic one-year renewals, unless employment is terminated prior to the end of the Employment Term. As a result, a Selling Shareholder becomes an employee (&#8220;Employed Selling Shareholder&#8221;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause, at any time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing&#894; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller Entity as of the closing of the Acquisition.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zf6b09bd21ff44739a3c0392b63cdecc7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">7.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities based on other employees in similar capacities within NewCo, the Company and the industry.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zc9193271eb714b1aa476e023bb31f886" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">8.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete agreement (the &#8220;Non- Compete Agreement&#8221;) which restricts the Selling Shareholder from engaging in competing business activities for a specified period of time (the &#8220;Non-Compete Term&#8221;). A Non-Compete Agreement is executed with the Selling Shareholders in all cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing business during the Non-Compete Term.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zc6974f91f7764b3f915b23e5309287aa" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">9.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Non-Compete Term commences as of the date of the Acquisition and expires on the later of:</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z53bdd95832d748f6aa4c9c6730b311ce" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Two years after the date an Employed Selling Shareholders&#8217; employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">17</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="TEXT-ALIGN: left">
<table id="ze7e2701f19e2408292878371e3cc953a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">b.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Five to six years from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zfa0bd8608b4d4439ae76c55f73788493" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">10.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Non-Compete Agreement applies to a restricted region which is defined as a 15-mile radius from the Therapy Practice. That is, an Employed Selling Shareholder is permitted to engage in competing businesses or activities outside the 15-mile radius (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo immediately is permitted to engage in the competing business or activities outside the 15-mile radius.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z9b2b8cdd87f14227923166c5bc7f38bb" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">11.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &#8220;Call Option&#8221;) or on a required basis (the &#8220;Required Redemption&#8221;):</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z0b784f36186544cd8293a1028d0bac75" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Required Redemption</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z26b206e5289948b48a349e65e79469b1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">i.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Once the Required Redemption is triggered, the Company is obligated to purchase from the Seller Entity and the Seller Entity is obligated to sell to the Company, the allocable portion of the Seller Entity Interest based on the terminated Selling Shareholder&#8217;s pro rata ownership interest in the Seller Entity (the &#8220;Allocable Portion&#8221;). Required Redemption is</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 90pt">triggered when both of the following events have occurred:</div>

<div style="TEXT-ALIGN: left">
<table id="z7d3d0e1cf4c64126893555599ae59c3e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 108pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Termination of an Employed Selling Shareholder&#8217;s employment with NewCo, regardless of the reason for such termination, and</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z6aed19aaba2a4e259d008fd06e457fe0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 108pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The expiration of an agreed upon period of time, typically three to five years, as set forth in the relevant Partnership Agreement (the &#8220;Holding Period&#8221;).</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z37e80c4458144577b4d69fae6d58c377" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">ii.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">In the event an Employed Selling Shareholder&#8217;s employment terminates prior to the expiration of the Holding Period, the Required Redemption would occur only upon expiration of the Holding Period.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z4bfa1609de814fa5a4aac1e3313c00b7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">b.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Call Option</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zee05972f501147f29e41328c1c89bd53" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 108pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">I</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">In the event that an Employed Selling Shareholder&#8217;s employment terminates prior to expiration of the Holding Period, the Company has the contractual right, but not the obligation, to acquire the Employed Selling Shareholder&#8217;s Allocable Portion of the Seller Entity Interest from the Seller Entity through exercise of the Call Option.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zb8cefa4d9a3f434e9af96cd086c21289" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">c.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">For the Required Redemption and the Call Option, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Portion of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed monthly based on available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z7a2ce999bcfe49f38207db411014690e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">d.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings that is used in the Required Redemption noted above.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z1a63a0ea862c4d84be6cf5609e4d338a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">e.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Although, the Required Redemption and the Call Option do not have an expiration date, the Seller Entity Interest eventually will be purchased by the Company.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z6d199d383c9b4481a33004bac6b970df" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 54pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">f.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Required Redemption and the Call Option never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z19693fadb44948a285c06bac7376692d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">12.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">For the six months ended June 30, 2017, the following table details the changes in the carrying amount of mandatorily redeemable non-controlling interest:</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">18</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<table id="zdbdd08b62cf54821adea1c072804a221" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Six Months Ended</div>

<font style="COLOR: #000000">June 30, 2017</font></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Beginning balance</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">69,190</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Operating results allocated to mandatorily redeemable non-controlling interest partners</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">3,081</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Distributions to mandatorily redeemable non-controlling interest partners</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(3,272</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Changes in the redemption value of mandatorily redeemable non-controlling interest</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">6,592</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Payments for settlement of mandatorily redeemable non-controlling&#160; interest</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,230</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Purchases of businesses - initial liability related to mandatorily redeemable non-controlling interest</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">10,282</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Ending balance</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">83,643</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The following table details the carrying amount of the mandatorily redeemable non-controlling interest (in thousands) as of June 30, 2017:</div>

<div style="COLOR: #000000"><br>
</div>

<table id="z16013568bbb3428fa0e2ae15bc2c1999" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Contractual time period has lapsed but holder's employment has not been terminated</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">30,838</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Contractual time period has not lapsed and holder's employment has not been terminated</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">55,454</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Holder's employment has terminated and contractual time period has expired</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Holder's employment has terminated and contractual time period has not expired</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 88%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Redemption value prior to excess distributed earnings</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">86,292</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 88%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Excess distributions over earnings and losses</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,649</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; MARGIN-LEFT: 9pt; WIDTH: 88%; BACKGROUND-COLOR: #cceeff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">83,643</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">4. REDEEMABLE NON-CONTROLLING INTERESTS</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">When the Company acquires a majority interest in a Therapy Practice, those Acquisitions occur in a series of steps as described in numbers 1 through 10 of footnote 3 &#8211; Mandatorily Redeemable Non-Controlling Interests.&#160; For the Acquisitions that occurred after the first quarter of 2017, the Partnership Agreement contained provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &#8220;Call Right&#8221;) or at the option of the Seller Entity (the &#8220;Put Right&#8221;) as follows:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="TEXT-ALIGN: left">
<table id="za313ea234a6c4e01ab7c16188577ab9a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 22.5pt; align: right">1.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Put Right</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z1c39b30cc11d41c38a1d4403355bf564" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 108pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">In the event that any Selling Shareholder&#8217;s employment is terminated involuntarily by the Company without &#8220;Cause&#8221; pursuant to Section 7(d) of such Selling Shareholder&#8217;s Employment Agreement prior to the fifth anniversary of the Closing Date, the Seller Entity thereafter shall have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z5bdd4231722d48169937d3453a50253c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 108pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">b.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">In the event that any Selling Shareholder is not employed by NewCo as of the fifth anniversary of the Closing Date and the Company has not exercised its Call Right with respect to the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, Seller Entity thereafter shall have the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z665588fdff8c428dbbc70bfe12f676ce" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 108pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">c.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Seller Entity shall have the Put Right, and upon the exercise of the Put Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zcdf0374c2ee042e798e66de709d8fe96" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 22.5pt; align: right">2.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Call Right</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zdaf84a7ca2494270adc5421d95a7fc28" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 108pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">a.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">If any Selling Shareholder&#8217;s employment by NewCo is terminated (i) pursuant to a voluntary termination by the Selling Shareholder or (ii) by NewCo with &#8220;Cause&#8221; (as defined in the Selling Shareholder&#8217;s Employment Agreement), prior to the fifth anniversary of the Closing Date, the Company thereafter shall have an irrevocable right to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">19</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="TEXT-ALIGN: left">
<table id="z0f59dd5bbb1446479a6e11124b17b8dd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 108pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">b.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Company shall have the Call Right, and upon the exercise of the Call Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z703188065c2941459d27e0a5b52df621" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 22.5pt; align: right">3.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed monthly based on available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z82328c3917ea4cffb66ce632f2557509" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 22.5pt; align: right">4.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z382e9b4c082e435c817993faeb6c1dd9" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 22.5pt; align: right">5.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Put Right and the Call Right do not have an expiration date, but the Seller Entity Interest is not required to be purchased by the Company or sold by the Seller Entity.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z7e2c7cb975094a9eb34aba2a64eaad5c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 72pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 22.5pt; align: right">6.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">At June 30, 2017, the recorded initial value of $11.9 million approximates the Redemption Amount.&#160; Any allocation of earnings during the three months ended June 30, 2017 was immaterial.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">5. GOODWILL</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The changes in the carrying amount of goodwill consisted of the following (in thousands):</div>

<div style="COLOR: #000000"><br>
</div>

<table id="z9288baa569bf473cae80914139e418e6" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 90%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; WIDTH: 78%; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Six Months Ended</div>

<font style="COLOR: #000000">June 30, 2017</font></div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 78%; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 78%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Beginning balance</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">226,806</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 78%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Goodwill acquired during the period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">40,197</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 78%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Goodwill adjustments for purchase price allocation of business acquired</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">954</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 78%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Ending balance</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">267,957</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">6. INTANGIBLE ASSETS, NET</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Intangible assets, net as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):</div>

<div style="COLOR: #000000; TEXT-ALIGN: left"><br>
</div>

<table id="z076df079828748e6b47ba6b85ad67d01" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">December 31, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Tradenames</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">26,352</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">21,234</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Referral relationships, net of accumulated amortization of $6,214 and $5,275, respectively</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">18,613</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">14,859</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Non-compete agreements, net of accumulated amortization of $3,781 and $3,380, respectively</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">3,356</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,967</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">48,321</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">38,060</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">20</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Tradenames, referral relationships and non-compete agreements are related to the businesses acquired. Typically, the value assigned to tradenames has an indefinite life and is tested at least annually for impairment using the relief from royalty method in conjunction with the Company&#8217;s annual goodwill impairment test. The value assigned to referral relationships is being amortized over their respective estimated useful lives which range from six to 16 years. Non-compete agreements are amortized over the respective term of the agreements which range from five to six years.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The following table details the amount of amortization expense recorded for intangible assets for the three and six months ended June 30, 2017 and 2016 (in thousands):</div>

<div style="COLOR: #000000"><br>
</div>

<table id="z6089a904a21a4da39e7fdc498f4fd91a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="6" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">Three Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="6" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">Six Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Tradenames</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">21</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">42</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Referral relationships</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">481</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">352</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">939</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">675</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Non-compete agreements</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">206</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">147</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">401</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">281</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; MARGIN-LEFT: 9pt; WIDTH: 52%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">687</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">520</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,340</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">998</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Based on the balance of referral relationships and non-compete agreements as of June 30, 2017, the expected amount to be amortized in 2017 and thereafter by year is as follows (in thousands):</div>

<div style="COLOR: #000000; TEXT-ALIGN: left"><br>
</div>

<table id="z7ab0419cff2e48b592b15e7e8f6be53e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; WIDTH: 90%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; BACKGROUND-COLOR: #ffffff" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Referral Relationships</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; BACKGROUND-COLOR: #ffffff" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Non-Compete Agreements</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Years</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">Annual Amount</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Years</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">Annual Amount</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;1,993</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;860</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2018</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;2,063</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2018</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;883</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2019</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;1,973</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2019</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;810</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2020</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;1,973</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2020</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;597</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2021</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;1,973</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2021</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;519</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2022</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;1,924</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2022</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;88</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2023</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;1,817</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2024</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;1,698</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2025</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;1,592</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2026</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;1,131</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2027</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;971</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2028</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #ffffff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;401</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2029</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 25%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: right">&#160;43</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 4.83%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 20%; BACKGROUND-COLOR: #cceeff">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">7. ACCRUED EXPENSES</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Accrued expenses as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):</div>

<div style="COLOR: #000000"><br>
</div>

<table id="za3be2a3dc2d34ebeb1f31b35925a9e6f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">December 31, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Salaries and related costs</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">15,692</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">10,569</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Credit balances due to patients and payors</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,368</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">3,880</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Group health insurance claims</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,772</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,499</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Dividends payable to USPH shareholders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,516</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Other</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">5,887</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,808</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Total</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">31,235</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">21,756</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">8. NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Amounts outstanding under the Amended Credit Agreement and notes payable as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">
<table id="z5b74f0559a2f44e1bfb81ec4d9d68298" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">Summary of Credit Agreement and Notes Payable</div>
</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">December 31, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Credit Agreement average effective interest rate of 2.7% inclusive of unused fee</div>
</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">69,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">46,000</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Various notes payable with $2,345 plus accrued interest due in the next year,&#160;interest accrues in the range of 3.25% through 4.0% per annum</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">6,696</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">5,823</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">75,696</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">51,823</div>
</td>
<td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Less current portion</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,345</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(1,227</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Long term portion</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">73,351</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">50,596</div>
</td>
<td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">21</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Effective December 5, 2013,&#160;the Company&#160;entered into an Amended Credit Agreement, as defined below, with a commitment for a $125.0 million revolving credit facility with a maturity date of November 30, 2018. This agreement was amended in August 2015, January 2016 and March 2017 (hereafter referred to as &#8220;Amended Credit Agreement&#8221;). The Amended Credit Agreement is unsecured and has loan covenants, including requirements that the Company comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of the Company&#8217;s common stock, dividend payments to the Company&#8217;s common shareholders, capital expenditures and other corporate purposes. The pricing grid is based on the Company&#8217;s consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.5% to 2.5% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an unused commitment fee ranging from 0.1% to 0.25% depending on the Company&#8217;s consolidated leverage ratio and the amount of funds outstanding under the Amended Credit Agreement.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 0.1pt; MARGIN-RIGHT: 0.1pt">The January 2016 amendment to the Amended Credit Agreement increased the cash and noncash consideration that the Company could pay with respect to acquisitions permitted under the Amended Credit Agreement to $50,000,000 for any fiscal year, and increased the amount the Company may pay in cash dividends to its shareholders in an aggregate amount not to exceed $10,000,000 in any fiscal year. Further, the March 2017 amendment, among other items, increased the amount the Company may pay in cash dividends to its shareholders in an aggregate amount not to exceed $15,000,000 in any fiscal year.</div>

<div style="COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 0.1pt; MARGIN-RIGHT: 0.1pt"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">On June 30, 2017, $69.0 million was outstanding on the Amended Credit Agreement resulting in $56.0 million of availability. As of June 30, 2017 and the date of this report, the Company was in compliance with all of the covenants thereunder.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The Company generally enters into various notes payable as a means of financing a portion of its acquisitions and purchases of non-controlling interests. In conjunction with the acquisitions in the first six months of 2017, the Company entered into notes payable in the aggregate amount of $1.7 million, of which an aggregate principal payment of $625,000 is due in 2018 and an aggregate principal payment of $1,025,000 is due in 2019. Interest accrues at the rate of 4.0% per annum and is payable with each principal installment.&#160; In conjunction with the acquisitions in 2016 and the purchases of non-controlling interests, the Company entered into notes payable in the aggregate amount of $1.5 million of which an aggregate principal payment of $444,000 was paid in 2017, $250,000 is due in November 2017 and $819,000 is payable in 2018. Interest accrues 3.5% per annum and is payable with each principal installment.&#160; In conjunction with the acquisitions in 2015 and the purchases of non-controlling interests, the Company entered into notes payable in the aggregate amount of $4.9 million, of which an aggregate principal payment of $575,000 was paid in 2016, $525,000 due in 2017 (of which $250,000 was paid in the first quarter of 2017), $1.9 million is due in 2018 and $1.9 million in 2019. Interest accrues in the range of 3.25% to 4.0% per annum and is payable with each principal installment.</div>

<div style="COLOR: #000000; TEXT-ALIGN: left"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Aggregate annual payments of principal required pursuant to the Amended Credit Agreement and the above notes payable subsequent to June 30, 2017 are as follows (in thousands):</div>

<div style="COLOR: #000000"><br>
</div>

<table id="z5fb957bed5ad4d95b5480484ade46180" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 70%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 58%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">During the twelve months ended June 30, 2018</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">2,345</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 58%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">During the twelve months ended June 30, 2019</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">73,351</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; PADDING-BOTTOM: 4px; MARGIN-LEFT: 9pt; WIDTH: 58%; BACKGROUND-COLOR: #cceeff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">75,696</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The revolving credit facility (balance at June 30, 2017 of $69.0 million) matures on November 30, 2018.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">22</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">9. COMMON STOCK</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of the Company&#8217;s common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of its common stock (&#8220;March 2009 Authorization&#8221;). The Amended Credit Agreement permits share repurchases of up to $15,000,000, subject to compliance with covenants. The Company is required to retire shares purchased under the March 2009 Authorization.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Under the March 2009 Authorization, the Company has purchased a total of 859,499 shares. There is no expiration date for the share repurchase program. There are currently an additional estimated 248,344 shares (based on the closing price of $60.40 on June 30, 2017) that may be purchased from time to time in the open market or private transactions depending on price, availability and the Company&#8217;s cash position. The Company did not purchase any shares of its common stock during the six months ended June 30, 2017.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">23</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="TEXT-ALIGN: left">
<table id="z9f773ed9801242f89946f6e9c31f2d13" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 63pt; align: right"><a name="Item2."><!--Anchor--></a><font style="COLOR: #000000">Item 2.</font></td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The following is a discussion of our historical consolidated financial condition and results of operations, and should be read in conjunction with (i) our historical consolidated financial statements and accompanying notes thereto included elsewhere in this Quarterly Report on Form 10-Q; (ii) our Annual Report on Form 10-K for the year ended December 31, 2016 filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on June 07, 2017; and (iii) our management&#8217;s discussion and analysis of financial condition and results of operations included in our 2016 Form 10-K. This discussion includes forward-looking statements that are subject to risk and uncertainties. Actual results may differ substantially from the statements we make in this section due to a number of factors that are discussed in &#8220;Forward-Looking Statements&#8221; herein and &#8220;Part I &#8211; Item 1A. Risk Factors&#8221; of our Annual Report on Form 10-K for the year ended December 31, 2016.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">References to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and the &#8220;Company&#8221; shall mean U.S. Physical Therapy, Inc. and its subsidiaries.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">EXECUTIVE SUMMARY</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Our Business</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">We operate outpatient physical therapy clinics that provide preventive and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. As of June 30, 2017, we operated 566 clinics in 41 states.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">We also manage physical therapy facilities for third parties, primarily physicians, with 27 third-party facilities under management as of June 30, 2017.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">During the six months of 2017 and the year ended 2016, we acquired the following clinic groups:</div>

<div style="COLOR: #000000"><br>
</div>

<div>
<table id="z9a6a5de243a44474b76f891f4e2f6318" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 90%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; PADDING-LEFT: 19%; WIDTH: 54%" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 12%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;Date</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">% Interest Acquired</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">Number of Clinics</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 54%" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 12%" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">June 2017 Acquisition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">June 30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">60</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">9</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">May 2017 Acquisition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">May 31</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">70</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">4</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">January 2017 Acquisition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">January 1</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">70</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">17</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 54%; BACKGROUND-COLOR: #cceeff" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">February 2016 Acquisition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">February 29</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">55</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">8</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 54%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 7.2pt; TEXT-INDENT: -7.2pt">November 2016 Acquisition</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 12%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">November 30</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">60</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">12</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">On June 30, 2017, we acquired a 60% interest in a nine-clinic physical therapy practice.&#160; The purchase price for the 60% interest was $15.8 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, in June 2018 and 2019. On May 31, 2017 we also acquired 70% interest in a four-clinic physical therapy practice. The purchase price for the 70% interest was $2.3 million in cash and $250,000 in a seller note that is payable in two principal installments totaling $125,000 each, plus accrued interest, in May 2018 and 2019. On January 1, 2017, we acquired a 70% interest in a seventeen-clinic physical therapy practice.&#160; The purchase price for the 70% interest was $10.7 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, in January 2018 and 2019.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">In addition to the above clinic groups, we acquired a 55% interest in a company which is a leading provider of workforce performance solutions. Services provided include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers including a number of Fortune 500 companies. Other clients include large insurers and their contractors. The purchase price for the 55% interest was $6.2 million in cash and $0.4 million in a seller note that is payable, principal plus accrued interest, in September 2018.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">24</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">On November 30, 2016, we acquired a 60% interest in a 12 clinic physical therapy practice. The purchase price for the 60% interest was $11.0 million in cash and $0.5 million in a seller note that is payable in two principal installments of $250,000 each, plus accrued interest, in November 2017 and 2018. On February 29, 2016, we acquired a 55% interest in an eight-clinic physical therapy practice.&#160; The purchase price for the 55% interest was $13.2 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, one of which was paid in February 2017 and one of which is due in February 2018.&#160; In addition, we acquired a single clinic practice in June 2016 for $50,000.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Selected Operating and Financial Data</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The following table presents selected operating and financial data that we believe are key indicators of our operating performance.</div>

<div style="COLOR: #000000"><br>
</div>

<div>
<table id="z6bf3dd0d97d84494a4addee8e798f957" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="6" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">For the Three Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="6" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">For the Six Months Ended</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Number of clinics, at the end of period</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">566</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">516</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">566</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">516</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Working Days</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">64</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">64</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">128</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">128</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Average visits per day per clinic</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">25.8</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">25.6</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">25.5</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">25.2</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Total patient visits</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">923,624</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">840,020</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,815,254</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,648,301</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 52%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Net patient revenue per visit</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">105.73</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">105.27</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">105.39</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">105.25</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">RESULTS OF OPERATIONS</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold">Three Months Ended June 30, 2017</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold">Compared to the Three Months Ended June 30, 2016</font></div>

<div style="COLOR: #000000"><br>
</div>

<div>
<table id="z0703540aa2cb45148c8d6046a8a0a3b3" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: left">&#183;</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">For the quarter ended June 30, 2017 (the &#8220;2017 Second Quarter&#8221;), our net income attributable to common shareholders prior to interest expense &#8211; mandatorily redeemable non-controlling interests &#8211; change in redemption value and costs related to restatement of financials, both net of tax (&#8220;operating results&#8221;), a non-generally accepted accounting principles (&#8220;non-GAAP&#8221;) measure, was $7.4 million as compared to $7.2 million in the comparable 2016 period (the &#8220;2016 Second Quarter&#8221;). Diluted earnings per share from operating results was $0.59 in the 2017 period as compared to $0.57 in the 2016 period.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div>
<table id="zcc76539454fe4a8ba5bab20a07d9fb23" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: left">&#183;</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">For the quarter ended June 30, 2017, our net income attributable to its shareholders, in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;), was $4.9 million, or $0.39 per diluted share, as compared to $6.0 million, or $0.48 per diluted share, for the 2016 period.&#160; See schedule below for a reconciliation of net income attributable to our shareholders to operating results.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">Operating results is defined as USPH&#8217;s net income attributable to common shareholders prior to interest expense &#8211; mandatorily redeemable non-controlling interests &#8211; change in redemption value and costs related to the restatement of financial statements, both net of tax.&#160; Management uses operating results, which eliminates this current non-cash item that can be subject to volatility and unusual costs, as one of the principal measures to evaluate and monitor financial performance period over period.&#160; Management believes that operating results is useful information for investors to use in comparing the Company's period-to-period results as well as for comparing with other similar businesses since most do not have mandatorily redeemable instruments and therefore have different liability and equity structures.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">25</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div>
<table id="z8f3ed15cabf64e58824d55ea0a0b020e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="6" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">Three Months Ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">(as restated)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Net income attributable to USPH shareholders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,941</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">6,012</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Adjustments:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Interest expense MRNCI * - change in redemption value</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">3,923</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1,931</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Costs related to restatement of financials - legal and accounting</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">177</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Tax effect at statutory rate (federal and state) of 39.25%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(1,609</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(758</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Operating results</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">7,432</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">7,185</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Basic&#160;and diluted net income attributable to USPH shareholders per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.39</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.48</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Basic&#160;and diluted operating results per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.59</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.57</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Shares used in computation:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Basic and diluted</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,579</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,511</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>
</div>

<div style="COLOR: #000000; TEXT-ALIGN: justify"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">*Mandatorily redeemable non-controlling interest</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Revenues</div>

<div style="COLOR: #000000"><br>
</div>

<div>
<table id="z28d6dc2611c444828ec7286dc1fd90fc" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 36pt; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Net revenues increased $13.9 million or 15.3% from $90.4 million in the second quarter of 2016 to $104.3 million in the second quarter of 2017, primarily due to a 10.0% increase in net patient revenues from the physical therapy operations and a full quarter of revenues from the workforce performance solutions business acquired in March 2017 (see above discussion under &#8220;Executive Summary&#8221;).</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div>
<table id="z82e68fac9dd64d49aced2c18d6d821da" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 36pt; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Net patient revenues from physical therapy operations increased approximately $9.3 million to $97.7 million in the 2017 period from $88.4 million in the 2016 period due to an increase in total patient visits of 10.0% from 840,000 to 923,700 plus an increase in average net patient revenue per visit to $105.73 from $105.27.&#160; Of the $9.3 million increase, $7.7 million was related to clinics opened or acquired in the past 12 months. For the 2017 and 2016 period, revenues from management contracts was $1.6 million for each period. The revenues from the recently acquired workforce performance solutions business was $4.4 million for the second quarter of 2017.&#160; Other revenue was $0.6 million for the 2017 period and $0.4 million for the 2016 period.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Net patient revenues are based on established billing rates less allowances and discounts for patients covered by contractual programs and workers&#8217; compensation. Net patient revenues are determined after contractual and other adjustments relating to patient discounts from certain payors. Payments received under contractual programs and workers&#8217; compensation are based on predetermined rates and are generally less than the established billing rates.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Clinic Operating Costs</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Total clinic operating costs were $79.7 million, or 76.5% of net revenues, in the second quarter of 2017 as compared to $67.4 million, or 74.5% of net revenues, in the 2016 period. The increase was attributable to $6.7 million in operating costs related to new clinics opened or acquired in the past 12 months (&#8220;New Clinics&#8221;), $3.7 million related to the addition of the workforce performance solutions business and $1.9 million related to clinics opened or acquired prior to July 1, 2016 (&#8220;Mature Clinics&#8221;). Each component of clinic operating costs is discussed below:</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">26</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">C<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold">linic Operating Costs&#8212;Salaries and Related Costs</font></div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">Salaries and related costs increased to $58.8 million for the 2017 Second Quarter from $48.8 million for the 2016 Second Quarter, an increase of $10.0 million, or 20.4%. Salaries and related costs for New Clinics and the workforce performance solutions business amounted to $8.0 million for the 2017 Second Quarter. Salaries and related costs for Mature Clinics increased by $2.0 million for the 2017 Second Quarter, of which $0.5&#160; million of the $2.0 million increase related to a full quarter of activity in 2017 for clinics opened or acquired in the first six months of 2016,&#160; as compared to the 2016 Second Quarter.&#160; Salaries and related costs as a percentage of net revenues were 56.4% for the 2017 Second Quarter and 54.0% for the 2016 Second Quarter.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">Clinic Operating Costs&#8212;Rent, Clinic Supplies, Contract Labor and Other Costs</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">Rent, clinic supplies, contract labor and other were $20.0 million for the 2017 Second Quarter and $17.5 million for the 2016 Second Quarter. For New Clinics and the workforce performance solutions business, rent, clinic supplies, contract labor and other amounted to $2.4 million for the 2017 Second Quarter. For Mature Clinics, rent, clinic supplies, contract labor and other remained relatively the same in the 2017 Second Quarter compared to the 2016 Second Quarter. Rent, clinic supplies, contract labor and other as a percentage of net revenues was 19.2% for the 2017 Second Quarter and 19.4% for the 2016 Second Quarter.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">Clinic Operating Costs&#8212;Provision for Doubtful Accounts</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">The provision for doubtful accounts was $0.9 million for the 2017 Second Quarter and $1.0 million for the 2016 Second Quarter. The provision for doubtful accounts for patient accounts receivable as a percentage of net patient revenues was 0.9% for the 2017 Second Quarter and 1.1% for the 2016 Second Quarter.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">Our provision for doubtful accounts for patient accounts receivable as a percentage of total patient accounts receivable was 3.8% at June 30, 2017, as compared to 4.4% at December 31, 2016. Our day&#8217;s sales outstanding were 37 days at June 30, 2017 and 36 days at December 31, 2016.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Gross Margin</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 0.1pt; MARGIN-RIGHT: 18.1pt">The gross margin for the 2017 Second Quarter was $24.5 million, or 23.5% of revenue, as compared to $23.0 million, or 25.5% of revenue, for the 2016 Second Quarter. The gross margin for the Company&#8217;s physical therapy clinics was 24.2% in the recent quarter as compared to 25.6% a year earlier. The gross margin on management contracts was 7.4% in the 2017 Second Quarter as compared to 22.5% in the 2016 Second Quarter. The gross margin for the recently acquired workforce performance solutions business was 15.0%.</div>

<div style="COLOR: #000000">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Corporate Office Costs</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Corporate office costs, consisting primarily of salaries and benefits of corporate office personnel, rent, insurance costs, depreciation and amortization, travel, legal, accounting, professional, and recruiting fees, were $8.9 million for the 2017 Second Quarter and $8.0 million for the 2016 Second Quarter. Included in the corporate office costs in the second quarter of 2017 was $177,000 of charges related to the legal and accounting costs for the restatement of our financial statements.&#160; As a percentage of net revenues, corporate office costs were 8.5% for the 2017 Second Quarter and 8.9% for the 2016 Second Quarter.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Interest Expense<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">&#160;</font>mandatorily redeemable non-controlling interest &#8211; change in redemption value</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-RIGHT: 18pt">Interest Expense<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">&#160;</font>mandatorily redeemable non-controlling interest &#8211; change in redemption value increased to $3.9 million in the 2017 Second Quarter from $1.9 million in the 2016 Second Quarter.&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The change in redemption value for acquired partnerships is based on t</font>he redemption amount (which is derived from a formula based on a specified multiple times the underlying business&#8217; trailing twelve months of earnings before interest, taxes, depreciation, amortization and our internal management fee) at the end of the reporting period compared to the end of the previous period. This change is directly related to an increase in the profitability and underlying value of the Company&#8217;s partnerships.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">27</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-RIGHT: 18pt">Interest Expense<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">&#160;</font>mandatorily redeemable non-controlling interest &#8211; earnings allocation</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-RIGHT: 18.1pt">Interest expense &#8211; mandatorily redeemable non-controlling interest &#8211; earnings allocable, which represent the portion of earnings allocable to the holders of mandatorily redeemable non-controlling interest, increased to $1.8 million in the 2017 Second Quarter from $1.3 million in the 2016 Second Quarter.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Interest Expense &#8211; debt and other</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Interest expense increased to $516,000 in the 2017 Second Quarter compared to $320,000 in the 2016 Second Quarter due to a higher average balance outstanding under our Amended Credit Agreement.&#160; At June 30, 2017, $69.0 million was outstanding under our Amended Credit Agreement. See &#8220;&#8212;Liquidity and Capital Resources&#8221; below for a discussion of the terms of our Amended Credit Agreement.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Provision for Income Taxes</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-RIGHT: 18pt">The provision for income taxes for the 2017 Second Quarter was $3.1 million and for the 2016 Second Quarter was $3.8 million. The provision for income taxes as a percentage of income before taxes less net income attributable to non-controlling interest was 38.4% in the 2017 Second Quarter and 38.7% in the 2016 Second Quarter.&#160; Included in the both Second Quarter of 2017 and quarter of 2016 was an excess tax benefit, which had the effect of reducing the effective tax rate, of $0.1 million related to accounting for stock compensation.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Non-controlling Interests</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Net income attributable to non-controlling interests was $1.4 million for the 2017 Second Quarter and $1.7 million for the 2016 Second Quarter.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold">Six Months Ended June 30, 2017</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold">Compared to the Six Months Ended June 30, 2016</font></div>

<div style="COLOR: #000000"><br>
</div>

<div>
<table id="zf8eab380e92e4ac8b99a28fa95b65079" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: left">&#183;</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">For the six months ended June 30, 2017, our operating results, a non-GAAP measure, were $14.0 million as compared to $13.0 million in the comparable 2016 period. Diluted earnings per share from operating results was $1.11 in the 2017 period as compared to $1.04 in the 2016 period.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div>
<table id="ze67d4766910b484bb5c70a2d89b50a3a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; TEXT-ALIGN: left">&#183;</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">For the six months ended June 30, 2017, our net income attributable to its shareholders, in accordance with GAAP, was $9.8 million, or $0.78 per diluted share, as compared to $10.5 million, or $0.84 per diluted share, for the 2016 period.&#160; See schedule below for a reconciliation of net income attributable to our shareholders to operating results.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">Operating results is defined as USPH&#8217;s net income attributable to common shareholders prior to interest expense &#8211; mandatorily redeemable non-controlling interests &#8211; change in redemption value and costs related to the restatement of financial statements, both net of tax.&#160; Management uses operating results, which eliminates this current non-cash item that can be subject to volatility and unusual costs, as one of the principal measures to evaluate and monitor financial performance period over period.&#160; Management believes that operating results is useful information for investors to use in comparing the Company's period-to-period results as well as for comparing with other similar businesses since most do not have mandatorily redeemable instruments and therefore have different liability and equity structures.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">28</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<!--PROfilePageNumberReset%Num%29%%%-->
<div>
<table id="z9e2398d5c5d242fbad1cb1dd871890e5" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom"></td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="6" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">For Six Months Ended June 30,</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">2016</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000" valign="bottom" colspan="2" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">(as restated)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Net income attributable to USPH shareholders</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">9,757</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">10,500</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Adjustments:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Interest expense MRNCI * - change in redemption value</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">6,592</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">4,122</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Costs related to restatement of financials - legal and accounting</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">312</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">-</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Tax effect at statutory rate (federal and state) of 39.25%</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(2,710</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">(1,618</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Operating results</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">13,951</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">13,004</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Basic&#160;and diluted net income attributable to USPH shareholders per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.78</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0.84</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Basic&#160;and diluted operating results per share</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1.11</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">$</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">1.04</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; MARGIN-LEFT: 9pt; WIDTH: 76%; BACKGROUND-COLOR: #ffffff; TEXT-INDENT: -9pt" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; WIDTH: 76%; BACKGROUND-COLOR: #cceeff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt">Shares used in computation:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #cceeff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: middle; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 76%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt">Basic and diluted</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,553</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; COLOR: #000000; TEXT-ALIGN: right; WIDTH: 9%; BACKGROUND-COLOR: #ffffff" valign="bottom">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">12,480</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #ffffff" valign="bottom" nowrap="nowrap">&#160;</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">*Mandatorily redeemable non-controlling interests</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Revenues</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: left">
<table id="z119d9f6bf1504b0e82fced88851a175e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Net revenues increased $24.5 million or 13.8% from $177.3 million in the 2016 First Six Months to $201.8 million in the 2017 First Six Months, primarily due to a 10.1% increase in net patient visits from 1,648,300 to 1,815,300, higher revenues from management contracts due to an increase in the number of facilities managed by the Company and revenues from the workforce performance solutions business acquired in March 2017.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: left">
<table id="z365eaebcb8844ccfa9cbda9f46bd14b6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Net patient revenues from physical therapy operations increased approximately $17.8 million to $191.3 million in the 2017 period from $173.5 million in the 2016 period due to an increase in total patient visits of 10.1% from 1,648,300 to 1,815,254 and slight increase in average net patient revenue per visit to $105.39 from $105.25.&#160; Of the $17.8 million increase, $14.5 related to New Clinics.&#160; For the 2017 First Six Months, revenues from management contracts was $3.5 million as compared to $2.9 million for the 2016 first six months. The revenues from the recently acquired workforce performance solutions business was $5.9 million for the four months of operations in 2017.&#160; Other revenue was $1.1 million for the 2017 First Six Months and $0.9 million for the 2016 First Six Months.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Net patient revenues are based on established billing rates less allowances and discounts for patients covered by contractual programs and workers&#8217; compensation. Net patient revenues are determined after contractual and other adjustments relating to patient discounts from certain payors. Payments received under contractual programs and workers&#8217; compensation are based on predetermined rates and are generally less than the established billing rates.</div>

<div style="COLOR: #000000; TEXT-ALIGN: left"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Clinic Operating Costs</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Total clinic operating costs were $156.5 million, or 77.6% of net revenues, for the 2017 First Six Months as compared to $133.8 million, or 75.4% of net revenues, for the 2016 First Six Months. The increase was attributable to $12.8 million in operating costs related to New Clinics, an additional $2.7 million related to a full six months of activity in 2017 for clinics opened or acquired in the first six months of 2016 and $5.0 million related to the addition of the workforce performance solutions business. Each component of clinic operating costs is discussed below:</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">C<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold">linic Operating Costs&#8212;Salaries and Related Costs</font></div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">Salaries and related costs increased to $114.6 million for the 2017 First Six Months from $96.6 million for the 2016 First Six Months, an increase of $18.0 million, or 18.6%. Salaries and related costs for New Clinics and the workforce performance solutions business amounted to $13.5 million for the 2017 First Six Months. Salaries and related costs for Mature Clinics increased by $4.5 million for the 2017 First Six Months, primarily related to $1.9&#160; million for a full quarter of activity in 2017 for clinics opened or acquired in the first six months of 2016,&#160; as compared to the 2016 First Six Months.&#160; Salaries and related costs as a percentage of net revenues were 56.8% for the 2017 First Six Months and 54.5% for the 2016 First Six Months.</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">29</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">Clinic Operating Costs&#8212;Rent, Clinic Supplies, Contract Labor and Other Costs</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">Rent, clinic supplies, contract labor and other were $40.1 million for the 2017 First Six Months and $35.1 million for the 2016 First Six Months. For New Clinics and the workforce performance solutions business, rent, clinic supplies, contract labor and other amounted to $2.8 million for the 2017 First Six Months. For Mature Clinics, rent, clinic supplies, contract labor and other increased by $0.9 million in the 2017 First Six Months compared to the 2016 First Six Months. The $0.9 million increase related to a full quarter of activity in 2017 for clinics opened or acquired in the first six months of 2016,&#160; as compared to the 2016 First Six Months.&#160; For clinics opened or acquired prior to 2016, rent, clinic supplies, contract labor and other remained the same for the two six month periods.&#160; Rent, clinic supplies, contract labor and other as a percentage of net revenues was 19.9% for the 2017 First Six Months and 19.8% for the 2016 First Six Months.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">Clinic Operating Costs&#8212;Provision for Doubtful Accounts</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">The provision for doubtful accounts was $1.8 million for the 2017 First Six Months and $2.0 million for the 2016 First Six Months. The provision for doubtful accounts for patient accounts receivable as a percentage of net patient revenues was 0.9% for the 2017 First Six Months and 1.2% for the 2016 First Six Months.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">Our provision for doubtful accounts for patient accounts receivable as a percentage of total patient accounts receivable was 3.8% at June 30, 2017, as compared to 4.4% at December 31, 2016. Our day&#8217;s sales outstanding were 37 days at June 30, 2017 and 36 days at December 31, 2016.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Gross Margin</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 0.1pt; MARGIN-RIGHT: 18.1pt">The gross margin for the 2017 First Six Months was $45.3 million, or 22.4% of revenue, as compared to $43.6 million, or 24.6% of revenue, for the 2016 First Six Months. The gross margin for the Company&#8217;s physical therapy clinics was 22.9% in the recent quarter as compared to 24.6% a year earlier. The gross margin on management contracts was 11.3% in the 2017 First Six Months as compared to 21.2% in the 2016 First Six Months. The gross margin for the recently acquired workforce performance solutions business was 14.8%.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Corporate Office Costs</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Corporate office costs, consisting primarily of salaries and benefits of corporate office personnel, rent, insurance costs, depreciation and amortization, travel, legal, accounting, professional, and recruiting fees, were $17.4 million for the 2017 First Six Months and $17.0 million for the 2016 First Six Months. Included in the corporate office costs in the first six months of 2017 was $312,000 of charges related to the legal and accounting costs for the restatement of our financial statements.&#160; As a percentage of net revenues, corporate office costs were 8.6% for the 2017 First Six Months and 9.6% for the 2016 First Six Months.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">30</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Interest Expense<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">&#160;</font>mandatorily redeemable non-controlling interest &#8211; change in redemption value</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-RIGHT: 18pt">Interest Expense<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">&#160;</font>mandatorily redeemable non-controlling interest &#8211; change in redemption value increased to $6.6 million in the 2017 First Six Months from $4.1 million in the 2016 First Six Months.&#160; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">The change in redemption value for acquired partnerships is based on t</font>he redemption amount (which is derived from a formula based on a specified multiple times the underlying business&#8217; trailing twelve months of earnings before interest, taxes, depreciation, amortization and our internal management fee) at the end of the reporting period compared to the end of the previous period. This is a non-cash item and is directly related to the increase in the profitability and underlying value of the Company&#8217;s partnerships.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-RIGHT: 18pt">Interest Expense<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">&#160;</font>mandatorily redeemable non-controlling interest &#8211; earnings allocation</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-RIGHT: 18.1pt">Interest expense &#8211; mandatorily redeemable non-controlling interest &#8211; earnings allocable, which represent the portion of earnings allocable to the holders of mandatorily redeemable non-controlling interest, increased to $3.1 million in the 2017 First Six Months from $2.2 million in the 2016 First Six Months.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Interest Expense &#8211; debt and other</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Interest expense increased to $931,000 in the 2017 First Six Months compared to $628,000 in the 2016 First Six Months due to a higher average balance outstanding under our Amended Credit Agreement.&#160; At June 30, 2017, $69.0 million was outstanding under our Amended Credit Agreement. See &#8220;&#8212;Liquidity and Capital Resources&#8221; below for a discussion of the terms of our Amended Credit Agreement.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Provision for Income Taxes</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-RIGHT: 18pt">The provision for income taxes for the 2017 First Six Months was $4.9 million and for the 2016 First Six Months was $6.0 million. The provision for income taxes as a percentage of income before taxes less net income attributable to non-controlling interest was 33.4% in the 2017 First Six Months and 36.3% in the 2016 First Six Months.&#160; Included in the 2017 First Six Months was an excess tax benefit, which had the effect of reducing the effective tax rate, of $0.9 million related to accounting for stock compensation as compared to $0.6 million in the first six months of 2016.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Non-controlling Interests</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Net income attributable to non-controlling interests was $2.7 million for the 2017 First Six Months and $3.1 million for the 2016 First Six Months.<br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">LIQUIDITY AND CAPITAL RESOURCES</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">We believe that our business is generating sufficient cash flow from operations to allow us to meet our short-term and long-term cash requirements, other than those with respect to future acquisitions. At June 30, 2017 and December 31, 2016, we had $20.2 million and $20.0 million, respectively, in cash. Although the start-up costs associated with opening new clinics and our planned capital expenditures are significant, we believe that our cash and unused availability under our revolving credit agreement are sufficient to fund the working capital needs of our operating subsidiaries, future clinic development and acquisitions and investments through at least June 2018. Significant acquisitions would likely require additional financing.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Effective December 5, 2013, we entered into an Amended and Restated Credit Agreement with a commitment for a $125.0 million revolving credit facility with a maturity date of November 30, 2018. This agreement was amended in August 2015, January 2016 and March 2017 (hereafter referred to as &#8220;Amended Credit Agreement&#8221;). The Amended Credit Agreement is unsecured and has loan covenants, including requirements that the Company comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of the Company&#8217;s common stock, dividend payments to the Company&#8217;s common stockholders, capital expenditures and other corporate purposes. The pricing grid which is based on the Company&#8217;s consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.5% to 2.5% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an unused commitment fee ranging from 0.1% to 0.25% depending on the Company&#8217;s consolidated leverage ratio and the amount of funds outstanding under the Amended Credit Agreement. On June 30, 2017, $69.0 million was outstanding under our Amended Credit Agreement resulting in $56.0 million of availability.&#160; As of the date of this Quarterly Report, we were in compliance with all of the covenants thereunder.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">31</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Cash and cash equivalents increased by $0.2 million from December 31, 2016 to June 30, 2017.&#160; During the six months ended June 30, 2017, $22.2 million was provided by operations and $23.0 million from net proceeds drawn on the line of credit provided in our Amended Credit Agreement. The major uses of cash for investing and financing activities included: purchase of businesses ($33.7 million), purchases of fixed assets ($3.2 million), distributions to non-controlling interests ($2.7 million), cash dividends to our common shareholders ($2.5 million), payments to settle mandatorily redeemable non-controlling interests ($2.2 million), and payments on notes payable ($0.8 million).</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">On January 1, 2017, we acquired a 70% interest in a seventeen-clinic physical therapy practice.&#160; The purchase price for the 70% interest was $10.7 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, in January 2018 and 2019.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">In March 2017, we acquired a 55% interest in a company which is a leading provider of workforce performance solutions. Services provided include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers including a number of Fortune 500 companies. Other clients include large insurers and their contractors. The purchase price for the 55% interest was $6.2 million in cash and $0.4 million in a seller note that is payable, principal plus accrued interest, in September 2018.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">On May 31, 2017, we acquired a 70% interest in a four-clinic physical therapy practice. The purchase price for the 70% interest was $2.3 million in cash and $250,000 in a seller note that is payable in two principal installments totaling $125,000 each, plus accrued interest, in May 2018 and 2019.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">On June 30, 2017, we acquired a 60% interest in a nine-clinic physical therapy practice.&#160; The purchase price for the 60% interest was $15.8 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, in June 2018 and 2019.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">On November 30, 2016, we acquired a 60% interest in a 12 clinic physical therapy practice. The purchase price for the 60% interest was $11.0 million in cash and $0.5 million in a seller note that is payable in two principal installments of $250,000 each, plus accrued interest, in November 2017 and 2018. On February 29, 2016, we acquired a 55% interest in an eight-clinic physical therapy practice.&#160; The purchase price for the 55% interest was $13.2 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, one of which was paid in February 2017 and one of which is payable in February 2018.&#160; In addition, we acquired a single clinic practice in June 2016 for $50,000.</div>

<div style="COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 0.1pt; MARGIN-RIGHT: 0.1pt"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Historically, we have generated sufficient cash from operations to fund our development activities and to cover operational needs. We plan to continue developing new clinics and making additional acquisitions. We also from time to time purchase the non-controlling interests in our Clinic Partnerships. Generally, any acquisition or purchase of non-controlling interests is expected to be accomplished using a combination of cash and financing. Any large acquisition would likely require financing.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">We make reasonable and appropriate efforts to collect accounts receivable, including applicable deductible and co-payment amounts, in a consistent manner for all payor types. Claims are submitted to payors daily, weekly or monthly in accordance with our policy or payor&#8217;s requirements. When possible, we submit our claims electronically. The collection process is time consuming and typically involves the submission of claims to multiple payors whose payment of claims may be dependent upon the payment of another payor. Claims under litigation and vehicular incidents can take a year or longer to collect. Medicare and other payor claims relating to new clinics awaiting Medicare Rehab Agency status approval initially may not be submitted for six months or more. When all reasonable internal collection efforts have been exhausted, accounts are written off prior to sending them to outside collection firms. With managed care, commercial health plans and self-pay payor type receivables, the write-off generally occurs after the account receivable has been outstanding for at least 120 days.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">We generally enter into various notes payable as a means of financing our acquisitions. Our outstanding notes payable as of June 30, 2017 relate to certain of the acquisitions of businesses, purchases of non-controlling interests and settlements of mandatorily redeemable non-controlling interests that occurred in 2015 through June 2017. Typically, the notes are payable in equal annual installments of principal over two years plus any accrued and unpaid interest. Interest accrues at various interest rates ranging from 3.25% to 4.0% per annum, subject to adjustment. At June 30, 2017, the balance on these notes payable was $6.7 million.&#160; In addition, we assumed leases with remaining terms of 1 month to 6 years for the operating facilities.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">32</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">In conjunction with the above mentioned acquisitions, in the event that a limited minority partner&#8217;s employment ceases at any time after a specified date that is between three and five years from the acquisition date, we have agreed to repurchase that individual&#8217;s non-controlling interest at a predetermined multiple of earnings before interest and taxes.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">As of June 30, 2017, we have accrued $4.4 million related to credit balances due to patients and payors.&#160; This amount is expected to be paid in the next twelve months.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">From September 2001 through December 31, 2008, our Board of Directors (&#8220;Board&#8221;) authorized us to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of our common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of our common stock (&#8220;March 2009 Authorization&#8221;). Our Amended Credit Agreement permits share repurchases of up to $15,000,000, subject to compliance with covenants. We are required to retire shares purchased under the March 2009 Authorization.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">There is no expiration date for the share repurchase program. As of June 30, 2017, there are currently an additional estimated 248,344 shares (based on the closing price of $60.40 on June 30, 2017)&#160; that may be purchased from time to time in the open market or private transactions depending on price, availability and our cash position. We did not purchase any shares of our common stock during the six months ended June 30, 2017.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">FACTORS AFFECTING FUTURE RESULTS</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The risks related to our business and operations include:</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z4e1b31310f1c4ef49abeed0fa0c642d1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">cost, risks and uncertainties associated with the Company&#8217;s recent restatement of its prior financial statements due to the correction of its accounting methodology for redeemable noncontrolling partnership interests, and including any pending and future claims or proceedings relating to such matters&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="za632c78b8f20452aa4e449749bc36da7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification or enrollment status&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z513c1a29327643cf8d5044b26efef20a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="zaa6231c4d3fd4859921d7f5f2c59a934" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">business and regulatory conditions including federal and state regulations&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z2605fa902a8541d1a73543761d0bd023" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">governmental and other third party payor inspections, reviews, investigations and audits&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z151ca97406734e6e93dfbc04def14a6f" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for failure to comply&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="zbfe9e00be3874351a89fd4c10c868021" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">legal actions, which could subject us to increased operating costs and uninsured liabilities&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z47993a77fbe244e6af8ed12d77e22a17" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="zb4fca33fc7244de4bf877ad492b13175" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">revenue and earnings expectations&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z1bf60632af6b4dfe9db00f5d48da7791" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">general economic conditions&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z0e5f8a6456724ffea6e083d9c2896934" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">availability and cost of qualified physical therapists&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="zde308b98c145425e88bdaec74c53533e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">personnel productivity and retaining key personnel&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="zd253c418086f4be091088a8e7eece2b3" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z754a790fab2746008ec162b4315359fe" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">acquisitions, purchase of non-controlling interests (minority interests) and the successful integration of the operations of the acquired businesses&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z687119761e444a8795899616ed8f7478" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">our ability to design and maintain effective internal control over financial reporting and remediate the material weakness in internal control over financial reporting related to our accounting for redeemable non-controlling partnership interests&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z8b82df08614a4c6f933a397c70c5312d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">maintaining necessary insurance coverage&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z26789361952f4e1c9a89385ed948fb10" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">availability, terms, and use of capital&#894; and</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z83a6907b94344b04b5bf654baaae16b8" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">weather and other seasonal factors.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">See Risk Factors in Item 1A of our Annual Report on Form 10-K.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">33</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Forward-Looking Statements</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">We make statements in this report that are considered to be forward-looking statements within the meaning given such term under Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). These statements contain forward-looking information relating to the financial condition, results of operations, plans, objectives, future performance and business of our Company. These statements (often using words such as &#8220;believes&#8221;, &#8220;expects&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;appear&#8221;, &#8220;should&#8221; and similar words) involve risks and uncertainties that could cause actual results to differ materially from those we project. Included among such statements are those relating to opening new clinics, availability of personnel and the reimbursement environment. The forward-looking statements are based on our current views and assumptions and actual results could differ materially from those anticipated in such forward-looking statements as a result of certain risks, uncertainties, and factors, which include, but are not limited to:</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Many factors are beyond our control. Given these uncertainties, you should not place undue reliance on our forward-looking statements. Please see our periodic reports filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) for more information on these factors. Our forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as required by law, we are under no obligation to update any forward-looking statement, regardless of the reason the statement is no longer accurate.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: left">
<table id="zc86e57785bcb4ac395ce6428f530d2b8" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">cost, risks and uncertainties associated with the Company&#8217;s recent restatement of its prior financial statements due to the correction of its accounting methodology for redeemable noncontrolling partnership interests, and including any pending and future claims or proceedings relating to such matters&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z3d4faf0748e045618be1b9cb18dc65d4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">changes as the result of government enacted national healthcare reform&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zc1a1fafbcdfc47d99e98a205e4edf859" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification status&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zd9aaa26819fe45848ac223fd6a8cb59d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zed1eace57e5848fa8eb92eeb9db6be5e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">business and regulatory conditions including federal and state regulations&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zfc0071706fa9479895de08fe87d48668" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">governmental and other third party payor inspections, reviews, investigations and audits&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="za08e9814c1044148b6c7fbf52061da5c" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines and penalties for failure to comply&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z4b0f8b411d814deeb93f843ef6b7e407" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">legal actions&#894; which could subject us to increased operating costs and uninsured liabilities&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z5c83cb097b634ed0ac83b4f9cbb30b9a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z7a09325c629141f58d1fe44ae93e12ae" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">revenue and earnings expectations&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zb6f2cd3d70854c948054cbc24ef37743" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">general economic conditions&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="za0285c5620c34c89a0f1af29e3648bbd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">availability and cost of qualified physical therapists&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zc3f18dbee08543c5a89f3275063178c6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">personnel productivity and retaining key personnel&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z7ef8066d49c84ea797d29d3249e90b72" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="zd4b51d6225644f0698bf9b64cde72884" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">acquisitions, purchase of non-controlling interests (minority interests) and the successful integration of the operations of the acquired businesses&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z3cb8aa4f54614a8f949541f098138957" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">maintaining adequate internal controls&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z1b39ee3e91594bd8a21086aa52a852e6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">maintaining necessary insurance coverage&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="za738b362df264ff9a9c7055bdccc75d3" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">our ability to design and maintain effective internal control over financial reporting and remediate the material weakness in internal control over financial reporting related to our accounting for redeemable non-controlling partnership interests&#894;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z271f70e940fc441ca43c354ff7dd2de3" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">availability, terms, and use of capital&#894; and</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left">
<table id="z04dd4c333cf0493b95e622beb5aff7dc" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">weather and other seasonal factors.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 36pt">Many factors are beyond our control. Given these uncertainties, you should not place undue reliance on our forward-looking statements. Please see the other sections of this report and our other periodic reports filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) for more information on these factors. Our forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as required by law, we are under no obligation to update any forward-looking statement, regardless of the reason the statement may no longer be accurate.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0.1pt">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">34</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="TEXT-ALIGN: left">
<table id="zab37ec670fab49c890027d47936a6bbd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 62.05pt; align: right"><a name="ITEM3."><!--Anchor--></a><font style="COLOR: #000000">ITEM 3.</font></td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">We do not maintain any derivative instruments, interest rate swap arrangements, hedging contracts, futures contracts or the like. Our primary market risk exposure is the changes in interest rates obtainable on our Amended Credit Agreement. The interest on our Amended Credit Agreement is based on a variable rate. At June 30, 2017, $69.0 million was outstanding under our Amended Credit Agreement. Based on the balance of the Amended Credit Agreement at June 30, 2017, any change in the interest rate of 1% would yield a decrease or increase in annual interest expense of $690,000.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: left">
<table id="z11c609e3dbe44560b0e150c291521fc8" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 62.05pt; align: right"><a name="ITEM4."><!--Anchor--></a><font style="COLOR: #000000">ITEM 4.</font></td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold">CONTROLS AND PROCEDURES.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z3c96abcd0671458090fd9b54c837313b" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 27pt; align: right">(a)</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Evaluation of Disclosure Controls and Procedures</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Our management, including our Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) promulgated under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as a result of the material weakness in our internal control over financial reporting discussed </font>in the Company&#8217;s Annual Report on Form 10-K, for the year ended December 31, 2016<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">, our disclosure controls and procedures were not effective in ensuring that the information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding disclosure.</font></div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z10fca2e9f3ef4b1d9858c642f3a4b7f4" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 27pt; align: right">(b)</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Previously Reported Material Weaknesses in Internal Control over Financial Reporting</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">As discussed in the Company&#8217;s Annual Report on Form 10-K, for the year ended December 31, 2016, Management conducted an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2016.&#160; Based on this assessment, management concluded that our internal control over financial reporting was not effective as of December 31, 2016 as a result of the material weakness discussed below.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-LEFT: 49.5pt; MARGIN-RIGHT: 36pt">Redeemable non-controlling interests &#8211; We did not properly account for redeemable non-controlling interests. The Company&#8217;s business combination / purchase accounting controls relating to our accounting for redeemable non-controlling interests were not designed effectively to ensure that we correctly interpreted and applied technical accounting requirements concerning the classification of such interests on our consolidated financial statements.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify; MARGIN-LEFT: 27pt">Changes in Internal Control Over Financial Reporting</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Other than the material weakness described above, there have been no changes in our internal control over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</div>

<div style="COLOR: #000000; TEXT-ALIGN: left"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Subsequent to the period covered by this report we implemented the following changes to our internal control over financial reporting process as it relates to redeemable non-controlling interests to begin to remediate the material weakness.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: left">
<table id="z973dcea9c01445838a4260d24c4be2d8" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">The Assistant Controller reviews the language and terms of any new standard limited partnership agreement created by the Company&#8217;s legal department.&#160; The sections which contain language having a potential accounting impact are identified and listed on the &#8220;Accounting Considerations for Limited Partnership Agreements&#8221; checklist.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: left">
<table id="z470b4c69f43841c0b4bfa98fe19cdeb7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">For each new limited partnership agreement executed by the company&#8217;s legal department, the Assistant Controller obtains a completed and signed &#8220;Accounting Considerations for Limited Partnership Agreements&#8221; checklist from the company&#8217;s General Counsel indicating if the language having a potential accounting impact denoted on the checklist referenced above has changed.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">35</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="TEXT-ALIGN: left">
<table id="z3d71e26266d74e38b7699305dd8f3f5d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="COLOR: #000000; WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">If a change is denoted on the &#8220;Accounting Considerations for Limited Partnership Agreements&#8221; checklist, the Corporate or Assistant Controller will review the agreement and research the changed language for accounting and disclosure implications.&#160; If the nature of the language is such that interpretation is subjective, and Management does not believe they have the technical experience in that transaction type, research will include seeking outside counsel from a third party accounting expert, such as a consulting or accounting firm.&#160; A memo is drafted with the appropriate facts and resolution and approved by the Corporate Controller and Chief Financial Officer.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 2.5pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 2.5pt">Management believes the new process and controls stated above are precise enough to identify and prevent the type of accounting error which occurred related to limited partnership agreements.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 2.5pt">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">36</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">PART II&#8212;OTHER INFORMATION</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: left">
<table id="z505f879c7f09451e959b5206c86ae786" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; COLOR: #000000; WIDTH: 62.05pt; align: right">ITEM 1.</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold"><a name="LEGALPROCEEDINGS."><!--Anchor--></a>LEGAL PROCEEDINGS.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">We are involved in litigation and other proceedings arising in the ordinary course of business. On March 31, 2017, an alleged shareholder filed a putative class action lawsuit in the United States District Court for the Southern District of New York (the &#8220;Court&#8221;) against the Company, chief executive officer Christopher J. Reading, chief financial officer Lawrance C. McAfee and corporate controller Jon C. Bates, alleging, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">inter alia</font>, that the defendants misstated or omitted to state material information concerning the Company&#8217;s historical accounting for redeemable non-controlling interests of acquired partnerships, in alleged violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The complaint seeks a declaration that the action is a proper class action under Rule 23 of the Federal Rules of Civil Procedure, unspecified compensatory damages in an amount to be determined at trial and interest, costs and expenses.&#160; On June 26, 2017, the Court appointed a lead plaintiff in the matter. On July 31, 2017, the lead plaintiff filed an amended complaint, alleging substantially the same violations and seeking substantially the same unspecified damages. The amended complaint also names Glenn McDowell, the Company&#8217;s Chief Operating Officer, as an additional defendant. The proceeding is in its initial stages and the defendants have not yet answered, moved against or otherwise responded to the complaint, though they intend to file a motion to dismiss and defend themselves vigorously.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">While the ultimate outcome of lawsuits or other proceedings cannot be predicted with certainty, we do not believe the impact of existing lawsuits or other proceedings will have a material impact on our business, financial condition or results of operations.</div>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: left">
<table id="zb02681eb76df42e29b0a73cf423e26f6" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; WIDTH: 62.05pt; align: right"><a name="ITEM6."><!--Anchor--></a><font style="COLOR: #000000">ITEM 6.</font></td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold">EXHIBITS.</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000"><br>
</div>

<table id="zd09d0ba5048b4135aed1d00e4062c0fc" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal; TEXT-ALIGN: left"><u>Exhibit</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal; TEXT-ALIGN: left"><u>Number</u></div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left"><u>Description</u></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">31.1*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">31.2*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">31.3*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Rule 13a-14(a)/15d-14(a) Certification of Corporate Controller.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">32*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Certification Pursuant to 18 U.S.C 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.INS*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Instance Document</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.SCH*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Taxonomy Extension Schema Document</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.CAL*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Taxonomy Extension Calculation Linkbase Document</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.DEF*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Taxonomy Extension Definition Linkbase Document</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.LAB*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Taxonomy Extension Label Linkbase Document</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.PRE*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Taxonomy Extension Presentation Linkbase Document</div>
</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z5aac01336d3a4023a07cd9b4fc66617d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 27pt; align: right">*</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Filed herewith</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">37</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center"><a name="SIGNATURES"><!--Anchor--></a><font style="COLOR: #000000">SIGNATURES</font></div>

<div style="COLOR: #000000"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on our behalf by the undersigned thereunto duly authorized.</div>

<div style="COLOR: #000000"><br>
</div>

<table id="zd16df4e9db034950bd12d90f9548a8ec" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 49.96%">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 50.04%" colspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left">U.S. PHYSICAL THERAPY, INC.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 49.96%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 3.09%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 46.96%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 49.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 12pt; TEXT-INDENT: -12pt">Date: August 7, 2017</div>
</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 3.09%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">By:</div>
</td>
<td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 46.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">/s/ LAWRANCE W. MCAFEE</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 49.96%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 3.09%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 46.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Lawrance W. McAfee</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 49.96%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 3.09%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 46.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Chief Financial Officer</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 49.96%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 3.09%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 46.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">(duly authorized officer and principal financial and accounting officer)</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 49.96%">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 3.09%">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 46.96%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 49.96%">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 3.09%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">By:</div>
</td>
<td style="VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 2px solid; COLOR: #000000; WIDTH: 46.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;/s/ JON C. BATES</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 49.96%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 3.09%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 46.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Jon C. Bates</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 49.96%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 3.09%">&#160;</td>
<td style="VERTICAL-ALIGN: bottom; COLOR: #000000; WIDTH: 46.96%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Vice President/Corporate Controller</div>
</td>
</tr>
</table>

<div style="COLOR: #000000; TEXT-ALIGN: left; MARGIN-LEFT: 0.2pt; MARGIN-RIGHT: 0.2pt">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">38</div>

<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always; COLOR: #000000">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>

<div id="DSPFPageHeader" style="COLOR: #000000; WIDTH: 100%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left"><a style="FONT-SIZE: 8pt; FONT-WEIGHT: normal; FONT-STYLE: italic" href="#FINANCIALINFORMATION">Table of contents</a></div>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">INDEX OF EXHIBITS</div>

<div style="COLOR: #000000"><br>
</div>

<table id="z127f89fd248841f09f81e1cf4fbf3349" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="VERTICAL-ALIGN: top; WIDTH: 8%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal; TEXT-ALIGN: left"><u>Exhibit</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; COLOR: #000000; FONT-STYLE: normal; TEXT-ALIGN: left"><u>Number</u></div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left"><u>Description</u></div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="ex31_1.htm">31.1*</a></div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="ex31_2.htm">31.2*</a></div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="ex31_3.htm">31.3*</a></div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Rule 13a-14(a)/15d-14(a) Certification of Corporate Controller.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left"><a href="ex32.htm">32*</a></div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Certification Pursuant to 18 U.S.C 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.INS*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Instance Document</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.SCH*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Taxonomy Extension Schema Document</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.CAL*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Taxonomy Extension Calculation Linkbase Document</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.DEF*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Taxonomy Extension Definition Linkbase Document</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.LAB*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Taxonomy Extension Label Linkbase Document</div>
</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #ffffff">&#160;</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #ffffff">&#160;</td>
</tr>

<tr>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 8%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">101.PRE*</div>
</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 92%; BACKGROUND-COLOR: #cceeff">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">XBRL Taxonomy Extension Presentation Linkbase Document</div>
</td>
</tr>
</table>

<div style="COLOR: #000000"><br>
</div>

<div style="TEXT-ALIGN: justify">
<table id="zbee195f3b07e4f968860b0508ff9a784" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; VERTICAL-ALIGN: top; COLOR: #000000; WIDTH: 27pt; align: right">*</td>
<td style="VERTICAL-ALIGN: top; COLOR: #000000; TEXT-ALIGN: justify; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Filed herewith</div>
</td>
</tr>
</table>
</div>

<div style="COLOR: #000000; TEXT-ALIGN: justify">&#160;</div>

<div style="COLOR: #000000; TEXT-ALIGN: justify">&#160;</div>

<div style="TEXT-ALIGN: justify">
<div id="DSPFPageNumberArea" style="COLOR: #000000; TEXT-ALIGN: center">39</div>

<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31_1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Summit Financial Disclosure, LLC
    Document created using EDGARfilings PROfile 4.3.2.1
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; HEIGHT: 4px; COLOR: #000000; BORDER-TOP: medium none; MARGIN-RIGHT: auto; BORDER-RIGHT: medium none" align="center" noshade="noshade">
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT 31.1</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;CERTIFICATION</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">I, Christopher Reading, certify that:</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z749818aec6f74a4fbcad695254db1e49" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">1.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">I have reviewed this quarterly report on Form 10-Q of U.S. Physical Therapy, Inc.;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zb311f60302064d409be2f2e7a556ef59" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">2.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z23bd023bef2e4bee8ec79b9ddbc951e4" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">3.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zb167dd6cd28a42719027b0b064df1a04" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">4.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zb01237383e964f8a9c6e85c72e31e2b2" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">a.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z4381e0830b844f7c9bf9716215e6d504" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">b.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z439a2de624384acb9728be39c077956b" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">c.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z65210be61cac410a8a2b00a3ed7cef4c" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">d.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zd84cb63b5497449f8c6c6a06745bb5f2" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">5.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zf9127ffb764d4dfc853e5e686e2599c3" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">a.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z2883c13a694f46a5b29a800f531f89a9" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">b.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div>
<table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z4f0b2251e4ed43dc8d045577a00382c1" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">/s/ CHRISTOPHER READING</div>
</td>
</tr>

<tr>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Christopher Reading</div>
</td>
</tr>

<tr>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">President and Chief Executive Officer</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">(principal executive officer)</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Date: August 7, 2017</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<hr style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; HEIGHT: 2px; COLOR: #000000; MARGIN-LEFT: auto; BORDER-TOP: medium none; MARGIN-RIGHT: auto; BORDER-RIGHT: medium none" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31_2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Summit Financial Disclosure, LLC
    Document created using EDGARfilings PROfile 4.3.2.1
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; HEIGHT: 4px; COLOR: #000000; BORDER-TOP: medium none; MARGIN-RIGHT: auto; BORDER-RIGHT: medium none" align="center" noshade="noshade">
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT 31.2</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">I, Lawrance W. McAfee, certify that:</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zc3823a8539df463f8b5a5b2264ce63cc" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">1.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">I have reviewed this quarterly report on Form 10-Q of U.S. Physical Therapy, Inc.;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zba9f250389084639b71d8d74d2854f6c" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">2.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="ze956830fa997435c909a0c989df4141a" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">3.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z25bd42c1fd6b431c93a414b23dbf164f" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">4.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z5228a0404c554112b9d1475c7649d7c4" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">a.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zfeda779810e44d27a1ff56d182481694" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">b.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z3e0c1dadea2848e68d671250a1c7f033" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">c.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z47f688758aa542afb8dae199e4824c7d" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">d.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z685a59a3108e434ab8ae305f7093f25e" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">5.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="ze3238d3a680b43bb9533961b1aca8b05" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">a.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z01c78e9dc31b4ef8b6b4d5defd470dcc" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">b.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify"><br>
</div>

<div>
<table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z6290849310774bb0a3774d1ac70f2b75" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">/s/ LAWRANCE W. MCAFEE</div>
</td>
</tr>

<tr>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Lawrance W. McAfee</div>
</td>
</tr>

<tr>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Chief Financial Officer</div>
</td>
</tr>

<tr>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">(principal financial and accounting officer)</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Date: August 7, 2017</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<hr style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; HEIGHT: 2px; COLOR: #000000; MARGIN-LEFT: auto; BORDER-TOP: medium none; MARGIN-RIGHT: auto; BORDER-RIGHT: medium none" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>4
<FILENAME>ex31_3.htm
<DESCRIPTION>EXHIBIT 31.3
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Summit Financial Disclosure, LLC
    Document created using EDGARfilings PROfile 4.3.2.1
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; HEIGHT: 4px; COLOR: #000000; MARGIN-LEFT: auto; BORDER-TOP: medium none; MARGIN-RIGHT: auto; BORDER-RIGHT: medium none" align="center" noshade="noshade">
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 0.1pt; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-RIGHT: 0.1pt">EXHIBIT 31.3</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">I, Jon C. Bates, certify that:</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z04a798c2bee14801b957f179a4c97f58" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">1.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">I have reviewed this quarterly report on Form 10-Q of U.S. Physical Therapy, Inc.;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="ze29ea19e33584479887ed83d25db393f" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">2.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zbcd21e3eaf5845568895c421000e3366" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">3.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z3225b82eaa11472f85cb34ddbc99cd0e" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">4.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z9680d15e33004606acb216e02f91ddb5" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">a.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z0edc4efa07884d2a8af5942debb73e78" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">b.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z5ae00e4bfd90498f8bdc5fdceadafe58" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">c.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zfa3bac6cae5a428aaaa385c6803661e3" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">d.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zcae47da79a91474dbd878cbb61b4ef3e" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">5.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="zf0f73507c3a24e5399af2329ba68496b" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">a.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z55f2a63f863f480698ec223faa028e14" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="WIDTH: 27pt; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">b.</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify"><br>
</div>

<div>
<table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="ze00a6c1dde434110ad67403f7e4de755" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">/s/ JON C. BATES</div>
</td>
</tr>

<tr>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Jon C. Bates</div>
</td>
</tr>

<tr>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Vice President/Corporate Controller</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Date: August 7, 2017</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<hr style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; HEIGHT: 2px; COLOR: #000000; MARGIN-LEFT: auto; BORDER-TOP: medium none; MARGIN-RIGHT: auto; BORDER-RIGHT: medium none" align="center" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>ex32.htm
<DESCRIPTION>EXHIBIT 32
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Summit Financial Disclosure, LLC
    Document created using EDGARfilings PROfile 4.3.2.1
    Copyright 1995 - 2017 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; HEIGHT: 4px; COLOR: #000000; BORDER-TOP: medium none; MARGIN-RIGHT: auto; BORDER-RIGHT: medium none" align="center" noshade="noshade">
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT 32</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION OF PERIODIC REPORT</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">In connection with the Quarterly Report of U.S. Physical Therapy, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended June 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Christopher J. Reading, President and Chief Executive Officer of the Company, Lawrance W. McAfee, Chief Financial Officer of the Company, and Jon C. Bates, Vice President and Corporate Controller of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">August 7, 2017</div>

<div><br>
</div>

<table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="z9d67538d661a4ba29c54e25118ec76d5" cellspacing="0" cellpadding="0">
<tr>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">/s/ CHRISTOPHER J. READING</div>
</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Christopher J. Reading</div>
</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Chief Executive Officer</div>
</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">/s/ LAWRANCE W. MCAFEE</div>
</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Lawrance W. McAfee</div>
</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Chief Financial Officer</div>
</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: #000000 2px solid; WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">/s/ JON C. BATES</div>
</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Jon C. Bates</div>
</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 40%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">Vice President/Corporate Controller</div>
</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
</table>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">This certification is made solely pursuant to the requirement of Section 1350 of 18 U.S.C., and is not for any other purpose. A signed original of this written statement required by Section 906 has been provided to U. S. Physical Therapy, Inc. and will be retained by U. S. Physical Therapy, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">&#160;</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt">
<hr style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; HEIGHT: 2px; COLOR: #000000; MARGIN-LEFT: auto; BORDER-TOP: medium none; MARGIN-RIGHT: auto; BORDER-RIGHT: medium none" align="center" noshade="noshade">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>usph-20170630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 4.3.0.0 Summit Financial Printing, LLC. All rights reserved.-->
<xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:country="http://xbrl.sec.gov/country/2016-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2016-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31" xmlns:usph="http://usph.com/20170630" xmlns="http://www.xbrl.org/2003/instance">
  <link:schemaRef xlink:type="simple" xlink:href="usph-20170630.xsd" />
  <xbrli:context id="c20170101to20170630">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170807">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-08-07</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170401to20170630">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-04-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160401to20160630">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-04-01</xbrli:startDate>
      <xbrli:endDate>2016-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20160630">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20151231">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160630">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_StatementEquityComponentsAxis_ParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_StatementEquityComponentsAxis_ParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_StatementEquityComponentsAxis_ParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_StatementEquityComponentsAxis_TreasuryStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_StatementEquityComponentsAxis_RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_BusinessAcquisitionAxis_MarchTwoThousandSeventeenAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:MarchTwoThousandSeventeenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_UnusualOrInfrequentItemAxis_Year2019Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:Year2019Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_UnusualOrInfrequentItemAxis_Year2017Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:Year2017Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_UnusualOrInfrequentItemAxis_Year2018Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:Year2018Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20130401">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-04-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20151102">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-11-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_RangeAxis_MaximumMember_UnusualOrInfrequentItemAxis_Year2017Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">usph:Year2017Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20160331_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201609Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">usph:AccountingStandardsUpdate201609Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20161231_BusinessAcquisitionAxis_NovemberTwoThousandSixteenAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:NovemberTwoThousandSixteenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_MayTwoThousandSeventeenAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:MayTwoThousandSeventeenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20161231_BusinessAcquisitionAxis_FebruaryTwoThousandSixteenAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:FebruaryTwoThousandSixteenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_JanuaryTwoThousandSeventeenAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:JanuaryTwoThousandSeventeenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_JuneTwoThousandSeventeenAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:JuneTwoThousandSeventeenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_BusinessAcquisitionAxis_JanuaryTwoThousandSeventeenAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:JanuaryTwoThousandSeventeenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_BusinessAcquisitionAxis_NovemberTwoThousandSixteenAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:NovemberTwoThousandSixteenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_BusinessAcquisitionAxis_JuneTwoThousandSeventeenAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:JuneTwoThousandSeventeenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_BusinessAcquisitionAxis_MayTwoThousandSeventeenAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:MayTwoThousandSeventeenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_BusinessAcquisitionAxis_FebruaryTwoThousandSixteenAcquisitionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:FebruaryTwoThousandSixteenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160229to20160229_BusinessAcquisitionAxis_AcquisitionOfEightClinicPracticesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfEightClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-02-29</xbrli:startDate>
      <xbrli:endDate>2016-02-29</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161130to20161130_BusinessAcquisitionAxis_AcquisitionOfTwelveClinicPracticesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfTwelveClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-11-30</xbrli:startDate>
      <xbrli:endDate>2016-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170101_BusinessAcquisitionAxis_AcquisitionOfSeventeenClinicPracticesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfSeventeenClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-01-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_AcquisitionOfNineClinicPracticesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfNineClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170531to20170531_BusinessAcquisitionAxis_AcquisitionOfFourClinicPracticesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfFourClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-05-31</xbrli:startDate>
      <xbrli:endDate>2017-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_BusinessAcquisitionAxis_AcquisitionOfSeventeenClinicPracticesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfSeventeenClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170531_BusinessAcquisitionAxis_AcquisitionOfFourClinicPracticesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfFourClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-05-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_BusinessAcquisitionAxis_AcquisitionOfNineClinicPracticesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfNineClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160229_BusinessAcquisitionAxis_AcquisitionOfEightClinicPracticesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfEightClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-02-29</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161130_BusinessAcquisitionAxis_AcquisitionOfTwelveClinicPracticesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfTwelveClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-11-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170323_BusinessAcquisitionAxis_WorkforcePerformanceSolutionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:WorkforcePerformanceSolutionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-03-23</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_AcquisitionOfSingleClinicPracticesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfSingleClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170323to20170323_BusinessAcquisitionAxis_WorkforcePerformanceSolutionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:WorkforcePerformanceSolutionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-03-23</xbrli:startDate>
      <xbrli:endDate>2017-03-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170101_BusinessAcquisitionAxis_AcquisitionOfSeventeenClinicPracticesMember_StatementScenarioAxis_JanuaryTwoThousandEighteenMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">usph:JanuaryTwoThousandEighteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfSeventeenClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-01-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160229to20160229_BusinessAcquisitionAxis_AcquisitionOfEightClinicPracticesMember_StatementScenarioAxis_FebruaryTwoThousandSeventeenMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">usph:FebruaryTwoThousandSeventeenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfEightClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-02-29</xbrli:startDate>
      <xbrli:endDate>2016-02-29</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_AcquisitionOfNineClinicPracticesMember_StatementScenarioAxis_JuneTwoThousandNineteenMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">usph:JuneTwoThousandNineteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfNineClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161130to20161130_BusinessAcquisitionAxis_AcquisitionOfTwelveClinicPracticesMember_StatementScenarioAxis_NovemberTwoThousandSeventeenMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfTwelveClinicPracticesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">usph:NovemberTwoThousandSeventeenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-11-30</xbrli:startDate>
      <xbrli:endDate>2016-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160229to20160229_BusinessAcquisitionAxis_AcquisitionOfEightClinicPracticesMember_StatementScenarioAxis_FebruaryTwoThousandEighteenMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">usph:FebruaryTwoThousandEighteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfEightClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-02-29</xbrli:startDate>
      <xbrli:endDate>2016-02-29</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161130to20161130_BusinessAcquisitionAxis_AcquisitionOfTwelveClinicPracticesMember_StatementScenarioAxis_NovemberTwoThousandEighteenMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfTwelveClinicPracticesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">usph:NovemberTwoThousandEighteenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-11-30</xbrli:startDate>
      <xbrli:endDate>2016-11-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170101_BusinessAcquisitionAxis_AcquisitionOfSeventeenClinicPracticesMember_StatementScenarioAxis_JanuaryTwoThousandNineteenMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">usph:JanuaryTwoThousandNineteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfSeventeenClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-01-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170531to20170531_BusinessAcquisitionAxis_AcquisitionOfFourClinicPracticesMember_StatementScenarioAxis_MayTwoThousandEighteenMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfFourClinicPracticesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">usph:MayTwoThousandEighteenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-05-31</xbrli:startDate>
      <xbrli:endDate>2017-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170531to20170531_BusinessAcquisitionAxis_AcquisitionOfFourClinicPracticesMember_StatementScenarioAxis_MayTwoThousandNineteenMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">usph:MayTwoThousandNineteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfFourClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-05-31</xbrli:startDate>
      <xbrli:endDate>2017-05-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_AcquisitionOfNineClinicPracticesMember_StatementScenarioAxis_JuneTwoThousandEighteenMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">usph:JuneTwoThousandEighteenMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:AcquisitionOfNineClinicPracticesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20161231">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">us-gaap:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">us-gaap:SubsidiariesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">us-gaap:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TherapyPracticeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">us-gaap:SubsidiariesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170401to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-04-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170401to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-04-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160401to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-04-01</xbrli:startDate>
      <xbrli:endDate>2016-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160401to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-04-01</xbrli:startDate>
      <xbrli:endDate>2016-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160401to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">usph:ReferralRelationshipMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-04-01</xbrli:startDate>
      <xbrli:endDate>2016-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170401to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-04-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_DebtInstrumentAxis_PromissoryNotesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_DebtInstrumentAxis_PromissoryNotesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_CreditFacilityAxis_RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_CreditFacilityAxis_RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_CreditFacilityAxis_RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">usph:PromissoryNotesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-05</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_RangeAxis_MaximumMember_VariableRateAxis_BaseRateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_RangeAxis_MaximumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_RangeAxis_MinimumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_RangeAxis_MinimumMember_VariableRateAxis_BaseRateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20160131_CreditFacilityAxis_CreditAgreementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_CreditFacilityAxis_CreditAgreementMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20160131_CreditFacilityAxis_CreditAgreementMember_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">usph:CreditAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-01-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20151231_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TwoThousandFifteenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170630_BusinessAcquisitionAxis_TwoThousandSeventeenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TwoThousandSeventeenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20161231_BusinessAcquisitionAxis_TwoThousandSixteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TwoThousandSixteenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_TwoThousandSeventeenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TwoThousandSeventeenAcquisitionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20161231_BusinessAcquisitionAxis_TwoThousandSixteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TwoThousandSixteenAcquisitionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20150101to20151231_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TwoThousandFifteenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20150101to20151231_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TwoThousandFifteenAcquisitionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20160101to20161231_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TwoThousandFifteenAcquisitionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>
      <xbrli:endDate>2016-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170630_BusinessAcquisitionAxis_TwoThousandSixteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TwoThousandSixteenAcquisitionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20170101to20170331_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">usph:NotesPayableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">usph:TwoThousandFifteenAcquisitionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20081231">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20090331">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20090331_RangeAxis_MaximumMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="c20090301to20090331">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885978</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-03-01</xbrli:startDate>
      <xbrli:endDate>2009-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="U001">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U002">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U003">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="U004">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U005">
    <xbrli:measure>usph:Clinic</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U006">
    <xbrli:measure>usph:State</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U007">
    <xbrli:measure>usph:Facility</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U008">
    <xbrli:measure>usph:Region</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U009">
    <xbrli:measure>usph:Installment</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="U010">
    <xbrli:measure>usph:Subsidiary</xbrli:measure>
  </xbrli:unit>
  <!--Amendment Flag-->
  <dei:AmendmentFlag contextRef="c20170101to20170630">false</dei:AmendmentFlag>
  <!--Current Fiscal Year End Date-->
  <dei:CurrentFiscalYearEndDate contextRef="c20170101to20170630">--12-31</dei:CurrentFiscalYearEndDate>
  <!--Document Period End Date-->
  <dei:DocumentPeriodEndDate contextRef="c20170101to20170630">2017-06-30</dei:DocumentPeriodEndDate>
  <!--Entity Well-known Seasoned Issuer-->
  <dei:EntityWellKnownSeasonedIssuer contextRef="c20170101to20170630">No</dei:EntityWellKnownSeasonedIssuer>
  <!--Entity Voluntary Filers-->
  <dei:EntityVoluntaryFilers contextRef="c20170101to20170630">No</dei:EntityVoluntaryFilers>
  <!--Entity Current Reporting Status-->
  <dei:EntityCurrentReportingStatus contextRef="c20170101to20170630">Yes</dei:EntityCurrentReportingStatus>
  <!--Entity Filer Category-->
  <dei:EntityFilerCategory contextRef="c20170101to20170630">Accelerated Filer</dei:EntityFilerCategory>
  <!--Entity Registrant Name-->
  <dei:EntityRegistrantName contextRef="c20170101to20170630">U S PHYSICAL THERAPY INC /NV</dei:EntityRegistrantName>
  <!--Entity Central Index Key-->
  <dei:EntityCentralIndexKey contextRef="c20170101to20170630">0000885978</dei:EntityCentralIndexKey>
  <!--Entity Common Stock, Shares Outstanding-->
  <dei:EntityCommonStockSharesOutstanding contextRef="c20170807" unitRef="U001" decimals="INF">12581237</dei:EntityCommonStockSharesOutstanding>
  <!--Document Fiscal Year Focus-->
  <dei:DocumentFiscalYearFocus contextRef="c20170101to20170630">2017</dei:DocumentFiscalYearFocus>
  <!--Document Fiscal Period Focus-->
  <dei:DocumentFiscalPeriodFocus contextRef="c20170101to20170630">Q2</dei:DocumentFiscalPeriodFocus>
  <!--Document Type-->
  <dei:DocumentType contextRef="c20170101to20170630">10-Q</dei:DocumentType>
  <!--Accounts Payable, Trade, Current-->
  <us-gaap:AccountsPayableTradeCurrent contextRef="c20161231" unitRef="U002" decimals="-3">1634000</us-gaap:AccountsPayableTradeCurrent>
  <!--Accounts Payable, Trade, Current-->
  <us-gaap:AccountsPayableTradeCurrent contextRef="c20170630" unitRef="U002" decimals="-3">1613000</us-gaap:AccountsPayableTradeCurrent>
  <!--Accounts and Other Receivables, Net, Current-->
  <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c20161231" unitRef="U002" decimals="-3">2649000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
  <!--Accounts and Other Receivables, Net, Current-->
  <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c20170630" unitRef="U002" decimals="-3">5662000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
  <!--Accounts Payable and Accrued Liabilities Disclosure [Text Block]-->
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;7. ACCRUED EXPENSES&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Accrued expenses as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;December 31, 2016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Salaries and related costs&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;15,692&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;10,569&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Credit balances due to patients and payors&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;4,368&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;3,880&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Group health insurance claims&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2,772&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2,499&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Dividends payable to USPH shareholders&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2,516&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Other&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;5,887&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;4,808&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;31,235&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;21,756&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <!--Accounts Receivable, Net, Current-->
  <us-gaap:AccountsReceivableNetCurrent contextRef="c20170630" unitRef="U002" decimals="-3">46770000</us-gaap:AccountsReceivableNetCurrent>
  <!--Accounts Receivable, Net, Current-->
  <us-gaap:AccountsReceivableNetCurrent contextRef="c20161231" unitRef="U002" decimals="-3">38840000</us-gaap:AccountsReceivableNetCurrent>
  <!--Accrued Liabilities, Current-->
  <us-gaap:AccruedLiabilitiesCurrent contextRef="c20161231" unitRef="U002" decimals="-3">21756000</us-gaap:AccruedLiabilitiesCurrent>
  <!--Accrued Liabilities, Current-->
  <us-gaap:AccruedLiabilitiesCurrent contextRef="c20170630" unitRef="U002" decimals="-3">31235000</us-gaap:AccruedLiabilitiesCurrent>
  <!--Accrued Insurance, Current-->
  <us-gaap:AccruedInsuranceCurrent contextRef="c20161231" unitRef="U002" decimals="-3">2499000</us-gaap:AccruedInsuranceCurrent>
  <!--Accrued Insurance, Current-->
  <us-gaap:AccruedInsuranceCurrent contextRef="c20170630" unitRef="U002" decimals="-3">2772000</us-gaap:AccruedInsuranceCurrent>
  <!--Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment-->
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c20161231" unitRef="U002" decimals="-3">56018000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <!--Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment-->
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c20170630" unitRef="U002" decimals="-3">58200000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <!--Additional Paid in Capital-->
  <us-gaap:AdditionalPaidInCapital contextRef="c20170630" unitRef="U002" decimals="-3">71197000</us-gaap:AdditionalPaidInCapital>
  <!--Additional Paid in Capital-->
  <us-gaap:AdditionalPaidInCapital contextRef="c20161231" unitRef="U002" decimals="-3">68687000</us-gaap:AdditionalPaidInCapital>
  <!--Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Treasury Stock [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20170101to20170630_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Common Stock [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20170101to20170630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Parent [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20170101to20170630_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3">2345000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20170101to20170630" unitRef="U002" decimals="-3">2345000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Retained Earnings [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20170101to20170630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Noncontrolling Interest [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20170101to20170630_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition-Additional Paid-in Capital [Member]-->
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c20170101to20170630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">2345000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <!--Allowance for Doubtful Accounts Receivable, Current-->
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c20170630" unitRef="U002" decimals="-3">1859000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <!--Allowance for Doubtful Accounts Receivable, Current-->
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c20161231" unitRef="U002" decimals="-3">1792000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <!--Amortization of Intangible Assets-Referral Relationship [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20160101to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">675000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-Referral Relationship [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20170401to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">481000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20170101to20170630" unitRef="U002" decimals="-3">1340000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20160101to20160630" unitRef="U002" decimals="-3">998000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-Trademarks [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U002" decimals="-3">0</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20170401to20170630" unitRef="U002" decimals="-3">687000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-Trademarks [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20170401to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U002" decimals="-3">0</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-Trademarks [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20160101to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U002" decimals="-3">42000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-Non-compete Agreements [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">401000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-Non-compete Agreements [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20160101to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">281000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-Non-compete Agreements [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20160401to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">147000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-Trademarks [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20160401to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U002" decimals="-3">21000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20160401to20160630" unitRef="U002" decimals="-3">520000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-Referral Relationship [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">939000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-Referral Relationship [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20160401to20160630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">352000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of Intangible Assets-Non-compete Agreements [Member]-->
  <us-gaap:AmortizationOfIntangibleAssets contextRef="c20170401to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">206000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Assets-->
  <us-gaap:Assets contextRef="c20170630" unitRef="U002" decimals="-3">417325000</us-gaap:Assets>
  <!--Assets-->
  <us-gaap:Assets contextRef="c20161231" unitRef="U002" decimals="-3">351231000</us-gaap:Assets>
  <!--Assets, Current-->
  <us-gaap:AssetsCurrent contextRef="c20161231" unitRef="U002" decimals="-3">65964000</us-gaap:AssetsCurrent>
  <!--Assets, Current-->
  <us-gaap:AssetsCurrent contextRef="c20170630" unitRef="U002" decimals="-3">79606000</us-gaap:AssetsCurrent>
  <!--Business Acquisition, Date of Acquisition Agreement-November Two Thousand Sixteen Acquisition [Member]-->
  <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1 contextRef="c20160101to20161231_BusinessAcquisitionAxis_NovemberTwoThousandSixteenAcquisitionMember">2016-11-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
  <!--Business Acquisition, Date of Acquisition Agreement-May Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1 contextRef="c20170101to20170630_BusinessAcquisitionAxis_MayTwoThousandSeventeenAcquisitionMember">2017-05-31</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
  <!--Business Acquisition, Date of Acquisition Agreement-February Two Thousand Sixteen Acquisition [Member]-->
  <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1 contextRef="c20160101to20161231_BusinessAcquisitionAxis_FebruaryTwoThousandSixteenAcquisitionMember">2016-02-29</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
  <!--Business Acquisition, Date of Acquisition Agreement-January Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1 contextRef="c20170101to20170630_BusinessAcquisitionAxis_JanuaryTwoThousandSeventeenAcquisitionMember">2017-01-01</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
  <!--Business Acquisition, Date of Acquisition Agreement-June Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1 contextRef="c20170101to20170630_BusinessAcquisitionAxis_JuneTwoThousandSeventeenAcquisitionMember">2017-06-30</us-gaap:BusinessAcquisitionDateOfAcquisitionAgreement1>
  <!--Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets-->
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets contextRef="c20161231" unitRef="U002" decimals="-3">839000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
  <!--Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets-->
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets contextRef="c20170630" unitRef="U002" decimals="-3">1790000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets>
  <!--Business Combination, Consideration Transferred-->
  <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c20160101to20161231" unitRef="U002" decimals="0">75000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <!--Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables-->
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="c20161231" unitRef="U002" decimals="-3">1763000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
  <!--Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables-->
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="c20170630" unitRef="U002" decimals="-3">5868000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-March Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20170630_BusinessAcquisitionAxis_MarchTwoThousandSeventeenAcquisitionMember" unitRef="U004" decimals="INF">0.55</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-January Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20170630_BusinessAcquisitionAxis_JanuaryTwoThousandSeventeenAcquisitionMember" unitRef="U004" decimals="INF">0.7</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-November Two Thousand Sixteen Acquisition [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20161231_BusinessAcquisitionAxis_NovemberTwoThousandSixteenAcquisitionMember" unitRef="U004" decimals="INF">0.6</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-June Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20170630_BusinessAcquisitionAxis_JuneTwoThousandSeventeenAcquisitionMember" unitRef="U004" decimals="INF">0.6</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-May Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20170630_BusinessAcquisitionAxis_MayTwoThousandSeventeenAcquisitionMember" unitRef="U004" decimals="INF">0.7</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-February Two Thousand Sixteen Acquisition [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20161231_BusinessAcquisitionAxis_FebruaryTwoThousandSixteenAcquisitionMember" unitRef="U004" decimals="INF">0.55</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-Acquisition of Seventeen Clinic Practices [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20161231_BusinessAcquisitionAxis_AcquisitionOfSeventeenClinicPracticesMember" unitRef="U004" decimals="INF">0.7</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-Acquisition Of Four Clinic Practices [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20170531_BusinessAcquisitionAxis_AcquisitionOfFourClinicPracticesMember" unitRef="U004" decimals="INF">0.7</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-Acquisition Of Nine Clinic Practices [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20170630_BusinessAcquisitionAxis_AcquisitionOfNineClinicPracticesMember" unitRef="U004" decimals="INF">0.6</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-Acquisition Of Eight Clinic Practices [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20160229_BusinessAcquisitionAxis_AcquisitionOfEightClinicPracticesMember" unitRef="U004" decimals="INF">0.55</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-Acquisition Of Twelve Clinic Practices [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20161130_BusinessAcquisitionAxis_AcquisitionOfTwelveClinicPracticesMember" unitRef="U004" decimals="INF">0.6</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Percentage of Voting Interests Acquired-Workforce Performance Solutions [Member]-->
  <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c20170323_BusinessAcquisitionAxis_WorkforcePerformanceSolutionsMember" unitRef="U004" decimals="INF">0.55</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
  <!--Business Acquisition, Goodwill, Expected Tax Deductible Amount-->
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="c20161231" unitRef="U002" decimals="-3">32371000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
  <!--Business Acquisition, Goodwill, Expected Tax Deductible Amount-->
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="c20170630" unitRef="U002" decimals="-3">40197000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
  <!--Total liabilities-->
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="c20161231" unitRef="U002" decimals="-3">-1039000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <!--Total liabilities-->
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="c20170630" unitRef="U002" decimals="-3">-1919000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <!--ACQUISITIONS OF BUSINESSES-->
  <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;2. ACQUISITIONS OF BUSINESSES&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;On January 1, 2017, the Company acquired a 70% interest in a seventeen-clinic physical therapy practice.&amp;#160; The purchase price for the 70% interest was $10.7 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, in January 2018 and 2019.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&lt;font style="font-size: 10pt; font-family: 'Times New Roman';"&gt;On March 23, 2017, (effective March 1, 2017 for accounting purposes) the Company acquired a 55% interest in a company &lt;/font&gt;which is a leading provider of workforce performance solutions. Services provided include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers including a number of Fortune 500 companies. Other clients include large insurers and their contractors.&lt;font style="font-size: 10pt; font-family: 'Times New Roman';"&gt; The purchase price for the 55% interest was $6.2 million in cash and $0.4 million in a seller note that is payable, principal plus accrued interest, in September 2018.&lt;/font&gt;&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;On May 31, 2017 the Company acquired 70% interest in a four-clinic physical therapy practice. The purchase price for the 70% interest was $2.3 million in cash and $250,000 in a seller note that is payable in two principal installments totaling $125,000 each, plus accrued interest, in May 2018 and 2019.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;On June 30, 2017, the Company acquired a 60% interest in a nine-clinic physical therapy practice.&amp;#160; The purchase price for the 60% interest was $15.8 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, in June 2018 and 2019.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;"&gt;Also, in 2017, we purchased the assets and business of a physical therapy clinic for $100,000 and consolidated its business with an existing clinic.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The purchase price for the 2017 acquisitions has been preliminarily allocated as follows (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Cash paid, net of cash acquired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;33,665&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Seller notes&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,650&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total consideration&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;35,315&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total current assets&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;5,868&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total non-current assets&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,790&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(1,919&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 27pt; text-indent: -9pt;"&gt;Net tangible assets acquired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;5,739&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;4,693&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Non-compete&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,790&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Tradename&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;5,118&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Goodwill&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;40,197&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(11,940&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(10,282&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #cceeff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;35,315&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;On November 30, 2016, the Company acquired a 60% interest in a 12 clinic physical therapy practice. The purchase price for the 60% interest was $11.0 million in cash and $0.5 million in a seller note that is payable in two principal installments of $250,000 each, plus accrued interest, in November 2017 and 2018. On February 29, 2016, the Company acquired a 55% interest in an eight-clinic physical therapy practice. The purchase price for the 55% interest was $13.2 million in cash and $0.5 million in a seller note that is payable in two principal installments of $250,000 each, plus accrued interest, one of which was paid in February 2017 and one of which is due in February 2018. During 2016, two subsidiaries of the Company each acquired a single clinic therapy practice for an aggregate purchase price of $75,000.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The purchase prices for the 2016 acquisitions have been preliminarily allocated as follows (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Cash paid, net of cash acquired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;23,623&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Seller notes&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,000&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total consideration&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;24,623&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total current assets&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,763&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total non-current assets&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;839&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(1,039&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 27pt; text-indent: -9pt;"&gt;Net tangible assets acquired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,563&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;4,919&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Non-compete&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;847&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Tradename&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;3,802&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Goodwill&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;32,371&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(18,879&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #ffffff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;24,623&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;For the acquisition that occurred in the first quarter of 2016, the purchase price plus the fair value of the non-controlling interests was allocated to the fair value of certain assets acquired (patient accounts receivable, equipment, prepaid expenses and deposits, tradename, non-compete agreements and referral relationships) and liabilities assumed (accounts payable and accrued employee salary and benefits) based on the fair values at the acquisition date, with the amount exceeding the fair values being recorded as goodwill. For the acquisition that occurred after June 30, 2016, the purchase price plus the fair value of the non-controlling interests was allocated to the fair value of certain assets acquired (patient accounts receivable, equipment, prepaid expenses and deposits, tradename, non-compete agreements and referral relationships) and liabilities assumed (accounts payable and accrued employee salary and benefits) based on the preliminary estimates of the fair values at the acquisition date, with the amount exceeding the estimated fair values being recorded as goodwill. The Company is in the process of completing its formal valuation analysis. Thus, the final allocation of the purchase price will differ from the preliminary estimates used based on additional information obtained. Changes in the estimated valuation of the tangible and intangible assets acquired and the completion by the Company of the identification of any unrecorded pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in adjustments to goodwill.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;For the above acquisitions, total current assets primarily represent patient accounts receivable.&amp;#160; Total non-current assets are fixed assets, primarily equipment, used in the practices.&amp;#160; The estimated values assigned to the referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives.&amp;#160; For referral relationships, the range of the estimated lives was 12 to 13 years, and for non-compete agreements the estimated lives was six years. The values assigned to tradenames and goodwill is tested annually for impairment.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The consideration for each transaction was agreed upon through arm&amp;#8217;s length negotiations. Funding for the cash portion of the purchase price for the 2017 and 2016 acquisitions was derived from proceeds under the Amended Credit Agreement.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-left: 0.2pt; margin-right: 0.2pt;"&gt;The results of operations of these acquisitions have been included in the Company&amp;#8217;s consolidated financial statements since acquired.&amp;#160; Unaudited proforma consolidated financial information for acquisitions occurring in 2017 and 2016 have not been included as the results were not material to current operations.&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
  <!--Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value-->
  <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue contextRef="c20161231" unitRef="U002" decimals="-3">18879000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
  <!--Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value-->
  <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue contextRef="c20170630" unitRef="U002" decimals="-3">10282000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
  <!--Cash and Cash Equivalents, at Carrying Value-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c20161231" unitRef="U002" decimals="-3">20047000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and Cash Equivalents, at Carrying Value-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c20170630" unitRef="U002" decimals="-3">20242000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and Cash Equivalents, at Carrying Value-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c20151231" unitRef="U002" decimals="-3">15778000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and Cash Equivalents, at Carrying Value-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c20160630" unitRef="U002" decimals="-3">20453000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash Equivalents-->
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Cash Equivalents&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company maintains its cash and cash equivalents at financial institutions.&amp;#160; The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&amp;#8220;FDIC&amp;#8221;) insurance coverage and, as a result, there is a concentration of credit risk related on deposits in excess of FDIC insurance coverage. Management believes that the risk is not significant.&lt;/div&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <!--Cash and Cash Equivalents, Period Increase (Decrease)-->
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="c20170101to20170630" unitRef="U002" decimals="-3">195000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <!--Cash and Cash Equivalents, Period Increase (Decrease)-->
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="c20160101to20160630" unitRef="U002" decimals="-3">4675000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <!--Commitments and Contingencies-->
  <us-gaap:CommitmentsAndContingencies contextRef="c20161231" unitRef="U002" xsi:nil="true" />
  <!--Commitments and Contingencies-->
  <us-gaap:CommitmentsAndContingencies contextRef="c20170630" unitRef="U002" xsi:nil="true" />
  <!--Common Stock, Dividends, Per Share, Declared-->
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="c20160101to20160630" unitRef="U003" decimals="INF">0.34</us-gaap:CommonStockDividendsPerShareDeclared>
  <!--Common Stock, Dividends, Per Share, Declared-->
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="c20160401to20160630" unitRef="U003" decimals="INF">0.17</us-gaap:CommonStockDividendsPerShareDeclared>
  <!--Common Stock, Dividends, Per Share, Declared-->
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="c20170101to20170630" unitRef="U003" decimals="INF">0.40</us-gaap:CommonStockDividendsPerShareDeclared>
  <!--Common Stock, Dividends, Per Share, Declared-->
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="c20170401to20170630" unitRef="U003" decimals="INF">0.20</us-gaap:CommonStockDividendsPerShareDeclared>
  <!--Common Stock, Shares, Issued-->
  <us-gaap:CommonStockSharesIssued contextRef="c20170630" unitRef="U001" decimals="INF">14792744</us-gaap:CommonStockSharesIssued>
  <!--Common Stock, Shares, Issued-->
  <us-gaap:CommonStockSharesIssued contextRef="c20161231" unitRef="U001" decimals="INF">14732699</us-gaap:CommonStockSharesIssued>
  <!--Common Stock, Shares Authorized-->
  <us-gaap:CommonStockSharesAuthorized contextRef="c20161231" unitRef="U001" decimals="INF">20000000</us-gaap:CommonStockSharesAuthorized>
  <!--Common Stock, Shares Authorized-->
  <us-gaap:CommonStockSharesAuthorized contextRef="c20170630" unitRef="U001" decimals="INF">20000000</us-gaap:CommonStockSharesAuthorized>
  <!--Common Stock, Value, Issued-->
  <us-gaap:CommonStockValue contextRef="c20161231" unitRef="U002" decimals="-3">147000</us-gaap:CommonStockValue>
  <!--Common Stock, Value, Issued-->
  <us-gaap:CommonStockValue contextRef="c20170630" unitRef="U002" decimals="-3">147000</us-gaap:CommonStockValue>
  <!--Common Stock, Par or Stated Value Per Share-->
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c20170630" unitRef="U003" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Common Stock, Par or Stated Value Per Share-->
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="c20161231" unitRef="U003" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Contractual Adjustments and Third Party Settlements, Policy [Policy Text Block]-->
  <us-gaap:ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Contractual Allowances&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&amp;#8217;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&amp;#8217;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&amp;#8217;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, the historical difference between net revenues and corresponding cash collections has generally reflected a difference within approximately 1% of net revenues. Additionally, analysis of subsequent period&amp;#8217;s contractual write-offs on a payor basis reflects a difference within approximately 1% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% at June 30, 2017.&lt;/div&gt;&lt;/div&gt;</us-gaap:ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock>
  <!--Costs and Expenses-->
  <us-gaap:CostsAndExpenses contextRef="c20170101to20170630" unitRef="U002" decimals="-3">156535000</us-gaap:CostsAndExpenses>
  <!--Costs and Expenses-->
  <us-gaap:CostsAndExpenses contextRef="c20170401to20170630" unitRef="U002" decimals="-3">79717000</us-gaap:CostsAndExpenses>
  <!--Costs and Expenses-->
  <us-gaap:CostsAndExpenses contextRef="c20160401to20160630" unitRef="U002" decimals="-3">67371000</us-gaap:CostsAndExpenses>
  <!--Costs and Expenses-->
  <us-gaap:CostsAndExpenses contextRef="c20160101to20160630" unitRef="U002" decimals="-3">133784000</us-gaap:CostsAndExpenses>
  <!--Debt Disclosure [Text Block]-->
  <us-gaap:DebtDisclosureTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;8. NOTES PAYABLE AND AMENDED CREDIT AGREEMENT&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Amounts outstanding under the Amended Credit Agreement and notes payable as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;Summary of Credit Agreement and Notes Payable&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;December 31, 2016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Credit Agreement average effective interest rate of 2.7% inclusive of unused fee&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;69,000&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;46,000&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Various notes payable with $2,345 plus accrued interest due in the next year,&amp;#160;interest accrues in the range of 3.25% through 4.0% per annum&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;6,696&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;5,823&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 76%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;75,696&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;51,823&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;Less current portion&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(2,345&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(1,227&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;Long term portion&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;73,351&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;50,596&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="color: #000000;"&gt;&amp;#160;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Effective December 5, 2013,&amp;#160;the Company&amp;#160;entered into an Amended Credit Agreement, as defined below, with a commitment for a $125.0 million revolving credit facility with a maturity date of November 30, 2018. This agreement was amended in August 2015, January 2016 and March 2017 (hereafter referred to as &amp;#8220;Amended Credit Agreement&amp;#8221;). The Amended Credit Agreement is unsecured and has loan covenants, including requirements that the Company comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of the Company&amp;#8217;s common stock, dividend payments to the Company&amp;#8217;s common shareholders, capital expenditures and other corporate purposes. The pricing grid is based on the Company&amp;#8217;s consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.5% to 2.5% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an unused commitment fee ranging from 0.1% to 0.25% depending on the Company&amp;#8217;s consolidated leverage ratio and the amount of funds outstanding under the Amended Credit Agreement.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-left: 0.1pt; margin-right: 0.1pt;"&gt;The January 2016 amendment to the Amended Credit Agreement increased the cash and noncash consideration that the Company could pay with respect to acquisitions permitted under the Amended Credit Agreement to $50,000,000 for any fiscal year, and increased the amount the Company may pay in cash dividends to its shareholders in an aggregate amount not to exceed $10,000,000 in any fiscal year. Further, the March 2017 amendment, among other items, increased the amount the Company may pay in cash dividends to its shareholders in an aggregate amount not to exceed $15,000,000 in any fiscal year.&lt;/div&gt;&lt;div style="color: #000000; text-align: left; margin-left: 0.1pt; margin-right: 0.1pt;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;On June 30, 2017, $69.0 million was outstanding on the Amended Credit Agreement resulting in $56.0 million of availability. As of June 30, 2017 and the date of this report, the Company was in compliance with all of the covenants thereunder.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company generally enters into various notes payable as a means of financing a portion of its acquisitions and purchases of non-controlling interests. In conjunction with the acquisitions in the first six months of 2017, the Company entered into notes payable in the aggregate amount of $1.7 million, of which an aggregate principal payment of $625,000 is due in 2018 and an aggregate principal payment of $1,025,000 is due in 2019. Interest accrues at the rate of 4.0% per annum and is payable with each principal installment.&amp;#160; In conjunction with the acquisitions in 2016 and the purchases of non-controlling interests, the Company entered into notes payable in the aggregate amount of $1.5 million of which an aggregate principal payment of $444,000 was paid in 2017, $250,000 is due in November 2017 and $819,000 is payable in 2018. Interest accrues 3.5% per annum and is payable with each principal installment.&amp;#160; In conjunction with the acquisitions in 2015 and the purchases of non-controlling interests, the Company entered into notes payable in the aggregate amount of $4.9 million, of which an aggregate principal payment of $575,000 was paid in 2016, $525,000 due in 2017 (of which $250,000 was paid in the first quarter of 2017), $1.9 million is due in 2018 and $1.9 million in 2019. Interest accrues in the range of 3.25% to 4.0% per annum and is payable with each principal installment.&lt;/div&gt;&lt;div style="color: #000000; text-align: left;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Aggregate annual payments of principal required pursuant to the Amended Credit Agreement and the above notes payable subsequent to June 30, 2017 are as follows (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 58%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;During the twelve months ended June 30, 2018&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2,345&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 58%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;During the twelve months ended June 30, 2019&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;73,351&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 58%; background-color: #cceeff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;75,696&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The revolving credit facility (balance at June 30, 2017 of $69.0 million) matures on November 30, 2018.&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <!--Debt Instrument, Annual Principal Payment-Promissory Notes [Member]-->
  <us-gaap:DebtInstrumentAnnualPrincipalPayment contextRef="c20170630_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U002" decimals="-3">2345000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
  <!--Debt Instrument, Basis Spread on Variable Rate-Base Rate [Member]-Maximum [Member]-->
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c20170101to20170630_RangeAxis_MaximumMember_VariableRateAxis_BaseRateMember" unitRef="U004" decimals="INF">0.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <!--Debt Instrument, Basis Spread on Variable Rate-Maximum [Member]-LIBOR [Member]-->
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c20170101to20170630_RangeAxis_MaximumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember" unitRef="U004" decimals="INF">0.025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <!--Debt Instrument, Basis Spread on Variable Rate-LIBOR [Member]-Minimum [Member]-->
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c20170101to20170630_RangeAxis_MinimumMember_VariableRateAxis_LondonInterbankOfferedRateLIBORMember" unitRef="U004" decimals="INF">0.015</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <!--Debt Instrument, Basis Spread on Variable Rate-Minimum [Member]-Base Rate [Member]-->
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c20170101to20170630_RangeAxis_MinimumMember_VariableRateAxis_BaseRateMember" unitRef="U004" decimals="INF">0.001</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <!--Debt Instrument, Face Amount-Notes Payable [Member]-Two Thousand Fifteen Acquisition [Member]-->
  <us-gaap:DebtInstrumentFaceAmount contextRef="c20151231_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="-5">4900000</us-gaap:DebtInstrumentFaceAmount>
  <!--Debt Instrument, Face Amount-Notes Payable [Member]-Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:DebtInstrumentFaceAmount contextRef="c20170630_BusinessAcquisitionAxis_TwoThousandSeventeenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="-5">1700000</us-gaap:DebtInstrumentFaceAmount>
  <!--Debt Instrument, Face Amount-Notes Payable [Member]-Two Thousand Sixteen Acquisition [Member]-->
  <us-gaap:DebtInstrumentFaceAmount contextRef="c20161231_BusinessAcquisitionAxis_TwoThousandSixteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="-5">1500000</us-gaap:DebtInstrumentFaceAmount>
  <!--Debt Instrument, Interest Rate, Stated Percentage-Promissory Notes [Member]-Minimum [Member]-->
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c20170630_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MinimumMember" unitRef="U004" decimals="INF">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <!--Debt Instrument, Interest Rate, Stated Percentage-Promissory Notes [Member]-Maximum [Member]-->
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c20170630_DebtInstrumentAxis_PromissoryNotesMember_RangeAxis_MaximumMember" unitRef="U004" decimals="INF">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <!--Debt Instrument, Maturity Date-Revolving Credit Facility [Member]-->
  <us-gaap:DebtInstrumentMaturityDate contextRef="c20170101to20170630_CreditFacilityAxis_RevolvingCreditFacilityMember">2018-11-30</us-gaap:DebtInstrumentMaturityDate>
  <!--Deferred Tax Expense from Stock Options Exercised-->
  <us-gaap:DeferredTaxExpenseFromStockOptionsExercised contextRef="c20170101to20170630" unitRef="U002" decimals="-3">0</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
  <!--Deferred Tax Expense from Stock Options Exercised-->
  <us-gaap:DeferredTaxExpenseFromStockOptionsExercised contextRef="c20160101to20160630" unitRef="U002" decimals="-3">556000</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
  <!--Deferred Rent Credit, Noncurrent-->
  <us-gaap:DeferredRentCreditNoncurrent contextRef="c20161231" unitRef="U002" decimals="-3">1575000</us-gaap:DeferredRentCreditNoncurrent>
  <!--Deferred Rent Credit, Noncurrent-->
  <us-gaap:DeferredRentCreditNoncurrent contextRef="c20170630" unitRef="U002" decimals="-3">1789000</us-gaap:DeferredRentCreditNoncurrent>
  <!--Deferred Income Tax Expense (Benefit)-->
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c20170101to20170630" unitRef="U002" decimals="-3">-985000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <!--Deferred Income Tax Expense (Benefit)-->
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c20160101to20160630" unitRef="U002" decimals="-3">2503000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <!--Deferred taxes-->
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="c20161231" unitRef="U002" decimals="-3">15736000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <!--Deferred taxes-->
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="c20170630" unitRef="U002" decimals="-3">15443000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <!--Depreciation, Depletion and Amortization-->
  <us-gaap:DepreciationDepletionAndAmortization contextRef="c20170101to20170630" unitRef="U002" decimals="-3">4789000</us-gaap:DepreciationDepletionAndAmortization>
  <!--Depreciation, Depletion and Amortization-->
  <us-gaap:DepreciationDepletionAndAmortization contextRef="c20160101to20160630" unitRef="U002" decimals="-3">4158000</us-gaap:DepreciationDepletionAndAmortization>
  <!--Dividends payable to USPH shareholders-->
  <us-gaap:DividendsPayableCurrent contextRef="c20170630" unitRef="U002" decimals="-3">2516000</us-gaap:DividendsPayableCurrent>
  <!--Dividends payable to USPH shareholders-->
  <us-gaap:DividendsPayableCurrent contextRef="c20161231" unitRef="U002" decimals="-3">0</us-gaap:DividendsPayableCurrent>
  <!--Dividends, Common Stock, Cash-Retained Earnings [Member]-->
  <us-gaap:DividendsCommonStockCash contextRef="c20170101to20170630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">5031000</us-gaap:DividendsCommonStockCash>
  <!--Dividends, Common Stock, Cash-->
  <us-gaap:DividendsCommonStockCash contextRef="c20170101to20170630" unitRef="U002" decimals="-3">5031000</us-gaap:DividendsCommonStockCash>
  <!--Dividends, Common Stock, Cash-Common Stock [Member]-->
  <us-gaap:DividendsCommonStockCash contextRef="c20170101to20170630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:DividendsCommonStockCash>
  <!--Dividends, Common Stock, Cash-Treasury Stock [Member]-->
  <us-gaap:DividendsCommonStockCash contextRef="c20170101to20170630_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3">0</us-gaap:DividendsCommonStockCash>
  <!--Dividends, Common Stock, Cash-Additional Paid-in Capital [Member]-->
  <us-gaap:DividendsCommonStockCash contextRef="c20170101to20170630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">0</us-gaap:DividendsCommonStockCash>
  <!--Dividends, Common Stock, Cash-Parent [Member]-->
  <us-gaap:DividendsCommonStockCash contextRef="c20170101to20170630_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3">5031000</us-gaap:DividendsCommonStockCash>
  <!--Dividends, Common Stock, Cash-Noncontrolling Interest [Member]-->
  <us-gaap:DividendsCommonStockCash contextRef="c20170101to20170630_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3">0</us-gaap:DividendsCommonStockCash>
  <!--Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)-->
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="c20170401to20170630" unitRef="U003" decimals="2">0.39</us-gaap:EarningsPerShareBasicAndDiluted>
  <!--Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)-->
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="c20160101to20160630" unitRef="U003" decimals="2">0.84</us-gaap:EarningsPerShareBasicAndDiluted>
  <!--Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)-->
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="c20160401to20160630" unitRef="U003" decimals="2">0.48</us-gaap:EarningsPerShareBasicAndDiluted>
  <!--Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)-->
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="c20170101to20170630" unitRef="U003" decimals="2">0.78</us-gaap:EarningsPerShareBasicAndDiluted>
  <!--Employee-related Liabilities, Current-->
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c20170630" unitRef="U002" decimals="-3">15692000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <!--Employee-related Liabilities, Current-->
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c20161231" unitRef="U002" decimals="-3">10569000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <!--Fair Value of Financial Instruments, Policy [Policy Text Block]-->
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Fair Value of Financial Instruments&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement approximates its fair value. The interest rate on the Amended Credit Agreement, which is tied to the Eurodollar Rate, is set at various short-term intervals, as detailed in the Amended Credit Agreement.&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <!--Finite-Lived Intangible Assets, Amortization Expense, Year Two-Non-compete Agreements [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">883000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <!--Finite-Lived Intangible Assets, Amortization Expense, Year Two-Referral Relationship [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">2063000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
  <!--Finite-Lived Intangible Assets, Accumulated Amortization-Non-compete Agreements [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20161231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">3380000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <!--Finite-Lived Intangible Assets, Accumulated Amortization-Non-compete Agreements [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">3781000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <!--Finite-Lived Intangible Assets, Accumulated Amortization-Referral Relationship [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20161231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">5275000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <!--Finite-Lived Intangible Assets, Accumulated Amortization-Referral Relationship [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">6214000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <!--Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months-Referral Relationship [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">1993000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <!--Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months-Non-compete Agreements [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">860000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
  <!--Finite-Lived Intangible Asset, Useful Life-Referral Relationship [Member]-Minimum [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MinimumMember">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <!--Finite-Lived Intangible Asset, Useful Life-Maximum [Member]-Non-compete Agreements [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MaximumMember">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <!--Finite-Lived Intangible Asset, Useful Life-Non-compete Agreements [Member]-Minimum [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember_RangeAxis_MinimumMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <!--Finite-Lived Intangible Asset, Useful Life-Referral Relationship [Member]-Maximum [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MaximumMember">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <!--Finite-Lived Intangible Assets, Amortization Expense, Year Five-Non-compete Agreements [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">519000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
  <!--Finite-Lived Intangible Assets, Amortization Expense, Year Five-Referral Relationship [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">1973000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
  <!--Finite-lived Intangible Assets Amortization Expense [Table Text Block]-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The following table details the amount of amortization expense recorded for intangible assets for the three and six months ended June 30, 2017 and 2016 (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;Three Months Ended&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;Six Months Ended&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 52%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Tradenames&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;21&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;42&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 52%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;481&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;352&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;939&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;675&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 52%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Non-compete agreements&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;206&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;147&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;401&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;281&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 52%; background-color: #ffffff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;687&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;520&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,340&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;998&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
  <!--Finite-Lived Intangible Assets, Amortization Expense, Year Four-Referral Relationship [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">1973000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
  <!--Finite-Lived Intangible Assets, Amortization Expense, Year Four-Non-compete Agreements [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">597000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
  <!--Finite-Lived Intangible Assets, Amortization Expense, Year Three-Referral Relationship [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">1973000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <!--Finite-Lived Intangible Assets, Amortization Expense, Year Three-Non-compete Agreements [Member]-->
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">810000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
  <!--Furniture and Fixtures, Gross-->
  <us-gaap:FurnitureAndFixturesGross contextRef="c20161231" unitRef="U002" decimals="-3">48426000</us-gaap:FurnitureAndFixturesGross>
  <!--Furniture and Fixtures, Gross-->
  <us-gaap:FurnitureAndFixturesGross contextRef="c20170630" unitRef="U002" decimals="-3">50644000</us-gaap:FurnitureAndFixturesGross>
  <!--Gain (Loss) on Disposition of Property Plant Equipment-->
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c20160101to20160630" unitRef="U002" decimals="-3">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <!--Gain (Loss) on Disposition of Property Plant Equipment-->
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c20170101to20170630" unitRef="U002" decimals="-3">-65000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <!--Goodwill adjustments for purchase price allocation of business acquired-->
  <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c20170101to20170630" unitRef="U002" decimals="-3">954000</us-gaap:GoodwillPurchaseAccountingAdjustments>
  <!--Goodwill-->
  <us-gaap:Goodwill contextRef="c20161231" unitRef="U002" decimals="-3">226806000</us-gaap:Goodwill>
  <!--Goodwill-->
  <us-gaap:Goodwill contextRef="c20170630" unitRef="U002" decimals="-3">267957000</us-gaap:Goodwill>
  <!--Goodwill and Intangible Assets, Policy [Policy Text Block]-->
  <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Goodwill&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009, from the purchase of some or all of a particular local management&amp;#8217;s equity interest in an existing clinic. Effective January 1, 2009, if the purchase price of a non-controlling interest related to non-acquired Clinic Partnerships by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The carrying value of goodwill and other identifiable intangible assets with indefinite lives are tested for impairment annually and upon the occurrence of certain events, and are written down to fair value if considered impaired. The Company evaluates goodwill for impairment on at least an annual basis (in its third quarter) by comparing the fair value of its reporting units to the carrying value of each reporting unit including related goodwill. The Company&amp;#8217;s business is primarily made up of various clinics within partnerships. The partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&amp;#8217;s reporting units when performing its annual goodwill impairment test. In the second quarter of 2017, there were six regions.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The estimated fair value of a reporting unit is determined using two factors: (i) earnings prior to taxes, depreciation and amortization for the reporting unit multiplied by a price/earnings ratio used in the industry and (ii) a discounted cash flow analysis. A weight is assigned to each factor and the sum of each weight times the factor is considered the estimated fair value. For 2016, the factors (i.e., price/earnings ratio, discount rate and residual capitalization rate) were updated to reflect current market conditions. The evaluation of goodwill in 2016 did not result in any goodwill amounts that were deemed impaired.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company has not identified any triggering events occurring after the testing date that would impact the impairment testing results obtained. Factors which could result in future impairment charges include but are not limited to:&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;cost, risks and uncertainties associated with the Company&amp;#8217;s recent restatement of its prior financial statements due to the correction of its accounting methodology for redeemable noncontrolling partnership interests, and including any pending and future claims or proceedings relating to such matters&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;changes as the result of government enacted national healthcare reform&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification or enrollment status&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;business and regulatory conditions including federal and state regulation&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;governmental and other third party payor inspections, reviews, investigations and audits&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information and associated fines and penalties for failure to comply&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;legal actions, which could subject us to increased operating costs and uninsured liabilities&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;revenue and earnings expectations&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;general economic conditions&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;availability and cost of qualified physical and occupational therapists&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;personnel productivity and retaining key personnel&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain operations and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;acquisitions, purchases of non-controlling interests (minority interests) and the successful integration of the operations of the acquired business&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;maintaining necessary insurance coverage&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;availability, terms, and use of capital&amp;#894; and&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;weather and other seasonal factors.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
  <!--Goodwill Disclosure [Text Block]-->
  <us-gaap:GoodwillDisclosureTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;5. GOODWILL&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The changes in the carrying amount of goodwill consisted of the following (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; width: 78%; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: center;"&gt;Six Months Ended&lt;/div&gt;&lt;font style="color: #000000;"&gt;June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; width: 78%; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 78%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Beginning balance&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;226,806&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 78%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Goodwill acquired during the period&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;40,197&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 78%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Goodwill adjustments for purchase price allocation of business acquired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;954&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 78%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Ending balance&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;267,957&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillDisclosureTextBlock>
  <!--Goodwill, Acquired During Period-->
  <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c20170101to20170630" unitRef="U002" decimals="-3">40197000</us-gaap:GoodwillAcquiredDuringPeriod>
  <!--Gross Profit-->
  <us-gaap:GrossProfit contextRef="c20160101to20160630" unitRef="U002" decimals="-3">43554000</us-gaap:GrossProfit>
  <!--Gross Profit-->
  <us-gaap:GrossProfit contextRef="c20170401to20170630" unitRef="U002" decimals="-3">24534000</us-gaap:GrossProfit>
  <!--Gross Profit-->
  <us-gaap:GrossProfit contextRef="c20170101to20170630" unitRef="U002" decimals="-3">45281000</us-gaap:GrossProfit>
  <!--Gross Profit-->
  <us-gaap:GrossProfit contextRef="c20160401to20160630" unitRef="U002" decimals="-3">23059000</us-gaap:GrossProfit>
  <!--Health Care Organization, Patient Service Revenue-->
  <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="c20170101to20170630" unitRef="U002" decimals="-3">191311000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
  <!--Health Care Organization, Patient Service Revenue-->
  <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="c20170401to20170630" unitRef="U002" decimals="-3">97657000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
  <!--Health Care Organization, Patient Service Revenue-->
  <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="c20160401to20160630" unitRef="U002" decimals="-3">88433000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
  <!--Health Care Organization, Patient Service Revenue-->
  <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="c20160101to20160630" unitRef="U002" decimals="-3">173482000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
  <!--Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]-->
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances which indicate that the amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.&lt;/div&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
  <!--Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]-->
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Long-Lived Assets&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the assets. Estimated useful lives for furniture and equipment range from three to eight years and for software purchased from three to seven years. Leasehold improvements are amortized over the shorter of the lease term or estimated useful lives of the assets, which is generally three to five years.&lt;/div&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <!--Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c20170401to20170630" unitRef="U002" decimals="-3">9475000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <!--Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c20160401to20160630" unitRef="U002" decimals="-3">11473000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <!--Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c20170101to20170630" unitRef="U002" decimals="-3">17321000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <!--Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c20160101to20160630" unitRef="U002" decimals="-3">19598000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <!--Income Tax Expense (Benefit)-->
  <us-gaap:IncomeTaxExpenseBenefit contextRef="c20160401to20160630" unitRef="U002" decimals="-3">3802000</us-gaap:IncomeTaxExpenseBenefit>
  <!--Income Tax Expense (Benefit)-->
  <us-gaap:IncomeTaxExpenseBenefit contextRef="c20170401to20170630" unitRef="U002" decimals="-3">3085000</us-gaap:IncomeTaxExpenseBenefit>
  <!--Income Tax Expense (Benefit)-->
  <us-gaap:IncomeTaxExpenseBenefit contextRef="c20170101to20170630" unitRef="U002" decimals="-3">4897000</us-gaap:IncomeTaxExpenseBenefit>
  <!--Income Tax Expense (Benefit)-->
  <us-gaap:IncomeTaxExpenseBenefit contextRef="c20160101to20160630" unitRef="U002" decimals="-3">5974000</us-gaap:IncomeTaxExpenseBenefit>
  <!--Income Tax Expense (Benefit)-Accounting Standards Update 2016-09 [Member]-->
  <us-gaap:IncomeTaxExpenseBenefit contextRef="c20160101to20160331_AdjustmentsForNewAccountingPronouncementsAxis_AccountingStandardsUpdate201609Member" unitRef="U002" decimals="-5">500000</us-gaap:IncomeTaxExpenseBenefit>
  <!--Income Taxes Paid, Net-->
  <us-gaap:IncomeTaxesPaidNet contextRef="c20170101to20170630" unitRef="U002" decimals="-3">7516000</us-gaap:IncomeTaxesPaidNet>
  <!--Income Taxes Paid, Net-->
  <us-gaap:IncomeTaxesPaidNet contextRef="c20160101to20160630" unitRef="U002" decimals="-3">5513000</us-gaap:IncomeTaxesPaidNet>
  <!--Income Tax, Policy [Policy Text Block]-->
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Income Taxes&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company did not have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the six months ended June 30, 2017. The Company will book any interest or penalties, if required, in interest and/or other income/expense as appropriate.&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <!--Increase (Decrease) in Accounts Receivable-->
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c20160101to20160630" unitRef="U002" decimals="-3">2449000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <!--Increase (Decrease) in Accounts Receivable-->
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c20170101to20170630" unitRef="U002" decimals="-3">4006000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <!--Increase (Decrease) in Accounts Payable and Accrued Liabilities-->
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c20160101to20160630" unitRef="U002" decimals="-3">6603000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <!--Increase (Decrease) in Accounts Payable and Accrued Liabilities-->
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c20170101to20170630" unitRef="U002" decimals="-3">5043000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <!--Increase (Decrease) in Accounts Receivable and Other Operating Assets-->
  <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets contextRef="c20160101to20160630" unitRef="U002" decimals="-3">-53000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
  <!--Increase (Decrease) in Accounts Receivable and Other Operating Assets-->
  <us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets contextRef="c20170101to20170630" unitRef="U002" decimals="-3">3406000</us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets>
  <!--Increase (Decrease) in Other Operating Assets-->
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c20160101to20160630" unitRef="U002" decimals="-3">2443000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <!--Increase (Decrease) in Other Operating Assets-->
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c20170101to20170630" unitRef="U002" decimals="-3">2342000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <!--Increase (Decrease) in Other Operating Liabilities-->
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c20160101to20160630" unitRef="U002" decimals="-3">447000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <!--Increase (Decrease) in Other Operating Liabilities-->
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c20170101to20170630" unitRef="U002" decimals="-3">77000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <!--Intangible Assets Disclosure [Text Block]-->
  <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;6. INTANGIBLE ASSETS, NET&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Intangible assets, net as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):&lt;/div&gt;&lt;div style="color: #000000; text-align: left;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;December 31, 2016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Tradenames&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;26,352&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;21,234&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Referral relationships, net of accumulated amortization of $6,214 and $5,275, respectively&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;18,613&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;14,859&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Non-compete agreements, net of accumulated amortization of $3,781 and $3,380, respectively&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;3,356&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,967&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 76%; background-color: #ffffff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;48,321&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;38,060&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Tradenames, referral relationships and non-compete agreements are related to the businesses acquired. Typically, the value assigned to tradenames has an indefinite life and is tested at least annually for impairment using the relief from royalty method in conjunction with the Company&amp;#8217;s annual goodwill impairment test. The value assigned to referral relationships is being amortized over their respective estimated useful lives which range from six to 16 years. Non-compete agreements are amortized over the respective term of the agreements which range from five to six years.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The following table details the amount of amortization expense recorded for intangible assets for the three and six months ended June 30, 2017 and 2016 (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;Three Months Ended&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;Six Months Ended&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 52%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Tradenames&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;21&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;42&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 52%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;481&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;352&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;939&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;675&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 52%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Non-compete agreements&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;206&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;147&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;401&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;281&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 52%; background-color: #ffffff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;687&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;520&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,340&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;998&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Based on the balance of referral relationships and non-compete agreements as of June 30, 2017, the expected amount to be amortized in 2017 and thereafter by year is as follows (in thousands):&lt;/div&gt;&lt;div style="color: #000000; text-align: left;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; border-collapse: collapse; width: 90%;"&gt;&lt;tr&gt;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;Referral Relationships&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;Non-Compete Agreements&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;Years&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;Annual Amount&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;Years&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;Annual Amount&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2017&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,993&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2017&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;860&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;2,063&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;883&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,973&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;810&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,973&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;597&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2021&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,973&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2021&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;519&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2022&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,924&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2022&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;88&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2023&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,817&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2024&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,698&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2025&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,592&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2026&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,131&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2027&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;971&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2028&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;401&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2029&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;43&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
  <!--Intangible Assets, Net (Excluding Goodwill)-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c20170630" unitRef="U002" decimals="-3">48321000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--Intangible Assets, Net (Excluding Goodwill)-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c20161231" unitRef="U002" decimals="-3">38060000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--Intangible Assets, Net (Excluding Goodwill)-Trademarks [Member]-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U002" decimals="-3">26352000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--Intangible Assets, Net (Excluding Goodwill)-Non-compete Agreements [Member]-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c20161231_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">1967000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--Intangible Assets, Net (Excluding Goodwill)-Trademarks [Member]-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c20161231_FiniteLivedIntangibleAssetsByMajorClassAxis_TrademarksMember" unitRef="U002" decimals="-3">21234000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--Intangible Assets, Net (Excluding Goodwill)-Referral Relationship [Member]-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">18613000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--Intangible Assets, Net (Excluding Goodwill)-Non-compete Agreements [Member]-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">3356000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--Intangible Assets, Net (Excluding Goodwill)-Referral Relationship [Member]-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c20161231_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">14859000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--Interest Expense-->
  <us-gaap:InterestExpense contextRef="c20170101to20170630" unitRef="U002" decimals="-3">10604000</us-gaap:InterestExpense>
  <!--Interest Expense-->
  <us-gaap:InterestExpense contextRef="c20160401to20160630" unitRef="U002" decimals="-3">3581000</us-gaap:InterestExpense>
  <!--Interest Expense-->
  <us-gaap:InterestExpense contextRef="c20170401to20170630" unitRef="U002" decimals="-3">6226000</us-gaap:InterestExpense>
  <!--Interest Expense-->
  <us-gaap:InterestExpense contextRef="c20160101to20160630" unitRef="U002" decimals="-3">6967000</us-gaap:InterestExpense>
  <!--Interest and Other Income-->
  <us-gaap:InterestAndOtherIncome contextRef="c20170101to20170630" unitRef="U002" decimals="-3">47000</us-gaap:InterestAndOtherIncome>
  <!--Interest and Other Income-->
  <us-gaap:InterestAndOtherIncome contextRef="c20160101to20160630" unitRef="U002" decimals="-3">41000</us-gaap:InterestAndOtherIncome>
  <!--Interest and Other Income-->
  <us-gaap:InterestAndOtherIncome contextRef="c20170401to20170630" unitRef="U002" decimals="-3">23000</us-gaap:InterestAndOtherIncome>
  <!--Interest and Other Income-->
  <us-gaap:InterestAndOtherIncome contextRef="c20160401to20160630" unitRef="U002" decimals="-3">21000</us-gaap:InterestAndOtherIncome>
  <!--Interest Expense on Prepetition Liabilities Recognized in Statement of Operations-->
  <us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations contextRef="c20170101to20170630" unitRef="U002" decimals="0">0</us-gaap:InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations>
  <!--Interest Paid, Net-->
  <us-gaap:InterestPaidNet contextRef="c20160101to20160630" unitRef="U002" decimals="-3">512000</us-gaap:InterestPaidNet>
  <!--Interest Paid, Net-->
  <us-gaap:InterestPaidNet contextRef="c20170101to20170630" unitRef="U002" decimals="-3">104000</us-gaap:InterestPaidNet>
  <!--Labor and Related Expense-->
  <us-gaap:LaborAndRelatedExpense contextRef="c20170101to20170630" unitRef="U002" decimals="-3">114606000</us-gaap:LaborAndRelatedExpense>
  <!--Labor and Related Expense-->
  <us-gaap:LaborAndRelatedExpense contextRef="c20170401to20170630" unitRef="U002" decimals="-3">58779000</us-gaap:LaborAndRelatedExpense>
  <!--Labor and Related Expense-->
  <us-gaap:LaborAndRelatedExpense contextRef="c20160401to20160630" unitRef="U002" decimals="-3">48837000</us-gaap:LaborAndRelatedExpense>
  <!--Labor and Related Expense-->
  <us-gaap:LaborAndRelatedExpense contextRef="c20160101to20160630" unitRef="U002" decimals="-3">96641000</us-gaap:LaborAndRelatedExpense>
  <!--Leasehold Improvements, Gross-->
  <us-gaap:LeaseholdImprovementsGross contextRef="c20170630" unitRef="U002" decimals="-3">27729000</us-gaap:LeaseholdImprovementsGross>
  <!--Leasehold Improvements, Gross-->
  <us-gaap:LeaseholdImprovementsGross contextRef="c20161231" unitRef="U002" decimals="-3">26765000</us-gaap:LeaseholdImprovementsGross>
  <!--Liabilities-->
  <us-gaap:Liabilities contextRef="c20161231" unitRef="U002" decimals="-3">162543000</us-gaap:Liabilities>
  <!--Liabilities-->
  <us-gaap:Liabilities contextRef="c20170630" unitRef="U002" decimals="-3">209419000</us-gaap:Liabilities>
  <!--Liabilities and Equity-->
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c20170630" unitRef="U002" decimals="-3">417325000</us-gaap:LiabilitiesAndStockholdersEquity>
  <!--Liabilities and Equity-->
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c20161231" unitRef="U002" decimals="-3">351231000</us-gaap:LiabilitiesAndStockholdersEquity>
  <!--Liabilities, Current-->
  <us-gaap:LiabilitiesCurrent contextRef="c20161231" unitRef="U002" decimals="-3">24617000</us-gaap:LiabilitiesCurrent>
  <!--Liabilities, Current-->
  <us-gaap:LiabilitiesCurrent contextRef="c20170630" unitRef="U002" decimals="-3">35193000</us-gaap:LiabilitiesCurrent>
  <!--Line of Credit Facility, Unused Capacity, Commitment Fee Percentage-Maximum [Member]-->
  <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="c20170101to20170630_RangeAxis_MaximumMember" unitRef="U004" decimals="INF">0.0025</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
  <!--Line of Credit Facility, Unused Capacity, Commitment Fee Percentage-Minimum [Member]-->
  <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage contextRef="c20170101to20170630_RangeAxis_MinimumMember" unitRef="U004" decimals="INF">0.001</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
  <!--Line of Credit Facility, Maximum Borrowing Capacity-Revolving Credit Facility [Member]-->
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c20131205_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-5">125000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <!--Line of Credit Facility, Interest Rate During Period-Revolving Credit Facility [Member]-->
  <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="c20170101to20170630_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U004" decimals="3">0.027</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
  <!--Line of Credit Facility, Interest Rate During Period-Two Thousand Seventeen Acquisition [Member]-Notes Payable [Member]-->
  <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="c20170101to20170630_BusinessAcquisitionAxis_TwoThousandSeventeenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U004" decimals="INF">0.040</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
  <!--Line of Credit Facility, Interest Rate During Period-Two Thousand Sixteen Acquisition [Member]-Notes Payable [Member]-->
  <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="c20160101to20161231_BusinessAcquisitionAxis_TwoThousandSixteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U004" decimals="INF">0.035</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
  <!--Line of Credit Facility, Interest Rate During Period-Minimum [Member]-Notes Payable [Member]-Two Thousand Fifteen Acquisition [Member]-->
  <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="c20150101to20151231_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_RangeAxis_MinimumMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U004" decimals="INF">0.0325</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
  <!--Line of Credit Facility, Interest Rate During Period-Two Thousand Fifteen Acquisition [Member]-Notes Payable [Member]-Maximum [Member]-->
  <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="c20150101to20151231_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_RangeAxis_MaximumMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U004" decimals="INF">0.040</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
  <!--Line of Credit Facility, Remaining Borrowing Capacity-Revolving Credit Facility [Member]-->
  <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c20170630_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-5">56000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
  <!--Payments/Long term debt, Total-Promissory Notes [Member]-->
  <us-gaap:LongTermDebt contextRef="c20161231_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U002" decimals="-3">5823000</us-gaap:LongTermDebt>
  <!--Payments/Long term debt, Total-Promissory Notes [Member]-->
  <us-gaap:LongTermDebt contextRef="c20170630_DebtInstrumentAxis_PromissoryNotesMember" unitRef="U002" decimals="-3">6696000</us-gaap:LongTermDebt>
  <!--Payments/Long term debt, Total-Revolving Credit Facility [Member]-->
  <us-gaap:LongTermDebt contextRef="c20170630_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-3">69000000</us-gaap:LongTermDebt>
  <!--Payments/Long term debt, Total-Revolving Credit Facility [Member]-->
  <us-gaap:LongTermDebt contextRef="c20161231_CreditFacilityAxis_RevolvingCreditFacilityMember" unitRef="U002" decimals="-3">46000000</us-gaap:LongTermDebt>
  <!--Payments/Long term debt, Total-->
  <us-gaap:LongTermDebt contextRef="c20170630" unitRef="U002" decimals="-3">75696000</us-gaap:LongTermDebt>
  <!--Payments/Long term debt, Total-->
  <us-gaap:LongTermDebt contextRef="c20161231" unitRef="U002" decimals="-3">51823000</us-gaap:LongTermDebt>
  <!--Long-term Debt, Current Maturities-->
  <us-gaap:LongTermDebtCurrent contextRef="c20170630" unitRef="U002" decimals="-3">2345000</us-gaap:LongTermDebtCurrent>
  <!--Long-term Debt, Current Maturities-->
  <us-gaap:LongTermDebtCurrent contextRef="c20161231" unitRef="U002" decimals="-3">1227000</us-gaap:LongTermDebtCurrent>
  <!--Long-term Debt, Maturities, Repayments of Principal in Year Three-Notes Payable [Member]-Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c20170630_BusinessAcquisitionAxis_TwoThousandSeventeenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="0">1025000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
  <!--Long-term Debt, Maturities, Repayments of Principal in Year Three-Two Thousand Fifteen Acquisition [Member]-Notes Payable [Member]-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c20151231_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="-5">1900000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
  <!--Long-term Debt, Excluding Current Maturities-->
  <us-gaap:LongTermDebtNoncurrent contextRef="c20170630" unitRef="U002" decimals="-3">73351000</us-gaap:LongTermDebtNoncurrent>
  <!--Long-term Debt, Excluding Current Maturities-->
  <us-gaap:LongTermDebtNoncurrent contextRef="c20161231" unitRef="U002" decimals="-3">50596000</us-gaap:LongTermDebtNoncurrent>
  <!--Long-term Debt, Maturities, Repayments of Principal in Year Two-Notes Payable [Member]-Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c20170630_BusinessAcquisitionAxis_TwoThousandSeventeenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="0">625000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <!--Long-term Debt, Maturities, Repayments of Principal in Year Two-Notes Payable [Member]-Two Thousand Sixteen Acquisition [Member]-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c20161231_BusinessAcquisitionAxis_TwoThousandSixteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="0">819000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <!--Long-term Debt, Maturities, Repayments of Principal in Year Two-Notes Payable [Member]-Two Thousand Fifteen Acquisition [Member]-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c20151231_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="-5">1900000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <!--Long-term Debt, Maturities, Repayments of Principal in Year Two-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c20170630" unitRef="U002" decimals="-3">73351000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <!--Long-term Line of Credit, Noncurrent-->
  <us-gaap:LongTermLineOfCredit contextRef="c20161231" unitRef="U002" decimals="-3">46000000</us-gaap:LongTermLineOfCredit>
  <!--Long-term Line of Credit, Noncurrent-->
  <us-gaap:LongTermLineOfCredit contextRef="c20170630" unitRef="U002" decimals="-3">69000000</us-gaap:LongTermLineOfCredit>
  <!--During the twelve months ended June 30, 2018-Notes Payable [Member]-Two Thousand Sixteen Acquisition [Member]-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c20161231_BusinessAcquisitionAxis_TwoThousandSixteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="0">250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <!--During the twelve months ended June 30, 2018-Notes Payable [Member]-Two Thousand Fifteen Acquisition [Member]-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c20151231_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="0">525000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <!--During the twelve months ended June 30, 2018-->
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c20170630" unitRef="U002" decimals="-3">2345000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <!--Notes Payable, Noncurrent-->
  <us-gaap:LongTermNotesPayable contextRef="c20161231" unitRef="U002" decimals="-3">4596000</us-gaap:LongTermNotesPayable>
  <!--Notes Payable, Noncurrent-->
  <us-gaap:LongTermNotesPayable contextRef="c20170630" unitRef="U002" decimals="-3">4351000</us-gaap:LongTermNotesPayable>
  <!--Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders-Treasury Stock [Member]-->
  <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c20170101to20170630_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
  <!--Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders-Noncontrolling Interest [Member]-->
  <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c20170101to20170630_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3">2665000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
  <!--Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders-Parent [Member]-->
  <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c20170101to20170630_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
  <!--Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders-Retained Earnings [Member]-->
  <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c20170101to20170630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
  <!--Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders-Additional Paid-in Capital [Member]-->
  <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c20170101to20170630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
  <!--Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders-->
  <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c20170101to20170630" unitRef="U002" decimals="-3">2665000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
  <!--Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders-Common Stock [Member]-->
  <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c20170101to20170630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
  <!--Noncontrolling Interest Disclosure [Text Block]-->
  <us-gaap:MinorityInterestDisclosureTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;3. MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Prior to the second quarter of 2017, when the Company acquired a majority interest (the &amp;#8220;Acquisition&amp;#8221;) in a physical therapy clinic business (referred to as &amp;#8220;Therapy Practice&amp;#8221;), these Acquisitions occurred in a series of steps which are described below.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;1.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &amp;#8220;Seller Entity&amp;#8221;). The Seller Entity is owned by one or more individuals (the &amp;#8220;Selling Shareholders&amp;#8221;) most of whom are physical therapists that work in the Therapy Practice and provide physical therapy services to patients.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;2.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In conjunction with the Acquisition, the Seller Entity contributes the Therapy Practice into a newly-formed limited partnership (&amp;#8220;NewCo&amp;#8221;), in exchange for one hundred percent (100%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a wholly-owned subsidiary of the Seller Entity.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;3.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company enters into an agreement (the &amp;#8220;Purchase Agreement&amp;#8221;) to acquire from the Seller Entity a majority (ranges from 50% to 90%) of the limited partnership interest and, in all cases, 100% of the general partnership interest in NewCo. The Company does not purchase 100% of the limited partnership interest because the Selling Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in the form of cash at closing and a small two-year note in lieu of an escrow (the &amp;#8220;Purchase Price&amp;#8221;). The Purchase Agreement does not contain any future earn-out or other contingent consideration that is payable to the Seller Entity or the Selling Shareholders.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;4.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company and the Seller Entity also execute a partnership agreement (the &amp;#8220;Partnership Agreement&amp;#8221;) for NewCo that sets forth the rights and obligations of the limited and general partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;5.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited partnership interest in NewCo (&amp;#8220;Seller Entity Interest&amp;#8221;).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;6.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In most cases, some or all of the Selling Shareholders enter into an employment agreement (the&amp;#160; &amp;#8220;Employment Agreement&amp;#8221;) with NewCo with an initial term that ranges from three to five years (the &amp;#8220;Employment Term&amp;#8221;), with automatic one-year renewals, unless employment is terminated prior to the end of the Employment Term. As a result, a Selling Shareholder becomes an employee (&amp;#8220;Employed Selling Shareholder&amp;#8221;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause, at any time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing&amp;#894; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller Entity as of the closing of the Acquisition.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;7.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities based on other employees in similar capacities within NewCo, the Company and the industry.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;8.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete agreement (the &amp;#8220;Non- Compete Agreement&amp;#8221;) which restricts the Selling Shareholder from engaging in competing business activities for a specified period of time (the &amp;#8220;Non-Compete Term&amp;#8221;). A Non-Compete Agreement is executed with the Selling Shareholders in all cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing business during the Non-Compete Term.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;9.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Non-Compete Term commences as of the date of the Acquisition and expires on the later of:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 54pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;a.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Two years after the date an Employed Selling Shareholders&amp;#8217; employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 54pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;b.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Five to six years from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;10.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Non-Compete Agreement applies to a restricted region which is defined as a 15-mile radius from the Therapy Practice. That is, an Employed Selling Shareholder is permitted to engage in competing businesses or activities outside the 15-mile radius (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo immediately is permitted to engage in the competing business or activities outside the 15-mile radius.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;11.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &amp;#8220;Call Option&amp;#8221;) or on a required basis (the &amp;#8220;Required Redemption&amp;#8221;):&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 54pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;a.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Required Redemption&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 72pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;i.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Once the Required Redemption is triggered, the Company is obligated to purchase from the Seller Entity and the Seller Entity is obligated to sell to the Company, the allocable portion of the Seller Entity Interest based on the terminated Selling Shareholder&amp;#8217;s pro rata ownership interest in the Seller Entity (the &amp;#8220;Allocable Portion&amp;#8221;). Required Redemption is&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-left: 90pt;"&gt;triggered when both of the following events have occurred:&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 108pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;1.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Termination of an Employed Selling Shareholder&amp;#8217;s employment with NewCo, regardless of the reason for such termination, and&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 108pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;2.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The expiration of an agreed upon period of time, typically three to five years, as set forth in the relevant Partnership Agreement (the &amp;#8220;Holding Period&amp;#8221;).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 72pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;ii.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In the event an Employed Selling Shareholder&amp;#8217;s employment terminates prior to the expiration of the Holding Period, the Required Redemption would occur only upon expiration of the Holding Period.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 54pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;b.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Call Option&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 108pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;I&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In the event that an Employed Selling Shareholder&amp;#8217;s employment terminates prior to expiration of the Holding Period, the Company has the contractual right, but not the obligation, to acquire the Employed Selling Shareholder&amp;#8217;s Allocable Portion of the Seller Entity Interest from the Seller Entity through exercise of the Call Option.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 54pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;c.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;For the Required Redemption and the Call Option, the purchase price is derived from a formula based on a specified multiple of NewCo&amp;#8217;s trailing twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&amp;#8217;s internal management fee, plus an Allocable Portion of any undistributed earnings of NewCo (the &amp;#8220;Redemption Amount&amp;#8221;). NewCo&amp;#8217;s earnings are distributed monthly based on available cash within NewCo&amp;#894; therefore, the undistributed earnings amount is small, if any.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 54pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;d.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings that is used in the Required Redemption noted above.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 54pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;e.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Although, the Required Redemption and the Call Option do not have an expiration date, the Seller Entity Interest eventually will be purchased by the Company.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 54pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;f.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Required Redemption and the Call Option never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;12.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;An Employed Selling Shareholder&amp;#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&amp;#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &amp;#8220;claw back&amp;#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &amp;#8220;cause&amp;#8221; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&amp;#8217;s only recourse against the Employed Selling Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;For the six months ended June 30, 2017, the following table details the changes in the carrying amount of mandatorily redeemable non-controlling interest:&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: center;"&gt;Six Months Ended&lt;/div&gt;&lt;font style="color: #000000;"&gt;June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Beginning balance&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;69,190&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Operating results allocated to mandatorily redeemable non-controlling interest partners&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;3,081&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Distributions to mandatorily redeemable non-controlling interest partners&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(3,272&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Changes in the redemption value of mandatorily redeemable non-controlling interest&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;6,592&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Payments for settlement of mandatorily redeemable non-controlling&amp;#160; interest&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(2,230&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: middle; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Purchases of businesses - initial liability related to mandatorily redeemable non-controlling interest&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;10,282&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Ending balance&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;83,643&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The following table details the carrying amount of the mandatorily redeemable non-controlling interest (in thousands) as of June 30, 2017:&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Contractual time period has lapsed but holder's employment has not been terminated&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;30,838&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Contractual time period has not lapsed and holder's employment has not been terminated&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;55,454&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Holder's employment has terminated and contractual time period has expired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Holder's employment has terminated and contractual time period has not expired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Redemption value prior to excess distributed earnings&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;86,292&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Excess distributions over earnings and losses&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(2,649&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #cceeff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;83,643&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
  <!--Stockholders' Equity Attributable to Noncontrolling Interest-->
  <us-gaap:MinorityInterest contextRef="c20170630" unitRef="U002" decimals="-3">1182000</us-gaap:MinorityInterest>
  <!--Stockholders' Equity Attributable to Noncontrolling Interest-->
  <us-gaap:MinorityInterest contextRef="c20161231" unitRef="U002" decimals="-3">1140000</us-gaap:MinorityInterest>
  <!--Net Cash Provided by (Used in) Operating Activities-->
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c20170101to20170630" unitRef="U002" decimals="-3">22191000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <!--Net Cash Provided by (Used in) Operating Activities-->
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c20160101to20160630" unitRef="U002" decimals="-3">31053000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <!--Net Cash Provided by (Used in) Investing Activities-->
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c20160101to20160630" unitRef="U002" decimals="-3">-16619000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <!--Net Cash Provided by (Used in) Investing Activities-->
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c20170101to20170630" unitRef="U002" decimals="-3">-36848000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <!--Net Income (Loss) Attributable to Parent-->
  <us-gaap:NetIncomeLoss contextRef="c20160401to20160630" unitRef="U002" decimals="-3">6012000</us-gaap:NetIncomeLoss>
  <!--Net Income (Loss) Attributable to Parent-->
  <us-gaap:NetIncomeLoss contextRef="c20170101to20170630" unitRef="U002" decimals="-3">9757000</us-gaap:NetIncomeLoss>
  <!--Net Income (Loss) Attributable to Parent-->
  <us-gaap:NetIncomeLoss contextRef="c20170401to20170630" unitRef="U002" decimals="-3">4941000</us-gaap:NetIncomeLoss>
  <!--Net Income (Loss) Attributable to Parent-->
  <us-gaap:NetIncomeLoss contextRef="c20160101to20160630" unitRef="U002" decimals="-3">10500000</us-gaap:NetIncomeLoss>
  <!--Net Income (Loss) Attributable to Redeemable Noncontrolling Interest-->
  <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest contextRef="c20170101to20170630" unitRef="U002" decimals="-3">3081000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
  <!--Net Cash Provided by (Used in) Financing Activities-->
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c20160101to20160630" unitRef="U002" decimals="-3">-9759000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <!--Net Cash Provided by (Used in) Financing Activities-->
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c20170101to20170630" unitRef="U002" decimals="-3">14852000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <!--Net Income (Loss) Attributable to Noncontrolling Interest-->
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c20170101to20170630" unitRef="U002" decimals="-3">2667000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <!--Net Income (Loss) Attributable to Noncontrolling Interest-->
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c20170401to20170630" unitRef="U002" decimals="-3">1449000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <!--Net Income (Loss) Attributable to Noncontrolling Interest-->
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c20160101to20160630" unitRef="U002" decimals="-3">3124000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <!--Net Income (Loss) Attributable to Noncontrolling Interest-->
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c20160401to20160630" unitRef="U002" decimals="-3">1659000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <!--Recently Adopted Accounting Guidance-->
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Recently Adopted Accounting Guidance&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In March 2016, the FASB issued guidance to simplify some provisions in stock compensation accounting.&amp;#160; The guidance amends how excess tax benefits and a company&amp;#8217;s payments to cover tax bills for the recipients&amp;#8217; shares should be classified.&amp;#160; Prior to this guidance, excess tax benefits were recorded in additional paid-in capital, but will now become a component of the income tax provision/benefit in the period in which they occur.&amp;#160; This guidance allows companies to estimate the number of stock awards expected to vest and revises the withholding requirements for classifying stock awards as equity.&amp;#160; For public business entities, this guidance is effective for fiscal years starting after December 15, 2016, including interim periods within those fiscal years but early adoption is allowed.&amp;#160; The Company adopted this accounting treatment in the fourth quarter of 2016 and retrospectively adjusted each quarter period in 2016.&amp;#160; The adoption increased earnings, by decreasing the tax provision, by $0.5 million for the three months ended March 31, 2016.&amp;#160;&amp;#160; The election to record forfeitures in the period they occur is consistent with the Company&amp;#8217;s past approach, due to the immateriality of past forfeitures, and the Company believes the effect to be immaterial on the consolidated financial statements.&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <!--Number of clinic practices acquired-February Two Thousand Sixteen Acquisition [Member]-->
  <us-gaap:NumberOfBusinessesAcquired contextRef="c20160101to20161231_BusinessAcquisitionAxis_FebruaryTwoThousandSixteenAcquisitionMember" unitRef="U005" decimals="INF">8</us-gaap:NumberOfBusinessesAcquired>
  <!--Number of clinic practices acquired-November Two Thousand Sixteen Acquisition [Member]-->
  <us-gaap:NumberOfBusinessesAcquired contextRef="c20160101to20161231_BusinessAcquisitionAxis_NovemberTwoThousandSixteenAcquisitionMember" unitRef="U005" decimals="INF">12</us-gaap:NumberOfBusinessesAcquired>
  <!--Number of clinic practices acquired-May Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:NumberOfBusinessesAcquired contextRef="c20170101to20170630_BusinessAcquisitionAxis_MayTwoThousandSeventeenAcquisitionMember" unitRef="U005" decimals="INF">4</us-gaap:NumberOfBusinessesAcquired>
  <!--Number of clinic practices acquired-January Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:NumberOfBusinessesAcquired contextRef="c20170101to20170630_BusinessAcquisitionAxis_JanuaryTwoThousandSeventeenAcquisitionMember" unitRef="U005" decimals="INF">17</us-gaap:NumberOfBusinessesAcquired>
  <!--Number of clinic practices acquired-June Two Thousand Seventeen Acquisition [Member]-->
  <us-gaap:NumberOfBusinessesAcquired contextRef="c20170101to20170630_BusinessAcquisitionAxis_JuneTwoThousandSeventeenAcquisitionMember" unitRef="U005" decimals="INF">9</us-gaap:NumberOfBusinessesAcquired>
  <!--Number of clinic practices acquired-Acquisition Of Eight Clinic Practices [Member]-->
  <us-gaap:NumberOfBusinessesAcquired contextRef="c20160229to20160229_BusinessAcquisitionAxis_AcquisitionOfEightClinicPracticesMember" unitRef="U005" decimals="INF">8</us-gaap:NumberOfBusinessesAcquired>
  <!--Number of clinic practices acquired-Acquisition Of Twelve Clinic Practices [Member]-->
  <us-gaap:NumberOfBusinessesAcquired contextRef="c20161130to20161130_BusinessAcquisitionAxis_AcquisitionOfTwelveClinicPracticesMember" unitRef="U005" decimals="INF">12</us-gaap:NumberOfBusinessesAcquired>
  <!--Number of clinic practices acquired-Acquisition of Seventeen Clinic Practices [Member]-->
  <us-gaap:NumberOfBusinessesAcquired contextRef="c20170101to20170101_BusinessAcquisitionAxis_AcquisitionOfSeventeenClinicPracticesMember" unitRef="U005" decimals="INF">17</us-gaap:NumberOfBusinessesAcquired>
  <!--Number of clinic practices acquired-Acquisition Of Nine Clinic Practices [Member]-->
  <us-gaap:NumberOfBusinessesAcquired contextRef="c20170101to20170630_BusinessAcquisitionAxis_AcquisitionOfNineClinicPracticesMember" unitRef="U005" decimals="INF">9</us-gaap:NumberOfBusinessesAcquired>
  <!--Number of clinic practices acquired-Acquisition Of Four Clinic Practices [Member]-->
  <us-gaap:NumberOfBusinessesAcquired contextRef="c20170531to20170531_BusinessAcquisitionAxis_AcquisitionOfFourClinicPracticesMember" unitRef="U005" decimals="INF">4</us-gaap:NumberOfBusinessesAcquired>
  <!--Number of States in which Entity Operates-->
  <us-gaap:NumberOfStatesInWhichEntityOperates contextRef="c20170630" unitRef="U006" decimals="INF">41</us-gaap:NumberOfStatesInWhichEntityOperates>
  <!--Noncontrolling Interest, Increase from Sale of Parent Equity Interest-->
  <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c20170101to20170630" unitRef="U002" decimals="-3">6592000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
  <!--Contributions of non-controlling interest partners-->
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c20170101to20170630" unitRef="U002" decimals="-3">40000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <!--Contributions of non-controlling interest partners-Common Stock [Member]-->
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c20170101to20170630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <!--Contributions of non-controlling interest partners-Retained Earnings [Member]-->
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c20170101to20170630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <!--Contributions of non-controlling interest partners-Additional Paid-in Capital [Member]-->
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c20170101to20170630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <!--Contributions of non-controlling interest partners-Noncontrolling Interest [Member]-->
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c20170101to20170630_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3">40000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <!--Contributions of non-controlling interest partners-Treasury Stock [Member]-->
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c20170101to20170630_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3">0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <!--Contributions of non-controlling interest partners-Parent [Member]-->
  <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c20170101to20170630_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3">0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
  <!--Operating Income (Loss)-->
  <us-gaap:OperatingIncomeLoss contextRef="c20160101to20160630" unitRef="U002" decimals="-3">26524000</us-gaap:OperatingIncomeLoss>
  <!--Operating Income (Loss)-->
  <us-gaap:OperatingIncomeLoss contextRef="c20160401to20160630" unitRef="U002" decimals="-3">15033000</us-gaap:OperatingIncomeLoss>
  <!--Operating Income (Loss)-->
  <us-gaap:OperatingIncomeLoss contextRef="c20170401to20170630" unitRef="U002" decimals="-3">15678000</us-gaap:OperatingIncomeLoss>
  <!--Operating Income (Loss)-->
  <us-gaap:OperatingIncomeLoss contextRef="c20170101to20170630" unitRef="U002" decimals="-3">27878000</us-gaap:OperatingIncomeLoss>
  <!--Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]-->
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &amp;#8220;Company&amp;#8221;). All significant intercompany transactions and balances have been eliminated. The Company primarily operates through subsidiary clinic partnerships, in which the Company generally owns a 1% general partnership interest in all the Clinic Partnerships. Our limited partnership interests range from 49% to 99% in the Clinic Partnerships.&amp;#160; The managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in the majority of the clinics (hereinafter referred to as &amp;#8220;Clinic Partnerships&amp;#8221;). To a lesser extent, the Company operates some clinics, through wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &amp;#8220;Wholly-Owned Facilities&amp;#8221;).&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and other referral sources by offering these therapists a competitive salary and incentives based on the profitability of the clinic that they manage. The Company also looks for therapists with whom to establish new, de novo clinics to be owned jointly by the Company and such therapists&amp;#894; in these situations, the therapist is offered the opportunity to co-invest in the new clinic and also receives a competitive salary for managing the clinic. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior owners typically continue on as employees to manage the clinic operations, retaining a non-controlling ownership interest in the clinics and receiving a competitive salary for managing the clinic operations. In addition, we have developed satellite clinic facilities as part of existing Clinic Partnerships and Wholly-Owned facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned facilities operate more than one clinic location. In 2017, we intend to continue to acquire clinic practices and continue to focus on developing new clinics and on opening satellite clinics where appropriate along with increasing our patient volume through marketing and new programs.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;During the first six months of 2017 and the year ended 2016, the Company acquired an interest in the following clinic groups:&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%;"&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;&amp;#160;Date&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;% Interest Acquired&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;Number of Clinics&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%;"&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;&amp;#160;2017&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;June 2017 Acquisition&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;June 30&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;60&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;9&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;May 2017 Acquisition&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;May 31&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;70&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;4&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;January 2017 Acquisition&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;January 1&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;70&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;17&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%; background-color: #cceeff;"&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;&amp;#160;2016&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;February 2016 Acquisition&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;February 29&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;55&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;8&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;November 2016 Acquisition&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;November 30&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;60&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;12&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;"&gt;In addition to the above clinic groups, in March 2017, the Company acquired a 55% interest in a company which is a leading provider of workforce performance solutions. Services provided include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers including a number of Fortune 500 companies. Other clients include large insurers and their contractors. Also, during the second quarter, the Company purchased the assets and business of a physical therapy clinic and consolidated its business with an existing clinic.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;As of June 30, 2017, the Company operated 566 clinics in 41 states.&amp;#160; The Company also manages physical therapy facilities for third parties, primarily physicians, with 27 third-party facilities under management as of June 30, 2017.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The results of operations of the acquired clinics have been included in the Company&amp;#8217;s consolidated financial statements since the date of their respective acquisition.&amp;#160; The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-right: 0.1pt;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-right: 0.1pt;"&gt;The accompanying unaudited consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions for Form 10-Q. However, the statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. Management believes this report contains all necessary adjustments (consisting only of normal recurring adjustments) to present fairly, in all material respects, the Company&amp;#8217;s financial position, results of operations and cash flows for the interim periods presented. For further information regarding the Company&amp;#8217;s accounting policies, please read the audited financial statements included in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December 31, 2016.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company believes, and the Chief Executive Officer, Chief Financial Officer and Corporate Controller have certified, that the financial statements included in this report present fairly, in all material respects, the Company&amp;#8217;s financial position, results of operations and cash flows for the interim periods presented.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Operating results for the six months ended June 30, 2017 are not necessarily indicative of the results the Company expects for the entire year.&amp;#160; Please also review the Risk Factors section included in our Annual Report on Form 10-K for the year ended December 31, 2016.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: italic; text-align: left;"&gt;Clinic Partnerships&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by the managing therapist, directly or indirectly, are recorded within the balance sheets and income statements as non-controlling interests.&amp;#160; For acquired Clinic Partnerships with mandatorily redeemable non-controlling interests, the earnings and liabilities attributable to the non-controlling interest are recorded within the statements of net income line items: Interest expense &amp;#8211; mandatorily redeemable non-controlling interests &amp;#8211; earnings allocable and in the balance sheet line item: Mandatorily redeemable non-controlling interests.&amp;#160; For acquired Clinic Partnerships with redeemable non-controlling interests, the earnings attributable to the redeemable non-controlling interest are recorded within the statements of net income line item &amp;#8211; net income attributable to non-controlling interest and the equity interests are recorded on the balance sheet as redeemable non-controlling interests.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: italic; text-align: left;"&gt;Wholly-Owned Facilities&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing due to the profit sharing therapists. The amount is expensed as compensation and included in clinic operating costs &amp;#8211; salaries and related costs. The respective liability is included in current liabilities &amp;#8211; accrued expenses on the balance sheets.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Restatement of Prior Financial Statements&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;As disclosed in our Current Report on Form 8-K filed March 16, 2017, and further described in our Annual Report on Form 10-K for the year ended December 31, 2016 filed on June 7, 2017, prior to issuing the 2016 annual financial statements, the Company determined it had previously incorrectly accounted for the non-controlling interests in the Company&amp;#8217;s subsidiary clinic partnerships that were mandatorily redeemable. Management and the Company&amp;#8217;s board of directors concluded this error was material to previously issued annual and quarterly consolidated financial statements.&amp;#160; Additional information regarding the restatement is available in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December 31, 2016. Financial information in this Form 10-Q related to all periods prior to the quarter ended December 31, 2016 has been amended where necessary to reflect the restatement. Therefore, this Form 10-Q should be read in conjunction with the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December 31, 2016.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Significant Accounting Policies&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Cash Equivalents&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company maintains its cash and cash equivalents at financial institutions.&amp;#160; The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&amp;#8220;FDIC&amp;#8221;) insurance coverage and, as a result, there is a concentration of credit risk related on deposits in excess of FDIC insurance coverage. Management believes that the risk is not significant.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Long-Lived Assets&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the assets. Estimated useful lives for furniture and equipment range from three to eight years and for software purchased from three to seven years. Leasehold improvements are amortized over the shorter of the lease term or estimated useful lives of the assets, which is generally three to five years.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances which indicate that the amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Goodwill&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009, from the purchase of some or all of a particular local management&amp;#8217;s equity interest in an existing clinic. Effective January 1, 2009, if the purchase price of a non-controlling interest related to non-acquired Clinic Partnerships by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The carrying value of goodwill and other identifiable intangible assets with indefinite lives are tested for impairment annually and upon the occurrence of certain events, and are written down to fair value if considered impaired. The Company evaluates goodwill for impairment on at least an annual basis (in its third quarter) by comparing the fair value of its reporting units to the carrying value of each reporting unit including related goodwill. The Company&amp;#8217;s business is primarily made up of various clinics within partnerships. The partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&amp;#8217;s reporting units when performing its annual goodwill impairment test. In the second quarter of 2017, there were six regions.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The estimated fair value of a reporting unit is determined using two factors: (i) earnings prior to taxes, depreciation and amortization for the reporting unit multiplied by a price/earnings ratio used in the industry and (ii) a discounted cash flow analysis. A weight is assigned to each factor and the sum of each weight times the factor is considered the estimated fair value. For 2016, the factors (i.e., price/earnings ratio, discount rate and residual capitalization rate) were updated to reflect current market conditions. The evaluation of goodwill in 2016 did not result in any goodwill amounts that were deemed impaired.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company has not identified any triggering events occurring after the testing date that would impact the impairment testing results obtained. Factors which could result in future impairment charges include but are not limited to:&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;cost, risks and uncertainties associated with the Company&amp;#8217;s recent restatement of its prior financial statements due to the correction of its accounting methodology for redeemable noncontrolling partnership interests, and including any pending and future claims or proceedings relating to such matters&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;changes as the result of government enacted national healthcare reform&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification or enrollment status&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;business and regulatory conditions including federal and state regulation&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;governmental and other third party payor inspections, reviews, investigations and audits&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information and associated fines and penalties for failure to comply&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;legal actions, which could subject us to increased operating costs and uninsured liabilities&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;revenue and earnings expectations&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;general economic conditions&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;availability and cost of qualified physical and occupational therapists&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;personnel productivity and retaining key personnel&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain operations and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;acquisitions, purchases of non-controlling interests (minority interests) and the successful integration of the operations of the acquired business&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;maintaining necessary insurance coverage&amp;#894;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;availability, terms, and use of capital&amp;#894; and&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 18pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;&amp;#183;&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;weather and other seasonal factors.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Mandatorily Redeemable Non-Controlling Interests&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;"&gt;The non-controlling interests that are reflected as mandatorily redeemable non-controlling interests in the consolidated financial statements consist of those owners who have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase the non-controlling interest of those owners at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&amp;#160; The redemption rights are triggered at such time as both of the following events have occurred: 1) termination of the owner&amp;#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically three to five years, as defined in the limited partnership agreement.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;"&gt;On the date the Company acquires a controlling interest in a partnership and the limited partnership agreement contains mandatory redemption rights, the fair value of the non-controlling interest is recorded in the long-term liabilities section of the consolidated balance sheet under the caption &amp;#8211; &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Mandatorily redeemable non-controlling interests&lt;/font&gt;.&amp;#160; Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to its then current redemption value, based on the predetermined formula defined in the respective limited partnership agreement.&amp;#160; The Company reflects any adjustment in the redemption value and any earnings attributable to the mandatorily redeemable non-controlling interest in its consolidated statements of net income by recording the adjustments and earnings to other income and expense in the captions - &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Interest expense &amp;#8211; mandatorily redeemable non-controlling interests &amp;#8211; change in redemption value and Interest expense &amp;#8211; mandatorily redeemable non-controlling interests &amp;#8211; earnings allocable&lt;/font&gt;.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Redeemable Non-Controlling Interests&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;"&gt;The non-controlling interests that are reflected as redeemable non-controlling interests in the consolidated financial statements consist of those owners who have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase the non-controlling interest of those owners, if certain conditions are met and the owners request the purchase.&amp;#160; The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&amp;#160; The redemption rights can be triggered by the owner at such time as both of the following events have occurred: 1) termination of the owner&amp;#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically three to five years, as defined in the limited partnership agreement.&amp;#160; The redemption rights are not automatic (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;"&gt;On the date the Company acquires a controlling interest in a partnership and the limited partnership agreement contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &amp;#8211; &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Redeemable non-controlling interests&lt;/font&gt;.&amp;#160; Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial value, based on the predetermined formula defined in the respective limited partnership agreement.&amp;#160; Hence, the value of the non-controlling interest is not adjusted below its initial value.&amp;#160; The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the statements of net income.&amp;#160; Although the adjustments are not reflected in the statements of net income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation.&amp;#160; The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the income statement.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Non-Controlling Interests&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company recognizes non-controlling interests as equity in the consolidated financial statements separate from the parent entity&amp;#8217;s equity. Changes in a parent entity&amp;#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling interest on the deconsolidation date.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;When the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall, as applicable, is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Revenue Recognition&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Revenues are recognized in the period in which services are rendered. Net patient revenues (patient revenues less estimated contractual adjustments) are reported at the estimated net realizable amounts from third-party payors, patients and others for services rendered. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off experience.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company determines allowances for doubtful accounts based on the specific agings and payor classifications at each clinic. The provision for doubtful accounts is included in clinic operating costs in the statement of net income. Net accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for doubtful accounts, includes only those amounts the Company estimates to be collectible.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Medicare Reimbursement&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&amp;#8216;&amp;#8216;MPFS&amp;#8217;&amp;#8217;). The MPFS rates have historically been subject to an automatic annual update based on a formula, called the sustainable growth rate (&amp;#8216;&amp;#8216;SGR&amp;#8217;&amp;#8217;) formula. The use of the SGR formula would have resulted in calculated automatic reductions in rates in every year since 2002&amp;#894; however, for each year through September 30, 2015, Centers for Medicare &amp;amp; Medicaid Services (&amp;#8216;&amp;#8216;CMS&amp;#8217;&amp;#8217;) or Congress has taken action to prevent the implementation of SGR formula reductions. On April 16, 2015, the Medicare Access and CHIP Reauthorization Act of 2015 (&amp;#8216;&amp;#8216;MACRA&amp;#8217;&amp;#8217;) was signed into law, eliminating the SGR formula and the associated annual automatic rate reductions.&amp;#160; The MACRA promotes the development of new payment models that focus on quality and outcomes.&amp;#160; As a result of MACRA and CMS&amp;#8217; adjustment to the applicable conversion factor, the net fee schedule payment rates were increased for 2017 by 0.24%.&amp;#160; For 2018 and 2019, a 0.5% increase will be applied each year to the fee schedule payment rates, unless further adjusted by CMS.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years, and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extends the 2% reductions to Medicare payments through fiscal year 2025.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-left: 0.2pt; margin-right: 0.2pt;"&gt;As a result of the Balanced Budget Act of 1997, the formula for determining the total amount paid by Medicare in any one year for outpatient physical therapy, occupational therapy, and/or speech/language pathology services provided to any Medicare beneficiary (i.e., the &amp;#8216;&amp;#8216;Therapy Cap&amp;#8217;&amp;#8217; or &amp;#8216;&amp;#8216;Limit&amp;#8217;&amp;#8217;) was established. Based on the statutory definitions which constrained how the Therapy Cap would be applied, there is one Limit for Physical Therapy and Speech Language Pathology Services combined, and one Limit for Occupational Therapy. For 2017, the annual Limit on outpatient therapy services is $1,980 for Physical and Speech Language Pathology Services combined and $1,980 for Occupational Therapy Services. Historically, these Therapy Caps applied to outpatient therapy services provided in all settings, except for services provided in departments of hospitals. However, the Protecting Access to Medicare Act of 2014, and prior legislation, extended the Therapy Caps to services furnished in hospital outpatient department settings. The application of these annual limits to hospital outpatient department settings will sunset on December 31, 2017 unless Congress extends it.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In the Deficit Reduction Act of 2005, Congress implemented an exceptions process to the annual Limit for therapy expenses for therapy services above the annual Limit. Therapy services above the annual Limit that are medically necessary satisfy an exception to the annual Limit and such claims are payable by the Medicare program. The MACRA extended the exceptions process for outpatient therapy caps through December 31, 2017. Unless Congress extends the exceptions process further, the exceptions no longer will be available in those outpatient therapy setting where the annual Limits are applicable. For any claim above the annual Limit, the claim must contain a modifier indicating that the services are medically necessary and justified by appropriate documentation in the medical record.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Furthermore, under the Middle Class Tax Relief and Job Creation Act of 2012 (&amp;#8216;&amp;#8216;MCTRA&amp;#8217;&amp;#8217;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services&amp;#894; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;CMS adopted a multiple procedure payment reduction (&amp;#8216;&amp;#8216;MPPR&amp;#8217;&amp;#8217;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &amp;#8212; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value Unit (&amp;#8216;&amp;#8216;RVU&amp;#8217;&amp;#8217;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by 50%. In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&amp;#8217;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge, CMS has rejected claims if the required data is not included in the claim.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Physician Quality Reporting System, or &amp;#8216;&amp;#8216;PQRS,&amp;#8217;&amp;#8217; is a CMS reporting program that uses a combination of incentive payments and payment reductions to promote reporting of quality information by &amp;#8216;&amp;#8216;eligible professionals.&amp;#8217;&amp;#8217; Although physical therapists, occupational therapists and qualified speech-language therapists were generally able to participate in the PQRS program, therapy professionals for whose services we bill through our certified rehabilitation agencies cannot participate because the Medicare claims processing systems currently cannot accommodate institutional providers such as certified rehabilitation agencies. Eligible professionals, such as those of our therapy professionals for whose services we bill using their individual Medicare provider numbers, who do not satisfactorily report data on quality measures will be subject to a 2% reduction in their Medicare payment in 2016 and 2017. As required under the MACRA, the PQRS program has been replaced with the Merit-Based Incentive Payment System (MIPS) on January 1, 2017. Physical therapists and occupational therapists are not required to participate in the MIPS program until January 1, 2019 or later, as determined by CMS.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. The Company believes that it is in compliance in all material respects with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the Company&amp;#8217;s financial statements as of June 30, 2017. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the six months ended June 30, 2017, net revenue from Medicare accounts for approximately $45.8 million.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Management Contract Revenues&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Management contract revenues are derived from contractual arrangements whereby the Company manages a clinic for third party owners. The Company does not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized when services are performed. Costs, typically salaries for the Company&amp;#8217;s employees, are recorded when incurred. Management contract revenues are included in &amp;#8220;other revenues&amp;#8221; in the accompanying Consolidated Statements of Net Income.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Contractual Allowances&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&amp;#8217;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&amp;#8217;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&amp;#8217;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, the historical difference between net revenues and corresponding cash collections has generally reflected a difference within approximately 1% of net revenues. Additionally, analysis of subsequent period&amp;#8217;s contractual write-offs on a payor basis reflects a difference within approximately 1% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% at June 30, 2017.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Income Taxes&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company did not have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the six months ended June 30, 2017. The Company will book any interest or penalties, if required, in interest and/or other income/expense as appropriate.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Fair Value of Financial Instruments&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement approximates its fair value. The interest rate on the Amended Credit Agreement, which is tied to the Eurodollar Rate, is set at various short-term intervals, as detailed in the Amended Credit Agreement.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Segment Reporting&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by chief operating decision makers in deciding how to allocate resources and in assessing performance. The Company identifies operating segments based on management responsibility and believes it meets the criteria for aggregating its operating segments into a single reporting segment.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Use of Estimates&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In preparing the Company&amp;#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, purchase accounting, goodwill impairment, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Self-Insurance Program&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company utilizes a self-insurance plan for its employee group health insurance coverage administered by a third party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&amp;#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through June 30, 2017.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Restricted Stock&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock granted to employees, other than officers, lapse in equal annual installments on the following four anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the first year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The restricted stock issued is included in basic and diluted shares for the earnings per share computation.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Recently Adopted Accounting Guidance&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In March 2016, the FASB issued guidance to simplify some provisions in stock compensation accounting.&amp;#160; The guidance amends how excess tax benefits and a company&amp;#8217;s payments to cover tax bills for the recipients&amp;#8217; shares should be classified.&amp;#160; Prior to this guidance, excess tax benefits were recorded in additional paid-in capital, but will now become a component of the income tax provision/benefit in the period in which they occur.&amp;#160; This guidance allows companies to estimate the number of stock awards expected to vest and revises the withholding requirements for classifying stock awards as equity.&amp;#160; For public business entities, this guidance is effective for fiscal years starting after December 15, 2016, including interim periods within those fiscal years but early adoption is allowed.&amp;#160; The Company adopted this accounting treatment in the fourth quarter of 2016 and retrospectively adjusted each quarter period in 2016.&amp;#160; The adoption increased earnings, by decreasing the tax provision, by $0.5 million for the three months ended March 31, 2016.&amp;#160;&amp;#160; The election to record forfeitures in the period they occur is consistent with the Company&amp;#8217;s past approach, due to the immateriality of past forfeitures, and the Company believes the effect to be immaterial on the consolidated financial statements.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Recently Issued Accounting Guidance&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In January 2017, the FASB issued ASU 2017-04, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Simplifying the Test for Goodwill Impairment (Topic 350),&lt;/font&gt; which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment change. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods within those years, beginning after December 15, 2019. The Company is currently evaluating the impact of adopting this ASU on our consolidated financial statements and do not expect adoption to have a material impact.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In February 2016, the FASB issued amended accounting guidance (ASU 2016-02 - &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Leases&lt;/font&gt;) which replaced most existing lease accounting guidance under U. S. generally accepted accounting principles. Among other changes, the amended guidance requires that a right-to-use asset, which is an asset that represents the lessee&amp;#8217;s right to use, and a lease liability, which is a lessee&amp;#8217;s obligation to make lease payments arising for a lease measured on a discounted basis, be recognized on the balance sheet by lessees for those leases with a term of greater than 12 months. The amended guidance is effective for reporting periods beginning after December 15, 2018&amp;#894; however, early adoption is permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Since the Company leases all but one of its clinic facilities, it has been evaluating various lease management systems to capture the necessary information and the impact that this amended accounting guidance will have on its consolidated financial statements. The Company believes the adoption of this guidance will significantly affect total assets and liabilities in the consolidated balance sheet.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In May 2014, March 2016, April 2016, and December 2016, the FASB issued ASU 2014-09, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;, ASU 2016-08, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Revenue from Contracts with Customers, Principal versus Agent Considerations&lt;/font&gt;, ASU 2016-10, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing&lt;/font&gt;, ASU 2016-12, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients&lt;/font&gt;, and ASU 2016-20, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customer&lt;/font&gt; (collectively &amp;#8220;the standards&amp;#8221;), respectively, which supersede most of the current revenue recognition requirements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. New disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers are also required. The original standards were effective for fiscal years beginning after December 15, 2016; however, in July 2015, the FASB approved a one-year deferral of these standards, with a new effective date for fiscal years beginning after December 15, 2017. The standards require the selection of a retrospective or cumulative effect transition method. The Company does not anticipate a material adjustment upon adoption of these standards.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Subsequent Event&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company has evaluated events occurring after the balance sheet date for possible disclosure as a subsequent event through the date that these consolidated financial statements were issued. No disclosure was required.&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <!--Other Assets, Current-->
  <us-gaap:OtherAssetsCurrent contextRef="c20170630" unitRef="U002" decimals="-3">6932000</us-gaap:OtherAssetsCurrent>
  <!--Other Assets, Current-->
  <us-gaap:OtherAssetsCurrent contextRef="c20161231" unitRef="U002" decimals="-3">4428000</us-gaap:OtherAssetsCurrent>
  <!--Other Assets, Noncurrent-->
  <us-gaap:OtherAssetsNoncurrent contextRef="c20161231" unitRef="U002" decimals="-3">1228000</us-gaap:OtherAssetsNoncurrent>
  <!--Other Assets, Noncurrent-->
  <us-gaap:OtherAssetsNoncurrent contextRef="c20170630" unitRef="U002" decimals="-3">1268000</us-gaap:OtherAssetsNoncurrent>
  <!--Other Liabilities, Noncurrent-->
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="c20170630" unitRef="U002" decimals="-3">0</us-gaap:OtherLiabilitiesNoncurrent>
  <!--Other Liabilities, Noncurrent-->
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="c20161231" unitRef="U002" decimals="-3">829000</us-gaap:OtherLiabilitiesNoncurrent>
  <!--Other Revenue, Net-->
  <us-gaap:OtherSalesRevenueNet contextRef="c20160401to20160630" unitRef="U002" decimals="-3">1997000</us-gaap:OtherSalesRevenueNet>
  <!--Other Revenue, Net-->
  <us-gaap:OtherSalesRevenueNet contextRef="c20170401to20170630" unitRef="U002" decimals="-3">6594000</us-gaap:OtherSalesRevenueNet>
  <!--Other Revenue, Net-->
  <us-gaap:OtherSalesRevenueNet contextRef="c20160101to20160630" unitRef="U002" decimals="-3">3856000</us-gaap:OtherSalesRevenueNet>
  <!--Other Revenue, Net-->
  <us-gaap:OtherSalesRevenueNet contextRef="c20170101to20170630" unitRef="U002" decimals="-3">10505000</us-gaap:OtherSalesRevenueNet>
  <!--Other Accrued Liabilities, Current-->
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c20170630" unitRef="U002" decimals="-3">5887000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <!--Other Accrued Liabilities, Current-->
  <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c20161231" unitRef="U002" decimals="-3">4808000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <!--Payments for (Proceeds from) Businesses and Interest in Affiliates-->
  <us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates contextRef="c20170101to20170630" unitRef="U002" decimals="-3">0</us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates>
  <!--Payments for (Proceeds from) Businesses and Interest in Affiliates-->
  <us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates contextRef="c20160101to20160630" unitRef="U002" decimals="-3">250000</us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates>
  <!--Payments for Repurchase of Redeemable Noncontrolling Interest-->
  <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest contextRef="c20170101to20170630" unitRef="U002" decimals="-3">2230000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
  <!--Payments for Repurchase of Redeemable Noncontrolling Interest-->
  <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest contextRef="c20160101to20160630" unitRef="U002" decimals="-3">1136000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
  <!--Payments to Acquire Businesses, Gross-Acquisition of Seventeen Clinic Practices [Member]-->
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c20170101to20170101_BusinessAcquisitionAxis_AcquisitionOfSeventeenClinicPracticesMember" unitRef="U002" decimals="-5">10700000</us-gaap:PaymentsToAcquireBusinessesGross>
  <!--Payments to Acquire Businesses, Gross-Acquisition Of Twelve Clinic Practices [Member]-->
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c20161130to20161130_BusinessAcquisitionAxis_AcquisitionOfTwelveClinicPracticesMember" unitRef="U002" decimals="-5">11000000</us-gaap:PaymentsToAcquireBusinessesGross>
  <!--Payments to Acquire Businesses, Gross-Acquisition Of Nine Clinic Practices [Member]-->
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c20170101to20170630_BusinessAcquisitionAxis_AcquisitionOfNineClinicPracticesMember" unitRef="U002" decimals="-5">15800000</us-gaap:PaymentsToAcquireBusinessesGross>
  <!--Payments to Acquire Businesses, Gross-Acquisition Of Four Clinic Practices [Member]-->
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c20170531to20170531_BusinessAcquisitionAxis_AcquisitionOfFourClinicPracticesMember" unitRef="U002" decimals="-5">2300000</us-gaap:PaymentsToAcquireBusinessesGross>
  <!--Payments to Acquire Businesses, Gross-Acquisition Of Single Clinic Practices [Member]-->
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c20170101to20170630_BusinessAcquisitionAxis_AcquisitionOfSingleClinicPracticesMember" unitRef="U002" decimals="0">100000</us-gaap:PaymentsToAcquireBusinessesGross>
  <!--Payments to Acquire Businesses, Gross-Acquisition Of Eight Clinic Practices [Member]-->
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c20160229to20160229_BusinessAcquisitionAxis_AcquisitionOfEightClinicPracticesMember" unitRef="U002" decimals="-5">13200000</us-gaap:PaymentsToAcquireBusinessesGross>
  <!--Payments to Acquire Businesses, Gross-Workforce Performance Solutions [Member]-->
  <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c20170323to20170323_BusinessAcquisitionAxis_WorkforcePerformanceSolutionsMember" unitRef="U002" decimals="-5">6200000</us-gaap:PaymentsToAcquireBusinessesGross>
  <!--Payments to Acquire Businesses, Net of Cash Acquired-->
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c20170101to20170630" unitRef="U002" decimals="-3">33665000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <!--Payments to Acquire Businesses, Net of Cash Acquired-->
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c20160101to20160630" unitRef="U002" decimals="-3">12958000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <!--Payments to Acquire Businesses, Net of Cash Acquired-->
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c20160101to20161231" unitRef="U002" decimals="-3">23623000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <!--Payments of Ordinary Dividends, Noncontrolling Interest-->
  <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="c20160101to20160630" unitRef="U002" decimals="-3">2893000</us-gaap:PaymentsOfDividendsMinorityInterest>
  <!--Payments of Ordinary Dividends, Noncontrolling Interest-->
  <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="c20170101to20170630" unitRef="U002" decimals="-3">2665000</us-gaap:PaymentsOfDividendsMinorityInterest>
  <!--Payments of Ordinary Dividends, Common Stock-->
  <us-gaap:PaymentsOfDividendsCommonStock contextRef="c20170101to20170630" unitRef="U002" decimals="-3">2516000</us-gaap:PaymentsOfDividendsCommonStock>
  <!--Payments of Ordinary Dividends, Common Stock-->
  <us-gaap:PaymentsOfDividendsCommonStock contextRef="c20160101to20160630" unitRef="U002" decimals="-3">4254000</us-gaap:PaymentsOfDividendsCommonStock>
  <!--Payments to Noncontrolling Interests-->
  <us-gaap:PaymentsToMinorityShareholders contextRef="c20170101to20170630" unitRef="U002" decimals="-3">10282000</us-gaap:PaymentsToMinorityShareholders>
  <!--Payments to Acquire Productive Assets-->
  <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c20170101to20170630" unitRef="U002" decimals="-3">3245000</us-gaap:PaymentsToAcquireProductiveAssets>
  <!--Payments to Acquire Productive Assets-->
  <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c20160101to20160630" unitRef="U002" decimals="-3">3453000</us-gaap:PaymentsToAcquireProductiveAssets>
  <!--Preferred Stock, Shares Issued-->
  <us-gaap:PreferredStockSharesIssued contextRef="c20161231" unitRef="U001" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <!--Preferred Stock, Shares Issued-->
  <us-gaap:PreferredStockSharesIssued contextRef="c20170630" unitRef="U001" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <!--Preferred Stock, Shares Authorized-->
  <us-gaap:PreferredStockSharesAuthorized contextRef="c20161231" unitRef="U001" decimals="INF">500000</us-gaap:PreferredStockSharesAuthorized>
  <!--Preferred Stock, Shares Authorized-->
  <us-gaap:PreferredStockSharesAuthorized contextRef="c20170630" unitRef="U001" decimals="INF">500000</us-gaap:PreferredStockSharesAuthorized>
  <!--Preferred Stock, Par or Stated Value Per Share-->
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c20161231" unitRef="U003" decimals="INF">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <!--Preferred Stock, Par or Stated Value Per Share-->
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="c20170630" unitRef="U003" decimals="INF">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <!--Preferred Stock, Shares Outstanding-->
  <us-gaap:PreferredStockSharesOutstanding contextRef="c20170630" unitRef="U001" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <!--Preferred Stock, Shares Outstanding-->
  <us-gaap:PreferredStockSharesOutstanding contextRef="c20161231" unitRef="U001" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <!--Preferred Stock, Value, Issued-->
  <us-gaap:PreferredStockValue contextRef="c20161231" unitRef="U002" decimals="-3">0</us-gaap:PreferredStockValue>
  <!--Preferred Stock, Value, Issued-->
  <us-gaap:PreferredStockValue contextRef="c20170630" unitRef="U002" decimals="-3">0</us-gaap:PreferredStockValue>
  <!--Proceeds from (Payments for) Other Financing Activities-->
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c20160101to20160630" unitRef="U002" decimals="-3">1000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <!--Proceeds from (Payments for) Other Financing Activities-->
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c20170101to20170630" unitRef="U002" decimals="-3">40000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <!--Proceeds from Lines of Credit-->
  <us-gaap:ProceedsFromLinesOfCredit contextRef="c20170101to20170630" unitRef="U002" decimals="-3">49000000</us-gaap:ProceedsFromLinesOfCredit>
  <!--Proceeds from Lines of Credit-->
  <us-gaap:ProceedsFromLinesOfCredit contextRef="c20160101to20160630" unitRef="U002" decimals="-3">93000000</us-gaap:ProceedsFromLinesOfCredit>
  <!--Proceeds from Sale of Productive Assets-->
  <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="c20170101to20170630" unitRef="U002" decimals="-3">62000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <!--Proceeds from Sale of Productive Assets-->
  <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="c20160101to20160630" unitRef="U002" decimals="-3">42000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <!--Net Income (Loss), Including Portion Attributable to Noncontrolling Interest-->
  <us-gaap:ProfitLoss contextRef="c20160401to20160630" unitRef="U002" decimals="-3">7671000</us-gaap:ProfitLoss>
  <!--Net Income (Loss), Including Portion Attributable to Noncontrolling Interest-->
  <us-gaap:ProfitLoss contextRef="c20160101to20160630" unitRef="U002" decimals="-3">13624000</us-gaap:ProfitLoss>
  <!--Net Income (Loss), Including Portion Attributable to Noncontrolling Interest-->
  <us-gaap:ProfitLoss contextRef="c20170101to20170630" unitRef="U002" decimals="-3">12424000</us-gaap:ProfitLoss>
  <!--Net Income (Loss), Including Portion Attributable to Noncontrolling Interest-->
  <us-gaap:ProfitLoss contextRef="c20170401to20170630" unitRef="U002" decimals="-3">6390000</us-gaap:ProfitLoss>
  <!--Net Income (Loss), Including Portion Attributable to Noncontrolling Interest-Noncontrolling Interest [Member]-->
  <us-gaap:ProfitLoss contextRef="c20170101to20170630_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3">2667000</us-gaap:ProfitLoss>
  <!--Net Income (Loss), Including Portion Attributable to Noncontrolling Interest-Treasury Stock [Member]-->
  <us-gaap:ProfitLoss contextRef="c20170101to20170630_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3">0</us-gaap:ProfitLoss>
  <!--Net Income (Loss), Including Portion Attributable to Noncontrolling Interest-Parent [Member]-->
  <us-gaap:ProfitLoss contextRef="c20170101to20170630_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3">9757000</us-gaap:ProfitLoss>
  <!--Net Income (Loss), Including Portion Attributable to Noncontrolling Interest-Common Stock [Member]-->
  <us-gaap:ProfitLoss contextRef="c20170101to20170630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:ProfitLoss>
  <!--Net Income (Loss), Including Portion Attributable to Noncontrolling Interest-Retained Earnings [Member]-->
  <us-gaap:ProfitLoss contextRef="c20170101to20170630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">9757000</us-gaap:ProfitLoss>
  <!--Net Income (Loss), Including Portion Attributable to Noncontrolling Interest-Additional Paid-in Capital [Member]-->
  <us-gaap:ProfitLoss contextRef="c20170101to20170630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">0</us-gaap:ProfitLoss>
  <!--Property, Plant and Equipment, Useful Life-Maximum [Member]-Leasehold Improvements [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MaximumMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment, Useful Life-Furniture and Fixtures [Member]-Maximum [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MaximumMember">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment, Useful Life-Minimum [Member]-Furniture and Fixtures [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember_RangeAxis_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment, Useful Life-Maximum [Member]-Computer Software, Intangible Asset [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MaximumMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment, Useful Life-Minimum [Member]-Computer Software, Intangible Asset [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_ComputerSoftwareIntangibleAssetMember_RangeAxis_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment, Useful Life-Minimum [Member]-Leasehold Improvements [Member]-->
  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c20170101to20170630_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember_RangeAxis_MinimumMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <!--Property, Plant and Equipment, Net-->
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="c20170630" unitRef="U002" decimals="-3">20173000</us-gaap:PropertyPlantAndEquipmentNet>
  <!--Property, Plant and Equipment, Net-->
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="c20161231" unitRef="U002" decimals="-3">19173000</us-gaap:PropertyPlantAndEquipmentNet>
  <!--Property, Plant and Equipment, Gross-->
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="c20161231" unitRef="U002" decimals="-3">75191000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Property, Plant and Equipment, Gross-->
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="c20170630" unitRef="U002" decimals="-3">78373000</us-gaap:PropertyPlantAndEquipmentGross>
  <!--Provision for Doubtful Accounts-->
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="c20170401to20170630" unitRef="U002" decimals="-3">888000</us-gaap:ProvisionForDoubtfulAccounts>
  <!--Provision for Doubtful Accounts-->
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="c20170101to20170630" unitRef="U002" decimals="-3">1786000</us-gaap:ProvisionForDoubtfulAccounts>
  <!--Provision for Doubtful Accounts-->
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="c20160401to20160630" unitRef="U002" decimals="-3">956000</us-gaap:ProvisionForDoubtfulAccounts>
  <!--Provision for Doubtful Accounts-->
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="c20160101to20160630" unitRef="U002" decimals="-3">2045000</us-gaap:ProvisionForDoubtfulAccounts>
  <!--Redeemable Noncontrolling Interest, Equity, Redemption Value-->
  <us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue contextRef="c20170630" unitRef="U002" decimals="-3">86292000</us-gaap:RedeemableNoncontrollingInterestEquityRedemptionValue>
  <!--Redeemable non-controlling interests-->
  <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="c20170630" unitRef="U002" decimals="-3">11940000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
  <!--Redeemable non-controlling interests-->
  <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="c20161231" unitRef="U002" decimals="-3">0</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
  <!--Redeemable Noncontrolling Interest [Table Text Block]-->
  <us-gaap:RedeemableNoncontrollingInterestTableTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;For the six months ended June 30, 2017, the following table details the changes in the carrying amount of mandatorily redeemable non-controlling interest:&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: center;"&gt;Six Months Ended&lt;/div&gt;&lt;font style="color: #000000;"&gt;June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Beginning balance&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;69,190&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Operating results allocated to mandatorily redeemable non-controlling interest partners&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;3,081&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Distributions to mandatorily redeemable non-controlling interest partners&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(3,272&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Changes in the redemption value of mandatorily redeemable non-controlling interest&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;6,592&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Payments for settlement of mandatorily redeemable non-controlling&amp;#160; interest&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(2,230&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: middle; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Purchases of businesses - initial liability related to mandatorily redeemable non-controlling interest&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;10,282&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Ending balance&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;83,643&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
  <!--Repayments of Notes Payable-->
  <us-gaap:RepaymentsOfNotesPayable contextRef="c20170101to20170630" unitRef="U002" decimals="-3">777000</us-gaap:RepaymentsOfNotesPayable>
  <!--Repayments of Notes Payable-->
  <us-gaap:RepaymentsOfNotesPayable contextRef="c20160101to20160630" unitRef="U002" decimals="-3">533000</us-gaap:RepaymentsOfNotesPayable>
  <!--Repayments of Debt-Two Thousand Fifteen Acquisition [Member]-Notes Payable [Member]-->
  <us-gaap:RepaymentsOfDebt contextRef="c20160101to20161231_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="0">575000</us-gaap:RepaymentsOfDebt>
  <!--Repayments of Debt-Two Thousand Sixteen Acquisition [Member]-Notes Payable [Member]-->
  <us-gaap:RepaymentsOfDebt contextRef="c20170101to20170630_BusinessAcquisitionAxis_TwoThousandSixteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="0">444000</us-gaap:RepaymentsOfDebt>
  <!--Repayments of Debt-Notes Payable [Member]-Two Thousand Fifteen Acquisition [Member]-->
  <us-gaap:RepaymentsOfDebt contextRef="c20170101to20170331_BusinessAcquisitionAxis_TwoThousandFifteenAcquisitionMember_ShortTermDebtTypeAxis_NotesPayableMember" unitRef="U002" decimals="0">250000</us-gaap:RepaymentsOfDebt>
  <!--Repayments of Lines of Credit-->
  <us-gaap:RepaymentsOfLinesOfCredit contextRef="c20170101to20170630" unitRef="U002" decimals="-3">26000000</us-gaap:RepaymentsOfLinesOfCredit>
  <!--Repayments of Lines of Credit-->
  <us-gaap:RepaymentsOfLinesOfCredit contextRef="c20160101to20160630" unitRef="U002" decimals="-3">94500000</us-gaap:RepaymentsOfLinesOfCredit>
  <!--Restructuring Charges-->
  <us-gaap:RestructuringCharges contextRef="c20160401to20160630" unitRef="U002" decimals="-3">32000</us-gaap:RestructuringCharges>
  <!--Restructuring Charges-->
  <us-gaap:RestructuringCharges contextRef="c20170401to20170630" unitRef="U002" decimals="-3">17000</us-gaap:RestructuringCharges>
  <!--Restructuring Charges-->
  <us-gaap:RestructuringCharges contextRef="c20170101to20170630" unitRef="U002" decimals="-3">23000</us-gaap:RestructuringCharges>
  <!--Restructuring Charges-->
  <us-gaap:RestructuringCharges contextRef="c20160101to20160630" unitRef="U002" decimals="-3">45000</us-gaap:RestructuringCharges>
  <!--Retained Earnings (Accumulated Deficit)-->
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c20161231" unitRef="U002" decimals="-3">150342000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <!--Retained Earnings (Accumulated Deficit)-->
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c20170630" unitRef="U002" decimals="-3">155068000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <!--Revenue Recognition, Policy [Policy Text Block]-->
  <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Revenue Recognition&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Revenues are recognized in the period in which services are rendered. Net patient revenues (patient revenues less estimated contractual adjustments) are reported at the estimated net realizable amounts from third-party payors, patients and others for services rendered. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off experience.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company determines allowances for doubtful accounts based on the specific agings and payor classifications at each clinic. The provision for doubtful accounts is included in clinic operating costs in the statement of net income. Net accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for doubtful accounts, includes only those amounts the Company estimates to be collectible.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Medicare Reimbursement&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&amp;#8216;&amp;#8216;MPFS&amp;#8217;&amp;#8217;). The MPFS rates have historically been subject to an automatic annual update based on a formula, called the sustainable growth rate (&amp;#8216;&amp;#8216;SGR&amp;#8217;&amp;#8217;) formula. The use of the SGR formula would have resulted in calculated automatic reductions in rates in every year since 2002&amp;#894; however, for each year through September 30, 2015, Centers for Medicare &amp;amp; Medicaid Services (&amp;#8216;&amp;#8216;CMS&amp;#8217;&amp;#8217;) or Congress has taken action to prevent the implementation of SGR formula reductions. On April 16, 2015, the Medicare Access and CHIP Reauthorization Act of 2015 (&amp;#8216;&amp;#8216;MACRA&amp;#8217;&amp;#8217;) was signed into law, eliminating the SGR formula and the associated annual automatic rate reductions.&amp;#160; The MACRA promotes the development of new payment models that focus on quality and outcomes.&amp;#160; As a result of MACRA and CMS&amp;#8217; adjustment to the applicable conversion factor, the net fee schedule payment rates were increased for 2017 by 0.24%.&amp;#160; For 2018 and 2019, a 0.5% increase will be applied each year to the fee schedule payment rates, unless further adjusted by CMS.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years, and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extends the 2% reductions to Medicare payments through fiscal year 2025.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-left: 0.2pt; margin-right: 0.2pt;"&gt;As a result of the Balanced Budget Act of 1997, the formula for determining the total amount paid by Medicare in any one year for outpatient physical therapy, occupational therapy, and/or speech/language pathology services provided to any Medicare beneficiary (i.e., the &amp;#8216;&amp;#8216;Therapy Cap&amp;#8217;&amp;#8217; or &amp;#8216;&amp;#8216;Limit&amp;#8217;&amp;#8217;) was established. Based on the statutory definitions which constrained how the Therapy Cap would be applied, there is one Limit for Physical Therapy and Speech Language Pathology Services combined, and one Limit for Occupational Therapy. For 2017, the annual Limit on outpatient therapy services is $1,980 for Physical and Speech Language Pathology Services combined and $1,980 for Occupational Therapy Services. Historically, these Therapy Caps applied to outpatient therapy services provided in all settings, except for services provided in departments of hospitals. However, the Protecting Access to Medicare Act of 2014, and prior legislation, extended the Therapy Caps to services furnished in hospital outpatient department settings. The application of these annual limits to hospital outpatient department settings will sunset on December 31, 2017 unless Congress extends it.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In the Deficit Reduction Act of 2005, Congress implemented an exceptions process to the annual Limit for therapy expenses for therapy services above the annual Limit. Therapy services above the annual Limit that are medically necessary satisfy an exception to the annual Limit and such claims are payable by the Medicare program. The MACRA extended the exceptions process for outpatient therapy caps through December 31, 2017. Unless Congress extends the exceptions process further, the exceptions no longer will be available in those outpatient therapy setting where the annual Limits are applicable. For any claim above the annual Limit, the claim must contain a modifier indicating that the services are medically necessary and justified by appropriate documentation in the medical record.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Furthermore, under the Middle Class Tax Relief and Job Creation Act of 2012 (&amp;#8216;&amp;#8216;MCTRA&amp;#8217;&amp;#8217;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services&amp;#894; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;CMS adopted a multiple procedure payment reduction (&amp;#8216;&amp;#8216;MPPR&amp;#8217;&amp;#8217;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &amp;#8212; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value Unit (&amp;#8216;&amp;#8216;RVU&amp;#8217;&amp;#8217;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by 50%. In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&amp;#8217;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge, CMS has rejected claims if the required data is not included in the claim.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Physician Quality Reporting System, or &amp;#8216;&amp;#8216;PQRS,&amp;#8217;&amp;#8217; is a CMS reporting program that uses a combination of incentive payments and payment reductions to promote reporting of quality information by &amp;#8216;&amp;#8216;eligible professionals.&amp;#8217;&amp;#8217; Although physical therapists, occupational therapists and qualified speech-language therapists were generally able to participate in the PQRS program, therapy professionals for whose services we bill through our certified rehabilitation agencies cannot participate because the Medicare claims processing systems currently cannot accommodate institutional providers such as certified rehabilitation agencies. Eligible professionals, such as those of our therapy professionals for whose services we bill using their individual Medicare provider numbers, who do not satisfactorily report data on quality measures will be subject to a 2% reduction in their Medicare payment in 2016 and 2017. As required under the MACRA, the PQRS program has been replaced with the Merit-Based Incentive Payment System (MIPS) on January 1, 2017. Physical therapists and occupational therapists are not required to participate in the MIPS program until January 1, 2019 or later, as determined by CMS.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. The Company believes that it is in compliance in all material respects with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the Company&amp;#8217;s financial statements as of June 30, 2017. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the six months ended June 30, 2017, net revenue from Medicare accounts for approximately $45.8 million.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Management Contract Revenues&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Management contract revenues are derived from contractual arrangements whereby the Company manages a clinic for third party owners. The Company does not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized when services are performed. Costs, typically salaries for the Company&amp;#8217;s employees, are recorded when incurred. Management contract revenues are included in &amp;#8220;other revenues&amp;#8221; in the accompanying Consolidated Statements of Net Income.&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <!--Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]-->
  <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Based on the balance of referral relationships and non-compete agreements as of June 30, 2017, the expected amount to be amortized in 2017 and thereafter by year is as follows (in thousands):&lt;/div&gt;&lt;div style="color: #000000; text-align: left;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; border-collapse: collapse; width: 90%;"&gt;&lt;tr&gt;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;Referral Relationships&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;Non-Compete Agreements&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;Years&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;Annual Amount&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;Years&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;Annual Amount&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2017&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,993&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2017&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;860&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;2,063&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2018&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;883&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,973&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2019&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;810&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,973&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2020&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;597&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2021&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,973&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2021&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;519&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2022&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,924&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2022&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;88&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2023&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,817&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2024&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,698&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2025&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,592&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2026&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;1,131&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2027&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;971&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2028&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;401&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;2029&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;"&gt;&amp;#160;43&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
  <!--Revenue, Net-->
  <us-gaap:SalesRevenueNet contextRef="c20170401to20170630" unitRef="U002" decimals="-3">104251000</us-gaap:SalesRevenueNet>
  <!--Revenue, Net-->
  <us-gaap:SalesRevenueNet contextRef="c20170101to20170630" unitRef="U002" decimals="-3">201816000</us-gaap:SalesRevenueNet>
  <!--Revenue, Net-->
  <us-gaap:SalesRevenueNet contextRef="c20160401to20160630" unitRef="U002" decimals="-3">90430000</us-gaap:SalesRevenueNet>
  <!--Revenue, Net-->
  <us-gaap:SalesRevenueNet contextRef="c20160101to20160630" unitRef="U002" decimals="-3">177338000</us-gaap:SalesRevenueNet>
  <!--Schedule of Accrued Liabilities [Table Text Block]-->
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Accrued expenses as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;December 31, 2016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Salaries and related costs&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;15,692&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;10,569&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Credit balances due to patients and payors&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;4,368&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;3,880&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Group health insurance claims&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2,772&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2,499&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Dividends payable to USPH shareholders&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2,516&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Other&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;5,887&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;4,808&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Total&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;31,235&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;21,756&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <!--Schedule of Finite-Lived Intangible Assets [Table Text Block]-->
  <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Intangible assets, net as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):&lt;/div&gt;&lt;div style="color: #000000; text-align: left;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;December 31, 2016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Tradenames&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;26,352&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;21,234&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Referral relationships, net of accumulated amortization of $6,214 and $5,275, respectively&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;18,613&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;14,859&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Non-compete agreements, net of accumulated amortization of $3,781 and $3,380, respectively&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;3,356&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,967&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 76%; background-color: #ffffff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;48,321&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;38,060&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
  <!--Schedule of Maturities of Long-term Debt [Table Text Block]-->
  <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Aggregate annual payments of principal required pursuant to the Amended Credit Agreement and the above notes payable subsequent to June 30, 2017 are as follows (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 58%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;During the twelve months ended June 30, 2018&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;2,345&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 58%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;During the twelve months ended June 30, 2019&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;73,351&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 58%; background-color: #cceeff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;75,696&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
  <!--Schedule of Long-term Debt Instruments [Table Text Block]-->
  <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Amounts outstanding under the Amended Credit Agreement and notes payable as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;Summary of Credit Agreement and Notes Payable&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;December 31, 2016&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Credit Agreement average effective interest rate of 2.7% inclusive of unused fee&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;69,000&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;46,000&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Various notes payable with $2,345 plus accrued interest due in the next year,&amp;#160;interest accrues in the range of 3.25% through 4.0% per annum&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;6,696&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;5,823&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; width: 76%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;75,696&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;51,823&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;Less current portion&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(2,345&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(1,227&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;Long term portion&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;73,351&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;50,596&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
  <!--Schedule of Preliminary Purchase Prices Allocation-->
  <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The purchase price for the 2017 acquisitions has been preliminarily allocated as follows (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Cash paid, net of cash acquired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;33,665&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Seller notes&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,650&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total consideration&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;35,315&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total current assets&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;5,868&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total non-current assets&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,790&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(1,919&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 27pt; text-indent: -9pt;"&gt;Net tangible assets acquired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;5,739&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;4,693&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Non-compete&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,790&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Tradename&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;5,118&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Goodwill&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;40,197&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Fair value of non-controlling interest (classified as redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(11,940&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(10,282&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #cceeff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;35,315&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The purchase prices for the 2016 acquisitions have been preliminarily allocated as follows (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Cash paid, net of cash acquired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;23,623&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Seller notes&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,000&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total consideration&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;24,623&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Estimated fair value of net tangible assets acquired:&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total current assets&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,763&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total non-current assets&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;839&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;"&gt;Total liabilities&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(1,039&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 27pt; text-indent: -9pt;"&gt;Net tangible assets acquired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;1,563&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Referral relationships&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;4,919&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Non-compete&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;847&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Tradename&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;3,802&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Goodwill&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;32,371&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(18,879&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #ffffff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;24,623&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
  <!--Schedule of Goodwill [Table Text Block]-->
  <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The changes in the carrying amount of goodwill consisted of the following (in thousands):&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; width: 78%; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: center;"&gt;Six Months Ended&lt;/div&gt;&lt;font style="color: #000000;"&gt;June 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; width: 78%; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 78%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Beginning balance&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;226,806&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; width: 78%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Goodwill acquired during the period&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;40,197&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 78%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Goodwill adjustments for purchase price allocation of business acquired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;954&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 78%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Ending balance&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;267,957&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
  <!--Segment Reporting, Policy [Policy Text Block]-->
  <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Segment Reporting&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by chief operating decision makers in deciding how to allocate resources and in assessing performance. The Company identifies operating segments based on management responsibility and believes it meets the criteria for aggregating its operating segments into a single reporting segment.&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
  <!--Selling, General and Administrative Expense-->
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c20160401to20160630" unitRef="U002" decimals="-3">8026000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Selling, General and Administrative Expense-->
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c20170101to20170630" unitRef="U002" decimals="-3">17403000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Selling, General and Administrative Expense-->
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c20160101to20160630" unitRef="U002" decimals="-3">17030000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Selling, General and Administrative Expense-->
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c20170401to20170630" unitRef="U002" decimals="-3">8856000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <!--Equity-based awards compensation expense-->
  <us-gaap:ShareBasedCompensation contextRef="c20170101to20170630" unitRef="U002" decimals="-3">2345000</us-gaap:ShareBasedCompensation>
  <!--Equity-based awards compensation expense-->
  <us-gaap:ShareBasedCompensation contextRef="c20160101to20160630" unitRef="U002" decimals="-3">2484000</us-gaap:ShareBasedCompensation>
  <!--Closing price (in dollars per share)-->
  <us-gaap:SharesIssuedPricePerShare contextRef="c20170630" unitRef="U003" decimals="INF">60.40</us-gaap:SharesIssuedPricePerShare>
  <!--Shares, Outstanding-Common Stock [Member]-->
  <us-gaap:SharesOutstanding contextRef="c20161231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3">14733000</us-gaap:SharesOutstanding>
  <!--Shares, Outstanding-Treasury Stock [Member]-->
  <us-gaap:SharesOutstanding contextRef="c20161231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3">-2215000</us-gaap:SharesOutstanding>
  <!--Shares, Outstanding-Treasury Stock [Member]-->
  <us-gaap:SharesOutstanding contextRef="c20170630_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3">-2215000</us-gaap:SharesOutstanding>
  <!--Shares, Outstanding-Common Stock [Member]-->
  <us-gaap:SharesOutstanding contextRef="c20170630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3">14793000</us-gaap:SharesOutstanding>
  <!--Mandatorily redeemable non-controlling interests-->
  <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent contextRef="c20161231" unitRef="U002" decimals="-3">69190000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent>
  <!--Mandatorily redeemable non-controlling interests-->
  <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent contextRef="c20170630" unitRef="U002" decimals="-3">83643000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent>
  <!--Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c20170101to20170630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3">60000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <!--Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures-Common Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c20170101to20170630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <!--Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures-Treasury Stock [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c20170101to20170630_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <!--Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures-Noncontrolling Interest [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c20170101to20170630_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <!--Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures-Retained Earnings [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c20170101to20170630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <!--Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures-Additional Paid-in Capital [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c20170101to20170630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <!--Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures-->
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c20170101to20170630" unitRef="U002" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <!--Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures-Parent [Member]-->
  <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c20170101to20170630_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
  <!--Stock Repurchase Program, Number of Shares Authorized to be Repurchased-->
  <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased contextRef="c20081231" unitRef="U001" decimals="INF">2250000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
  <!--Stock Repurchase Program, Number of Shares Authorized to be Repurchased-->
  <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased contextRef="c20090331" unitRef="U001" decimals="0">1200000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
  <!--Total purchased shares (in shares)-->
  <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c20090301to20090331" unitRef="U001" decimals="INF">859499</us-gaap:StockRepurchasedDuringPeriodShares>
  <!--Total purchased shares (in shares)-->
  <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c20170101to20170630" unitRef="U001" decimals="INF">0</us-gaap:StockRepurchasedDuringPeriodShares>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20161231" unitRef="U002" decimals="-3">188688000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20170630" unitRef="U002" decimals="-3">195966000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Parent [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20161231_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3">187548000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20161231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">68687000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Noncontrolling Interest [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20161231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3">1140000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Retained Earnings [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20161231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">150342000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Common Stock [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20161231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">147000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Treasury Stock [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20161231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Parent [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20170630_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3">194784000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Additional Paid-in Capital [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20170630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">71197000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Treasury Stock [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20170630_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3">-31628000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Common Stock [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20170630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">147000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Retained Earnings [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20170630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">155068000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest-Noncontrolling Interest [Member]-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c20170630_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3">1182000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Stockholders' Equity Note Disclosure [Text Block]-->
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;9. COMMON STOCK&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of the Company&amp;#8217;s common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of its common stock (&amp;#8220;March 2009 Authorization&amp;#8221;). The Amended Credit Agreement permits share repurchases of up to $15,000,000, subject to compliance with covenants. The Company is required to retire shares purchased under the March 2009 Authorization.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Under the March 2009 Authorization, the Company has purchased a total of 859,499 shares. There is no expiration date for the share repurchase program. There are currently an additional estimated 248,344 shares (based on the closing price of $60.40 on June 30, 2017) that may be purchased from time to time in the open market or private transactions depending on price, availability and the Company&amp;#8217;s cash position. The Company did not purchase any shares of its common stock during the six months ended June 30, 2017.&lt;/div&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <!--Stockholders' Equity Attributable to Parent-->
  <us-gaap:StockholdersEquity contextRef="c20161231" unitRef="U002" decimals="-3">187548000</us-gaap:StockholdersEquity>
  <!--Stockholders' Equity Attributable to Parent-->
  <us-gaap:StockholdersEquity contextRef="c20170630" unitRef="U002" decimals="-3">194784000</us-gaap:StockholdersEquity>
  <!--Subsequent Events, Policy [Policy Text Block]-->
  <us-gaap:SubsequentEventsPolicyPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Subsequent Event&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company has evaluated events occurring after the balance sheet date for possible disclosure as a subsequent event through the date that these consolidated financial statements were issued. No disclosure was required.&lt;/div&gt;&lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
  <!--Treasury Stock, Shares-->
  <us-gaap:TreasuryStockShares contextRef="c20170630" unitRef="U001" decimals="INF">2214737</us-gaap:TreasuryStockShares>
  <!--Treasury Stock, Shares-->
  <us-gaap:TreasuryStockShares contextRef="c20161231" unitRef="U001" decimals="INF">2214737</us-gaap:TreasuryStockShares>
  <!--Treasury Stock, Value-->
  <us-gaap:TreasuryStockValue contextRef="c20170630" unitRef="U002" decimals="-3">31628000</us-gaap:TreasuryStockValue>
  <!--Treasury Stock, Value-->
  <us-gaap:TreasuryStockValue contextRef="c20161231" unitRef="U002" decimals="-3">31628000</us-gaap:TreasuryStockValue>
  <!--Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense-->
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c20170101to20170630" unitRef="U002" decimals="0">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
  <!--Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued-->
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="c20170630" unitRef="U002" decimals="0">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
  <!--Use of Estimates, Policy [Policy Text Block]-->
  <us-gaap:UseOfEstimates contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Use of Estimates&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In preparing the Company&amp;#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, purchase accounting, goodwill impairment, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.&lt;/div&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
  <!--Weighted Average Number of Shares Outstanding, Diluted-->
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c20160101to20160630" unitRef="U001" decimals="-3">12480000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <!--Weighted Average Number of Shares Outstanding, Diluted-->
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c20160401to20160630" unitRef="U001" decimals="-3">12511000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <!--Weighted Average Number of Shares Outstanding, Diluted-->
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c20170101to20170630" unitRef="U001" decimals="-3">12553000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <!--Weighted Average Number of Shares Outstanding, Diluted-->
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c20170401to20170630" unitRef="U001" decimals="-3">12579000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <!--Weighted Average Number of Shares Outstanding, Basic-->
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c20160401to20160630" unitRef="U001" decimals="-3">12511000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <!--Weighted Average Number of Shares Outstanding, Basic-->
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c20170101to20170630" unitRef="U001" decimals="-3">12553000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <!--Weighted Average Number of Shares Outstanding, Basic-->
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c20170401to20170630" unitRef="U001" decimals="-3">12579000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <!--Weighted Average Number of Shares Outstanding, Basic-->
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c20160101to20160630" unitRef="U001" decimals="-3">12480000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <!--REDEEMABLE NON-CONTROLLING INTERESTS [Text Block]-->
  <usph:REDEEMABLENONCONTROLLINGINTERESTSTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;4. REDEEMABLE NON-CONTROLLING INTERESTS&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;When the Company acquires a majority interest in a Therapy Practice, those Acquisitions occur in a series of steps as described in numbers 1 through 10 of footnote 3 &amp;#8211; Mandatorily Redeemable Non-Controlling Interests.&amp;#160; For the Acquisitions that occurred after the first quarter of 2017, the Partnership Agreement contained provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &amp;#8220;Call Right&amp;#8221;) or at the option of the Seller Entity (the &amp;#8220;Put Right&amp;#8221;) as follows:&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 72pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;"&gt;1.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Put Right&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 108pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;a.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In the event that any Selling Shareholder&amp;#8217;s employment is terminated involuntarily by the Company without &amp;#8220;Cause&amp;#8221; pursuant to Section 7(d) of such Selling Shareholder&amp;#8217;s Employment Agreement prior to the fifth anniversary of the Closing Date, the Seller Entity thereafter shall have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&amp;#8217;s Allocable Percentage of Seller Entity&amp;#8217;s Interest at the purchase price described in &amp;#8220;3&amp;#8221; below.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 108pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;b.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In the event that any Selling Shareholder is not employed by NewCo as of the fifth anniversary of the Closing Date and the Company has not exercised its Call Right with respect to the Terminated Selling Shareholder&amp;#8217;s Allocable Percentage of Seller Entity&amp;#8217;s Interest, Seller Entity thereafter shall have the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&amp;#8217;s Allocable Percentage of Seller Entity&amp;#8217;s Interest at the purchase price described in &amp;#8220;3&amp;#8221; below.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 108pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;c.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In the event that any Selling Shareholder&amp;#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Seller Entity shall have the Put Right, and upon the exercise of the Put Right, the Terminated Selling Shareholder&amp;#8217;s Allocable Percentage of Seller Entity&amp;#8217;s Interest shall be redeemed by the Company at the purchase price described in &amp;#8220;3&amp;#8221; below.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 72pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;"&gt;2.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;Call Right&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 108pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;a.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;If any Selling Shareholder&amp;#8217;s employment by NewCo is terminated (i) pursuant to a voluntary termination by the Selling Shareholder or (ii) by NewCo with &amp;#8220;Cause&amp;#8221; (as defined in the Selling Shareholder&amp;#8217;s Employment Agreement), prior to the fifth anniversary of the Closing Date, the Company thereafter shall have an irrevocable right to purchase from Seller Entity the Terminated Selling Shareholder&amp;#8217;s Allocable Percentage of Seller Entity&amp;#8217;s Interest, in each case at the purchase price described in &amp;#8220;3&amp;#8221; below.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 108pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;"&gt;b.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;In the event that any Selling Shareholder&amp;#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Company shall have the Call Right, and upon the exercise of the Call Right, the Terminated Selling Shareholder&amp;#8217;s Allocable Percentage of Seller Entity&amp;#8217;s Interest shall be redeemed by the Company at the purchase price described in &amp;#8220;3&amp;#8221; below.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 72pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;"&gt;3.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&amp;#8217;s trailing twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&amp;#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &amp;#8220;Redemption Amount&amp;#8221;). NewCo&amp;#8217;s earnings are distributed monthly based on available cash within NewCo&amp;#894; therefore, the undistributed earnings amount is small, if any.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 72pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;"&gt;4.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 72pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;"&gt;5.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Put Right and the Call Right do not have an expiration date, but the Seller Entity Interest is not required to be purchased by the Company or sold by the Seller Entity.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align: left;"&gt;&lt;table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td style="color: #000000; width: 72pt;"&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;"&gt;6.&lt;/td&gt;&lt;td style="vertical-align: top; color: #000000; text-align: left; width: auto;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;An Employed Selling Shareholder&amp;#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&amp;#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &amp;#8220;claw back&amp;#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &amp;#8220;cause&amp;#8221; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&amp;#8217;s only recourse against the Employed Selling Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;At June 30, 2017, the recorded initial value of $11.9 million approximates the Redemption Amount.&amp;#160; Any allocation of earnings during the three months ended June 30, 2017 was immaterial.&lt;/div&gt;&lt;/div&gt;</usph:REDEEMABLENONCONTROLLINGINTERESTSTextBlock>
  <!--Patients And Payors Related Liability-->
  <usph:PatientsAndPayorsRelatedLiability contextRef="c20170630" unitRef="U002" decimals="-3">4368000</usph:PatientsAndPayorsRelatedLiability>
  <!--Patients And Payors Related Liability-->
  <usph:PatientsAndPayorsRelatedLiability contextRef="c20161231" unitRef="U002" decimals="-3">3880000</usph:PatientsAndPayorsRelatedLiability>
  <!--Finite Lived Intangible Assets Amortization Expense Year Six-Non-compete Agreements [Member]-->
  <usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearSix contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember" unitRef="U002" decimals="-3">88000</usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearSix>
  <!--Finite Lived Intangible Assets Amortization Expense Year Six-Referral Relationship [Member]-->
  <usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearSix contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">1924000</usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearSix>
  <!--Finite Lived Intangible Assets Amortization Expense Year Ten-Referral Relationship [Member]-->
  <usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearTen contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">1131000</usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearTen>
  <!--Finite Lived Intangible Assets Amortization Expense Year Twelve-Referral Relationship [Member]-->
  <usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">401000</usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve>
  <!--Finite Lived Intangible Assets Amortization Expense Year Nine-Referral Relationship [Member]-->
  <usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearNine contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">1592000</usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearNine>
  <!--Finite Lived Intangible Assets Amortization Expense Year Thirteen-Referral Relationship [Member]-->
  <usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">43000</usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen>
  <!--Finite Lived Intangible Assets Amortization Expense Year Eleven-Referral Relationship [Member]-->
  <usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">971000</usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven>
  <!--Finite Lived Intangible Assets Amortization Expense Year Seven-Referral Relationship [Member]-->
  <usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">1817000</usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven>
  <!--Finite Lived Intangible Assets Amortization Expense Year Eight-Referral Relationship [Member]-->
  <usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearEight contextRef="c20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember" unitRef="U002" decimals="-3">1698000</usph:FiniteLivedIntangibleAssetsAmortizationExpenseYearEight>
  <!--Acquisition of Noncontrolling Interest Seller Financing Portion-->
  <usph:AcquisitionOfNoncontrollingInterestSellerFinancingPortion contextRef="c20160101to20160630" unitRef="U002" decimals="-3">388000</usph:AcquisitionOfNoncontrollingInterestSellerFinancingPortion>
  <!--Acquisition of Noncontrolling Interest Seller Financing Portion-->
  <usph:AcquisitionOfNoncontrollingInterestSellerFinancingPortion contextRef="c20170101to20170630" unitRef="U002" decimals="-3">0</usph:AcquisitionOfNoncontrollingInterestSellerFinancingPortion>
  <!--Purchase Of Business Seller Financing Portion-->
  <usph:PurchaseOfBusinessSellerFinancingPortion contextRef="c20160101to20160630" unitRef="U002" decimals="-3">500000</usph:PurchaseOfBusinessSellerFinancingPortion>
  <!--Purchase Of Business Seller Financing Portion-->
  <usph:PurchaseOfBusinessSellerFinancingPortion contextRef="c20170101to20170630" unitRef="U002" decimals="-3">1650000</usph:PurchaseOfBusinessSellerFinancingPortion>
  <!--Sale Of Noncontrolling Interest-->
  <usph:SaleOfNoncontrollingInterest contextRef="c20160101to20160630" unitRef="U002" decimals="-3">-148000</usph:SaleOfNoncontrollingInterest>
  <!--Sale Of Noncontrolling Interest-->
  <usph:SaleOfNoncontrollingInterest contextRef="c20170101to20170630" unitRef="U002" decimals="-3">0</usph:SaleOfNoncontrollingInterest>
  <!--Increase (decrease) in Mandatorily Redeemable Non-controlling Interests-->
  <usph:IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests contextRef="c20160101to20160630" unitRef="U002" decimals="-3">4028000</usph:IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests>
  <!--Increase (decrease) in Mandatorily Redeemable Non-controlling Interests-->
  <usph:IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests contextRef="c20170101to20170630" unitRef="U002" decimals="-3">6401000</usph:IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests>
  <!--Payment to Settle Redeemable Non-controlling Interest Financing Portion-->
  <usph:PaymentToSettleRedeemableNonControllingInterestFinancingPortion contextRef="c20170101to20170630" unitRef="U002" decimals="-3">0</usph:PaymentToSettleRedeemableNonControllingInterestFinancingPortion>
  <!--Payment to Settle Redeemable Non-controlling Interest Financing Portion-->
  <usph:PaymentToSettleRedeemableNonControllingInterestFinancingPortion contextRef="c20160101to20160630" unitRef="U002" decimals="-3">126000</usph:PaymentToSettleRedeemableNonControllingInterestFinancingPortion>
  <!--Rent Clinic Supplies Contract Labor And Other-->
  <usph:RentClinicSuppliesContractLaborAndOther contextRef="c20160101to20160630" unitRef="U002" decimals="-3">35053000</usph:RentClinicSuppliesContractLaborAndOther>
  <!--Rent Clinic Supplies Contract Labor And Other-->
  <usph:RentClinicSuppliesContractLaborAndOther contextRef="c20170401to20170630" unitRef="U002" decimals="-3">20033000</usph:RentClinicSuppliesContractLaborAndOther>
  <!--Rent Clinic Supplies Contract Labor And Other-->
  <usph:RentClinicSuppliesContractLaborAndOther contextRef="c20170101to20170630" unitRef="U002" decimals="-3">40120000</usph:RentClinicSuppliesContractLaborAndOther>
  <!--Rent Clinic Supplies Contract Labor And Other-->
  <usph:RentClinicSuppliesContractLaborAndOther contextRef="c20160401to20160630" unitRef="U002" decimals="-3">17546000</usph:RentClinicSuppliesContractLaborAndOther>
  <!--Interest Expense, Debt and Other Expense-->
  <usph:InterestExpenseDebtAndOther contextRef="c20160401to20160630" unitRef="U002" decimals="-3">320000</usph:InterestExpenseDebtAndOther>
  <!--Interest Expense, Debt and Other Expense-->
  <usph:InterestExpenseDebtAndOther contextRef="c20160101to20160630" unitRef="U002" decimals="-3">628000</usph:InterestExpenseDebtAndOther>
  <!--Interest Expense, Debt and Other Expense-->
  <usph:InterestExpenseDebtAndOther contextRef="c20170101to20170630" unitRef="U002" decimals="-3">931000</usph:InterestExpenseDebtAndOther>
  <!--Interest Expense, Debt and Other Expense-->
  <usph:InterestExpenseDebtAndOther contextRef="c20170401to20170630" unitRef="U002" decimals="-3">516000</usph:InterestExpenseDebtAndOther>
  <!--Interest Expense, Mandatorily Redeemable Non-controlling Interests - Increase (Decrease) in Redemption Value-->
  <usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue contextRef="c20170401to20170630" unitRef="U002" decimals="-3">3923000</usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue>
  <!--Interest Expense, Mandatorily Redeemable Non-controlling Interests - Increase (Decrease) in Redemption Value-->
  <usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue contextRef="c20170101to20170630" unitRef="U002" decimals="-3">6592000</usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue>
  <!--Interest Expense, Mandatorily Redeemable Non-controlling Interests - Increase (Decrease) in Redemption Value-->
  <usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue contextRef="c20160401to20160630" unitRef="U002" decimals="-3">1931000</usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue>
  <!--Interest Expense, Mandatorily Redeemable Non-controlling Interests - Increase (Decrease) in Redemption Value-->
  <usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue contextRef="c20160101to20160630" unitRef="U002" decimals="-3">4122000</usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue>
  <!--Interest Expense, Mandatorily Redeemable Non-controlling Interests - Earnings Allocable-->
  <usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable contextRef="c20170101to20170630" unitRef="U002" decimals="-3">3081000</usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable>
  <!--Interest Expense, Mandatorily Redeemable Non-controlling Interests - Earnings Allocable-->
  <usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable contextRef="c20160401to20160630" unitRef="U002" decimals="-3">1330000</usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable>
  <!--Interest Expense, Mandatorily Redeemable Non-controlling Interests - Earnings Allocable-->
  <usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable contextRef="c20160101to20160630" unitRef="U002" decimals="-3">2217000</usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable>
  <!--Interest Expense, Mandatorily Redeemable Non-controlling Interests - Earnings Allocable-->
  <usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable contextRef="c20170401to20170630" unitRef="U002" decimals="-3">1787000</usph:InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable>
  <!--Carrying Amount of Redeemable Non-Controlling Interest [Table Text Block]-->
  <usph:CarryingAmountOfRedeemableNonControllingInterestTableTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The following table details the carrying amount of the mandatorily redeemable non-controlling interest (in thousands) as of June 30, 2017:&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"&gt;June 30, 2017&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Contractual time period has lapsed but holder's employment has not been terminated&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;30,838&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Contractual time period has not lapsed and holder's employment has not been terminated&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;55,454&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Holder's employment has terminated and contractual time period has expired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Holder's employment has terminated and contractual time period has not expired&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Redemption value prior to excess distributed earnings&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;86,292&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;"&gt;Excess distributions over earnings and losses&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;(2,649&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #cceeff; text-indent: -9pt;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;$&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;83,643&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</usph:CarryingAmountOfRedeemableNonControllingInterestTableTextBlock>
  <!--Maximum Percentage Of Repurchase Of Common Stock-Maximum [Member]-->
  <usph:MaximumPercentageOfRepurchaseOfCommonStock contextRef="c20090331_RangeAxis_MaximumMember" unitRef="U004" decimals="INF">0.1</usph:MaximumPercentageOfRepurchaseOfCommonStock>
  <!--Bank Credit Agreement To Permit Share Repurchases Of Common Stock-Maximum [Member]-->
  <usph:BankCreditAgreementToPermitShareRepurchasesOfCommonStock contextRef="c20090331_RangeAxis_MaximumMember" unitRef="U002" decimals="0">15000000</usph:BankCreditAgreementToPermitShareRepurchasesOfCommonStock>
  <!--Additional Estimated Repurchase Of Common Stock-->
  <usph:AdditionalEstimatedRepurchaseOfCommonStock contextRef="c20170101to20170630" unitRef="U001" decimals="0">248344</usph:AdditionalEstimatedRepurchaseOfCommonStock>
  <!--Cash And Noncash Consideration With Respect To Acquisition After Amendement-Credit Agreement [Member]-->
  <usph:CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement contextRef="c20160101to20160131_CreditFacilityAxis_CreditAgreementMember" unitRef="U002" decimals="0">50000000</usph:CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement>
  <!--Dividends Cash After Amendment-Credit Agreement [Member]-Maximum [Member]-->
  <usph:DividendsCashAfterAmendment contextRef="c20170101to20170630_CreditFacilityAxis_CreditAgreementMember_RangeAxis_MaximumMember" unitRef="U002" decimals="0">15000000</usph:DividendsCashAfterAmendment>
  <!--Dividends Cash After Amendment-Maximum [Member]-Credit Agreement [Member]-->
  <usph:DividendsCashAfterAmendment contextRef="c20160101to20160131_CreditFacilityAxis_CreditAgreementMember_RangeAxis_MaximumMember" unitRef="U002" decimals="0">10000000</usph:DividendsCashAfterAmendment>
  <!--Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans-Parent [Member]-->
  <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans contextRef="c20170101to20170630_StatementEquityComponentsAxis_ParentMember" unitRef="U002" decimals="-3">165000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
  <!--Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans-Common Stock [Member]-->
  <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans contextRef="c20170101to20170630_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
  <!--Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans-Treasury Stock [Member]-->
  <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans contextRef="c20170101to20170630_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U002" decimals="-3">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
  <!--Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans-Retained Earnings [Member]-->
  <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans contextRef="c20170101to20170630_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U002" decimals="-3">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
  <!--Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans-->
  <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans contextRef="c20170101to20170630" unitRef="U002" decimals="-3">165000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
  <!--Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans-Noncontrolling Interest [Member]-->
  <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans contextRef="c20170101to20170630_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U002" decimals="-3">0</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
  <!--Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans-Additional Paid-in Capital [Member]-->
  <usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans contextRef="c20170101to20170630_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U002" decimals="-3">165000</usph:TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans>
  <!--Business Combination Acquisition Fair Value of Redeemable Non-Controlling Interests-->
  <usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests contextRef="c20170630" unitRef="U002" decimals="-3">-11940000</usph:BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests>
  <!--Business Acquisition Cost Of Acquired Entity Debt Issued-Acquisition Of Nine Clinic Practices [Member]-->
  <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued contextRef="c20170630_BusinessAcquisitionAxis_AcquisitionOfNineClinicPracticesMember" unitRef="U002" decimals="-5">500000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
  <!--Business Acquisition Cost Of Acquired Entity Debt Issued-Acquisition of Seventeen Clinic Practices [Member]-->
  <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued contextRef="c20161231_BusinessAcquisitionAxis_AcquisitionOfSeventeenClinicPracticesMember" unitRef="U002" decimals="-5">500000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
  <!--Business Acquisition Cost Of Acquired Entity Debt Issued-Acquisition Of Eight Clinic Practices [Member]-->
  <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued contextRef="c20160229_BusinessAcquisitionAxis_AcquisitionOfEightClinicPracticesMember" unitRef="U002" decimals="-5">500000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
  <!--Business Acquisition Cost Of Acquired Entity Debt Issued-Workforce Performance Solutions [Member]-->
  <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued contextRef="c20170323_BusinessAcquisitionAxis_WorkforcePerformanceSolutionsMember" unitRef="U002" decimals="-5">400000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
  <!--Business Acquisition Cost Of Acquired Entity Debt Issued-Acquisition Of Twelve Clinic Practices [Member]-->
  <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued contextRef="c20161130_BusinessAcquisitionAxis_AcquisitionOfTwelveClinicPracticesMember" unitRef="U002" decimals="-5">500000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
  <!--Business Acquisition Cost Of Acquired Entity Debt Issued-Acquisition Of Four Clinic Practices [Member]-->
  <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued contextRef="c20170531_BusinessAcquisitionAxis_AcquisitionOfFourClinicPracticesMember" unitRef="U002" decimals="0">250000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
  <!--Business Acquisition Cost Of Acquired Entity Debt Issued-->
  <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued contextRef="c20170630" unitRef="U002" decimals="-3">1650000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
  <!--Business Acquisition Cost Of Acquired Entity Debt Issued-->
  <usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued contextRef="c20161231" unitRef="U002" decimals="-3">1000000</usph:BusinessAcquisitionCostOfAcquiredEntityDebtIssued>
  <!--Business Acquisition Number Of Installments To Payment Of Purchase Consideration-Acquisition of Seventeen Clinic Practices [Member]-->
  <usph:BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration contextRef="c20170101to20170101_BusinessAcquisitionAxis_AcquisitionOfSeventeenClinicPracticesMember" unitRef="U009" decimals="INF">2</usph:BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration>
  <!--Business Acquisition Number Of Installments To Payment Of Purchase Consideration-Acquisition Of Four Clinic Practices [Member]-->
  <usph:BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration contextRef="c20170531to20170531_BusinessAcquisitionAxis_AcquisitionOfFourClinicPracticesMember" unitRef="U009" decimals="INF">2</usph:BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration>
  <!--Business Acquisition Number Of Installments To Payment Of Purchase Consideration-Acquisition Of Twelve Clinic Practices [Member]-->
  <usph:BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration contextRef="c20161130to20161130_BusinessAcquisitionAxis_AcquisitionOfTwelveClinicPracticesMember" unitRef="U009" decimals="INF">2</usph:BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration>
  <!--Business Acquisition Number Of Installments To Payment Of Purchase Consideration-Acquisition Of Eight Clinic Practices [Member]-->
  <usph:BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration contextRef="c20160229to20160229_BusinessAcquisitionAxis_AcquisitionOfEightClinicPracticesMember" unitRef="U009" decimals="INF">2</usph:BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration>
  <!--Business Acquisition Number Of Installments To Payment Of Purchase Consideration-Acquisition Of Nine Clinic Practices [Member]-->
  <usph:BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration contextRef="c20170101to20170630_BusinessAcquisitionAxis_AcquisitionOfNineClinicPracticesMember" unitRef="U009" decimals="INF">2</usph:BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration>
  <!--Payments To Acquire Businesses Consideration-->
  <usph:PaymentsToAcquireBusinessesConsideration contextRef="c20161231" unitRef="U002" decimals="-3">24623000</usph:PaymentsToAcquireBusinessesConsideration>
  <!--Payments To Acquire Businesses Consideration-->
  <usph:PaymentsToAcquireBusinessesConsideration contextRef="c20170630" unitRef="U002" decimals="-3">35315000</usph:PaymentsToAcquireBusinessesConsideration>
  <!--Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest-January Two Thousand Eighteen [Member]-Acquisition of Seventeen Clinic Practices [Member]-->
  <usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest contextRef="c20170101to20170101_BusinessAcquisitionAxis_AcquisitionOfSeventeenClinicPracticesMember_StatementScenarioAxis_JanuaryTwoThousandEighteenMember" unitRef="U002" decimals="0">250000</usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest>
  <!--Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest-February Two Thousand Seventeen [Member]-Acquisition Of Eight Clinic Practices [Member]-->
  <usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest contextRef="c20160229to20160229_BusinessAcquisitionAxis_AcquisitionOfEightClinicPracticesMember_StatementScenarioAxis_FebruaryTwoThousandSeventeenMember" unitRef="U002" decimals="0">250000</usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest>
  <!--Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest-June Two Thousand Nineteen [Member]-Acquisition Of Nine Clinic Practices [Member]-->
  <usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest contextRef="c20170101to20170630_BusinessAcquisitionAxis_AcquisitionOfNineClinicPracticesMember_StatementScenarioAxis_JuneTwoThousandNineteenMember" unitRef="U002" decimals="0">250000</usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest>
  <!--Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest-Acquisition Of Twelve Clinic Practices [Member]-November Two Thousand Seventeen [Member]-->
  <usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest contextRef="c20161130to20161130_BusinessAcquisitionAxis_AcquisitionOfTwelveClinicPracticesMember_StatementScenarioAxis_NovemberTwoThousandSeventeenMember" unitRef="U002" decimals="0">250000</usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest>
  <!--Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest-February Two Thousand Eighteen [Member]-Acquisition Of Eight Clinic Practices [Member]-->
  <usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest contextRef="c20160229to20160229_BusinessAcquisitionAxis_AcquisitionOfEightClinicPracticesMember_StatementScenarioAxis_FebruaryTwoThousandEighteenMember" unitRef="U002" decimals="0">250000</usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest>
  <!--Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest-Acquisition Of Twelve Clinic Practices [Member]-November Two Thousand Eighteen [Member]-->
  <usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest contextRef="c20161130to20161130_BusinessAcquisitionAxis_AcquisitionOfTwelveClinicPracticesMember_StatementScenarioAxis_NovemberTwoThousandEighteenMember" unitRef="U002" decimals="0">250000</usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest>
  <!--Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest-January Two Thousand Nineteen [Member]-Acquisition of Seventeen Clinic Practices [Member]-->
  <usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest contextRef="c20170101to20170101_BusinessAcquisitionAxis_AcquisitionOfSeventeenClinicPracticesMember_StatementScenarioAxis_JanuaryTwoThousandNineteenMember" unitRef="U002" decimals="0">250000</usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest>
  <!--Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest-Acquisition Of Four Clinic Practices [Member]-May Two Thousand Eighteen [Member]-->
  <usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest contextRef="c20170531to20170531_BusinessAcquisitionAxis_AcquisitionOfFourClinicPracticesMember_StatementScenarioAxis_MayTwoThousandEighteenMember" unitRef="U002" decimals="0">125000</usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest>
  <!--Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest-May Two Thousand Nineteen [Member]-Acquisition Of Four Clinic Practices [Member]-->
  <usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest contextRef="c20170531to20170531_BusinessAcquisitionAxis_AcquisitionOfFourClinicPracticesMember_StatementScenarioAxis_MayTwoThousandNineteenMember" unitRef="U002" decimals="0">125000</usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest>
  <!--Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest-June Two Thousand Eighteen [Member]-Acquisition Of Nine Clinic Practices [Member]-->
  <usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest contextRef="c20170101to20170630_BusinessAcquisitionAxis_AcquisitionOfNineClinicPracticesMember_StatementScenarioAxis_JuneTwoThousandEighteenMember" unitRef="U002" decimals="0">250000</usph:BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest>
  <!--Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships-->
  <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships contextRef="c20170630" unitRef="U002" decimals="-3">4693000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
  <!--Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships-->
  <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships contextRef="c20161231" unitRef="U002" decimals="-3">4919000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships>
  <!--Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename-->
  <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename contextRef="c20170630" unitRef="U002" decimals="-3">5118000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
  <!--Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename-->
  <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename contextRef="c20161231" unitRef="U002" decimals="-3">3802000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename>
  <!--Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements-->
  <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements contextRef="c20170630" unitRef="U002" decimals="-3">1790000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
  <!--Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements-->
  <usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements contextRef="c20161231" unitRef="U002" decimals="-3">847000</usph:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements>
  <!--Business Combination, Acquired Finite-Lived Intangible Asset, Useful Life-Referral Relationship [Member]-Maximum [Member]-->
  <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife contextRef="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MaximumMember">P13Y</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
  <!--Business Combination, Acquired Finite-Lived Intangible Asset, Useful Life-Non-compete Agreements [Member]-->
  <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife contextRef="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_NoncompeteAgreementsMember">P6Y</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
  <!--Business Combination, Acquired Finite-Lived Intangible Asset, Useful Life-Referral Relationship [Member]-Minimum [Member]-->
  <usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife contextRef="c20170101to20170630_FiniteLivedIntangibleAssetsByMajorClassAxis_ReferralRelationshipMember_RangeAxis_MinimumMember">P12Y</usph:BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife>
  <!--Business Acquisition Purchase Price Allocation Net Tangible Asset-->
  <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset contextRef="c20161231" unitRef="U002" decimals="-3">1563000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
  <!--Business Acquisition Purchase Price Allocation Net Tangible Asset-->
  <usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset contextRef="c20170630" unitRef="U002" decimals="-3">5739000</usph:BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset>
  <!--Number Of Subsidiaries Acquired Clinic Practices-->
  <usph:NumberOfSubsidiariesAcquiredClinicPractices contextRef="c20160101to20161231" unitRef="U010" decimals="INF">2</usph:NumberOfSubsidiariesAcquiredClinicPractices>
  <!--Contractual Time Period Has Not Lapsed And Holders Employment Has Not Been Terminated-->
  <usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated contextRef="c20170630" unitRef="U002" decimals="-3">55454000</usph:ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated>
  <!--Excess Distributions Over Earnings and Losses-->
  <usph:ExcessDistributionsOverEarningsAndLosses contextRef="c20170630" unitRef="U002" decimals="-3">2649000</usph:ExcessDistributionsOverEarningsAndLosses>
  <!--Contractual Time Period Has Lapsed But Holders Employment Has Not Been Terminated-->
  <usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated contextRef="c20170630" unitRef="U002" decimals="-3">30838000</usph:ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated>
  <!--Distributions to Lmited Partners and Redeemable Noncontrolling Interests-->
  <usph:DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests contextRef="c20170101to20170630" unitRef="U002" decimals="-3">3272000</usph:DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests>
  <!--Business Acquisition Consideration Payable, Term of Note-Therapy Practice [Member]-NewCo. [Member]-->
  <usph:BusinessAcquisitionConsiderationPayableTermOfNote contextRef="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember">P2Y</usph:BusinessAcquisitionConsiderationPayableTermOfNote>
  <!--Business Acquisition, Percentage of General Partnership Interest Acquired-Therapy Practice [Member]-NewCo. [Member]-->
  <usph:BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired contextRef="c20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember" unitRef="U004" decimals="INF">1</usph:BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired>
  <!--Business Acquisition Percentage Of Equity Interest In Subsidiary Contributed-NewCo. [Member]-Therapy Practice [Member]-->
  <usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed contextRef="c20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember" unitRef="U004" decimals="INF">1</usph:BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed>
  <!--Required Redemption Term, under Condition of Termination of Employment of Employed Selling Shareholders-Minimum [Member]-Therapy Practice [Member]-NewCo. [Member]-->
  <usph:RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders contextRef="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember_RangeAxis_MinimumMember">P3Y</usph:RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders>
  <!--Required Redemption Term, under Condition of Termination of Employment of Employed Selling Shareholders-NewCo. [Member]-Therapy Practice [Member]-Maximum [Member]-->
  <usph:RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders contextRef="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember_RangeAxis_MaximumMember">P5Y</usph:RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders>
  <!--Term of Employment Agreement-NewCo. [Member]-Therapy Practice [Member]-Maximum [Member]-->
  <usph:TermOfEmploymentAgreement contextRef="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember_RangeAxis_MaximumMember">P5Y</usph:TermOfEmploymentAgreement>
  <!--Term of Employment Agreement-Minimum [Member]-Therapy Practice [Member]-NewCo. [Member]-->
  <usph:TermOfEmploymentAgreement contextRef="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember_RangeAxis_MinimumMember">P3Y</usph:TermOfEmploymentAgreement>
  <!--Non-Compete Agreement Term under Condition of Termination of Employment of Employed Selling Shareholder-Therapy Practice [Member]-NewCo. [Member]-->
  <usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder contextRef="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember">P2Y</usph:NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder>
  <!--Non-Compete Agreement Term under Condition Two-NewCo. [Member]-Therapy Practice [Member]-Maximum [Member]-->
  <usph:NonCompeteAgreementBasicTerm contextRef="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember_RangeAxis_MaximumMember">P6Y</usph:NonCompeteAgreementBasicTerm>
  <!--Non-Compete Agreement Term under Condition Two-Minimum [Member]-Therapy Practice [Member]-NewCo. [Member]-->
  <usph:NonCompeteAgreementBasicTerm contextRef="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember_RangeAxis_MinimumMember">P5Y</usph:NonCompeteAgreementBasicTerm>
  <!--Increase Due To Revaluation Fair Value Of Redeemable Non-Controlling Interest-->
  <usph:IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest contextRef="c20170101to20170630" unitRef="U002" decimals="-3">2230000</usph:IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest>
  <!--Business Acquisition, Percentage of Limited Partnership Interest Acquired-Therapy Practice [Member]-Minimum [Member]-->
  <usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired contextRef="c20170630_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MinimumMember" unitRef="U004" decimals="INF">0.5</usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired>
  <!--Business Acquisition, Percentage of Limited Partnership Interest Acquired-Therapy Practice [Member]-Maximum [Member]-->
  <usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired contextRef="c20170630_BusinessAcquisitionAxis_TherapyPracticeMember_RangeAxis_MaximumMember" unitRef="U004" decimals="INF">0.9</usph:BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired>
  <!--Holders Employment Has Terminated and Contractual Time Period Has Expired-->
  <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired contextRef="c20170630" unitRef="U002" decimals="-3">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired>
  <!--Employment Agreement Renewal Term-Therapy Practice [Member]-NewCo. [Member]-->
  <usph:EmploymentAgreementRenewalTerm contextRef="c20170101to20170630_BusinessAcquisitionAxis_TherapyPracticeMember_LegalEntityAxis_SubsidiariesMember">P1Y</usph:EmploymentAgreementRenewalTerm>
  <!--Holders Employment Has Terminated and Contractual Time Period Has Not Expired-->
  <usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired contextRef="c20170630" unitRef="U002" decimals="-3">0</usph:HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired>
  <!--Redeemable Non Controlling Interests [Policy Text Block]-->
  <usph:RedeemableNonControllingInterestsPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Redeemable Non-Controlling Interests&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;"&gt;The non-controlling interests that are reflected as redeemable non-controlling interests in the consolidated financial statements consist of those owners who have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase the non-controlling interest of those owners, if certain conditions are met and the owners request the purchase.&amp;#160; The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&amp;#160; The redemption rights can be triggered by the owner at such time as both of the following events have occurred: 1) termination of the owner&amp;#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically three to five years, as defined in the limited partnership agreement.&amp;#160; The redemption rights are not automatic (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;"&gt;On the date the Company acquires a controlling interest in a partnership and the limited partnership agreement contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &amp;#8211; &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Redeemable non-controlling interests&lt;/font&gt;.&amp;#160; Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial value, based on the predetermined formula defined in the respective limited partnership agreement.&amp;#160; Hence, the value of the non-controlling interest is not adjusted below its initial value.&amp;#160; The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the statements of net income.&amp;#160; Although the adjustments are not reflected in the statements of net income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation.&amp;#160; The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the income statement.&lt;/div&gt;&lt;/div&gt;</usph:RedeemableNonControllingInterestsPolicyTextBlock>
  <!--Restricted Stock Policy [Policy Text Block]-->
  <usph:RestrictedStockPolicyPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Restricted Stock&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock granted to employees, other than officers, lapse in equal annual installments on the following four anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the first year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The restricted stock issued is included in basic and diluted shares for the earnings per share computation.&lt;/div&gt;&lt;/div&gt;</usph:RestrictedStockPolicyPolicyTextBlock>
  <!--Mandatorily Redeemable Non Controlling Interests [Policy Text Block]-->
  <usph:MandatorilyRedeemableNonControllingInterestsPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Mandatorily Redeemable Non-Controlling Interests&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;"&gt;The non-controlling interests that are reflected as mandatorily redeemable non-controlling interests in the consolidated financial statements consist of those owners who have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase the non-controlling interest of those owners at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&amp;#160; The redemption rights are triggered at such time as both of the following events have occurred: 1) termination of the owner&amp;#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically three to five years, as defined in the limited partnership agreement.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;"&gt;On the date the Company acquires a controlling interest in a partnership and the limited partnership agreement contains mandatory redemption rights, the fair value of the non-controlling interest is recorded in the long-term liabilities section of the consolidated balance sheet under the caption &amp;#8211; &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Mandatorily redeemable non-controlling interests&lt;/font&gt;.&amp;#160; Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to its then current redemption value, based on the predetermined formula defined in the respective limited partnership agreement.&amp;#160; The Company reflects any adjustment in the redemption value and any earnings attributable to the mandatorily redeemable non-controlling interest in its consolidated statements of net income by recording the adjustments and earnings to other income and expense in the captions - &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Interest expense &amp;#8211; mandatorily redeemable non-controlling interests &amp;#8211; change in redemption value and Interest expense &amp;#8211; mandatorily redeemable non-controlling interests &amp;#8211; earnings allocable&lt;/font&gt;.&lt;/div&gt;&lt;/div&gt;</usph:MandatorilyRedeemableNonControllingInterestsPolicyTextBlock>
  <!--Recently Issued Accounting Guidance [Policy Text Block]-->
  <usph:RecentlyIssuedAccountingGuidancePolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Recently Issued Accounting Guidance&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In January 2017, the FASB issued ASU 2017-04, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Simplifying the Test for Goodwill Impairment (Topic 350),&lt;/font&gt; which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment change. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods within those years, beginning after December 15, 2019. The Company is currently evaluating the impact of adopting this ASU on our consolidated financial statements and do not expect adoption to have a material impact.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In February 2016, the FASB issued amended accounting guidance (ASU 2016-02 - &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Leases&lt;/font&gt;) which replaced most existing lease accounting guidance under U. S. generally accepted accounting principles. Among other changes, the amended guidance requires that a right-to-use asset, which is an asset that represents the lessee&amp;#8217;s right to use, and a lease liability, which is a lessee&amp;#8217;s obligation to make lease payments arising for a lease measured on a discounted basis, be recognized on the balance sheet by lessees for those leases with a term of greater than 12 months. The amended guidance is effective for reporting periods beginning after December 15, 2018&amp;#894; however, early adoption is permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Since the Company leases all but one of its clinic facilities, it has been evaluating various lease management systems to capture the necessary information and the impact that this amended accounting guidance will have on its consolidated financial statements. The Company believes the adoption of this guidance will significantly affect total assets and liabilities in the consolidated balance sheet.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;&amp;#160;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;In May 2014, March 2016, April 2016, and December 2016, the FASB issued ASU 2014-09, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Revenue from Contracts with Customers&lt;/font&gt;, ASU 2016-08, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Revenue from Contracts with Customers, Principal versus Agent Considerations&lt;/font&gt;, ASU 2016-10, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing&lt;/font&gt;, ASU 2016-12, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients&lt;/font&gt;, and ASU 2016-20, &lt;font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"&gt;Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customer&lt;/font&gt; (collectively &amp;#8220;the standards&amp;#8221;), respectively, which supersede most of the current revenue recognition requirements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. New disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers are also required. The original standards were effective for fiscal years beginning after December 15, 2016; however, in July 2015, the FASB approved a one-year deferral of these standards, with a new effective date for fiscal years beginning after December 15, 2017. The standards require the selection of a retrospective or cumulative effect transition method. The Company does not anticipate a material adjustment upon adoption of these standards.&lt;/div&gt;&lt;/div&gt;</usph:RecentlyIssuedAccountingGuidancePolicyTextBlock>
  <!--Non controlling Interests Policy [Policy Text Block]-->
  <usph:NonControllingInterestsPolicyPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Non-Controlling Interests&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company recognizes non-controlling interests as equity in the consolidated financial statements separate from the parent entity&amp;#8217;s equity. Changes in a parent entity&amp;#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling interest on the deconsolidation date.&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;When the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall, as applicable, is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.&lt;/div&gt;&lt;/div&gt;</usph:NonControllingInterestsPolicyPolicyTextBlock>
  <!--Self Insurance Program Policy [Policy Text Block]-->
  <usph:SelfInsuranceProgramPolicyPolicyTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;"&gt;Self-Insurance Program&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;The Company utilizes a self-insurance plan for its employee group health insurance coverage administered by a third party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&amp;#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through June 30, 2017.&lt;/div&gt;&lt;/div&gt;</usph:SelfInsuranceProgramPolicyPolicyTextBlock>
  <!--Schedule of Business Acquisitions, Clinic Acquisition [Table Text Block]-->
  <usph:ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock contextRef="c20170101to20170630">&lt;div style="font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"&gt;During the first six months of 2017 and the year ended 2016, the Company acquired an interest in the following clinic groups:&lt;/div&gt;&lt;div style="color: #000000;"&gt;&lt;br /&gt;&lt;/div&gt;&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%;"&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;&amp;#160;Date&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;% Interest Acquired&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;Number of Clinics&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%;"&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;&amp;#160;2017&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;June 2017 Acquisition&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;June 30&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;60&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;9&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;May 2017 Acquisition&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;May 31&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;70&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;4&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;January 2017 Acquisition&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;January 1&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;70&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;17&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%; background-color: #cceeff;"&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;&amp;#160;2016&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;February 2016 Acquisition&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;February 29&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;55&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;8&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;"&gt;November 2016 Acquisition&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;November 30&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;60&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman';"&gt;%&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"&gt;&lt;div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;"&gt;12&lt;/div&gt;&lt;/td&gt;&lt;td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</usph:ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock>
  <!--Redeemable Non-controlling Interest, Redemption Rights, Commencement Period-Maximum [Member]-->
  <usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod contextRef="c20170101to20170630_RangeAxis_MaximumMember">P5Y</usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod>
  <!--Redeemable Non-controlling Interest, Redemption Rights, Commencement Period-Minimum [Member]-->
  <usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod contextRef="c20170101to20170630_RangeAxis_MinimumMember">P3Y</usph:RedeemableNonControllingInterestRedemptionRightsCommencementPeriod>
  <!--Annual Limit Occupational Therapy Services-Year 2017 [Member]-Maximum [Member]-->
  <usph:AnnualLimitOccupationalTherapyServices contextRef="c20170101to20170630_RangeAxis_MaximumMember_UnusualOrInfrequentItemAxis_Year2017Member" unitRef="U002" decimals="0">1980</usph:AnnualLimitOccupationalTherapyServices>
  <!--Reduction In Medicare Spending Percentage-->
  <usph:ReductionInMedicareSpendingPercentage contextRef="c20170101to20170630" unitRef="U004" decimals="2">0.02</usph:ReductionInMedicareSpendingPercentage>
  <!--Net revenue from Medicare-->
  <usph:NetRevenueFromMedicare contextRef="c20170101to20170630" unitRef="U002" decimals="-5">45800000</usph:NetRevenueFromMedicare>
  <!--Number Of Clinics Operated-->
  <usph:NumberOfClinicsOperated contextRef="c20170630" unitRef="U005" decimals="INF">566</usph:NumberOfClinicsOperated>
  <!--Percentage Reduction For Service In Office Or Other Non Institutional Settings-->
  <usph:PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings contextRef="c20170101to20170630" unitRef="U004" decimals="1">0.5</usph:PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings>
  <!--Percentage Of Practice Expense Component Of Relative Value Unit-->
  <usph:PercentageOfPracticeExpenseComponentOfRelativeValueUnit contextRef="c20170101to20170630" unitRef="U004" decimals="INF">1</usph:PercentageOfPracticeExpenseComponentOfRelativeValueUnit>
  <!--Period Of Federal Debt Ceiling In Connection With Deficit Reductions-->
  <usph:PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions contextRef="c20170101to20170630">P10Y</usph:PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions>
  <!--Amount Of Reductions In Federal Spending-->
  <usph:AmountOfReductionsInFederalSpending contextRef="c20170101to20170630" unitRef="U002" decimals="-11">1200000000000</usph:AmountOfReductionsInFederalSpending>
  <!--Expected Reduction In Medicare Spending Percentage-->
  <usph:ExpectedReductionInMedicareSpendingPercentage contextRef="c20130401" unitRef="U004" decimals="2">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
  <!--Expected Reduction In Medicare Spending Percentage-->
  <usph:ExpectedReductionInMedicareSpendingPercentage contextRef="c20151102" unitRef="U004" decimals="2">0.02</usph:ExpectedReductionInMedicareSpendingPercentage>
  <!--Combined Physical Therapy Speech Language Pathology Expenses-->
  <usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses contextRef="c20170101to20170630" unitRef="U002" decimals="0">3700</usph:CombinedPhysicalTherapySpeechLanguagePathologyExpenses>
  <!--Percentage Of General Partnership Interest Owned-->
  <usph:PercentageOfGeneralPartnershipInterestOwned contextRef="c20170101to20170630" unitRef="U004" decimals="2">0.01</usph:PercentageOfGeneralPartnershipInterestOwned>
  <!--Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage-->
  <usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage contextRef="c20170101to20170630" unitRef="U004" decimals="2">0.01</usph:DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage>
  <!--Percentage Of Medicare Payment-Year2019 [Member]-->
  <usph:PercentageOfMedicarePayment contextRef="c20170101to20170630_UnusualOrInfrequentItemAxis_Year2019Member" unitRef="U004" decimals="3">0.005</usph:PercentageOfMedicarePayment>
  <!--Percentage Of Medicare Payment-Year 2017 [Member]-->
  <usph:PercentageOfMedicarePayment contextRef="c20170101to20170630_UnusualOrInfrequentItemAxis_Year2017Member" unitRef="U004" decimals="4">0.0024</usph:PercentageOfMedicarePayment>
  <!--Percentage Of Medicare Payment-Year2018 [Member]-->
  <usph:PercentageOfMedicarePayment contextRef="c20170101to20170630_UnusualOrInfrequentItemAxis_Year2018Member" unitRef="U004" decimals="3">0.005</usph:PercentageOfMedicarePayment>
  <!--Number Of Third Party Facilities-->
  <usph:NumberOfThirdPartyFacilities contextRef="c20170101to20170630" unitRef="U007" decimals="INF">27</usph:NumberOfThirdPartyFacilities>
  <!--Mandatorily Redeemable Non-controlling Interest, Redemption Rights, Commencement Period-Maximum [Member]-->
  <usph:MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod contextRef="c20170101to20170630_RangeAxis_MaximumMember">P5Y</usph:MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod>
  <!--Mandatorily Redeemable Non-controlling Interest, Redemption Rights, Commencement Period-Minimum [Member]-->
  <usph:MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod contextRef="c20170101to20170630_RangeAxis_MinimumMember">P3Y</usph:MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod>
  <!--Annual Limit On Physical Therapy And Speech Language Pathology Services-Year 2017 [Member]-Maximum [Member]-->
  <usph:AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices contextRef="c20170101to20170630_RangeAxis_MaximumMember_UnusualOrInfrequentItemAxis_Year2017Member" unitRef="U002" decimals="0">1980</usph:AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices>
  <!--Number of regions-->
  <usph:NumberOfRegions contextRef="c20170101to20170630" unitRef="U008" decimals="INF">6</usph:NumberOfRegions>
  <!--Percentage Of Limited Partnership Interest Owned-Maximum [Member]-->
  <usph:PercentageOfLimitedPartnershipInterestOwned contextRef="c20170101to20170630_RangeAxis_MaximumMember" unitRef="U004" decimals="2">0.99</usph:PercentageOfLimitedPartnershipInterestOwned>
  <!--Percentage Of Limited Partnership Interest Owned-Minimum [Member]-->
  <usph:PercentageOfLimitedPartnershipInterestOwned contextRef="c20170101to20170630_RangeAxis_MinimumMember" unitRef="U004" decimals="2">0.49</usph:PercentageOfLimitedPartnershipInterestOwned>
  <!--Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues-->
  <usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues contextRef="c20170101to20170630" unitRef="U004" decimals="2">0.01</usph:DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues>
  <!--Maximum Contractual Allowance Reserve Estimate-->
  <usph:MaximumContractualAllowanceReserveEstimate contextRef="c20170101to20170630" unitRef="U004" decimals="2">0.01</usph:MaximumContractualAllowanceReserveEstimate>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>usph-20170630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 4.3.0.0 Summit Financial Printing, LLC. All rights reserved.-->
<xs:schema targetNamespace="http://usph.com/20170630" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:usph="http://usph.com/20170630" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20170630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20170630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20170630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="usph-20170630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://usph.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedBalanceSheetsUnaudited" id="ConsolidatedBalanceSheetsUnaudited">
        <link:definition>010000 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" id="ConsolidatedBalanceSheetsUnauditedParenthetical">
        <!--Parent Role: CONSOLIDATED BALANCE SHEETS (unaudited)-->
        <link:definition>010100 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementsOfNetIncomeUnaudited" id="ConsolidatedStatementsOfNetIncomeUnaudited">
        <link:definition>020000 - Statement - CONSOLIDATED STATEMENTS OF NET INCOME (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" id="ConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>030000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/ConsolidatedStatementOfShareholdersEquityUnaudited" id="ConsolidatedStatementOfShareholdersEquityUnaudited">
        <link:definition>040000 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies" id="BasisOfPresentationAndSignificantAccountingPolicies">
        <link:definition>060100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinesses" id="AcquisitionsOfBusinesses">
        <link:definition>060200 - Disclosure - ACQUISITIONS OF BUSINESSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterests" id="MandatorilyRedeemableNoncontrollingInterests">
        <link:definition>060300 - Disclosure - MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RedeemableNoncontrollingInterests" id="RedeemableNoncontrollingInterests">
        <link:definition>060400 - Disclosure - REDEEMABLE NON-CONTROLLING INTERESTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/Goodwill" id="Goodwill">
        <link:definition>060500 - Disclosure - GOODWILL</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNet" id="IntangibleAssetsNet">
        <link:definition>060600 - Disclosure - INTANGIBLE ASSETS, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpenses" id="AccruedExpenses">
        <link:definition>060700 - Disclosure - ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreement" id="NotesPayableAndAmendedCreditAgreement">
        <link:definition>060800 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommonStock" id="CommonStock">
        <link:definition>060900 - Disclosure - COMMON STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" id="BasisOfPresentationAndSignificantAccountingPoliciesPolicies">
        <!--Parent Role: BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES-->
        <link:definition>070100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" id="BasisOfPresentationAndSignificantAccountingPoliciesTables">
        <!--Parent Role: BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES-->
        <link:definition>080100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" id="AcquisitionsOfBusinessesTables">
        <!--Parent Role: ACQUISITIONS OF BUSINESSES-->
        <link:definition>080200 - Disclosure - ACQUISITIONS OF BUSINESSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsTables" id="MandatorilyRedeemableNoncontrollingInterestsTables">
        <!--Parent Role: MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS-->
        <link:definition>080300 - Disclosure - MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/GoodwillTables" id="GoodwillTables">
        <!--Parent Role: GOODWILL-->
        <link:definition>080500 - Disclosure - GOODWILL (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetTables" id="IntangibleAssetsNetTables">
        <!--Parent Role: INTANGIBLE ASSETS, NET-->
        <link:definition>080600 - Disclosure - INTANGIBLE ASSETS, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpensesTables" id="AccruedExpensesTables">
        <!--Parent Role: ACCRUED EXPENSES-->
        <link:definition>080700 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables" id="NotesPayableAndAmendedCreditAgreementTables">
        <!--Parent Role: NOTES PAYABLE AND AMENDED CREDIT AGREEMENT-->
        <link:definition>080800 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails" id="BasisOfPresentationAndSignificantAccountingPoliciesDetails">
        <!--Parent Role: BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES-->
        <link:definition>090100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesScheduleOfClinicAcquisitionDetails" id="BasisOfPresentationAndSignificantAccountingPoliciesScheduleOfClinicAcquisitionDetails">
        <!--Parent Role: BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES-->
        <link:definition>090102 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Clinic Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" id="AcquisitionsOfBusinessesDetails">
        <!--Parent Role: ACQUISITIONS OF BUSINESSES-->
        <link:definition>090200 - Disclosure - ACQUISITIONS OF BUSINESSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsDetails" id="MandatorilyRedeemableNoncontrollingInterestsDetails">
        <!--Parent Role: MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS-->
        <link:definition>090300 - Disclosure - MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/RedeemableNoncontrollingInterestsDetails" id="RedeemableNoncontrollingInterestsDetails">
        <!--Parent Role: REDEEMABLE NON-CONTROLLING INTERESTS-->
        <link:definition>090400 - Disclosure - REDEEMABLE NON-CONTROLLING INTERESTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/GoodwillDetails" id="GoodwillDetails">
        <!--Parent Role: GOODWILL-->
        <link:definition>090500 - Disclosure - GOODWILL (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails" id="IntangibleAssetsNetIntangibleAssetsNetDetails">
        <!--Parent Role: INTANGIBLE ASSETS, NET-->
        <link:definition>090600 - Disclosure - INTANGIBLE ASSETS, NET - Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" id="IntangibleAssetsNetAmortizationExpensesDetails">
        <!--Parent Role: INTANGIBLE ASSETS, NET-->
        <link:definition>090602 - Disclosure - INTANGIBLE ASSETS, NET - Amortization Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfTradenameReferralRelationshipsAndNoncompetitionAgreementsDetails" id="IntangibleAssetsNetAmortizationOfTradenameReferralRelationshipsAndNoncompetitionAgreementsDetails">
        <!--Parent Role: INTANGIBLE ASSETS, NET-->
        <link:definition>090604 - Disclosure - INTANGIBLE ASSETS, NET - Amortization of Tradename, Referral Relationships and Non-Competition Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
        <!--Parent Role: ACCRUED EXPENSES-->
        <link:definition>090700 - Disclosure - ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" id="NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails">
        <!--Parent Role: NOTES PAYABLE AND AMENDED CREDIT AGREEMENT-->
        <link:definition>090800 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT - Summary of Notes Payable and Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementDetails" id="NotesPayableAndAmendedCreditAgreementDetails">
        <!--Parent Role: NOTES PAYABLE AND AMENDED CREDIT AGREEMENT-->
        <link:definition>090802 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" id="NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails">
        <!--Parent Role: NOTES PAYABLE AND AMENDED CREDIT AGREEMENT-->
        <link:definition>090804 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://usph.com/role/CommonStockDetails" id="CommonStockDetails">
        <!--Parent Role: COMMON STOCK-->
        <link:definition>090900 - Disclosure - COMMON STOCK (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2016-01-31" schemaLocation="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2016-01-31" schemaLocation="http://xbrl.sec.gov/currency/2016/currency-2016-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2016-01-31" schemaLocation="http://xbrl.sec.gov/exch/2016/exch-2016-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:element name="REDEEMABLENONCONTROLLINGINTERESTSAbstract" id="usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="REDEEMABLENONCONTROLLINGINTERESTSTextBlock" id="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ReferralRelationshipMember" id="usph_ReferralRelationshipMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PatientsAndPayorsRelatedLiability" id="usph_PatientsAndPayorsRelatedLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DocumentAndEntityInformationAbstract" id="usph_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CashPaidDuringPeriodForAbstract" id="usph_CashPaidDuringPeriodForAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AcquisitionOfNoncontrollingInterestSellerFinancingPortion" id="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="PurchaseOfBusinessSellerFinancingPortion" id="usph_PurchaseOfBusinessSellerFinancingPortion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="SaleOfNoncontrollingInterest" id="usph_SaleOfNoncontrollingInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" id="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="PaymentToSettleRedeemableNonControllingInterestFinancingPortion" id="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="RentClinicSuppliesContractLaborAndOther" id="usph_RentClinicSuppliesContractLaborAndOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="InterestExpenseDebtAndOther" id="usph_InterestExpenseDebtAndOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" id="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" id="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" id="usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MaximumPercentageOfRepurchaseOfCommonStock" id="usph_MaximumPercentageOfRepurchaseOfCommonStock" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AdditionalEstimatedRepurchaseOfCommonStock" id="usph_AdditionalEstimatedRepurchaseOfCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="DividendsCashAfterAmendment" id="usph_DividendsCashAfterAmendment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NotesPayableMember" id="usph_NotesPayableMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CreditAgreementMember" id="usph_CreditAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TwoThousandSeventeenAcquisitionMember" id="usph_TwoThousandSeventeenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TwoThousandSixteenAcquisitionMember" id="usph_TwoThousandSixteenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TwoThousandFifteenAcquisitionMember" id="usph_TwoThousandFifteenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PromissoryNotesMember" id="usph_PromissoryNotesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="AcquisitionOfFourClinicPracticesMember" id="usph_AcquisitionOfFourClinicPracticesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MayTwoThousandEighteenMember" id="usph_MayTwoThousandEighteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AcquisitionOfNineClinicPracticesMember" id="usph_AcquisitionOfNineClinicPracticesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MayTwoThousandNineteenMember" id="usph_MayTwoThousandNineteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="JuneTwoThousandEighteenMember" id="usph_JuneTwoThousandEighteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="JuneTwoThousandNineteenMember" id="usph_JuneTwoThousandNineteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" id="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PaymentsToAcquireBusinessesConsideration" id="usph_PaymentsToAcquireBusinessesConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" id="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NovemberTwoThousandEighteenMember" id="usph_NovemberTwoThousandEighteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="JanuaryTwoThousandEighteenMember" id="usph_JanuaryTwoThousandEighteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="JanuaryTwoThousandNineteenMember" id="usph_JanuaryTwoThousandNineteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NovemberTwoThousandSeventeenMember" id="usph_NovemberTwoThousandSeventeenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="FebruaryTwoThousandEighteenMember" id="usph_FebruaryTwoThousandEighteenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NumberOfSubsidiariesAcquiredClinicPractices" id="usph_NumberOfSubsidiariesAcquiredClinicPractices" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="FebruaryTwoThousandSeventeenMember" id="usph_FebruaryTwoThousandSeventeenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="WorkforcePerformanceSolutionsMember" id="usph_WorkforcePerformanceSolutionsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AcquisitionOfTwelveClinicPracticesMember" id="usph_AcquisitionOfTwelveClinicPracticesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AcquisitionOfSeventeenClinicPracticesMember" id="usph_AcquisitionOfSeventeenClinicPracticesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AcquisitionOfEightClinicPracticesMember" id="usph_AcquisitionOfEightClinicPracticesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AcquisitionOfSingleClinicPracticesMember" id="usph_AcquisitionOfSingleClinicPracticesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CarryingAmountOfRedeemableNonControllingInterestAbstract" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ExcessDistributionsOverEarningsAndLosses" id="usph_ExcessDistributionsOverEarningsAndLosses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" id="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" id="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="TherapyPracticeMember" id="usph_TherapyPracticeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionConsiderationPayableTermOfNote" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" id="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="TermOfEmploymentAgreement" id="usph_TermOfEmploymentAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NonCompeteAgreementBasicTerm" id="usph_NonCompeteAgreementBasicTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" id="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="EmploymentAgreementRenewalTerm" id="usph_EmploymentAgreementRenewalTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="RedeemableNonControllingInterestsPolicyTextBlock" id="usph_RedeemableNonControllingInterestsPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RestrictedStockPolicyPolicyTextBlock" id="usph_RestrictedStockPolicyPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" id="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="RecentlyIssuedAccountingGuidancePolicyTextBlock" id="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NonControllingInterestsPolicyPolicyTextBlock" id="usph_NonControllingInterestsPolicyPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SelfInsuranceProgramPolicyPolicyTextBlock" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" id="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MayTwoThousandSeventeenAcquisitionMember" id="usph_MayTwoThousandSeventeenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="JuneTwoThousandSeventeenAcquisitionMember" id="usph_JuneTwoThousandSeventeenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="FebruaryTwoThousandSixteenAcquisitionMember" id="usph_FebruaryTwoThousandSixteenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="JanuaryTwoThousandSeventeenAcquisitionMember" id="usph_JanuaryTwoThousandSeventeenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="NovemberTwoThousandSixteenAcquisitionMember" id="usph_NovemberTwoThousandSixteenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DepreciationAmortizationImpairmentTable" id="usph_DepreciationAmortizationImpairmentTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MarchTwoThousandSeventeenAcquisitionMember" id="usph_MarchTwoThousandSeventeenAcquisitionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AnnualLimitOccupationalTherapyServices" id="usph_AnnualLimitOccupationalTherapyServices" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ReductionInMedicareSpendingPercentage" id="usph_ReductionInMedicareSpendingPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NetRevenueFromMedicare" id="usph_NetRevenueFromMedicare" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="NumberOfClinicsOperated" id="usph_NumberOfClinicsOperated" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AmountOfReductionsInFederalSpending" id="usph_AmountOfReductionsInFederalSpending" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="ExpectedReductionInMedicareSpendingPercentage" id="usph_ExpectedReductionInMedicareSpendingPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="PercentageOfGeneralPartnershipInterestOwned" id="usph_PercentageOfGeneralPartnershipInterestOwned" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfMedicarePayment" id="usph_PercentageOfMedicarePayment" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberOfThirdPartyFacilities" id="usph_NumberOfThirdPartyFacilities" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" id="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" id="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NumberOfRegions" id="usph_NumberOfRegions" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PercentageOfLimitedPartnershipInterestOwned" id="usph_PercentageOfLimitedPartnershipInterestOwned" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MaximumContractualAllowanceReserveEstimate" id="usph_MaximumContractualAllowanceReserveEstimate" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AccountingStandardsUpdate201609Member" id="usph_AccountingStandardsUpdate201609Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="Year2017Member" id="usph_Year2017Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="Year2018Member" id="usph_Year2018Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="Year2019Member" id="usph_Year2019Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="DepreciationAmortizationImpairmentLineItems" id="usph_DepreciationAmortizationImpairmentLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>usph-20170630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 4.3.0.0 Summit Financial Printing, LLC. All rights reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#MandatorilyRedeemableNoncontrollingInterestsDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#AcquisitionsOfBusinessesDetails" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedStatementsOfCashFlowsUnaudited" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfNetIncomeUnaudited" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedStatementsOfNetIncomeUnaudited" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedBalanceSheetsUnaudited" />
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheetsUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="calculation: LiabilitiesAndStockholdersEquity to RedeemableNoncontrollingInterestEquityCarryingAmount" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="MinorityInterest" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to MinorityInterest" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="TreasuryStockValue" xlink:title="calculation: StockholdersEquity to TreasuryStockValue" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="AdditionalPaidInCapital" xlink:title="calculation: StockholdersEquity to AdditionalPaidInCapital" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="calculation: StockholdersEquity to RetainedEarningsAccumulatedDeficit" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="CommonStockValue" xlink:title="calculation: StockholdersEquity to CommonStockValue" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="StockholdersEquity" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to StockholdersEquity" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="calculation: LiabilitiesAndStockholdersEquity to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LongTermLineOfCredit" xlink:title="calculation: Liabilities to LongTermLineOfCredit" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccruedLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to AccruedLiabilitiesCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableTradeCurrent" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableTradeCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="LongTermDebtCurrent" xlink:title="calculation: LiabilitiesCurrent to LongTermDebtCurrent" order="3.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LiabilitiesCurrent" xlink:title="calculation: Liabilities to LiabilitiesCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="DeferredRentCreditNoncurrent" xlink:title="DeferredRentCreditNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DeferredRentCreditNoncurrent" xlink:title="calculation: Liabilities to DeferredRentCreditNoncurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="DeferredTaxLiabilitiesNoncurrent" xlink:title="DeferredTaxLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="DeferredTaxLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to DeferredTaxLiabilitiesNoncurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LongTermNotesPayable" xlink:title="calculation: Liabilities to LongTermNotesPayable" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to OtherLiabilitiesNoncurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:label="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:title="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:title="calculation: Liabilities to SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="Liabilities" xlink:title="calculation: LiabilitiesAndStockholdersEquity to Liabilities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OtherAssetsNoncurrent" xlink:title="calculation: Assets to OtherAssetsNoncurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="AccountsReceivableNetCurrent" xlink:title="calculation: AssetsCurrent to AccountsReceivableNetCurrent" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="AccountsAndOtherReceivablesNetCurrent" xlink:title="calculation: AssetsCurrent to AccountsAndOtherReceivablesNetCurrent" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="OtherAssetsCurrent" xlink:title="calculation: AssetsCurrent to OtherAssetsCurrent" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="calculation: AssetsCurrent to CashAndCashEquivalentsAtCarryingValue" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="AssetsCurrent" xlink:title="calculation: Assets to AssetsCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="Goodwill" xlink:title="calculation: Assets to Goodwill" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="FurnitureAndFixturesGross" xlink:title="calculation: PropertyPlantAndEquipmentGross to FurnitureAndFixturesGross" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="LeaseholdImprovementsGross" xlink:title="calculation: PropertyPlantAndEquipmentGross to LeaseholdImprovementsGross" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="calculation: PropertyPlantAndEquipmentNet to PropertyPlantAndEquipmentGross" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="calculation: PropertyPlantAndEquipmentNet to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="calculation: Assets to PropertyPlantAndEquipmentNet" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="calculation: Assets to IntangibleAssetsNetExcludingGoodwill" order="4.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfNetIncomeUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeTaxExpenseBenefit" xlink:title="calculation: ProfitLoss to IncomeTaxExpenseBenefit" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="SalesRevenueNet" xlink:title="SalesRevenueNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="HealthCareOrganizationPatientServiceRevenue" xlink:title="HealthCareOrganizationPatientServiceRevenue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SalesRevenueNet" xlink:to="HealthCareOrganizationPatientServiceRevenue" xlink:title="calculation: SalesRevenueNet to HealthCareOrganizationPatientServiceRevenue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="OtherSalesRevenueNet" xlink:title="OtherSalesRevenueNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SalesRevenueNet" xlink:to="OtherSalesRevenueNet" xlink:title="calculation: SalesRevenueNet to OtherSalesRevenueNet" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="SalesRevenueNet" xlink:title="calculation: GrossProfit to SalesRevenueNet" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="calculation: CostsAndExpenses to ProvisionForDoubtfulAccounts" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="RestructuringCharges" xlink:title="calculation: CostsAndExpenses to RestructuringCharges" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RentClinicSuppliesContractLaborAndOther" xlink:label="RentClinicSuppliesContractLaborAndOther" xlink:title="RentClinicSuppliesContractLaborAndOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="RentClinicSuppliesContractLaborAndOther" xlink:title="calculation: CostsAndExpenses to RentClinicSuppliesContractLaborAndOther" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CostsAndExpenses" xlink:to="LaborAndRelatedExpense" xlink:title="calculation: CostsAndExpenses to LaborAndRelatedExpense" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="CostsAndExpenses" xlink:title="calculation: GrossProfit to CostsAndExpenses" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="GrossProfit" xlink:title="calculation: OperatingIncomeLoss to GrossProfit" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="calculation: OperatingIncomeLoss to SellingGeneralAndAdministrativeExpense" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="OperatingIncomeLoss" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to OperatingIncomeLoss" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" xlink:label="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" xlink:title="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="InterestExpense" xlink:to="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" xlink:title="calculation: InterestExpense to InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" order="0.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="InterestExpense" xlink:to="InterestExpenseDebtAndOther" xlink:title="calculation: InterestExpense to InterestExpenseDebtAndOther" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" xlink:label="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" xlink:title="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="InterestExpense" xlink:to="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" xlink:title="calculation: InterestExpense to InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="InterestExpense" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to InterestExpense" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="InterestAndOtherIncome" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to InterestAndOtherIncome" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="calculation: ProfitLoss to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="ProfitLoss" xlink:title="calculation: NetIncomeLoss to ProfitLoss" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="calculation: NetIncomeLoss to NetIncomeLossAttributableToNoncontrollingInterest" order="0.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlowsUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireBusinessesNetOfCashAcquired" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireProductiveAssets" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:label="PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:title="PaymentsForProceedsFromBusinessesAndInterestInAffiliates" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsForProceedsFromBusinessesAndInterestInAffiliates" order="3.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="ProceedsFromSaleOfProductiveAssets" xlink:title="ProceedsFromSaleOfProductiveAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSaleOfProductiveAssets" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSaleOfProductiveAssets" order="4.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="calculation: CashAndCashEquivalentsPeriodIncreaseDecrease to NetCashProvidedByUsedInInvestingActivities" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ProfitLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ProfitLoss" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingAssets" order="16.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" order="15.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ProvisionForDoubtfulAccounts" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DeferredIncomeTaxExpenseBenefit" order="11.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="17.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DepreciationDepletionAndAmortization" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DepreciationDepletionAndAmortization" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsReceivable" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsReceivable" order="13.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="GainLossOnSaleOfPropertyPlantEquipment" xlink:title="GainLossOnSaleOfPropertyPlantEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainLossOnSaleOfPropertyPlantEquipment" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainLossOnSaleOfPropertyPlantEquipment" order="7.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingLiabilities" order="18.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ShareBasedCompensation" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" xlink:label="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" xlink:title="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" order="9.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="calculation: CashAndCashEquivalentsPeriodIncreaseDecrease to NetCashProvidedByUsedInOperatingActivities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromLinesOfCredit" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromLinesOfCredit" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfNotesPayable" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfNotesPayable" order="8.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromPaymentsForOtherFinancingActivities" order="10.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfLinesOfCredit" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfLinesOfCredit" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsMinorityInterest" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsMinorityInterest" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:label="DeferredTaxExpenseFromStockOptionsExercised" xlink:title="DeferredTaxExpenseFromStockOptionsExercised" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="DeferredTaxExpenseFromStockOptionsExercised" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to DeferredTaxExpenseFromStockOptionsExercised" order="11.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsCommonStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsCommonStock" order="6.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:label="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:title="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" order="12.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="calculation: CashAndCashEquivalentsPeriodIncreaseDecrease to NetCashProvidedByUsedInFinancingActivities" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="calculation: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:label="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:title="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ExcessDistributionsOverEarningsAndLosses" xlink:label="ExcessDistributionsOverEarningsAndLosses" xlink:title="ExcessDistributionsOverEarningsAndLosses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:to="ExcessDistributionsOverEarningsAndLosses" xlink:title="calculation: SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent to ExcessDistributionsOverEarningsAndLosses" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:label="RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:title="RedeemableNoncontrollingInterestEquityRedemptionValue" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="calculation: RedeemableNoncontrollingInterestEquityRedemptionValue to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:to="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="calculation: RedeemableNoncontrollingInterestEquityRedemptionValue to ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="calculation: RedeemableNoncontrollingInterestEquityRedemptionValue to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:to="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="calculation: RedeemableNoncontrollingInterestEquityRedemptionValue to ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" order="0.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:to="RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:title="calculation: SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent to RedeemableNoncontrollingInterestEquityRedemptionValue" order="0.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="DividendsPayableCurrent" xlink:title="DividendsPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="DividendsPayableCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to DividendsPayableCurrent" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to EmployeeRelatedLiabilitiesCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to OtherAccruedLiabilitiesCurrent" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="PatientsAndPayorsRelatedLiability" xlink:title="calculation: AccruedLiabilitiesCurrent to PatientsAndPayorsRelatedLiability" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="AccruedInsuranceCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to AccruedInsuranceCurrent" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="calculation: LongTermDebt to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LongTermDebt" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="calculation: LongTermDebt to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2.0" weight="1.0" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>usph-20170630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 4.3.0.0 Summit Financial Printing, LLC. All rights reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://usph.com/role/CommonStockDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#CommonStockDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#NotesPayableAndAmendedCreditAgreementDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfTradenameReferralRelationshipsAndNoncompetitionAgreementsDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#IntangibleAssetsNetAmortizationOfTradenameReferralRelationshipsAndNoncompetitionAgreementsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#IntangibleAssetsNetAmortizationExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#IntangibleAssetsNetIntangibleAssetsNetDetails" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#GoodwillDetails" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#RedeemableNoncontrollingInterestsDetails" />
  <link:roleRef roleURI="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#MandatorilyRedeemableNoncontrollingInterestsDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#AcquisitionsOfBusinessesDetails" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesScheduleOfClinicAcquisitionDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#BasisOfPresentationAndSignificantAccountingPoliciesScheduleOfClinicAcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#BasisOfPresentationAndSignificantAccountingPoliciesDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables" xlink:type="simple" xlink:href="usph-20170630.xsd#NotesPayableAndAmendedCreditAgreementTables" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="usph-20170630.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="usph-20170630.xsd#IntangibleAssetsNetTables" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillTables" xlink:type="simple" xlink:href="usph-20170630.xsd#GoodwillTables" />
  <link:roleRef roleURI="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsTables" xlink:type="simple" xlink:href="usph-20170630.xsd#MandatorilyRedeemableNoncontrollingInterestsTables" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" xlink:type="simple" xlink:href="usph-20170630.xsd#AcquisitionsOfBusinessesTables" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="usph-20170630.xsd#BasisOfPresentationAndSignificantAccountingPoliciesTables" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="usph-20170630.xsd#BasisOfPresentationAndSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://usph.com/role/CommonStock" xlink:type="simple" xlink:href="usph-20170630.xsd#CommonStock" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreement" xlink:type="simple" xlink:href="usph-20170630.xsd#NotesPayableAndAmendedCreditAgreement" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpenses" xlink:type="simple" xlink:href="usph-20170630.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="usph-20170630.xsd#IntangibleAssetsNet" />
  <link:roleRef roleURI="http://usph.com/role/Goodwill" xlink:type="simple" xlink:href="usph-20170630.xsd#Goodwill" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterests" xlink:type="simple" xlink:href="usph-20170630.xsd#RedeemableNoncontrollingInterests" />
  <link:roleRef roleURI="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterests" xlink:type="simple" xlink:href="usph-20170630.xsd#MandatorilyRedeemableNoncontrollingInterests" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses" xlink:type="simple" xlink:href="usph-20170630.xsd#AcquisitionsOfBusinesses" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:type="simple" xlink:href="usph-20170630.xsd#BasisOfPresentationAndSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementOfShareholdersEquityUnaudited" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedStatementOfShareholdersEquityUnaudited" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedStatementsOfCashFlowsUnaudited" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfNetIncomeUnaudited" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedStatementsOfNetIncomeUnaudited" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedBalanceSheetsUnauditedParenthetical" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedBalanceSheetsUnaudited" />
  <link:roleRef roleURI="http://usph.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="usph-20170630.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/DocumentAndEntityInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheetsUnaudited" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfNetIncomeUnaudited" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementOfShareholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="definition: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="definition: StatementLineItems to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesOutstanding" xlink:title="definition: StatementLineItems to SharesOutstanding" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="definition: StatementLineItems to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="definition: StatementLineItems to TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="definition: StatementLineItems to MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:label="NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:title="NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:title="definition: StatementLineItems to NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="DividendsCommonStockCash" xlink:title="definition: StatementLineItems to DividendsCommonStockCash" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ProfitLoss" xlink:title="definition: StatementLineItems to ProfitLoss" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="12.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: StatementTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="CommonStockMember" xlink:title="definition: EquityComponentDomain to CommonStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="AdditionalPaidInCapitalMember" xlink:title="definition: EquityComponentDomain to AdditionalPaidInCapitalMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="RetainedEarningsMember" xlink:title="definition: EquityComponentDomain to RetainedEarningsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="TreasuryStockMember" xlink:title="definition: EquityComponentDomain to TreasuryStockMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="ParentMember" xlink:title="definition: EquityComponentDomain to ParentMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="NoncontrollingInterestMember" xlink:title="definition: EquityComponentDomain to NoncontrollingInterestMember" order="6.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterests" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterests" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/Goodwill" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNet" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpenses" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreement" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStock" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DepreciationAmortizationImpairmentLineItems" xlink:label="DepreciationAmortizationImpairmentLineItems" xlink:title="DepreciationAmortizationImpairmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfGeneralPartnershipInterestOwned" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageOfGeneralPartnershipInterestOwned" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfLimitedPartnershipInterestOwned" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageOfLimitedPartnershipInterestOwned" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfClinicsOperated" xlink:label="NumberOfClinicsOperated" xlink:title="NumberOfClinicsOperated" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfClinicsOperated" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfClinicsOperated" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfStatesInWhichEntityOperates" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfStatesInWhichEntityOperates" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfThirdPartyFacilities" xlink:label="NumberOfThirdPartyFacilities" xlink:title="NumberOfThirdPartyFacilities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfThirdPartyFacilities" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfThirdPartyFacilities" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PropertyPlantAndEquipmentUsefulLife" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfRegions" xlink:label="NumberOfRegions" xlink:title="NumberOfRegions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfRegions" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NumberOfRegions" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfMedicarePayment" xlink:label="PercentageOfMedicarePayment" xlink:title="PercentageOfMedicarePayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfMedicarePayment" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageOfMedicarePayment" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="AmountOfReductionsInFederalSpending" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to AmountOfReductionsInFederalSpending" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="ReductionInMedicareSpendingPercentage" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to ReductionInMedicareSpendingPercentage" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="ExpectedReductionInMedicareSpendingPercentage" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to ExpectedReductionInMedicareSpendingPercentage" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:label="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:title="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AnnualLimitOccupationalTherapyServices" xlink:label="AnnualLimitOccupationalTherapyServices" xlink:title="AnnualLimitOccupationalTherapyServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="AnnualLimitOccupationalTherapyServices" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to AnnualLimitOccupationalTherapyServices" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to CombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageOfPracticeExpenseComponentOfRelativeValueUnit" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NetRevenueFromMedicare" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to NetRevenueFromMedicare" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="MaximumContractualAllowanceReserveEstimate" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to MaximumContractualAllowanceReserveEstimate" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:label="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="IncomeTaxExpenseBenefit" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to IncomeTaxExpenseBenefit" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DepreciationAmortizationImpairmentTable" xlink:label="DepreciationAmortizationImpairmentTable" xlink:title="DepreciationAmortizationImpairmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DepreciationAmortizationImpairmentTable" xlink:title="definition: DepreciationAmortizationImpairmentLineItems to DepreciationAmortizationImpairmentTable" order="29.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="RangeAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to BusinessAcquisitionAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MarchTwoThousandSeventeenAcquisitionMember" xlink:label="MarchTwoThousandSeventeenAcquisitionMember" xlink:title="MarchTwoThousandSeventeenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="MarchTwoThousandSeventeenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to MarchTwoThousandSeventeenAcquisitionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to PropertyPlantAndEquipmentByTypeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerSoftwareIntangibleAssetMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ComputerSoftwareIntangibleAssetMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to UnusualOrInfrequentItemAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain_2" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain_2" xlink:title="definition: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_Year2017Member" xlink:label="Year2017Member" xlink:title="Year2017Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2017Member" xlink:title="definition: UnusualOrInfrequentItemDomain to Year2017Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_Year2018Member" xlink:label="Year2018Member" xlink:title="Year2018Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2018Member" xlink:title="definition: UnusualOrInfrequentItemDomain to Year2018Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_Year2019Member" xlink:label="Year2019Member" xlink:title="Year2019Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2019Member" xlink:title="definition: UnusualOrInfrequentItemDomain to Year2019Member" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="definition: DepreciationAmortizationImpairmentTable to AdjustmentsForNewAccountingPronouncementsAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember_2" xlink:title="TypeOfAdoptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember_2" xlink:title="definition: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AccountingStandardsUpdate201609Member" xlink:label="AccountingStandardsUpdate201609Member" xlink:title="AccountingStandardsUpdate201609Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201609Member" xlink:title="definition: TypeOfAdoptionMember to AccountingStandardsUpdate201609Member" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesScheduleOfClinicAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionDateOfAcquisitionAgreement1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JuneTwoThousandSeventeenAcquisitionMember" xlink:label="JuneTwoThousandSeventeenAcquisitionMember" xlink:title="JuneTwoThousandSeventeenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="JuneTwoThousandSeventeenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to JuneTwoThousandSeventeenAcquisitionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MayTwoThousandSeventeenAcquisitionMember" xlink:label="MayTwoThousandSeventeenAcquisitionMember" xlink:title="MayTwoThousandSeventeenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="MayTwoThousandSeventeenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to MayTwoThousandSeventeenAcquisitionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JanuaryTwoThousandSeventeenAcquisitionMember" xlink:label="JanuaryTwoThousandSeventeenAcquisitionMember" xlink:title="JanuaryTwoThousandSeventeenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="JanuaryTwoThousandSeventeenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to JanuaryTwoThousandSeventeenAcquisitionMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FebruaryTwoThousandSixteenAcquisitionMember" xlink:label="FebruaryTwoThousandSixteenAcquisitionMember" xlink:title="FebruaryTwoThousandSixteenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="FebruaryTwoThousandSixteenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to FebruaryTwoThousandSixteenAcquisitionMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NovemberTwoThousandSixteenAcquisitionMember" xlink:label="NovemberTwoThousandSixteenAcquisitionMember" xlink:title="NovemberTwoThousandSixteenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NovemberTwoThousandSixteenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to NovemberTwoThousandSixteenAcquisitionMember" order="5.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="definition: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesGross" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" xlink:label="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" xlink:title="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" xlink:label="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" xlink:title="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfSubsidiariesAcquiredClinicPractices" xlink:label="NumberOfSubsidiariesAcquiredClinicPractices" xlink:title="NumberOfSubsidiariesAcquiredClinicPractices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfSubsidiariesAcquiredClinicPractices" xlink:title="definition: BusinessAcquisitionLineItems to NumberOfSubsidiariesAcquiredClinicPractices" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationConsiderationTransferred1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="definition: BusinessAcquisitionLineItems to BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfSeventeenClinicPracticesMember" xlink:label="AcquisitionOfSeventeenClinicPracticesMember" xlink:title="AcquisitionOfSeventeenClinicPracticesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfSeventeenClinicPracticesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AcquisitionOfSeventeenClinicPracticesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_WorkforcePerformanceSolutionsMember" xlink:label="WorkforcePerformanceSolutionsMember" xlink:title="WorkforcePerformanceSolutionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="WorkforcePerformanceSolutionsMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to WorkforcePerformanceSolutionsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfFourClinicPracticesMember" xlink:label="AcquisitionOfFourClinicPracticesMember" xlink:title="AcquisitionOfFourClinicPracticesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfFourClinicPracticesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AcquisitionOfFourClinicPracticesMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfNineClinicPracticesMember" xlink:label="AcquisitionOfNineClinicPracticesMember" xlink:title="AcquisitionOfNineClinicPracticesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfNineClinicPracticesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AcquisitionOfNineClinicPracticesMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfTwelveClinicPracticesMember" xlink:label="AcquisitionOfTwelveClinicPracticesMember" xlink:title="AcquisitionOfTwelveClinicPracticesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfTwelveClinicPracticesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AcquisitionOfTwelveClinicPracticesMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfEightClinicPracticesMember" xlink:label="AcquisitionOfEightClinicPracticesMember" xlink:title="AcquisitionOfEightClinicPracticesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfEightClinicPracticesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AcquisitionOfEightClinicPracticesMember" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfSingleClinicPracticesMember" xlink:label="AcquisitionOfSingleClinicPracticesMember" xlink:title="AcquisitionOfSingleClinicPracticesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfSingleClinicPracticesMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AcquisitionOfSingleClinicPracticesMember" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementScenarioAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementScenarioAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain_2" xlink:title="ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain_2" xlink:title="definition: StatementScenarioAxis to ScenarioUnspecifiedDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JanuaryTwoThousandEighteenMember" xlink:label="JanuaryTwoThousandEighteenMember" xlink:title="JanuaryTwoThousandEighteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="JanuaryTwoThousandEighteenMember" xlink:title="definition: ScenarioUnspecifiedDomain to JanuaryTwoThousandEighteenMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JanuaryTwoThousandNineteenMember" xlink:label="JanuaryTwoThousandNineteenMember" xlink:title="JanuaryTwoThousandNineteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="JanuaryTwoThousandNineteenMember" xlink:title="definition: ScenarioUnspecifiedDomain to JanuaryTwoThousandNineteenMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MayTwoThousandEighteenMember" xlink:label="MayTwoThousandEighteenMember" xlink:title="MayTwoThousandEighteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="MayTwoThousandEighteenMember" xlink:title="definition: ScenarioUnspecifiedDomain to MayTwoThousandEighteenMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MayTwoThousandNineteenMember" xlink:label="MayTwoThousandNineteenMember" xlink:title="MayTwoThousandNineteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="MayTwoThousandNineteenMember" xlink:title="definition: ScenarioUnspecifiedDomain to MayTwoThousandNineteenMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JuneTwoThousandEighteenMember" xlink:label="JuneTwoThousandEighteenMember" xlink:title="JuneTwoThousandEighteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="JuneTwoThousandEighteenMember" xlink:title="definition: ScenarioUnspecifiedDomain to JuneTwoThousandEighteenMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JuneTwoThousandNineteenMember" xlink:label="JuneTwoThousandNineteenMember" xlink:title="JuneTwoThousandNineteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="JuneTwoThousandNineteenMember" xlink:title="definition: ScenarioUnspecifiedDomain to JuneTwoThousandNineteenMember" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NovemberTwoThousandSeventeenMember" xlink:label="NovemberTwoThousandSeventeenMember" xlink:title="NovemberTwoThousandSeventeenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="NovemberTwoThousandSeventeenMember" xlink:title="definition: ScenarioUnspecifiedDomain to NovemberTwoThousandSeventeenMember" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NovemberTwoThousandEighteenMember" xlink:label="NovemberTwoThousandEighteenMember" xlink:title="NovemberTwoThousandEighteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="NovemberTwoThousandEighteenMember" xlink:title="definition: ScenarioUnspecifiedDomain to NovemberTwoThousandEighteenMember" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FebruaryTwoThousandSeventeenMember" xlink:label="FebruaryTwoThousandSeventeenMember" xlink:title="FebruaryTwoThousandSeventeenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="FebruaryTwoThousandSeventeenMember" xlink:title="definition: ScenarioUnspecifiedDomain to FebruaryTwoThousandSeventeenMember" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FebruaryTwoThousandEighteenMember" xlink:label="FebruaryTwoThousandEighteenMember" xlink:title="FebruaryTwoThousandEighteenMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScenarioUnspecifiedDomain" xlink:to="FebruaryTwoThousandEighteenMember" xlink:title="definition: ScenarioUnspecifiedDomain to FebruaryTwoThousandEighteenMember" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="definition: BusinessAcquisitionLineItems to BusinessAcquisitionConsiderationPayableTermOfNote" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="TermOfEmploymentAgreement" xlink:title="definition: BusinessAcquisitionLineItems to TermOfEmploymentAgreement" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="EmploymentAgreementRenewalTerm" xlink:title="definition: BusinessAcquisitionLineItems to EmploymentAgreementRenewalTerm" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="definition: BusinessAcquisitionLineItems to NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="NonCompeteAgreementBasicTerm" xlink:title="definition: BusinessAcquisitionLineItems to NonCompeteAgreementBasicTerm" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" xlink:label="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" xlink:title="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionLineItems" xlink:to="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" xlink:title="definition: BusinessAcquisitionLineItems to RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="BusinessAcquisitionLineItems" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="definition: BusinessAcquisitionLineItems to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="10.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TherapyPracticeMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to TherapyPracticeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="LegalEntityAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to LegalEntityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="definition: LegalEntityAxis to EntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="EntityDomain_2" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LegalEntityAxis" xlink:to="EntityDomain_2" xlink:title="definition: LegalEntityAxis to EntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityDomain" xlink:to="SubsidiariesMember" xlink:title="definition: EntityDomain to SubsidiariesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestsDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to IntangibleAssetsNetExcludingGoodwill" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetUsefulLife" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfIntangibleAssets" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to AmortizationOfIntangibleAssets" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="2.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationOfTradenameReferralRelationshipsAndNoncompetitionAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="definition: FiniteLivedIntangibleAssetsLineItems to ScheduleOfFiniteLivedIntangibleAssetsTable" order="14.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="definition: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain_2" xlink:title="definition: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="definition: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebt" xlink:title="definition: DebtInstrumentLineItems to LongTermDebt" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtCurrent" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtCurrent" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtNoncurrent" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtNoncurrent" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityInterestRateDuringPeriod" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentAnnualPrincipalPayment" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentInterestRateStatedPercentage" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="definition: DebtInstrumentTable to DebtInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain_2" xlink:title="DebtInstrumentNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain_2" xlink:title="definition: DebtInstrumentAxis to DebtInstrumentNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentNameDomain" xlink:to="PromissoryNotesMember" xlink:title="definition: DebtInstrumentNameDomain to PromissoryNotesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="definition: DebtInstrumentTable to CreditFacilityAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain_2" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain_2" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="definition: CreditFacilityDomain to RevolvingCreditFacilityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="definition: DebtInstrumentTable to RangeAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityMaximumBorrowingCapacity" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentMaturityDate" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentMaturityDate" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentBasisSpreadOnVariableRate1" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="definition: DebtInstrumentLineItems to CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DividendsCashAfterAmendment" xlink:title="definition: DebtInstrumentLineItems to DividendsCashAfterAmendment" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityRemainingBorrowingCapacity" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentFaceAmount" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentFaceAmount" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="definition: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="definition: DebtInstrumentLineItems to LineOfCreditFacilityInterestRateDuringPeriod" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="DebtInstrumentLineItems" xlink:to="RepaymentsOfDebt" xlink:title="definition: DebtInstrumentLineItems to RepaymentsOfDebt" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentTable" xlink:title="definition: DebtInstrumentLineItems to DebtInstrumentTable" order="14.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="definition: DebtInstrumentTable to CreditFacilityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain_2" xlink:title="CreditFacilityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain_2" xlink:title="definition: CreditFacilityAxis to CreditFacilityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="definition: CreditFacilityDomain to RevolvingCreditFacilityMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="CreditFacilityDomain" xlink:to="CreditAgreementMember" xlink:title="definition: CreditFacilityDomain to CreditAgreementMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="definition: DebtInstrumentTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="VariableRateAxis" xlink:title="VariableRateAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="VariableRateAxis" xlink:title="definition: DebtInstrumentTable to VariableRateAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="VariableRateDomain" xlink:title="VariableRateDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="VariableRateAxis" xlink:to="VariableRateDomain" xlink:title="definition: VariableRateAxis to VariableRateDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="VariableRateDomain_2" xlink:title="VariableRateDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="VariableRateAxis" xlink:to="VariableRateDomain_2" xlink:title="definition: VariableRateAxis to VariableRateDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="LondonInterbankOfferedRateLIBORMember" xlink:title="LondonInterbankOfferedRateLIBORMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="VariableRateDomain" xlink:to="LondonInterbankOfferedRateLIBORMember" xlink:title="definition: VariableRateDomain to LondonInterbankOfferedRateLIBORMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BaseRateMember" xlink:label="BaseRateMember" xlink:title="BaseRateMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="VariableRateDomain" xlink:to="BaseRateMember" xlink:title="definition: VariableRateDomain to BaseRateMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="definition: DebtInstrumentTable to ShortTermDebtTypeAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain_2" xlink:title="ShortTermDebtTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain_2" xlink:title="definition: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableMember" xlink:title="definition: ShortTermDebtTypeDomain to NotesPayableMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtInstrumentTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: DebtInstrumentTable to BusinessAcquisitionAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TwoThousandFifteenAcquisitionMember" xlink:label="TwoThousandFifteenAcquisitionMember" xlink:title="TwoThousandFifteenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TwoThousandFifteenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to TwoThousandFifteenAcquisitionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TwoThousandSixteenAcquisitionMember" xlink:label="TwoThousandSixteenAcquisitionMember" xlink:title="TwoThousandSixteenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TwoThousandSixteenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to TwoThousandSixteenAcquisitionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TwoThousandSeventeenAcquisitionMember" xlink:label="TwoThousandSeventeenAcquisitionMember" xlink:title="TwoThousandSeventeenAcquisitionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TwoThousandSeventeenAcquisitionMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to TwoThousandSeventeenAcquisitionMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="definition: EquityClassOfTreasuryStockLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MaximumPercentageOfRepurchaseOfCommonStock" xlink:label="MaximumPercentageOfRepurchaseOfCommonStock" xlink:title="MaximumPercentageOfRepurchaseOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="MaximumPercentageOfRepurchaseOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to MaximumPercentageOfRepurchaseOfCommonStock" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to BankCreditAgreementToPermitShareRepurchasesOfCommonStock" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="StockRepurchasedDuringPeriodShares" xlink:title="definition: EquityClassOfTreasuryStockLineItems to StockRepurchasedDuringPeriodShares" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="definition: EquityClassOfTreasuryStockLineItems to AdditionalEstimatedRepurchaseOfCommonStock" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="SharesIssuedPricePerShare" xlink:title="definition: EquityClassOfTreasuryStockLineItems to SharesIssuedPricePerShare" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="ClassOfTreasuryStockTable" xlink:title="definition: EquityClassOfTreasuryStockLineItems to ClassOfTreasuryStockTable" order="7.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ClassOfTreasuryStockTable" xlink:to="RangeAxis" xlink:title="definition: ClassOfTreasuryStockTable to RangeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="1.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>usph-20170630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 4.3.0.0 Summit Financial Printing, LLC. All rights reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl1" xml:lang="en-US" id="dei_AmendmentFlag_lbl1">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl1" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CurrentFiscalYearEndDate_lbl1" xml:lang="en-US" id="dei_CurrentFiscalYearEndDate_lbl1">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl1" xlink:title="label: CurrentFiscalYearEndDate to dei_CurrentFiscalYearEndDate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl1" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl1">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl1" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:label xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityDomain_lbl" xml:lang="en-US" id="dei_EntityDomain_lbl">Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityDomain" xlink:to="dei_EntityDomain_lbl" xlink:title="label: EntityDomain to dei_EntityDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:label xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US" id="dei_EntityWellKnownSeasonedIssuer_lbl">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:title="label: EntityWellKnownSeasonedIssuer to dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityWellKnownSeasonedIssuer_lbl1" xml:lang="en-US" id="dei_EntityWellKnownSeasonedIssuer_lbl1">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl1" xlink:title="label: EntityWellKnownSeasonedIssuer to dei_EntityWellKnownSeasonedIssuer_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:label xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US" id="dei_EntityVoluntaryFilers_lbl">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:title="label: EntityVoluntaryFilers to dei_EntityVoluntaryFilers_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityVoluntaryFilers_lbl1" xml:lang="en-US" id="dei_EntityVoluntaryFilers_lbl1">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl1" xlink:title="label: EntityVoluntaryFilers to dei_EntityVoluntaryFilers_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" id="dei_EntityCurrentReportingStatus_lbl">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:title="label: EntityCurrentReportingStatus to dei_EntityCurrentReportingStatus_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCurrentReportingStatus_lbl1" xml:lang="en-US" id="dei_EntityCurrentReportingStatus_lbl1">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl1" xlink:title="label: EntityCurrentReportingStatus to dei_EntityCurrentReportingStatus_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="dei_EntityFilerCategory_lbl">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:title="label: EntityFilerCategory to dei_EntityFilerCategory_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFilerCategory_lbl1" xml:lang="en-US" id="dei_EntityFilerCategory_lbl1">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl1" xlink:title="label: EntityFilerCategory to dei_EntityFilerCategory_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:label xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityPublicFloat_lbl" xml:lang="en-US" id="dei_EntityPublicFloat_lbl">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:title="label: EntityPublicFloat to dei_EntityPublicFloat_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl1" xml:lang="en-US" id="dei_EntityRegistrantName_lbl1">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl1" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl1" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl1">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl1" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding_lbl">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:title="label: EntityCommonStockSharesOutstanding to dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCommonStockSharesOutstanding_lbl1" xml:lang="en-US" id="dei_EntityCommonStockSharesOutstanding_lbl1">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl1" xlink:title="label: EntityCommonStockSharesOutstanding to dei_EntityCommonStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl1" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl1">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl1" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl1" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl1">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl1" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:label xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LegalEntityAxis_lbl" xml:lang="en-US" id="dei_LegalEntityAxis_lbl">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:title="label: LegalEntityAxis to dei_LegalEntityAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl1" xml:lang="en-US" id="dei_DocumentType_lbl1">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl1" xlink:title="label: DocumentType to dei_DocumentType_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountingPoliciesAbstract_lbl">BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:title="label: AccountingPoliciesAbstract to us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl">Payables and Accruals [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableTradeCurrent_lbl">Accounts payable - trade</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:title="label: AccountsPayableTradeCurrent to us-gaap_AccountsPayableTradeCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableTradeCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableTradeCurrent_lbl1">Accounts Payable, Trade, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl1" xlink:title="label: AccountsPayableTradeCurrent to us-gaap_AccountsPayableTradeCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl">Accounts receivable - other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:title="label: AccountsAndOtherReceivablesNetCurrent to us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1">Accounts and Other Receivables, Net, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" xlink:title="label: AccountsAndOtherReceivablesNetCurrent to us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl">ACCRUED EXPENSES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsReceivableNetCurrent_lbl">Patient accounts receivable, less allowance for doubtful accounts of $1,859 and $1,792, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:title="label: AccountsReceivableNetCurrent to us-gaap_AccountsReceivableNetCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsReceivableNetCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsReceivableNetCurrent_lbl1">Accounts Receivable, Net, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl1" xlink:title="label: AccountsReceivableNetCurrent to us-gaap_AccountsReceivableNetCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl1">Accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl2" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl2">Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedInsuranceCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedInsuranceCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedInsuranceCurrent_lbl">Group health insurance claims</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedInsuranceCurrent" xlink:to="us-gaap_AccruedInsuranceCurrent_lbl" xlink:title="label: AccruedInsuranceCurrent to us-gaap_AccruedInsuranceCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedInsuranceCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedInsuranceCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedInsuranceCurrent_lbl1">Accrued Insurance, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedInsuranceCurrent" xlink:to="us-gaap_AccruedInsuranceCurrent_lbl1" xlink:title="label: AccruedInsuranceCurrent to us-gaap_AccruedInsuranceCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl">Less accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapital_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl1">Additional Paid in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl1" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl">Additional Paid-In Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl1">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:title="label: AdjustmentsForNewAccountingPronouncementsAxis to us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl">Compensation expense - equity-based awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" xlink:title="label: AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl">Allowance for doubtful accounts, patient accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:title="label: AllowanceForDoubtfulAccountsReceivableCurrent to us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xml:lang="en-US" id="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1">Allowance for Doubtful Accounts Receivable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" xlink:title="label: AllowanceForDoubtfulAccountsReceivableCurrent to us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US" id="us-gaap_AmortizationOfIntangibleAssets_lbl">Total amortization expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:title="label: AmortizationOfIntangibleAssets to us-gaap_AmortizationOfIntangibleAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AmortizationOfIntangibleAssets_lbl1" xml:lang="en-US" id="us-gaap_AmortizationOfIntangibleAssets_lbl1">Amortization of Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl1" xlink:title="label: AmortizationOfIntangibleAssets to us-gaap_AmortizationOfIntangibleAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Assets_lbl" xml:lang="en-US" id="us-gaap_Assets_lbl">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl" xlink:title="label: Assets to us-gaap_Assets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Assets_lbl1" xml:lang="en-US" id="us-gaap_Assets_lbl1">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl1" xlink:title="label: Assets to us-gaap_Assets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl1">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl1">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl1" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl1">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl1" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BaseRateMember" xlink:label="BaseRateMember" xlink:title="BaseRateMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BaseRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BaseRateMember_lbl" xml:lang="en-US" id="us-gaap_BaseRateMember_lbl">Base Rate [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BaseRateMember" xlink:to="us-gaap_BaseRateMember_lbl" xlink:title="label: BaseRateMember to us-gaap_BaseRateMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl">Acquisition date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" xlink:title="label: BusinessAcquisitionDateOfAcquisitionAgreement1 to us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1">Business Acquisition, Date of Acquisition Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:to="us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" xlink:title="label: BusinessAcquisitionDateOfAcquisitionAgreement1 to us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAxis_lbl">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:title="label: BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionAxis_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAxis_lbl1">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl1" xlink:title="label: BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl">Total non-current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAcquireeDomain_lbl">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:title="label: BusinessAcquisitionAcquireeDomain to us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationConsiderationTransferred1_lbl">Aggregate purchase price for the acquired clinic practices</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:title="label: BusinessCombinationConsiderationTransferred1 to us-gaap_BusinessCombinationConsiderationTransferred1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1">Business Combination, Consideration Transferred</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xlink:title="label: BusinessCombinationConsiderationTransferred1 to us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl">Percentage of interest acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfVotingInterestsAcquired to us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationsAbstract_lbl">ACQUISITIONS OF BUSINESSES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:title="label: BusinessCombinationsAbstract to us-gaap_BusinessCombinationsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionLineItems_lbl">Business Acquisition [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:title="label: BusinessAcquisitionLineItems to us-gaap_BusinessAcquisitionLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionLineItems_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionLineItems_lbl1">Business Acquisition [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl1" xlink:title="label: BusinessAcquisitionLineItems to us-gaap_BusinessAcquisitionLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount to us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount to us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet to us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="BusinessCombinationDisclosureTextBlock" xlink:title="BusinessCombinationDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationDisclosureTextBlock_lbl">ACQUISITIONS OF BUSINESSES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:title="label: BusinessCombinationDisclosureTextBlock to us-gaap_BusinessCombinationDisclosureTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:label="BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:title="BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl" xml:lang="en-US" id="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl">Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl" xlink:title="label: BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue to us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl1" xml:lang="en-US" id="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl1">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl1" xlink:title="label: BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue to us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl">Cash and cash equivalents - end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1">Cash and cash equivalents - beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl3" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl3">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl3" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl">Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:title="label: CashAndCashEquivalentsPolicyTextBlock to us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl">Net increase in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:title="label: CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl1">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl1" xlink:title="label: CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl">Non-cash investing and financing transactions during the period:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xml:lang="en-US" id="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" xlink:title="label: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfTreasuryStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfTreasuryStockTable_lbl" xml:lang="en-US" id="us-gaap_ClassOfTreasuryStockTable_lbl">Class of Treasury Stock [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfTreasuryStockTable" xlink:to="us-gaap_ClassOfTreasuryStockTable_lbl" xlink:title="label: ClassOfTreasuryStockTable to us-gaap_ClassOfTreasuryStockTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl">Commitments and contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingencies_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl1">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl1" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US" id="us-gaap_CommonStockDividendsPerShareDeclared_lbl">Dividends declared per common share (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:title="label: CommonStockDividendsPerShareDeclared to us-gaap_CommonStockDividendsPerShareDeclared_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xml:lang="en-US" id="us-gaap_CommonStockDividendsPerShareDeclared_lbl1">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl1" xlink:title="label: CommonStockDividendsPerShareDeclared to us-gaap_CommonStockDividendsPerShareDeclared_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl1" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl">Common stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl1">Common Stock, Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl">Common stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl1">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl">Common stock, $.01 par value, 20,000,000 shares authorized, 14,792,744 and 14,732,699 shares issued, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockValue_lbl1" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl1">Common Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl1" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl1">Common Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xml:lang="en-US" id="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl">Software [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xlink:title="label: ComputerSoftwareIntangibleAssetMember to us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xml:lang="en-US" id="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1">Computer Software, Intangible Asset [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" xlink:title="label: ComputerSoftwareIntangibleAssetMember to us-gaap_ComputerSoftwareIntangibleAssetMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:label="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:title="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl">Contractual Allowances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:to="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" xlink:title="label: ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock to us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1">Contractual Adjustments and Third Party Settlements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:to="us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" xlink:title="label: ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock to us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_CostsAndExpensesAbstract_lbl">Clinic operating costs:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:title="label: CostsAndExpensesAbstract to us-gaap_CostsAndExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CostsAndExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_CostsAndExpensesAbstract_lbl1">Costs and Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl1" xlink:title="label: CostsAndExpensesAbstract to us-gaap_CostsAndExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US" id="us-gaap_CostsAndExpenses_lbl">Total clinic operating costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:title="label: CostsAndExpenses to us-gaap_CostsAndExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CostsAndExpenses_lbl1" xml:lang="en-US" id="us-gaap_CostsAndExpenses_lbl1">Costs and Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl1" xlink:title="label: CostsAndExpenses to us-gaap_CostsAndExpenses_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CreditFacilityAxis_lbl" xml:lang="en-US" id="us-gaap_CreditFacilityAxis_lbl">Credit Facility [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl" xlink:title="label: CreditFacilityAxis to us-gaap_CreditFacilityAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CreditFacilityAxis_lbl1" xml:lang="en-US" id="us-gaap_CreditFacilityAxis_lbl1">Credit Facility [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl1" xlink:title="label: CreditFacilityAxis to us-gaap_CreditFacilityAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CreditFacilityDomain_lbl" xml:lang="en-US" id="us-gaap_CreditFacilityDomain_lbl">Credit Facility [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl" xlink:title="label: CreditFacilityDomain to us-gaap_CreditFacilityDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CreditFacilityDomain_lbl1" xml:lang="en-US" id="us-gaap_CreditFacilityDomain_lbl1">Credit Facility [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl1" xlink:title="label: CreditFacilityDomain to us-gaap_CreditFacilityDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentLineItems_lbl">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:title="label: DebtInstrumentLineItems to us-gaap_DebtInstrumentLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock_lbl">NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DebtDisclosureTextBlock_lbl1">Debt Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl1" xlink:title="label: DebtDisclosureTextBlock to us-gaap_DebtDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_DebtDisclosureAbstract_lbl">NOTES PAYABLE AND AMENDED CREDIT AGREEMENT [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:title="label: DebtDisclosureAbstract to us-gaap_DebtDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentTable_lbl">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:title="label: DebtInstrumentTable to us-gaap_DebtInstrumentTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentAxis_lbl">Debt Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:title="label: DebtInstrumentAxis to us-gaap_DebtInstrumentAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl">Annual installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xlink:title="label: DebtInstrumentAnnualPrincipalPayment to us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1">Debt Instrument, Annual Principal Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" xlink:title="label: DebtInstrumentAnnualPrincipalPayment to us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl">Spread on variable rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:title="label: DebtInstrumentBasisSpreadOnVariableRate1 to us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" xlink:title="label: DebtInstrumentBasisSpreadOnVariableRate1 to us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl">Aggregate amount of notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentFaceAmount_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentFaceAmount_lbl1">Debt Instrument, Face Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl1" xlink:title="label: DebtInstrumentFaceAmount to us-gaap_DebtInstrumentFaceAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentNameDomain_lbl">Debt Instrument, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" xlink:title="label: DebtInstrumentNameDomain to us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl">Percentage of interest accrued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" xlink:title="label: DebtInstrumentInterestRateStatedPercentage to us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US" id="us-gaap_DebtInstrumentMaturityDate_lbl">Revolving credit facility maturity date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:title="label: DebtInstrumentMaturityDate to us-gaap_DebtInstrumentMaturityDate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtInstrumentMaturityDate_lbl1" xml:lang="en-US" id="us-gaap_DebtInstrumentMaturityDate_lbl1">Debt Instrument, Maturity Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl1" xlink:title="label: DebtInstrumentMaturityDate to us-gaap_DebtInstrumentMaturityDate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:label="DeferredTaxExpenseFromStockOptionsExercised" xlink:title="DeferredTaxExpenseFromStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl">Tax benefit from equity-based awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxExpenseFromStockOptionsExercised" xlink:to="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl" xlink:title="label: DeferredTaxExpenseFromStockOptionsExercised to us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl1">Deferred Tax Expense from Stock Options Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxExpenseFromStockOptionsExercised" xlink:to="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl1" xlink:title="label: DeferredTaxExpenseFromStockOptionsExercised to us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="DeferredRentCreditNoncurrent" xlink:title="DeferredRentCreditNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredRentCreditNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredRentCreditNoncurrent_lbl" xml:lang="en-US" id="us-gaap_DeferredRentCreditNoncurrent_lbl">Deferred rent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRentCreditNoncurrent" xlink:to="us-gaap_DeferredRentCreditNoncurrent_lbl" xlink:title="label: DeferredRentCreditNoncurrent to us-gaap_DeferredRentCreditNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredRentCreditNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredRentCreditNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_DeferredRentCreditNoncurrent_lbl1">Deferred Rent Credit, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredRentCreditNoncurrent" xlink:to="us-gaap_DeferredRentCreditNoncurrent_lbl1" xlink:title="label: DeferredRentCreditNoncurrent to us-gaap_DeferredRentCreditNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl">Deferred income tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1">Deferred Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="DeferredTaxLiabilitiesNoncurrent" xlink:title="DeferredTaxLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl">Deferred taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" xlink:title="label: DeferredTaxLiabilitiesNoncurrent to us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepreciationDepletionAndAmortization_lbl1" xml:lang="en-US" id="us-gaap_DepreciationDepletionAndAmortization_lbl1">Depreciation, Depletion and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl1" xlink:title="label: DepreciationDepletionAndAmortization to us-gaap_DepreciationDepletionAndAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="DividendsPayableCurrent" xlink:title="DividendsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DividendsPayableCurrent_lbl" xml:lang="en-US" id="us-gaap_DividendsPayableCurrent_lbl">Dividends payable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsPayableCurrent" xlink:to="us-gaap_DividendsPayableCurrent_lbl" xlink:title="label: DividendsPayableCurrent to us-gaap_DividendsPayableCurrent_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsCommonStockCash_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_DividendsCommonStockCash_lbl" xml:lang="en-US" id="us-gaap_DividendsCommonStockCash_lbl">Dividends declared to USPT shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl" xlink:title="label: DividendsCommonStockCash to us-gaap_DividendsCommonStockCash_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DividendsCommonStockCash_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DividendsCommonStockCash_lbl1" xml:lang="en-US" id="us-gaap_DividendsCommonStockCash_lbl1">Dividends, Common Stock, Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl1" xlink:title="label: DividendsCommonStockCash to us-gaap_DividendsCommonStockCash_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDiluted_lbl">Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:title="label: EarningsPerShareBasicAndDiluted to us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl">Salaries and related costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1">Employee-related Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="us-gaap_EquityAbstract_lbl">COMMON STOCK [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:title="label: EquityAbstract to us-gaap_EquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="us-gaap_EquityComponentDomain_lbl">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xlink:title="label: EquityComponentDomain to us-gaap_EquityComponentDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xml:lang="en-US" id="us-gaap_EquityClassOfTreasuryStockLineItems_lbl">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xlink:title="label: EquityClassOfTreasuryStockLineItems to us-gaap_EquityClassOfTreasuryStockLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xml:lang="en-US" id="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" xlink:title="label: FairValueOfFinancialInstrumentsPolicy to us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:title="label: FiniteLivedIntangibleAssetsByMajorClassAxis to us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl">2018</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl">Accumulated amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAccumulatedAmortization to us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl">2017</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl">Finite Lived Intangible Assets [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:title="label: FiniteLivedIntangibleAssetsLineItems to us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl">Estimated useful life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:title="label: FiniteLivedIntangibleAssetUsefulLife to us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:title="label: FiniteLivedIntangibleAssetUsefulLife to us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:title="label: FiniteLivedIntangibleAssetsMajorClassNameDomain to us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl">2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFive to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFive to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl">Amortization Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl">2020</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFour to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearFour to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl">2019</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThree to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xml:lang="en-US" id="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThree to us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FurnitureAndFixturesGross_lbl" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesGross_lbl">Furniture and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl" xlink:title="label: FurnitureAndFixturesGross to us-gaap_FurnitureAndFixturesGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FurnitureAndFixturesGross_lbl1" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesGross_lbl1">Furniture and Fixtures, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl1" xlink:title="label: FurnitureAndFixturesGross to us-gaap_FurnitureAndFixturesGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember_lbl">Furniture &amp; Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FurnitureAndFixturesMember_lbl1" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember_lbl1">Furniture and Fixtures [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl1" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="GainLossOnSaleOfPropertyPlantEquipment" xlink:title="GainLossOnSaleOfPropertyPlantEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US" id="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl">Loss on sale of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:title="label: GainLossOnSaleOfPropertyPlantEquipment to us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl1" xml:lang="en-US" id="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl1">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl1" xlink:title="label: GainLossOnSaleOfPropertyPlantEquipment to us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="GoodwillPurchaseAccountingAdjustments" xlink:title="GoodwillPurchaseAccountingAdjustments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xml:lang="en-US" id="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl">Goodwill adjustments for purchase price allocation of business acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillPurchaseAccountingAdjustments" xlink:to="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xlink:title="label: GoodwillPurchaseAccountingAdjustments to us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_Goodwill_lbl" xml:lang="en-US" id="us-gaap_Goodwill_lbl">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_Goodwill_lbl1" xml:lang="en-US" id="us-gaap_Goodwill_lbl1">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl1" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_Goodwill_lbl2" xml:lang="en-US" id="us-gaap_Goodwill_lbl2">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl2" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Goodwill_lbl3" xml:lang="en-US" id="us-gaap_Goodwill_lbl3">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Goodwill" xlink:to="us-gaap_Goodwill_lbl3" xlink:title="label: Goodwill to us-gaap_Goodwill_lbl3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="GoodwillAndIntangibleAssetsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:title="label: GoodwillAndIntangibleAssetsPolicyTextBlock to us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" xlink:title="label: GoodwillAndIntangibleAssetsPolicyTextBlock to us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="GoodwillDisclosureTextBlock" xlink:title="GoodwillDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_GoodwillDisclosureTextBlock_lbl">GOODWILL</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:title="label: GoodwillDisclosureTextBlock to us-gaap_GoodwillDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_GoodwillDisclosureTextBlock_lbl1">Goodwill Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl1" xlink:title="label: GoodwillDisclosureTextBlock to us-gaap_GoodwillDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="GoodwillRollForward" xlink:title="GoodwillRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillRollForward_lbl" xml:lang="en-US" id="us-gaap_GoodwillRollForward_lbl">Goodwill [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillRollForward" xlink:to="us-gaap_GoodwillRollForward_lbl" xlink:title="label: GoodwillRollForward to us-gaap_GoodwillRollForward_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillRollForward_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillRollForward_lbl1" xml:lang="en-US" id="us-gaap_GoodwillRollForward_lbl1">Goodwill [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillRollForward" xlink:to="us-gaap_GoodwillRollForward_lbl1" xlink:title="label: GoodwillRollForward to us-gaap_GoodwillRollForward_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="GoodwillAcquiredDuringPeriod" xlink:title="GoodwillAcquiredDuringPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xml:lang="en-US" id="us-gaap_GoodwillAcquiredDuringPeriod_lbl">Goodwill acquired during the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:title="label: GoodwillAcquiredDuringPeriod to us-gaap_GoodwillAcquiredDuringPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xml:lang="en-US" id="us-gaap_GoodwillAcquiredDuringPeriod_lbl1">Goodwill, Acquired During Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl1" xlink:title="label: GoodwillAcquiredDuringPeriod to us-gaap_GoodwillAcquiredDuringPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl">GOODWILL [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureAbstract to us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_GrossProfit_lbl" xml:lang="en-US" id="us-gaap_GrossProfit_lbl">Gross margin</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:title="label: GrossProfit to us-gaap_GrossProfit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrossProfit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GrossProfit_lbl1" xml:lang="en-US" id="us-gaap_GrossProfit_lbl1">Gross Profit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProfit" xlink:to="us-gaap_GrossProfit_lbl1" xlink:title="label: GrossProfit to us-gaap_GrossProfit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="HealthCareOrganizationPatientServiceRevenue" xlink:title="HealthCareOrganizationPatientServiceRevenue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl" xml:lang="en-US" id="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl">Net patient revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HealthCareOrganizationPatientServiceRevenue" xlink:to="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl" xlink:title="label: HealthCareOrganizationPatientServiceRevenue to us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl1" xml:lang="en-US" id="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl1">Health Care Organization, Patient Service Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HealthCareOrganizationPatientServiceRevenue" xlink:to="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl1" xlink:title="label: HealthCareOrganizationPatientServiceRevenue to us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl">Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl">Long-Lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" xlink:title="label: ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock to us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl">Income before taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl">Provision for income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl1">Increase in earnings by decreasing the tax provision due to adoption of new accounting treatment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl2" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl2">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementAbstract_lbl">CONSOLIDATED STATEMENTS OF NET INCOME (unaudited) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:title="label: IncomeStatementAbstract to us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl">Income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxesPaidNet_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxesPaidNet_lbl1">Income Taxes Paid, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl1" xlink:title="label: IncomeTaxesPaidNet to us-gaap_IncomeTaxesPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxPolicyTextBlock_lbl1">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl1" xlink:title="label: IncomeTaxPolicyTextBlock to us-gaap_IncomeTaxPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl">Increase in patient accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:title="label: IncreaseDecreaseInAccountsReceivable to us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1">Increase (Decrease) in Accounts Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" xlink:title="label: IncreaseDecreaseInAccountsReceivable to us-gaap_IncreaseDecreaseInAccountsReceivable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl">Increase in accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInAccountsPayableAndAccruedLiabilities to us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl">(Increase) decrease in accounts receivable - other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" xlink:title="label: IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets to us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1">Increase (Decrease) in Accounts Receivable and Other Operating Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" xlink:title="label: IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets to us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl">Increase in other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1">Increase (Decrease) in Other Operating Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl">Increase in other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="IntangibleAssetsDisclosureTextBlock" xlink:title="IntangibleAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl">INTANGIBLE ASSETS, NET</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:title="label: IntangibleAssetsDisclosureTextBlock to us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1">Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" xlink:title="label: IntangibleAssetsDisclosureTextBlock to us-gaap_IntangibleAssetsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl">INTANGIBLE ASSETS, NET [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xlink:title="label: IntangibleAssetsNetExcludingGoodwillAbstract to us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1">Other identifiable intangible assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xml:lang="en-US" id="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" xlink:title="label: IntangibleAssetsNetExcludingGoodwill to us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseAbstract" xlink:label="InterestExpenseAbstract" xlink:title="InterestExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestExpenseAbstract_lbl" xml:lang="en-US" id="us-gaap_InterestExpenseAbstract_lbl">Interest expense:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseAbstract" xlink:to="us-gaap_InterestExpenseAbstract_lbl" xlink:title="label: InterestExpenseAbstract to us-gaap_InterestExpenseAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestExpenseAbstract_lbl1" xml:lang="en-US" id="us-gaap_InterestExpenseAbstract_lbl1">Interest Expense [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseAbstract" xlink:to="us-gaap_InterestExpenseAbstract_lbl1" xlink:title="label: InterestExpenseAbstract to us-gaap_InterestExpenseAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_InterestExpense_lbl" xml:lang="en-US" id="us-gaap_InterestExpense_lbl">Total interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:title="label: InterestExpense to us-gaap_InterestExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestExpense_lbl1" xml:lang="en-US" id="us-gaap_InterestExpense_lbl1">Interest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpense" xlink:to="us-gaap_InterestExpense_lbl1" xlink:title="label: InterestExpense to us-gaap_InterestExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US" id="us-gaap_InterestAndOtherIncome_lbl">Interest and other income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" xlink:title="label: InterestAndOtherIncome to us-gaap_InterestAndOtherIncome_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestAndOtherIncome_lbl1" xml:lang="en-US" id="us-gaap_InterestAndOtherIncome_lbl1">Interest and Other Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl1" xlink:title="label: InterestAndOtherIncome to us-gaap_InterestAndOtherIncome_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:label="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xml:lang="en-US" id="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl">Interest expense recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:to="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" xlink:title="label: InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations to us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xml:lang="en-US" id="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1">Interest Expense on Prepetition Liabilities Recognized in Statement of Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:to="us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" xlink:title="label: InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations to us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl">Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestPaidNet_lbl1" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl1">Interest Paid, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl1" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="LondonInterbankOfferedRateLIBORMember" xlink:title="LondonInterbankOfferedRateLIBORMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" xml:lang="en-US" id="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl">LIBOR [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LondonInterbankOfferedRateLIBORMember" xlink:to="us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" xlink:title="label: LondonInterbankOfferedRateLIBORMember to us-gaap_LondonInterbankOfferedRateLIBORMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US" id="us-gaap_LaborAndRelatedExpense_lbl">Salaries and related costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:title="label: LaborAndRelatedExpense to us-gaap_LaborAndRelatedExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LaborAndRelatedExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LaborAndRelatedExpense_lbl1" xml:lang="en-US" id="us-gaap_LaborAndRelatedExpense_lbl1">Labor and Related Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl1" xlink:title="label: LaborAndRelatedExpense to us-gaap_LaborAndRelatedExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsGross_lbl" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsGross_lbl">Leasehold improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl" xlink:title="label: LeaseholdImprovementsGross to us-gaap_LeaseholdImprovementsGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsGross_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsGross_lbl1">Leasehold Improvements, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl1" xlink:title="label: LeaseholdImprovementsGross to us-gaap_LeaseholdImprovementsGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl1">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Liabilities_lbl" xml:lang="en-US" id="us-gaap_Liabilities_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Liabilities_lbl1" xml:lang="en-US" id="us-gaap_Liabilities_lbl1">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl1" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl">Total liabilities, redeemable non-controlling interests, USPH shareholders' equity and non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl1">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl">LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, USPH SHAREHOLDERS' EQUITY AND NON-CONTROLLING INTERESTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl1">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl1" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl1">Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl">Percentage of unused commitment fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:title="label: LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage to us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" xlink:title="label: LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage to us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl">Revolving credit facility commitment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:title="label: LineOfCreditFacilityMaximumBorrowingCapacity to us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" xlink:title="label: LineOfCreditFacilityMaximumBorrowingCapacity to us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl">Average effective interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:title="label: LineOfCreditFacilityInterestRateDuringPeriod to us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1">Average effective interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" xlink:title="label: LineOfCreditFacilityInterestRateDuringPeriod to us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl2" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl2">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl2" xlink:title="label: LineOfCreditFacilityInterestRateDuringPeriod to us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl">Remaining revolving credit outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:title="label: LineOfCreditFacilityRemainingBorrowingCapacity to us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xml:lang="en-US" id="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" xlink:title="label: LineOfCreditFacilityRemainingBorrowingCapacity to us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LongTermDebt_lbl" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl">Payments/Long term debt, Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebt_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebt_lbl1">Payments/Long term debt, Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl1" xlink:title="label: LongTermDebt to us-gaap_LongTermDebt_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="LongTermDebtByMaturityAbstract" xlink:title="LongTermDebtByMaturityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtByMaturityAbstract_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtByMaturityAbstract_lbl">Long Term Debt By Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_lbl" xlink:title="label: LongTermDebtByMaturityAbstract to us-gaap_LongTermDebtByMaturityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtByMaturityAbstract_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtByMaturityAbstract_lbl1">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_lbl1" xlink:title="label: LongTermDebtByMaturityAbstract to us-gaap_LongTermDebtByMaturityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl">Less current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtCurrent_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl1">Current portion of notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl1" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtCurrent_lbl2" xml:lang="en-US" id="us-gaap_LongTermDebtCurrent_lbl2">Long-term Debt, Current Maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl2" xlink:title="label: LongTermDebtCurrent to us-gaap_LongTermDebtCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl">Aggregate principal payment due in 2019</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtNoncurrent_lbl">Long term portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:title="label: LongTermDebtNoncurrent to us-gaap_LongTermDebtNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtNoncurrent_lbl1">Long-term Debt, Excluding Current Maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl1" xlink:title="label: LongTermDebtNoncurrent to us-gaap_LongTermDebtNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl">During the twelve months ended June 30, 2019</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1">Aggregate principal payment due in 2018</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl2" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl2">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl2" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermLineOfCredit_lbl" xml:lang="en-US" id="us-gaap_LongTermLineOfCredit_lbl">Revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl" xlink:title="label: LongTermLineOfCredit to us-gaap_LongTermLineOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermLineOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermLineOfCredit_lbl1" xml:lang="en-US" id="us-gaap_LongTermLineOfCredit_lbl1">Long-term Line of Credit, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl1" xlink:title="label: LongTermLineOfCredit to us-gaap_LongTermLineOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl">During the twelve months ended June 30, 2018</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xml:lang="en-US" id="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1">Aggregate principal payment due in 2017</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" xlink:title="label: LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths to us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US" id="us-gaap_LongTermNotesPayable_lbl">Notes payable, net of current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:title="label: LongTermNotesPayable to us-gaap_LongTermNotesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LongTermNotesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LongTermNotesPayable_lbl1" xml:lang="en-US" id="us-gaap_LongTermNotesPayable_lbl1">Notes Payable, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl1" xlink:title="label: LongTermNotesPayable to us-gaap_LongTermNotesPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MaximumMember_lbl" xml:lang="en-US" id="us-gaap_MaximumMember_lbl">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" xlink:title="label: MaximumMember to us-gaap_MaximumMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MaximumMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MaximumMember_lbl1" xml:lang="en-US" id="us-gaap_MaximumMember_lbl1">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="us-gaap_MaximumMember_lbl1" xlink:title="label: MaximumMember to us-gaap_MaximumMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MinimumMember_lbl" xml:lang="en-US" id="us-gaap_MinimumMember_lbl">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" xlink:title="label: MinimumMember to us-gaap_MinimumMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinimumMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinimumMember_lbl1" xml:lang="en-US" id="us-gaap_MinimumMember_lbl1">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="us-gaap_MinimumMember_lbl1" xlink:title="label: MinimumMember to us-gaap_MinimumMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl">Distribution to non-controlling interest partners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:title="label: MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders to us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" xlink:title="label: MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders to us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="MinorityInterestDisclosureTextBlock" xlink:title="MinorityInterestDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_MinorityInterestDisclosureTextBlock_lbl">MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:title="label: MinorityInterestDisclosureTextBlock to us-gaap_MinorityInterestDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterestDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterestDisclosureTextBlock_lbl1">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl1" xlink:title="label: MinorityInterestDisclosureTextBlock to us-gaap_MinorityInterestDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MinorityInterest_lbl" xml:lang="en-US" id="us-gaap_MinorityInterest_lbl">Non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:title="label: MinorityInterest to us-gaap_MinorityInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterest_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterest_lbl1">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl1" xlink:title="label: MinorityInterest to us-gaap_MinorityInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl">Net cash provided by operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl">FINANCING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl">Net cash used in investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl">INVESTING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl">OPERATING ACTIVITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl">Net income attributable to USPH shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl1">Net Income (Loss) Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_lbl">Operating results allocated to mandatorily redeemable non-controlling interest partners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_lbl" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterest to us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_lbl1">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_lbl1" xlink:title="label: NetIncomeLossAttributableToRedeemableNoncontrollingInterest to us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl">Net cash used in financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl">Less: net income attributable to non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterest to us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" xlink:title="label: NetIncomeLossAttributableToNoncontrollingInterest to us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl">Recently Adopted Accounting Guidance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US" id="us-gaap_NoncompeteAgreementsMember_lbl">Non-compete Agreements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:title="label: NoncompeteAgreementsMember to us-gaap_NoncompeteAgreementsMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfBusinessesAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfBusinessesAcquired_lbl" xml:lang="en-US" id="us-gaap_NumberOfBusinessesAcquired_lbl">Number of clinic practices acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesAcquired" xlink:to="us-gaap_NumberOfBusinessesAcquired_lbl" xlink:title="label: NumberOfBusinessesAcquired to us-gaap_NumberOfBusinessesAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfBusinessesAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NumberOfBusinessesAcquired_lbl1" xml:lang="en-US" id="us-gaap_NumberOfBusinessesAcquired_lbl1">Number of clinics</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfBusinessesAcquired" xlink:to="us-gaap_NumberOfBusinessesAcquired_lbl1" xlink:title="label: NumberOfBusinessesAcquired to us-gaap_NumberOfBusinessesAcquired_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xml:lang="en-US" id="us-gaap_NumberOfStatesInWhichEntityOperates_lbl">Number of states where clinics are operated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesInWhichEntityOperates" xlink:to="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xlink:title="label: NumberOfStatesInWhichEntityOperates to us-gaap_NumberOfStatesInWhichEntityOperates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NumberOfStatesInWhichEntityOperates_lbl1" xml:lang="en-US" id="us-gaap_NumberOfStatesInWhichEntityOperates_lbl1">Number of States in which Entity Operates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfStatesInWhichEntityOperates" xlink:to="us-gaap_NumberOfStatesInWhichEntityOperates_lbl1" xlink:title="label: NumberOfStatesInWhichEntityOperates to us-gaap_NumberOfStatesInWhichEntityOperates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:label="NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:title="NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl">Changes in the redemption value of mandatorily redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl" xlink:title="label: NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest to us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl1" xml:lang="en-US" id="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl1">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl1" xlink:title="label: NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest to us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:label="NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:title="NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_lbl">Contributions of non-controlling interest partners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_lbl" xlink:title="label: NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance to us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestMember_lbl">Non-controlling Interests [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:title="label: NoncontrollingInterestMember to us-gaap_NoncontrollingInterestMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestMember_lbl1" xml:lang="en-US" id="us-gaap_NoncontrollingInterestMember_lbl1">Noncontrolling Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl1" xlink:title="label: NoncontrollingInterestMember to us-gaap_NoncontrollingInterestMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl">Operating income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl1">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl1" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl">BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAssetsCurrent_lbl">Other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:title="label: OtherAssetsCurrent to us-gaap_OtherAssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAssetsCurrent_lbl1">Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl1" xlink:title="label: OtherAssetsCurrent to us-gaap_OtherAssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl1">Other Assets, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl">Other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl1">Other Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="OtherSalesRevenueNet" xlink:title="OtherSalesRevenueNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherSalesRevenueNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherSalesRevenueNet_lbl" xml:lang="en-US" id="us-gaap_OtherSalesRevenueNet_lbl">Other revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherSalesRevenueNet" xlink:to="us-gaap_OtherSalesRevenueNet_lbl" xlink:title="label: OtherSalesRevenueNet to us-gaap_OtherSalesRevenueNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherSalesRevenueNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherSalesRevenueNet_lbl1" xml:lang="en-US" id="us-gaap_OtherSalesRevenueNet_lbl1">Other Revenue, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherSalesRevenueNet" xlink:to="us-gaap_OtherSalesRevenueNet_lbl1" xlink:title="label: OtherSalesRevenueNet to us-gaap_OtherSalesRevenueNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1">Other Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ParentMember_lbl" xml:lang="en-US" id="us-gaap_ParentMember_lbl">Total Shareholders' Equity [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ParentMember" xlink:to="us-gaap_ParentMember_lbl" xlink:title="label: ParentMember to us-gaap_ParentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ParentMember_lbl1" xml:lang="en-US" id="us-gaap_ParentMember_lbl1">Parent [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ParentMember" xlink:to="us-gaap_ParentMember_lbl1" xlink:title="label: ParentMember to us-gaap_ParentMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US" id="us-gaap_PayablesAndAccrualsAbstract_lbl">ACCRUED EXPENSES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:title="label: PayablesAndAccrualsAbstract to us-gaap_PayablesAndAccrualsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:label="PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:title="PaymentsForProceedsFromBusinessesAndInterestInAffiliates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl" xml:lang="en-US" id="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl">Acquisitions of non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:to="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl" xlink:title="label: PaymentsForProceedsFromBusinessesAndInterestInAffiliates to us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl1" xml:lang="en-US" id="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl1">Payments for (Proceeds from) Businesses and Interest in Affiliates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:to="us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl1" xlink:title="label: PaymentsForProceedsFromBusinessesAndInterestInAffiliates to us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:label="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:title="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl">Payments to settle mandatorily redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl" xlink:title="label: PaymentsForRepurchaseOfRedeemableNoncontrollingInterest to us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl1">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl1" xlink:title="label: PaymentsForRepurchaseOfRedeemableNoncontrollingInterest to us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesGross_lbl">Cash paid for acquisition of interest in clinic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:title="label: PaymentsToAcquireBusinessesGross to us-gaap_PaymentsToAcquireBusinessesGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesGross_lbl1">Payments to Acquire Businesses, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl1" xlink:title="label: PaymentsToAcquireBusinessesGross to us-gaap_PaymentsToAcquireBusinessesGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl">Purchase of businesses, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1">Cash paid, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xml:lang="en-US" id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsMinorityInterest_lbl">Distributions to non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:title="label: PaymentsOfDividendsMinorityInterest to us-gaap_PaymentsOfDividendsMinorityInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" xlink:title="label: PaymentsOfDividendsMinorityInterest to us-gaap_PaymentsOfDividendsMinorityInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsOfDividendsCommonStock_lbl" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsCommonStock_lbl">Cash dividends paid to shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:title="label: PaymentsOfDividendsCommonStock to us-gaap_PaymentsOfDividendsCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xml:lang="en-US" id="us-gaap_PaymentsOfDividendsCommonStock_lbl1">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl1" xlink:title="label: PaymentsOfDividendsCommonStock to us-gaap_PaymentsOfDividendsCommonStock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="PaymentsToMinorityShareholders" xlink:title="PaymentsToMinorityShareholders" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PaymentsToMinorityShareholders_lbl" xml:lang="en-US" id="us-gaap_PaymentsToMinorityShareholders_lbl">Purchases of businesses - initial liability related to mandatorily redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:title="label: PaymentsToMinorityShareholders to us-gaap_PaymentsToMinorityShareholders_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToMinorityShareholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToMinorityShareholders_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToMinorityShareholders_lbl1">Payments to Noncontrolling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_lbl1" xlink:title="label: PaymentsToMinorityShareholders to us-gaap_PaymentsToMinorityShareholders_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireProductiveAssets_lbl">Purchase of fixed assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:title="label: PaymentsToAcquireProductiveAssets to us-gaap_PaymentsToAcquireProductiveAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireProductiveAssets_lbl1">Payments to Acquire Productive Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl1" xlink:title="label: PaymentsToAcquireProductiveAssets to us-gaap_PaymentsToAcquireProductiveAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl">Preferred stock, shares issued (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl1">Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl">Preferred stock, shares authorized (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl1">Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl">Preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl">Preferred stock, shares outstanding (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl1">Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl">Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockValue_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl1">Preferred Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl1" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:title="label: ProceedsFromPaymentsForOtherFinancingActivities to us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" xlink:title="label: ProceedsFromPaymentsForOtherFinancingActivities to us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromLinesOfCredit_lbl">Proceeds from revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:title="label: ProceedsFromLinesOfCredit to us-gaap_ProceedsFromLinesOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromLinesOfCredit_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromLinesOfCredit_lbl1">Proceeds from Lines of Credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl1" xlink:title="label: ProceedsFromLinesOfCredit to us-gaap_ProceedsFromLinesOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="ProceedsFromSaleOfProductiveAssets" xlink:title="ProceedsFromSaleOfProductiveAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl">Proceeds on sale of fixed assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfProductiveAssets" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xlink:title="label: ProceedsFromSaleOfProductiveAssets to us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl1">Proceeds from Sale of Productive Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfProductiveAssets" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl1" xlink:title="label: ProceedsFromSaleOfProductiveAssets to us-gaap_ProceedsFromSaleOfProductiveAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProfitLoss_lbl" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl">Net income including non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_ProfitLoss_lbl1" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl1">Net income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl1" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProfitLoss_lbl2" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl2">Net income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl2" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProfitLoss_lbl3" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl3">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl3" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl">Estimated useful lives</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:title="label: PropertyPlantAndEquipmentTypeDomain to us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl">Fixed assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentNetAbstract to us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" xlink:title="label: PropertyPlantAndEquipmentNetAbstract to us-gaap_PropertyPlantAndEquipmentNetAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl">Fixed assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl1">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl">Fixed assets, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl1">Property, Plant and Equipment, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:title="label: PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US" id="us-gaap_ProvisionForDoubtfulAccounts_lbl">Provision for doubtful accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:title="label: ProvisionForDoubtfulAccounts to us-gaap_ProvisionForDoubtfulAccounts_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xml:lang="en-US" id="us-gaap_ProvisionForDoubtfulAccounts_lbl1">Provision for Doubtful Accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl1" xlink:title="label: ProvisionForDoubtfulAccounts to us-gaap_ProvisionForDoubtfulAccounts_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RangeAxis_lbl" xml:lang="en-US" id="us-gaap_RangeAxis_lbl">Range [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" xlink:title="label: RangeAxis to us-gaap_RangeAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RangeAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RangeAxis_lbl1" xml:lang="en-US" id="us-gaap_RangeAxis_lbl1">Range [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="us-gaap_RangeAxis_lbl1" xlink:title="label: RangeAxis to us-gaap_RangeAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RangeMember_lbl" xml:lang="en-US" id="us-gaap_RangeMember_lbl">Range [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="us-gaap_RangeMember_lbl" xlink:title="label: RangeMember to us-gaap_RangeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RangeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RangeMember_lbl1" xml:lang="en-US" id="us-gaap_RangeMember_lbl1">Range [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="us-gaap_RangeMember_lbl1" xlink:title="label: RangeMember to us-gaap_RangeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:label="RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:title="RedeemableNoncontrollingInterestEquityRedemptionValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_lbl">Redemption value prior to excess distributed earnings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_lbl" xlink:title="label: RedeemableNoncontrollingInterestEquityRedemptionValue to us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_lbl1" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_lbl1">Redeemable Noncontrolling Interest, Equity, Redemption Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_lbl1" xlink:title="label: RedeemableNoncontrollingInterestEquityRedemptionValue to us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl">Redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1">Initial value of redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" xlink:title="label: RedeemableNoncontrollingInterestEquityCarryingAmount to us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="RedeemableNoncontrollingInterestTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl">Changes in Carrying Amount of Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:title="label: RedeemableNoncontrollingInterestTableTextBlock to us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" xlink:title="label: RedeemableNoncontrollingInterestTableTextBlock to us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl">Principal payments on notes payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfNotesPayable_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfNotesPayable_lbl1">Repayments of Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl1" xlink:title="label: RepaymentsOfNotesPayable to us-gaap_RepaymentsOfNotesPayable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfDebt_lbl">Payment of debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:title="label: RepaymentsOfDebt to us-gaap_RepaymentsOfDebt_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebt_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfDebt_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfDebt_lbl1">Repayments of Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl1" xlink:title="label: RepaymentsOfDebt to us-gaap_RepaymentsOfDebt_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US" id="us-gaap_RepaymentsOfLinesOfCredit_lbl">Payments on revolving line of credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:title="label: RepaymentsOfLinesOfCredit to us-gaap_RepaymentsOfLinesOfCredit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xml:lang="en-US" id="us-gaap_RepaymentsOfLinesOfCredit_lbl1">Repayments of Lines of Credit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl1" xlink:title="label: RepaymentsOfLinesOfCredit to us-gaap_RepaymentsOfLinesOfCredit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestructuringCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestructuringCharges_lbl" xml:lang="en-US" id="us-gaap_RestructuringCharges_lbl">Closure costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl" xlink:title="label: RestructuringCharges to us-gaap_RestructuringCharges_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestructuringCharges_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestructuringCharges_lbl1" xml:lang="en-US" id="us-gaap_RestructuringCharges_lbl1">Restructuring Charges</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl1" xlink:title="label: RestructuringCharges to us-gaap_RestructuringCharges_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsMember_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl1">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl1" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl">Retained earnings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="RevenueRecognitionPolicyTextBlock" xlink:title="RevenueRecognitionPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_RevenueRecognitionPolicyTextBlock_lbl">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:title="label: RevenueRecognitionPolicyTextBlock to us-gaap_RevenueRecognitionPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevenueRecognitionPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_RevenueRecognitionPolicyTextBlock_lbl1">Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl1" xlink:title="label: RevenueRecognitionPolicyTextBlock to us-gaap_RevenueRecognitionPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_RevolvingCreditFacilityMember_lbl" xml:lang="en-US" id="us-gaap_RevolvingCreditFacilityMember_lbl">Credit Facility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:title="label: RevolvingCreditFacilityMember to us-gaap_RevolvingCreditFacilityMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RevolvingCreditFacilityMember_lbl1" xml:lang="en-US" id="us-gaap_RevolvingCreditFacilityMember_lbl1">Revolving Credit Facility [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl1" xlink:title="label: RevolvingCreditFacilityMember to us-gaap_RevolvingCreditFacilityMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl">Amortization of Tradename, Referral Relationships and Non-Competition Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:title="label: ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock to us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" xlink:title="label: ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock to us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="SalesRevenueNet" xlink:title="SalesRevenueNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SalesRevenueNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US" id="us-gaap_SalesRevenueNet_lbl">Net revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl" xlink:title="label: SalesRevenueNet to us-gaap_SalesRevenueNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SalesRevenueNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SalesRevenueNet_lbl1" xml:lang="en-US" id="us-gaap_SalesRevenueNet_lbl1">Revenue, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl1" xlink:title="label: SalesRevenueNet to us-gaap_SalesRevenueNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" id="us-gaap_ScenarioUnspecifiedDomain_lbl">Scenario, Unspecified [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioUnspecifiedDomain_lbl" xlink:title="label: ScenarioUnspecifiedDomain to us-gaap_ScenarioUnspecifiedDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl">Schedule of Finite Lived Intangible Assets [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTable to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl">Summary of Accrued Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl">Intangible Assets, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" xlink:title="label: ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock to us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl">Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:title="label: ScheduleOfMaturitiesOfLongTermDebtTableTextBlock to us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" xlink:title="label: ScheduleOfMaturitiesOfLongTermDebtTableTextBlock to us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="ScheduleOfDebtInstrumentsTextBlock" xlink:title="ScheduleOfDebtInstrumentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl">Summary of Credit Agreement and Notes Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" xlink:title="label: ScheduleOfDebtInstrumentsTextBlock to us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDebtInstrumentsTextBlock" xlink:to="us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" xlink:title="label: ScheduleOfDebtInstrumentsTextBlock to us-gaap_ScheduleOfDebtInstrumentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl">Schedule of Preliminary Purchase Prices Allocation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTable to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl1">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl1" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTable to us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="ScheduleOfGoodwillTextBlock" xlink:title="ScheduleOfGoodwillTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfGoodwillTextBlock_lbl">Summary of Changes in Carrying Amount of Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:title="label: ScheduleOfGoodwillTextBlock to us-gaap_ScheduleOfGoodwillTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfGoodwillTextBlock_lbl1">Schedule of Goodwill [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl1" xlink:title="label: ScheduleOfGoodwillTextBlock to us-gaap_ScheduleOfGoodwillTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl">Segment Reporting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" xlink:title="label: SegmentReportingPolicyPolicyTextBlock to us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl">Corporate office costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1">Selling, General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensation_lbl">Equity-based awards compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:title="label: ShareBasedCompensation to us-gaap_ShareBasedCompensation_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US" id="us-gaap_SharesIssuedPricePerShare_lbl">Closing price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:title="label: SharesIssuedPricePerShare to us-gaap_SharesIssuedPricePerShare_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl">Ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl1">Beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl2">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl2" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:label="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:title="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl" xml:lang="en-US" id="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl">Redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl" xlink:title="label: SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent to us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl1">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl1" xlink:title="label: SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent to us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl2" xml:lang="en-US" id="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl2">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl2" xlink:title="label: SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent to us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl3" xml:lang="en-US" id="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl3">Mandatorily redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl3" xlink:title="label: SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent to us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_lbl3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermDebtTypeDomain_lbl" xml:lang="en-US" id="us-gaap_ShortTermDebtTypeDomain_lbl">Short-term Debt, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermDebtTypeDomain" xlink:to="us-gaap_ShortTermDebtTypeDomain_lbl" xlink:title="label: ShortTermDebtTypeDomain to us-gaap_ShortTermDebtTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US" id="us-gaap_ShortTermDebtTypeAxis_lbl">Short-term Debt, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:title="label: ShortTermDebtTypeAxis to us-gaap_ShortTermDebtTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="us-gaap_StatementLineItems_lbl">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:title="label: StatementLineItems to us-gaap_StatementLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementEquityComponentsAxis_lbl">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:title="label: StatementEquityComponentsAxis to us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfStockholdersEquityAbstract_lbl">CONSOLIDATED STATEMENTS OF EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:title="label: StatementOfStockholdersEquityAbstract to us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfCashFlowsAbstract_lbl">CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:title="label: StatementOfCashFlowsAbstract to us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementTable_lbl" xml:lang="en-US" id="us-gaap_StatementTable_lbl">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:title="label: StatementTable to us-gaap_StatementTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfFinancialPositionAbstract_lbl">CONSOLIDATED BALANCE SHEETS (unaudited) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:title="label: StatementOfFinancialPositionAbstract to us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US" id="us-gaap_StatementScenarioAxis_lbl">Scenario [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl" xlink:title="label: StatementScenarioAxis to us-gaap_StatementScenarioAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl">Issuance of restricted stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl">Issuance of restricted stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl">Common stock authorized by the Board of Directors (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xml:lang="en-US" id="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1">Stock Repurchase Program, Number of Shares Authorized to be Repurchased</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" xlink:title="label: StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased to us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US" id="us-gaap_StockRepurchasedDuringPeriodShares_lbl">Total purchased shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:title="label: StockRepurchasedDuringPeriodShares to us-gaap_StockRepurchasedDuringPeriodShares_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl">U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl1">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl1" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl">Beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1">Ending balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2">Total USPH shareholders' equity and non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl">COMMON STOCK</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl">Total USPH shareholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl1">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="SubsequentEventsPolicyPolicyTextBlock" xlink:title="SubsequentEventsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl">Subsequent Event</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsPolicyPolicyTextBlock" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xlink:title="label: SubsequentEventsPolicyPolicyTextBlock to us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl1">Subsequent Events, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsPolicyPolicyTextBlock" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl1" xlink:title="label: SubsequentEventsPolicyPolicyTextBlock to us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsidiariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsidiariesMember_lbl" xml:lang="en-US" id="us-gaap_SubsidiariesMember_lbl">NewCo. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiariesMember" xlink:to="us-gaap_SubsidiariesMember_lbl" xlink:title="label: SubsidiariesMember to us-gaap_SubsidiariesMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl1">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TrademarksMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TrademarksMember_lbl" xml:lang="en-US" id="us-gaap_TrademarksMember_lbl">Tradenames [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:title="label: TrademarksMember to us-gaap_TrademarksMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TrademarksMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TrademarksMember_lbl1" xml:lang="en-US" id="us-gaap_TrademarksMember_lbl1">Trademarks [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl1" xlink:title="label: TrademarksMember to us-gaap_TrademarksMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockMember_lbl">Treasury Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:title="label: TreasuryStockMember to us-gaap_TreasuryStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockMember_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockMember_lbl1">Treasury Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl1" xlink:title="label: TreasuryStockMember to us-gaap_TreasuryStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockShares_lbl">Treasury stock (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:title="label: TreasuryStockShares to us-gaap_TreasuryStockShares_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockShares_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockShares_lbl1">Treasury Stock, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl1" xlink:title="label: TreasuryStockShares to us-gaap_TreasuryStockShares_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockValue_lbl">Treasury stock at cost, 2,214,737 shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:title="label: TreasuryStockValue to us-gaap_TreasuryStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockValue_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockValue_lbl1">Treasury Stock, Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl1" xlink:title="label: TreasuryStockValue to us-gaap_TreasuryStockValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TypeOfAdoptionMember_lbl" xml:lang="en-US" id="us-gaap_TypeOfAdoptionMember_lbl">Type of Adoption [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl" xlink:title="label: TypeOfAdoptionMember to us-gaap_TypeOfAdoptionMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl">Unrecognized tax benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl1" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl1">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl1" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl">Accrued interest and penalties associated with any unrecognized tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xml:lang="en-US" id="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" xlink:title="label: UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued to us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnusualOrInfrequentItemDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnusualOrInfrequentItemDomain_lbl" xml:lang="en-US" id="us-gaap_UnusualOrInfrequentItemDomain_lbl">Unusual or Infrequent Item [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="us-gaap_UnusualOrInfrequentItemDomain_lbl" xlink:title="label: UnusualOrInfrequentItemDomain to us-gaap_UnusualOrInfrequentItemDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UnusualOrInfrequentItemAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UnusualOrInfrequentItemAxis_lbl" xml:lang="en-US" id="us-gaap_UnusualOrInfrequentItemAxis_lbl">Unusual or Infrequent Item [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="us-gaap_UnusualOrInfrequentItemAxis_lbl" xlink:title="label: UnusualOrInfrequentItemAxis to us-gaap_UnusualOrInfrequentItemAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UseOfEstimates_lbl1" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl1">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl1" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="VariableRateDomain" xlink:title="VariableRateDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableRateDomain_lbl" xml:lang="en-US" id="us-gaap_VariableRateDomain_lbl">Variable Rate [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl" xlink:title="label: VariableRateDomain to us-gaap_VariableRateDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="VariableRateAxis" xlink:title="VariableRateAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VariableRateAxis_lbl" xml:lang="en-US" id="us-gaap_VariableRateAxis_lbl">Variable Rate [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl" xlink:title="label: VariableRateAxis to us-gaap_VariableRateAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl">Shares used in computation - diluted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:title="label: WeightedAverageNumberOfDilutedSharesOutstanding to us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xlink:title="label: WeightedAverageNumberOfDilutedSharesOutstanding to us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl">Shares used in computation - basic (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingBasic to us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xlink:title="label: WeightedAverageNumberOfSharesOutstandingBasic to us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:label="REDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:title="REDEEMABLENONCONTROLLINGINTERESTSAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract_lbl1" xml:lang="en-US" id="usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract_lbl1">REDEEMABLE NON-CONTROLLING INTERESTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:to="usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract_lbl1" xlink:title="label: REDEEMABLENONCONTROLLINGINTERESTSAbstract to usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock" xlink:label="REDEEMABLENONCONTROLLINGINTERESTSTextBlock" xlink:title="REDEEMABLENONCONTROLLINGINTERESTSTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl" xml:lang="en-US" id="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl">The entire disclosure for a redeemable non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REDEEMABLENONCONTROLLINGINTERESTSTextBlock" xlink:to="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl" xlink:title="label: REDEEMABLENONCONTROLLINGINTERESTSTextBlock to usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl1" xml:lang="en-US" id="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl1">REDEEMABLE NON-CONTROLLING INTERESTS [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REDEEMABLENONCONTROLLINGINTERESTSTextBlock" xlink:to="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl1" xlink:title="label: REDEEMABLENONCONTROLLINGINTERESTSTextBlock to usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl2" xml:lang="en-US" id="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl2">REDEEMABLE NON-CONTROLLING INTERESTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REDEEMABLENONCONTROLLINGINTERESTSTextBlock" xlink:to="usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl2" xlink:title="label: REDEEMABLENONCONTROLLINGINTERESTSTextBlock to usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReferralRelationshipMember_lbl" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl">Referral relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReferralRelationshipMember_lbl1" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl1">Referral Relationship [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl1" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReferralRelationshipMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_ReferralRelationshipMember_lbl2" xml:lang="en-US" id="usph_ReferralRelationshipMember_lbl2">Referral Relationships [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReferralRelationshipMember" xlink:to="usph_ReferralRelationshipMember_lbl2" xlink:title="label: ReferralRelationshipMember to usph_ReferralRelationshipMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl">Carrying value as of the balance sheet date of obligations incurred due to patients and payors . Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl1" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl1">Patients And Payors Related Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl1" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PatientsAndPayorsRelatedLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PatientsAndPayorsRelatedLiability_lbl2" xml:lang="en-US" id="usph_PatientsAndPayorsRelatedLiability_lbl2">Credit balances due to patients and payors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PatientsAndPayorsRelatedLiability" xlink:to="usph_PatientsAndPayorsRelatedLiability_lbl2" xlink:title="label: PatientsAndPayorsRelatedLiability to usph_PatientsAndPayorsRelatedLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl">Amount of amortization expense expected to be recognized during the sixth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearSix to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl1" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl1">Finite Lived Intangible Assets Amortization Expense Year Six</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearSix to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl2" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl2">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl2" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearSix to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl">Amount of amortization expense expected to be recognized during the tenth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTen to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl1" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl1">Finite Lived Intangible Assets Amortization Expense Year Ten</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTen to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl2" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl2">2026</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl2" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTen to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl">Amount of amortization expense expected to be recognized during the twelfth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl1" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl1">Finite Lived Intangible Assets Amortization Expense Year Twelve</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl2" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl2">2028</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl2" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl">Amount of amortization expense expected to be recognized during the ninth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearNine to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl1" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl1">Finite Lived Intangible Assets Amortization Expense Year Nine</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearNine to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl2" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl2">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl2" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearNine to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl">Amount of amortization expense expected to be recognized during the thirteenth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl1" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl1">Finite Lived Intangible Assets Amortization Expense Year Thirteen</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl2" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl2">2029</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl2" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl">Amount of amortization expense expected to be recognized during the eleventh fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl1" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl1">Finite Lived Intangible Assets Amortization Expense Year Eleven</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl2" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl2">2027</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl2" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl">Amount of amortization expense expected to be recognized during the seventh fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl1" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl1">Finite Lived Intangible Assets Amortization Expense Year Seven</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl2" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl2">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl2" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl">Amount of amortization expense expected to be recognized during the eighth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearEight to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl1" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl1">Finite Lived Intangible Assets Amortization Expense Year Eight</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl1" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearEight to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl2" xml:lang="en-US" id="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl2">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" xlink:to="usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl2" xlink:title="label: FiniteLivedIntangibleAssetsAmortizationExpenseYearEight to usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DocumentAndEntityInformationAbstract" xlink:label="DocumentAndEntityInformationAbstract" xlink:title="DocumentAndEntityInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_DocumentAndEntityInformationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DocumentAndEntityInformationAbstract_lbl1" xml:lang="en-US" id="usph_DocumentAndEntityInformationAbstract_lbl1">Document And Entity Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="usph_DocumentAndEntityInformationAbstract_lbl1" xlink:title="label: DocumentAndEntityInformationAbstract to usph_DocumentAndEntityInformationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CashPaidDuringPeriodForAbstract" xlink:label="CashPaidDuringPeriodForAbstract" xlink:title="CashPaidDuringPeriodForAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_CashPaidDuringPeriodForAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CashPaidDuringPeriodForAbstract_lbl1" xml:lang="en-US" id="usph_CashPaidDuringPeriodForAbstract_lbl1">Cash Paid During Period For [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="usph_CashPaidDuringPeriodForAbstract_lbl1" xlink:title="label: CashPaidDuringPeriodForAbstract to usph_CashPaidDuringPeriodForAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CashPaidDuringPeriodForAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CashPaidDuringPeriodForAbstract_lbl2" xml:lang="en-US" id="usph_CashPaidDuringPeriodForAbstract_lbl2">Cash paid during the period for:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="usph_CashPaidDuringPeriodForAbstract_lbl2" xlink:title="label: CashPaidDuringPeriodForAbstract to usph_CashPaidDuringPeriodForAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion" xlink:label="AcquisitionOfNoncontrollingInterestSellerFinancingPortion" xlink:title="AcquisitionOfNoncontrollingInterestSellerFinancingPortion" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl" xml:lang="en-US" id="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl">Acquisition of non-controlling interest - seller financing portion in noncash investing or financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfNoncontrollingInterestSellerFinancingPortion" xlink:to="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl" xlink:title="label: AcquisitionOfNoncontrollingInterestSellerFinancingPortion to usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl1" xml:lang="en-US" id="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl1">Acquisition of Noncontrolling Interest Seller Financing Portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfNoncontrollingInterestSellerFinancingPortion" xlink:to="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl1" xlink:title="label: AcquisitionOfNoncontrollingInterestSellerFinancingPortion to usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl2" xml:lang="en-US" id="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl2">Acquisition of non-controlling interest - seller financing portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfNoncontrollingInterestSellerFinancingPortion" xlink:to="usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl2" xlink:title="label: AcquisitionOfNoncontrollingInterestSellerFinancingPortion to usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PurchaseOfBusinessSellerFinancingPortion" xlink:label="PurchaseOfBusinessSellerFinancingPortion" xlink:title="PurchaseOfBusinessSellerFinancingPortion" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl">Purchase of business - seller financing portion in noncash investing or financing activities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1">Purchase Of Business Seller Financing Portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xml:lang="en-US" id="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2">Purchase of business - seller financing portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfBusinessSellerFinancingPortion" xlink:to="usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" xlink:title="label: PurchaseOfBusinessSellerFinancingPortion to usph_PurchaseOfBusinessSellerFinancingPortion_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_SaleOfNoncontrollingInterest" xlink:label="SaleOfNoncontrollingInterest" xlink:title="SaleOfNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SaleOfNoncontrollingInterest_lbl" xml:lang="en-US" id="usph_SaleOfNoncontrollingInterest_lbl">Refers to amount of noncontrolling interest sold by an entity during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNoncontrollingInterest" xlink:to="usph_SaleOfNoncontrollingInterest_lbl" xlink:title="label: SaleOfNoncontrollingInterest to usph_SaleOfNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SaleOfNoncontrollingInterest_lbl1" xml:lang="en-US" id="usph_SaleOfNoncontrollingInterest_lbl1">Sale Of Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNoncontrollingInterest" xlink:to="usph_SaleOfNoncontrollingInterest_lbl1" xlink:title="label: SaleOfNoncontrollingInterest to usph_SaleOfNoncontrollingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SaleOfNoncontrollingInterest_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SaleOfNoncontrollingInterest_lbl2" xml:lang="en-US" id="usph_SaleOfNoncontrollingInterest_lbl2">Sale of non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfNoncontrollingInterest" xlink:to="usph_SaleOfNoncontrollingInterest_lbl2" xlink:title="label: SaleOfNoncontrollingInterest to usph_SaleOfNoncontrollingInterest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" xlink:label="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" xlink:title="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl" xml:lang="en-US" id="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl">Amount of increase (decrease) in mandatorily redeemable non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" xlink:to="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl" xlink:title="label: IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests to usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl1" xml:lang="en-US" id="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl1">Increase (decrease) in Mandatorily Redeemable Non-controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" xlink:to="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl1" xlink:title="label: IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests to usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl2" xml:lang="en-US" id="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl2">Increase in mandatorily redeemable non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" xlink:to="usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl2" xlink:title="label: IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests to usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion" xlink:label="PaymentToSettleRedeemableNonControllingInterestFinancingPortion" xlink:title="PaymentToSettleRedeemableNonControllingInterestFinancingPortion" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl" xml:lang="en-US" id="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl">The amount of payment to settle redeemable non-controlling interest related to financing portion during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentToSettleRedeemableNonControllingInterestFinancingPortion" xlink:to="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl" xlink:title="label: PaymentToSettleRedeemableNonControllingInterestFinancingPortion to usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl1" xml:lang="en-US" id="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl1">Payment to Settle Redeemable Non-controlling Interest Financing Portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentToSettleRedeemableNonControllingInterestFinancingPortion" xlink:to="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl1" xlink:title="label: PaymentToSettleRedeemableNonControllingInterestFinancingPortion to usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl2" xml:lang="en-US" id="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl2">Payment to settle redeemable non-controlling interest - financing portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentToSettleRedeemableNonControllingInterestFinancingPortion" xlink:to="usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl2" xlink:title="label: PaymentToSettleRedeemableNonControllingInterestFinancingPortion to usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RentClinicSuppliesContractLaborAndOther" xlink:label="RentClinicSuppliesContractLaborAndOther" xlink:title="RentClinicSuppliesContractLaborAndOther" />
    <link:label xlink:type="resource" xlink:label="usph_RentClinicSuppliesContractLaborAndOther_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RentClinicSuppliesContractLaborAndOther_lbl" xml:lang="en-US" id="usph_RentClinicSuppliesContractLaborAndOther_lbl">Amount of expense related to rent, clinic supplies, contract labor and other.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentClinicSuppliesContractLaborAndOther" xlink:to="usph_RentClinicSuppliesContractLaborAndOther_lbl" xlink:title="label: RentClinicSuppliesContractLaborAndOther to usph_RentClinicSuppliesContractLaborAndOther_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RentClinicSuppliesContractLaborAndOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RentClinicSuppliesContractLaborAndOther_lbl1" xml:lang="en-US" id="usph_RentClinicSuppliesContractLaborAndOther_lbl1">Rent Clinic Supplies Contract Labor And Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentClinicSuppliesContractLaborAndOther" xlink:to="usph_RentClinicSuppliesContractLaborAndOther_lbl1" xlink:title="label: RentClinicSuppliesContractLaborAndOther to usph_RentClinicSuppliesContractLaborAndOther_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RentClinicSuppliesContractLaborAndOther_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RentClinicSuppliesContractLaborAndOther_lbl2" xml:lang="en-US" id="usph_RentClinicSuppliesContractLaborAndOther_lbl2">Rent, clinic supplies, contract labor and other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RentClinicSuppliesContractLaborAndOther" xlink:to="usph_RentClinicSuppliesContractLaborAndOther_lbl2" xlink:title="label: RentClinicSuppliesContractLaborAndOther to usph_RentClinicSuppliesContractLaborAndOther_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_InterestExpenseDebtAndOther_lbl" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl">Debt related expenses and other expenses associated with nonoperating financing activities of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_InterestExpenseDebtAndOther_lbl1" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl1">Interest Expense, Debt and Other Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl1" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseDebtAndOther_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_InterestExpenseDebtAndOther_lbl2" xml:lang="en-US" id="usph_InterestExpenseDebtAndOther_lbl2">Debt and other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseDebtAndOther" xlink:to="usph_InterestExpenseDebtAndOther_lbl2" xlink:title="label: InterestExpenseDebtAndOther to usph_InterestExpenseDebtAndOther_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" xlink:label="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" xlink:title="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl" xml:lang="en-US" id="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl">Refers to expenses related to increase (decrease) in redemption value from mandatorily redeemable non-controlling interests. This expenses associated with non-operating financing activities of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" xlink:to="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl" xlink:title="label: InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue to usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl1" xml:lang="en-US" id="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl1">Interest Expense, Mandatorily Redeemable Non-controlling Interests - Increase (Decrease) in Redemption Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" xlink:to="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl1" xlink:title="label: InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue to usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl2" xml:lang="en-US" id="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl2">Mandatorily redeemable non-controlling interests - change in redemption value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" xlink:to="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl2" xlink:title="label: InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue to usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" xlink:label="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" xlink:title="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl" xml:lang="en-US" id="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl">Refers to expenses related to earnings from mandatorily redeemable non-controlling interests. This expenses associated with nonoperating financing activities of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" xlink:to="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl" xlink:title="label: InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable to usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl1" xml:lang="en-US" id="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl1">Interest Expense, Mandatorily Redeemable Non-controlling Interests - Earnings Allocable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" xlink:to="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl1" xlink:title="label: InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable to usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl2" xml:lang="en-US" id="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl2">Mandatorily redeemable non-controlling interests - earnings allocable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" xlink:to="usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl2" xlink:title="label: InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable to usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:label="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:title="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract_lbl1" xml:lang="en-US" id="usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract_lbl1">MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:to="usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract_lbl1" xlink:title="label: MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract to usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:label="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl">Tabular disclosure of carrying amount of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1">Carrying Amount of Redeemable Non-Controlling Interest [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2">Carrying Amount of Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestTableTextBlock to usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MaximumPercentageOfRepurchaseOfCommonStock" xlink:label="MaximumPercentageOfRepurchaseOfCommonStock" xlink:title="MaximumPercentageOfRepurchaseOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl" xml:lang="en-US" id="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl">Maximum percentage of repurchase of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumPercentageOfRepurchaseOfCommonStock" xlink:to="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl" xlink:title="label: MaximumPercentageOfRepurchaseOfCommonStock to usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl1" xml:lang="en-US" id="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl1">Maximum Percentage Of Repurchase Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumPercentageOfRepurchaseOfCommonStock" xlink:to="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl1" xlink:title="label: MaximumPercentageOfRepurchaseOfCommonStock to usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl2" xml:lang="en-US" id="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl2">Maximum percentage of repurchase of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumPercentageOfRepurchaseOfCommonStock" xlink:to="usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl2" xlink:title="label: MaximumPercentageOfRepurchaseOfCommonStock to usph_MaximumPercentageOfRepurchaseOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl">Bank credit agreement to permit share repurchases of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1">Bank Credit Agreement To Permit Share Repurchases Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xml:lang="en-US" id="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2">Bank credit agreement to permit share repurchases of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:to="usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" xlink:title="label: BankCreditAgreementToPermitShareRepurchasesOfCommonStock to usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl">Additional estimated repurchase of common stock during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1">Additional Estimated Repurchase Of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xml:lang="en-US" id="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2">Additional estimated shares (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalEstimatedRepurchaseOfCommonStock" xlink:to="usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" xlink:title="label: AdditionalEstimatedRepurchaseOfCommonStock to usph_AdditionalEstimatedRepurchaseOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl">Amount of cash and noncash consideration that could pay with respect to acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1">Cash And Noncash Consideration With Respect To Acquisition After Amendement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xml:lang="en-US" id="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2">Cash and noncash consideration with respect to acquisition after amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:to="usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" xlink:title="label: CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement to usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DividendsCashAfterAmendment_lbl" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl">Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DividendsCashAfterAmendment_lbl1" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl1">Dividends Cash After Amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl1" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DividendsCashAfterAmendment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DividendsCashAfterAmendment_lbl2" xml:lang="en-US" id="usph_DividendsCashAfterAmendment_lbl2">Cash dividends after amendment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DividendsCashAfterAmendment" xlink:to="usph_DividendsCashAfterAmendment_lbl2" xlink:title="label: DividendsCashAfterAmendment to usph_DividendsCashAfterAmendment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NotesPayableMember_lbl" xml:lang="en-US" id="usph_NotesPayableMember_lbl">A written promise to pay a note.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableMember" xlink:to="usph_NotesPayableMember_lbl" xlink:title="label: NotesPayableMember to usph_NotesPayableMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NotesPayableMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NotesPayableMember_lbl1" xml:lang="en-US" id="usph_NotesPayableMember_lbl1">Notes Payable [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NotesPayableMember" xlink:to="usph_NotesPayableMember_lbl1" xlink:title="label: NotesPayableMember to usph_NotesPayableMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:label xlink:type="resource" xlink:label="usph_CreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CreditAgreementMember_lbl" xml:lang="en-US" id="usph_CreditAgreementMember_lbl">A credit agreement is a legal contract in which a bank arranges to loan a customer a certain amount of money for a specified amount of time.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditAgreementMember" xlink:to="usph_CreditAgreementMember_lbl" xlink:title="label: CreditAgreementMember to usph_CreditAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CreditAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CreditAgreementMember_lbl1" xml:lang="en-US" id="usph_CreditAgreementMember_lbl1">Credit Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CreditAgreementMember" xlink:to="usph_CreditAgreementMember_lbl1" xlink:title="label: CreditAgreementMember to usph_CreditAgreementMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TwoThousandSeventeenAcquisitionMember" xlink:label="TwoThousandSeventeenAcquisitionMember" xlink:title="TwoThousandSeventeenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_TwoThousandSeventeenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TwoThousandSeventeenAcquisitionMember_lbl" xml:lang="en-US" id="usph_TwoThousandSeventeenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwoThousandSeventeenAcquisitionMember" xlink:to="usph_TwoThousandSeventeenAcquisitionMember_lbl" xlink:title="label: TwoThousandSeventeenAcquisitionMember to usph_TwoThousandSeventeenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TwoThousandSeventeenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TwoThousandSeventeenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_TwoThousandSeventeenAcquisitionMember_lbl1">Two Thousand Seventeen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwoThousandSeventeenAcquisitionMember" xlink:to="usph_TwoThousandSeventeenAcquisitionMember_lbl1" xlink:title="label: TwoThousandSeventeenAcquisitionMember to usph_TwoThousandSeventeenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TwoThousandSeventeenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TwoThousandSeventeenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_TwoThousandSeventeenAcquisitionMember_lbl2">2017 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwoThousandSeventeenAcquisitionMember" xlink:to="usph_TwoThousandSeventeenAcquisitionMember_lbl2" xlink:title="label: TwoThousandSeventeenAcquisitionMember to usph_TwoThousandSeventeenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TwoThousandSixteenAcquisitionMember" xlink:label="TwoThousandSixteenAcquisitionMember" xlink:title="TwoThousandSixteenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_TwoThousandSixteenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TwoThousandSixteenAcquisitionMember_lbl" xml:lang="en-US" id="usph_TwoThousandSixteenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwoThousandSixteenAcquisitionMember" xlink:to="usph_TwoThousandSixteenAcquisitionMember_lbl" xlink:title="label: TwoThousandSixteenAcquisitionMember to usph_TwoThousandSixteenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TwoThousandSixteenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TwoThousandSixteenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_TwoThousandSixteenAcquisitionMember_lbl1">Two Thousand Sixteen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwoThousandSixteenAcquisitionMember" xlink:to="usph_TwoThousandSixteenAcquisitionMember_lbl1" xlink:title="label: TwoThousandSixteenAcquisitionMember to usph_TwoThousandSixteenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TwoThousandSixteenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TwoThousandSixteenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_TwoThousandSixteenAcquisitionMember_lbl2">2016 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwoThousandSixteenAcquisitionMember" xlink:to="usph_TwoThousandSixteenAcquisitionMember_lbl2" xlink:title="label: TwoThousandSixteenAcquisitionMember to usph_TwoThousandSixteenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TwoThousandFifteenAcquisitionMember" xlink:label="TwoThousandFifteenAcquisitionMember" xlink:title="TwoThousandFifteenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_TwoThousandFifteenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TwoThousandFifteenAcquisitionMember_lbl" xml:lang="en-US" id="usph_TwoThousandFifteenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwoThousandFifteenAcquisitionMember" xlink:to="usph_TwoThousandFifteenAcquisitionMember_lbl" xlink:title="label: TwoThousandFifteenAcquisitionMember to usph_TwoThousandFifteenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TwoThousandFifteenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TwoThousandFifteenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_TwoThousandFifteenAcquisitionMember_lbl1">Two Thousand Fifteen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwoThousandFifteenAcquisitionMember" xlink:to="usph_TwoThousandFifteenAcquisitionMember_lbl1" xlink:title="label: TwoThousandFifteenAcquisitionMember to usph_TwoThousandFifteenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TwoThousandFifteenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TwoThousandFifteenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_TwoThousandFifteenAcquisitionMember_lbl2">2015 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TwoThousandFifteenAcquisitionMember" xlink:to="usph_TwoThousandFifteenAcquisitionMember_lbl2" xlink:title="label: TwoThousandFifteenAcquisitionMember to usph_TwoThousandFifteenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PromissoryNotesMember_lbl" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl">A written promise to pay a note to a third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PromissoryNotesMember_lbl1" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl1">Promissory Notes [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl1" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PromissoryNotesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PromissoryNotesMember_lbl2" xml:lang="en-US" id="usph_PromissoryNotesMember_lbl2">3.25% through 4.0% notes payable due in next year [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PromissoryNotesMember" xlink:to="usph_PromissoryNotesMember_lbl2" xlink:title="label: PromissoryNotesMember to usph_PromissoryNotesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl">Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1">Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xml:lang="en-US" id="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:to="usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" xlink:title="label: TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans to usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl">This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1">Business Combination Acquisition Fair Value of Redeemable Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xml:lang="en-US" id="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:to="usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" xlink:title="label: BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests to usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfFourClinicPracticesMember" xlink:label="AcquisitionOfFourClinicPracticesMember" xlink:title="AcquisitionOfFourClinicPracticesMember" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfFourClinicPracticesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AcquisitionOfFourClinicPracticesMember_lbl" xml:lang="en-US" id="usph_AcquisitionOfFourClinicPracticesMember_lbl">Acquisition of four clinic practices for an aggregate amount of cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfFourClinicPracticesMember" xlink:to="usph_AcquisitionOfFourClinicPracticesMember_lbl" xlink:title="label: AcquisitionOfFourClinicPracticesMember to usph_AcquisitionOfFourClinicPracticesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfFourClinicPracticesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AcquisitionOfFourClinicPracticesMember_lbl1" xml:lang="en-US" id="usph_AcquisitionOfFourClinicPracticesMember_lbl1">Acquisition Of Four Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfFourClinicPracticesMember" xlink:to="usph_AcquisitionOfFourClinicPracticesMember_lbl1" xlink:title="label: AcquisitionOfFourClinicPracticesMember to usph_AcquisitionOfFourClinicPracticesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MayTwoThousandEighteenMember" xlink:label="MayTwoThousandEighteenMember" xlink:title="MayTwoThousandEighteenMember" />
    <link:label xlink:type="resource" xlink:label="usph_MayTwoThousandEighteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MayTwoThousandEighteenMember_lbl" xml:lang="en-US" id="usph_MayTwoThousandEighteenMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MayTwoThousandEighteenMember" xlink:to="usph_MayTwoThousandEighteenMember_lbl" xlink:title="label: MayTwoThousandEighteenMember to usph_MayTwoThousandEighteenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MayTwoThousandEighteenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MayTwoThousandEighteenMember_lbl1" xml:lang="en-US" id="usph_MayTwoThousandEighteenMember_lbl1">May Two Thousand Eighteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MayTwoThousandEighteenMember" xlink:to="usph_MayTwoThousandEighteenMember_lbl1" xlink:title="label: MayTwoThousandEighteenMember to usph_MayTwoThousandEighteenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MayTwoThousandEighteenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MayTwoThousandEighteenMember_lbl2" xml:lang="en-US" id="usph_MayTwoThousandEighteenMember_lbl2">May 2018 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MayTwoThousandEighteenMember" xlink:to="usph_MayTwoThousandEighteenMember_lbl2" xlink:title="label: MayTwoThousandEighteenMember to usph_MayTwoThousandEighteenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfNineClinicPracticesMember" xlink:label="AcquisitionOfNineClinicPracticesMember" xlink:title="AcquisitionOfNineClinicPracticesMember" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfNineClinicPracticesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AcquisitionOfNineClinicPracticesMember_lbl" xml:lang="en-US" id="usph_AcquisitionOfNineClinicPracticesMember_lbl">Acquisition of nine clinic practices for an aggregate amount of cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfNineClinicPracticesMember" xlink:to="usph_AcquisitionOfNineClinicPracticesMember_lbl" xlink:title="label: AcquisitionOfNineClinicPracticesMember to usph_AcquisitionOfNineClinicPracticesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfNineClinicPracticesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AcquisitionOfNineClinicPracticesMember_lbl1" xml:lang="en-US" id="usph_AcquisitionOfNineClinicPracticesMember_lbl1">Acquisition Of Nine Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfNineClinicPracticesMember" xlink:to="usph_AcquisitionOfNineClinicPracticesMember_lbl1" xlink:title="label: AcquisitionOfNineClinicPracticesMember to usph_AcquisitionOfNineClinicPracticesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MayTwoThousandNineteenMember" xlink:label="MayTwoThousandNineteenMember" xlink:title="MayTwoThousandNineteenMember" />
    <link:label xlink:type="resource" xlink:label="usph_MayTwoThousandNineteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MayTwoThousandNineteenMember_lbl" xml:lang="en-US" id="usph_MayTwoThousandNineteenMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MayTwoThousandNineteenMember" xlink:to="usph_MayTwoThousandNineteenMember_lbl" xlink:title="label: MayTwoThousandNineteenMember to usph_MayTwoThousandNineteenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MayTwoThousandNineteenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MayTwoThousandNineteenMember_lbl1" xml:lang="en-US" id="usph_MayTwoThousandNineteenMember_lbl1">May Two Thousand Nineteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MayTwoThousandNineteenMember" xlink:to="usph_MayTwoThousandNineteenMember_lbl1" xlink:title="label: MayTwoThousandNineteenMember to usph_MayTwoThousandNineteenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MayTwoThousandNineteenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MayTwoThousandNineteenMember_lbl2" xml:lang="en-US" id="usph_MayTwoThousandNineteenMember_lbl2">May 2019 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MayTwoThousandNineteenMember" xlink:to="usph_MayTwoThousandNineteenMember_lbl2" xlink:title="label: MayTwoThousandNineteenMember to usph_MayTwoThousandNineteenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JuneTwoThousandEighteenMember" xlink:label="JuneTwoThousandEighteenMember" xlink:title="JuneTwoThousandEighteenMember" />
    <link:label xlink:type="resource" xlink:label="usph_JuneTwoThousandEighteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_JuneTwoThousandEighteenMember_lbl" xml:lang="en-US" id="usph_JuneTwoThousandEighteenMember_lbl">Refers to the first principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JuneTwoThousandEighteenMember" xlink:to="usph_JuneTwoThousandEighteenMember_lbl" xlink:title="label: JuneTwoThousandEighteenMember to usph_JuneTwoThousandEighteenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_JuneTwoThousandEighteenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_JuneTwoThousandEighteenMember_lbl1" xml:lang="en-US" id="usph_JuneTwoThousandEighteenMember_lbl1">June Two Thousand Eighteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JuneTwoThousandEighteenMember" xlink:to="usph_JuneTwoThousandEighteenMember_lbl1" xlink:title="label: JuneTwoThousandEighteenMember to usph_JuneTwoThousandEighteenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_JuneTwoThousandEighteenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_JuneTwoThousandEighteenMember_lbl2" xml:lang="en-US" id="usph_JuneTwoThousandEighteenMember_lbl2">June 2018 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JuneTwoThousandEighteenMember" xlink:to="usph_JuneTwoThousandEighteenMember_lbl2" xlink:title="label: JuneTwoThousandEighteenMember to usph_JuneTwoThousandEighteenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JuneTwoThousandNineteenMember" xlink:label="JuneTwoThousandNineteenMember" xlink:title="JuneTwoThousandNineteenMember" />
    <link:label xlink:type="resource" xlink:label="usph_JuneTwoThousandNineteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_JuneTwoThousandNineteenMember_lbl" xml:lang="en-US" id="usph_JuneTwoThousandNineteenMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JuneTwoThousandNineteenMember" xlink:to="usph_JuneTwoThousandNineteenMember_lbl" xlink:title="label: JuneTwoThousandNineteenMember to usph_JuneTwoThousandNineteenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_JuneTwoThousandNineteenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_JuneTwoThousandNineteenMember_lbl1" xml:lang="en-US" id="usph_JuneTwoThousandNineteenMember_lbl1">June Two Thousand Nineteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JuneTwoThousandNineteenMember" xlink:to="usph_JuneTwoThousandNineteenMember_lbl1" xlink:title="label: JuneTwoThousandNineteenMember to usph_JuneTwoThousandNineteenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_JuneTwoThousandNineteenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_JuneTwoThousandNineteenMember_lbl2" xml:lang="en-US" id="usph_JuneTwoThousandNineteenMember_lbl2">June 2019 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JuneTwoThousandNineteenMember" xlink:to="usph_JuneTwoThousandNineteenMember_lbl2" xlink:title="label: JuneTwoThousandNineteenMember to usph_JuneTwoThousandNineteenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl">The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1">Business Acquisition Cost Of Acquired Entity Debt Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2">Seller notes issued for acquisition of interest in clinic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl3" xml:lang="en-US" id="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl3">Seller notes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:to="usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl3" xlink:title="label: BusinessAcquisitionCostOfAcquiredEntityDebtIssued to usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" xlink:label="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" xlink:title="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl">Business acquisition number of installments to payment of purchase consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" xlink:to="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl" xlink:title="label: BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration to usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl1">Business Acquisition Number Of Installments To Payment Of Purchase Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" xlink:to="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl1" xlink:title="label: BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration to usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl2">Business acquisition number of installments to payment of purchase consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" xlink:to="usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl2" xlink:title="label: BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration to usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl">Payments to acquire businesses total consideration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl1">Payments To Acquire Businesses Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl1" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl2">Total consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl2" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl2" />
    <link:label xlink:type="resource" xlink:label="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xml:lang="en-US" id="usph_PaymentsToAcquireBusinessesConsideration_lbl3">Total consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireBusinessesConsideration" xlink:to="usph_PaymentsToAcquireBusinessesConsideration_lbl3" xlink:title="label: PaymentsToAcquireBusinessesConsideration to usph_PaymentsToAcquireBusinessesConsideration_lbl3" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" xlink:label="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" xlink:title="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl">Amount of business acquisition principal installments payable at cost of acquired by entity at accrued interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" xlink:to="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl" xlink:title="label: BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest to usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl1">Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" xlink:to="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl1" xlink:title="label: BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest to usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl2">Acquisition cost payable in two principal installments including accrued interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" xlink:to="usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl2" xlink:title="label: BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest to usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NovemberTwoThousandEighteenMember" xlink:label="NovemberTwoThousandEighteenMember" xlink:title="NovemberTwoThousandEighteenMember" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandEighteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NovemberTwoThousandEighteenMember_lbl" xml:lang="en-US" id="usph_NovemberTwoThousandEighteenMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandEighteenMember" xlink:to="usph_NovemberTwoThousandEighteenMember_lbl" xlink:title="label: NovemberTwoThousandEighteenMember to usph_NovemberTwoThousandEighteenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandEighteenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NovemberTwoThousandEighteenMember_lbl1" xml:lang="en-US" id="usph_NovemberTwoThousandEighteenMember_lbl1">November Two Thousand Eighteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandEighteenMember" xlink:to="usph_NovemberTwoThousandEighteenMember_lbl1" xlink:title="label: NovemberTwoThousandEighteenMember to usph_NovemberTwoThousandEighteenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandEighteenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NovemberTwoThousandEighteenMember_lbl2" xml:lang="en-US" id="usph_NovemberTwoThousandEighteenMember_lbl2">November 2018 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandEighteenMember" xlink:to="usph_NovemberTwoThousandEighteenMember_lbl2" xlink:title="label: NovemberTwoThousandEighteenMember to usph_NovemberTwoThousandEighteenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JanuaryTwoThousandEighteenMember" xlink:label="JanuaryTwoThousandEighteenMember" xlink:title="JanuaryTwoThousandEighteenMember" />
    <link:label xlink:type="resource" xlink:label="usph_JanuaryTwoThousandEighteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_JanuaryTwoThousandEighteenMember_lbl" xml:lang="en-US" id="usph_JanuaryTwoThousandEighteenMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JanuaryTwoThousandEighteenMember" xlink:to="usph_JanuaryTwoThousandEighteenMember_lbl" xlink:title="label: JanuaryTwoThousandEighteenMember to usph_JanuaryTwoThousandEighteenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_JanuaryTwoThousandEighteenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_JanuaryTwoThousandEighteenMember_lbl1" xml:lang="en-US" id="usph_JanuaryTwoThousandEighteenMember_lbl1">January Two Thousand Eighteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JanuaryTwoThousandEighteenMember" xlink:to="usph_JanuaryTwoThousandEighteenMember_lbl1" xlink:title="label: JanuaryTwoThousandEighteenMember to usph_JanuaryTwoThousandEighteenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_JanuaryTwoThousandEighteenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_JanuaryTwoThousandEighteenMember_lbl2" xml:lang="en-US" id="usph_JanuaryTwoThousandEighteenMember_lbl2">January 2018 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JanuaryTwoThousandEighteenMember" xlink:to="usph_JanuaryTwoThousandEighteenMember_lbl2" xlink:title="label: JanuaryTwoThousandEighteenMember to usph_JanuaryTwoThousandEighteenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xml:lang="en-US" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1">Estimated Fair Value Of Net Tangible Assets Acquired [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" xlink:title="label: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xml:lang="en-US" id="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2">Estimated fair value of net tangible assets acquired [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" xlink:title="label: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl">Amount of referral relationships at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Referral Relationships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2">Referral relationships</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl">The amount of tradename recognized as of the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Tradename</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2">Tradename</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl">The amount of non-competition agreements recognized as of the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Non Competition Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xml:lang="en-US" id="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2">Non-compete</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:to="usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" xlink:title="label: BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements to usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JanuaryTwoThousandNineteenMember" xlink:label="JanuaryTwoThousandNineteenMember" xlink:title="JanuaryTwoThousandNineteenMember" />
    <link:label xlink:type="resource" xlink:label="usph_JanuaryTwoThousandNineteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_JanuaryTwoThousandNineteenMember_lbl" xml:lang="en-US" id="usph_JanuaryTwoThousandNineteenMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JanuaryTwoThousandNineteenMember" xlink:to="usph_JanuaryTwoThousandNineteenMember_lbl" xlink:title="label: JanuaryTwoThousandNineteenMember to usph_JanuaryTwoThousandNineteenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_JanuaryTwoThousandNineteenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_JanuaryTwoThousandNineteenMember_lbl1" xml:lang="en-US" id="usph_JanuaryTwoThousandNineteenMember_lbl1">January Two Thousand Nineteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JanuaryTwoThousandNineteenMember" xlink:to="usph_JanuaryTwoThousandNineteenMember_lbl1" xlink:title="label: JanuaryTwoThousandNineteenMember to usph_JanuaryTwoThousandNineteenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_JanuaryTwoThousandNineteenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_JanuaryTwoThousandNineteenMember_lbl2" xml:lang="en-US" id="usph_JanuaryTwoThousandNineteenMember_lbl2">January 2019 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JanuaryTwoThousandNineteenMember" xlink:to="usph_JanuaryTwoThousandNineteenMember_lbl2" xlink:title="label: JanuaryTwoThousandNineteenMember to usph_JanuaryTwoThousandNineteenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl">Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1">Business Combination, Acquired Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xml:lang="en-US" id="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2">Estimated useful lives of acquired intangibles</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:to="usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" xlink:title="label: BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife to usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NovemberTwoThousandSeventeenMember" xlink:label="NovemberTwoThousandSeventeenMember" xlink:title="NovemberTwoThousandSeventeenMember" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandSeventeenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NovemberTwoThousandSeventeenMember_lbl" xml:lang="en-US" id="usph_NovemberTwoThousandSeventeenMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandSeventeenMember" xlink:to="usph_NovemberTwoThousandSeventeenMember_lbl" xlink:title="label: NovemberTwoThousandSeventeenMember to usph_NovemberTwoThousandSeventeenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandSeventeenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NovemberTwoThousandSeventeenMember_lbl1" xml:lang="en-US" id="usph_NovemberTwoThousandSeventeenMember_lbl1">November Two Thousand Seventeen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandSeventeenMember" xlink:to="usph_NovemberTwoThousandSeventeenMember_lbl1" xlink:title="label: NovemberTwoThousandSeventeenMember to usph_NovemberTwoThousandSeventeenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandSeventeenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NovemberTwoThousandSeventeenMember_lbl2" xml:lang="en-US" id="usph_NovemberTwoThousandSeventeenMember_lbl2">November 2017 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandSeventeenMember" xlink:to="usph_NovemberTwoThousandSeventeenMember_lbl2" xlink:title="label: NovemberTwoThousandSeventeenMember to usph_NovemberTwoThousandSeventeenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl">Amount of net tangible asset acquired at the acquisition date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1">Business Acquisition Purchase Price Allocation Net Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2">Net tangible assets acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:to="usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" xlink:title="label: BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset to usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FebruaryTwoThousandEighteenMember" xlink:label="FebruaryTwoThousandEighteenMember" xlink:title="FebruaryTwoThousandEighteenMember" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandEighteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FebruaryTwoThousandEighteenMember_lbl" xml:lang="en-US" id="usph_FebruaryTwoThousandEighteenMember_lbl">Refers to the first principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandEighteenMember" xlink:to="usph_FebruaryTwoThousandEighteenMember_lbl" xlink:title="label: FebruaryTwoThousandEighteenMember to usph_FebruaryTwoThousandEighteenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandEighteenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FebruaryTwoThousandEighteenMember_lbl1" xml:lang="en-US" id="usph_FebruaryTwoThousandEighteenMember_lbl1">February Two Thousand Eighteen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandEighteenMember" xlink:to="usph_FebruaryTwoThousandEighteenMember_lbl1" xlink:title="label: FebruaryTwoThousandEighteenMember to usph_FebruaryTwoThousandEighteenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandEighteenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FebruaryTwoThousandEighteenMember_lbl2" xml:lang="en-US" id="usph_FebruaryTwoThousandEighteenMember_lbl2">February 2018 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandEighteenMember" xlink:to="usph_FebruaryTwoThousandEighteenMember_lbl2" xlink:title="label: FebruaryTwoThousandEighteenMember to usph_FebruaryTwoThousandEighteenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfSubsidiariesAcquiredClinicPractices" xlink:label="NumberOfSubsidiariesAcquiredClinicPractices" xlink:title="NumberOfSubsidiariesAcquiredClinicPractices" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl" xml:lang="en-US" id="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl">Represents number of subsidiaries of the entity acquired clinic practices during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfSubsidiariesAcquiredClinicPractices" xlink:to="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl" xlink:title="label: NumberOfSubsidiariesAcquiredClinicPractices to usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl1" xml:lang="en-US" id="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl1">Number Of Subsidiaries Acquired Clinic Practices</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfSubsidiariesAcquiredClinicPractices" xlink:to="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl1" xlink:title="label: NumberOfSubsidiariesAcquiredClinicPractices to usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl2" xml:lang="en-US" id="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl2">Number of subsidiaries acquired clinic practices</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfSubsidiariesAcquiredClinicPractices" xlink:to="usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl2" xlink:title="label: NumberOfSubsidiariesAcquiredClinicPractices to usph_NumberOfSubsidiariesAcquiredClinicPractices_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FebruaryTwoThousandSeventeenMember" xlink:label="FebruaryTwoThousandSeventeenMember" xlink:title="FebruaryTwoThousandSeventeenMember" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandSeventeenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FebruaryTwoThousandSeventeenMember_lbl" xml:lang="en-US" id="usph_FebruaryTwoThousandSeventeenMember_lbl">Refers to the principal installment plus accrued interest payable date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandSeventeenMember" xlink:to="usph_FebruaryTwoThousandSeventeenMember_lbl" xlink:title="label: FebruaryTwoThousandSeventeenMember to usph_FebruaryTwoThousandSeventeenMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandSeventeenMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FebruaryTwoThousandSeventeenMember_lbl1" xml:lang="en-US" id="usph_FebruaryTwoThousandSeventeenMember_lbl1">February Two Thousand Seventeen [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandSeventeenMember" xlink:to="usph_FebruaryTwoThousandSeventeenMember_lbl1" xlink:title="label: FebruaryTwoThousandSeventeenMember to usph_FebruaryTwoThousandSeventeenMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandSeventeenMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FebruaryTwoThousandSeventeenMember_lbl2" xml:lang="en-US" id="usph_FebruaryTwoThousandSeventeenMember_lbl2">February 2017 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandSeventeenMember" xlink:to="usph_FebruaryTwoThousandSeventeenMember_lbl2" xlink:title="label: FebruaryTwoThousandSeventeenMember to usph_FebruaryTwoThousandSeventeenMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_WorkforcePerformanceSolutionsMember" xlink:label="WorkforcePerformanceSolutionsMember" xlink:title="WorkforcePerformanceSolutionsMember" />
    <link:label xlink:type="resource" xlink:label="usph_WorkforcePerformanceSolutionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_WorkforcePerformanceSolutionsMember_lbl" xml:lang="en-US" id="usph_WorkforcePerformanceSolutionsMember_lbl">Acquisition of part of a company which provides workforce performance solutions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WorkforcePerformanceSolutionsMember" xlink:to="usph_WorkforcePerformanceSolutionsMember_lbl" xlink:title="label: WorkforcePerformanceSolutionsMember to usph_WorkforcePerformanceSolutionsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_WorkforcePerformanceSolutionsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_WorkforcePerformanceSolutionsMember_lbl1" xml:lang="en-US" id="usph_WorkforcePerformanceSolutionsMember_lbl1">Workforce Performance Solutions [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WorkforcePerformanceSolutionsMember" xlink:to="usph_WorkforcePerformanceSolutionsMember_lbl1" xlink:title="label: WorkforcePerformanceSolutionsMember to usph_WorkforcePerformanceSolutionsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfTwelveClinicPracticesMember" xlink:label="AcquisitionOfTwelveClinicPracticesMember" xlink:title="AcquisitionOfTwelveClinicPracticesMember" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfTwelveClinicPracticesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AcquisitionOfTwelveClinicPracticesMember_lbl" xml:lang="en-US" id="usph_AcquisitionOfTwelveClinicPracticesMember_lbl">Acquisition of twelve clinic practices for an aggregate amount of cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfTwelveClinicPracticesMember" xlink:to="usph_AcquisitionOfTwelveClinicPracticesMember_lbl" xlink:title="label: AcquisitionOfTwelveClinicPracticesMember to usph_AcquisitionOfTwelveClinicPracticesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfTwelveClinicPracticesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AcquisitionOfTwelveClinicPracticesMember_lbl1" xml:lang="en-US" id="usph_AcquisitionOfTwelveClinicPracticesMember_lbl1">Acquisition Of Twelve Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfTwelveClinicPracticesMember" xlink:to="usph_AcquisitionOfTwelveClinicPracticesMember_lbl1" xlink:title="label: AcquisitionOfTwelveClinicPracticesMember to usph_AcquisitionOfTwelveClinicPracticesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfSeventeenClinicPracticesMember" xlink:label="AcquisitionOfSeventeenClinicPracticesMember" xlink:title="AcquisitionOfSeventeenClinicPracticesMember" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl" xml:lang="en-US" id="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl">Acquisition of seventeen clinic practices for an aggregate amount of cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfSeventeenClinicPracticesMember" xlink:to="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl" xlink:title="label: AcquisitionOfSeventeenClinicPracticesMember to usph_AcquisitionOfSeventeenClinicPracticesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl1" xml:lang="en-US" id="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl1">Acquisition of Seventeen Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfSeventeenClinicPracticesMember" xlink:to="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl1" xlink:title="label: AcquisitionOfSeventeenClinicPracticesMember to usph_AcquisitionOfSeventeenClinicPracticesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl2" xml:lang="en-US" id="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl2">Acquisition of Seventeen Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfSeventeenClinicPracticesMember" xlink:to="usph_AcquisitionOfSeventeenClinicPracticesMember_lbl2" xlink:title="label: AcquisitionOfSeventeenClinicPracticesMember to usph_AcquisitionOfSeventeenClinicPracticesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfEightClinicPracticesMember" xlink:label="AcquisitionOfEightClinicPracticesMember" xlink:title="AcquisitionOfEightClinicPracticesMember" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfEightClinicPracticesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AcquisitionOfEightClinicPracticesMember_lbl" xml:lang="en-US" id="usph_AcquisitionOfEightClinicPracticesMember_lbl">Acquisition of eight clinic practices for an aggregate amount of cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfEightClinicPracticesMember" xlink:to="usph_AcquisitionOfEightClinicPracticesMember_lbl" xlink:title="label: AcquisitionOfEightClinicPracticesMember to usph_AcquisitionOfEightClinicPracticesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfEightClinicPracticesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AcquisitionOfEightClinicPracticesMember_lbl1" xml:lang="en-US" id="usph_AcquisitionOfEightClinicPracticesMember_lbl1">Acquisition Of Eight Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfEightClinicPracticesMember" xlink:to="usph_AcquisitionOfEightClinicPracticesMember_lbl1" xlink:title="label: AcquisitionOfEightClinicPracticesMember to usph_AcquisitionOfEightClinicPracticesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfSingleClinicPracticesMember" xlink:label="AcquisitionOfSingleClinicPracticesMember" xlink:title="AcquisitionOfSingleClinicPracticesMember" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfSingleClinicPracticesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AcquisitionOfSingleClinicPracticesMember_lbl" xml:lang="en-US" id="usph_AcquisitionOfSingleClinicPracticesMember_lbl">Acquisition of a single clinic practice for an aggregate amount of cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfSingleClinicPracticesMember" xlink:to="usph_AcquisitionOfSingleClinicPracticesMember_lbl" xlink:title="label: AcquisitionOfSingleClinicPracticesMember to usph_AcquisitionOfSingleClinicPracticesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfSingleClinicPracticesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AcquisitionOfSingleClinicPracticesMember_lbl1" xml:lang="en-US" id="usph_AcquisitionOfSingleClinicPracticesMember_lbl1">Acquisition Of Single Clinic Practices [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfSingleClinicPracticesMember" xlink:to="usph_AcquisitionOfSingleClinicPracticesMember_lbl1" xlink:title="label: AcquisitionOfSingleClinicPracticesMember to usph_AcquisitionOfSingleClinicPracticesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AcquisitionOfSingleClinicPracticesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AcquisitionOfSingleClinicPracticesMember_lbl2" xml:lang="en-US" id="usph_AcquisitionOfSingleClinicPracticesMember_lbl2">Acquisition Of Single Clinic Practice [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AcquisitionOfSingleClinicPracticesMember" xlink:to="usph_AcquisitionOfSingleClinicPracticesMember_lbl2" xlink:title="label: AcquisitionOfSingleClinicPracticesMember to usph_AcquisitionOfSingleClinicPracticesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:label="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="CarryingAmountOfRedeemableNonControllingInterestAbstract" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1">Carrying Amount of Redeemable Non-Controlling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestAbstract to usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xml:lang="en-US" id="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2">Carrying Amount of Redeemable Non-Controlling Interest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" xlink:title="label: CarryingAmountOfRedeemableNonControllingInterestAbstract to usph_CarryingAmountOfRedeemableNonControllingInterestAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl">Refers to amount of contractual time period had not lapsed and holder's employment had not been terminated as of balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1">Contractual Time Period Has Not Lapsed And Holders Employment Has Not Been Terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xml:lang="en-US" id="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2">Contractual time period has not lapsed and holder's employment has not been terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" xlink:title="label: ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated to usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ExcessDistributionsOverEarningsAndLosses" xlink:label="ExcessDistributionsOverEarningsAndLosses" xlink:title="ExcessDistributionsOverEarningsAndLosses" />
    <link:label xlink:type="resource" xlink:label="usph_ExcessDistributionsOverEarningsAndLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ExcessDistributionsOverEarningsAndLosses_lbl" xml:lang="en-US" id="usph_ExcessDistributionsOverEarningsAndLosses_lbl">Refers to distributions in excess of earnings and undistributed (loss) earnings.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExcessDistributionsOverEarningsAndLosses" xlink:to="usph_ExcessDistributionsOverEarningsAndLosses_lbl" xlink:title="label: ExcessDistributionsOverEarningsAndLosses to usph_ExcessDistributionsOverEarningsAndLosses_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ExcessDistributionsOverEarningsAndLosses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ExcessDistributionsOverEarningsAndLosses_lbl1" xml:lang="en-US" id="usph_ExcessDistributionsOverEarningsAndLosses_lbl1">Excess Distributions Over Earnings and Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExcessDistributionsOverEarningsAndLosses" xlink:to="usph_ExcessDistributionsOverEarningsAndLosses_lbl1" xlink:title="label: ExcessDistributionsOverEarningsAndLosses to usph_ExcessDistributionsOverEarningsAndLosses_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ExcessDistributionsOverEarningsAndLosses_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_ExcessDistributionsOverEarningsAndLosses_lbl2" xml:lang="en-US" id="usph_ExcessDistributionsOverEarningsAndLosses_lbl2">Excess distributions over earnings and losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExcessDistributionsOverEarningsAndLosses" xlink:to="usph_ExcessDistributionsOverEarningsAndLosses_lbl2" xlink:title="label: ExcessDistributionsOverEarningsAndLosses to usph_ExcessDistributionsOverEarningsAndLosses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl">Refers to amount of contractual time period had lapsed but holder's employment had not been terminated as of balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1">Contractual Time Period Has Lapsed But Holders Employment Has Not Been Terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xml:lang="en-US" id="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2">Contractual time period has lapsed but holder's employment has not been terminated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:to="usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" xlink:title="label: ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated to usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:label="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:title="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" />
    <link:label xlink:type="resource" xlink:label="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl" xml:lang="en-US" id="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl">A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:to="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl" xlink:title="label: ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward to usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl1" xml:lang="en-US" id="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl1">Changes in Carrying Amount of Mandatorily Redeemable Non-Controlling Interests [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:to="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl1" xlink:title="label: ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward to usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl2" xml:lang="en-US" id="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl2">Changes in Carrying Amount of Redeemable Non-Controlling Interest [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:to="usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl2" xlink:title="label: ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward to usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" xlink:label="DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl" xml:lang="en-US" id="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl">The distributions during the period for redemption of mandatorily redeemable noncontrolling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl" xlink:title="label: DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xml:lang="en-US" id="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl1">Distributions to Lmited Partners and Redeemable Noncontrolling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl1" xlink:title="label: DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xml:lang="en-US" id="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl2">Distributions to mandatorily redeemable non-controlling interest partners</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" xlink:to="usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl2" xlink:title="label: DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests to usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:label xlink:type="resource" xlink:label="usph_TherapyPracticeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TherapyPracticeMember_lbl" xml:lang="en-US" id="usph_TherapyPracticeMember_lbl">Refers to the acquiree entity Therapy Practice.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TherapyPracticeMember" xlink:to="usph_TherapyPracticeMember_lbl" xlink:title="label: TherapyPracticeMember to usph_TherapyPracticeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TherapyPracticeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TherapyPracticeMember_lbl1" xml:lang="en-US" id="usph_TherapyPracticeMember_lbl1">Therapy Practice [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TherapyPracticeMember" xlink:to="usph_TherapyPracticeMember_lbl1" xlink:title="label: TherapyPracticeMember to usph_TherapyPracticeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl">Refers to the term of the note issued for consideration payable for the acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1">Business Acquisition Consideration Payable, Term of Note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2">Business acquisition, consideration payable, term of note</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:to="usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" xlink:title="label: BusinessAcquisitionConsiderationPayableTermOfNote to usph_BusinessAcquisitionConsiderationPayableTermOfNote_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl">Refers to the percentage of general partnership interest acquired in the business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1">Business Acquisition, Percentage of General Partnership Interest Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2">Business acquisition, percentage of general partnership interest acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl">Refers to the percentage of equity interest in subsidiary contributed for acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1">Business Acquisition Percentage Of Equity Interest In Subsidiary Contributed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2">Percentage of equity interest of subsidiary contributed for acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:to="usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed to usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" xlink:label="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" xlink:title="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" />
    <link:label xlink:type="resource" xlink:label="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl" xml:lang="en-US" id="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl">Refers to the required redemption term under condition of termination of an Employed Selling Shareholder's employment with subsidiary , regardless of the reason for such termination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" xlink:to="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl" xlink:title="label: RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders to usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl1" xml:lang="en-US" id="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl1">Required Redemption Term, under Condition of Termination of Employment of Employed Selling Shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" xlink:to="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl1" xlink:title="label: RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders to usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl2" xml:lang="en-US" id="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl2">Required redemption term, under condition of termination of employment of employed selling shareholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" xlink:to="usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl2" xlink:title="label: RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders to usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_TermOfEmploymentAgreement_lbl" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl">Refers to the term of employment agreement with the subsidiary entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_TermOfEmploymentAgreement_lbl1" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl1">Term of Employment Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl1" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_TermOfEmploymentAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_TermOfEmploymentAgreement_lbl2" xml:lang="en-US" id="usph_TermOfEmploymentAgreement_lbl2">Employment agreement term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfEmploymentAgreement" xlink:to="usph_TermOfEmploymentAgreement_lbl2" xlink:title="label: TermOfEmploymentAgreement to usph_TermOfEmploymentAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl">Refers to the term of non-compete agreement under the condition if an Employed Selling Shareholders' employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1">Non-Compete Agreement Term under Condition of Termination of Employment of Employed Selling Shareholder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xml:lang="en-US" id="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2">Non-Compete agreement term under condition of termination of employment of employed selling shareholder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:to="usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" xlink:title="label: NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder to usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl">Refers to the term of non-compete agreement regardless of whether the Selling Shareholder is employed by the subsidiary entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl1" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl1">Non-Compete Agreement Term under Condition Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl1" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonCompeteAgreementBasicTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonCompeteAgreementBasicTerm_lbl2" xml:lang="en-US" id="usph_NonCompeteAgreementBasicTerm_lbl2">Non-Compete agreement term regardless of whether the selling shareholder is employed</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonCompeteAgreementBasicTerm" xlink:to="usph_NonCompeteAgreementBasicTerm_lbl2" xlink:title="label: NonCompeteAgreementBasicTerm to usph_NonCompeteAgreementBasicTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" xlink:label="IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" xlink:title="IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" />
    <link:label xlink:type="resource" xlink:label="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl" xml:lang="en-US" id="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl">Refers to the amount of increase due to revaluation fair value of redeemable non-controlling interest from sale of a portion of the parent's controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" xlink:to="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl" xlink:title="label: IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest to usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl1" xml:lang="en-US" id="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl1">Increase Due To Revaluation Fair Value Of Redeemable Non-Controlling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" xlink:to="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl1" xlink:title="label: IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest to usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl2" xml:lang="en-US" id="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl2">Payments for settlement of mandatorily redeemable non-controlling interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" xlink:to="usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl2" xlink:title="label: IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest to usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl">Refers to the percentage of limited partnership interest acquired in the business combination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1">Business Acquisition, Percentage of Limited Partnership Interest Acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xml:lang="en-US" id="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2">Business acquisition, percentage of limited partnership acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:to="usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" xlink:title="label: BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired to usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl">Refers to holder's employment has terminated and contractual time period has expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1">Holders Employment Has Terminated and Contractual Time Period Has Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2">Holder's employment has terminated and contractual time period has expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl">Refers to the renewal term of the employment agreement with the subsidiary entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl1" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl1">Employment Agreement Renewal Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl1" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_EmploymentAgreementRenewalTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_EmploymentAgreementRenewalTerm_lbl2" xml:lang="en-US" id="usph_EmploymentAgreementRenewalTerm_lbl2">Employment agreement renewal term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmploymentAgreementRenewalTerm" xlink:to="usph_EmploymentAgreementRenewalTerm_lbl2" xlink:title="label: EmploymentAgreementRenewalTerm to usph_EmploymentAgreementRenewalTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl">Refers to holder's employment has terminated and contractual time period has not expired.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1">Holders Employment Has Terminated and Contractual Time Period Has Not Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xml:lang="en-US" id="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2">Holder's employment has terminated and contractual time period has not expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:to="usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" xlink:title="label: HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired to usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RedeemableNonControllingInterestsPolicyTextBlock" xlink:label="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="RedeemableNonControllingInterestsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl">Disclosure of accounting policy for redeemable non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1">Redeemable Non Controlling Interests [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2">Redeemable Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" xlink:title="label: RedeemableNonControllingInterestsPolicyTextBlock to usph_RedeemableNonControllingInterestsPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RestrictedStockPolicyPolicyTextBlock" xlink:label="RestrictedStockPolicyPolicyTextBlock" xlink:title="RestrictedStockPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for restricted stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl1">Restricted Stock Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl1" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_RestrictedStockPolicyPolicyTextBlock_lbl2">Restricted Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockPolicyPolicyTextBlock" xlink:to="usph_RestrictedStockPolicyPolicyTextBlock_lbl2" xlink:title="label: RestrictedStockPolicyPolicyTextBlock to usph_RestrictedStockPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" xlink:label="MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" xlink:title="MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl" xml:lang="en-US" id="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl">Disclosure of accounting policy for mandatorily non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl" xlink:title="label: MandatorilyRedeemableNonControllingInterestsPolicyTextBlock to usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl1">Mandatorily Redeemable Non Controlling Interests [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl1" xlink:title="label: MandatorilyRedeemableNonControllingInterestsPolicyTextBlock to usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl2">Mandatorily Redeemable Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" xlink:to="usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl2" xlink:title="label: MandatorilyRedeemableNonControllingInterestsPolicyTextBlock to usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RecentlyIssuedAccountingGuidancePolicyTextBlock" xlink:label="RecentlyIssuedAccountingGuidancePolicyTextBlock" xlink:title="RecentlyIssuedAccountingGuidancePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl" xml:lang="en-US" id="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl">Disclosure of accounting policy for new accounting pronouncements that have been issued but not yet adopted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RecentlyIssuedAccountingGuidancePolicyTextBlock" xlink:to="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl" xlink:title="label: RecentlyIssuedAccountingGuidancePolicyTextBlock to usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl1" xml:lang="en-US" id="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl1">Recently Issued Accounting Guidance [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RecentlyIssuedAccountingGuidancePolicyTextBlock" xlink:to="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl1" xlink:title="label: RecentlyIssuedAccountingGuidancePolicyTextBlock to usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl2" xml:lang="en-US" id="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl2">Recently Issued Accounting Guidance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RecentlyIssuedAccountingGuidancePolicyTextBlock" xlink:to="usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl2" xlink:title="label: RecentlyIssuedAccountingGuidancePolicyTextBlock to usph_RecentlyIssuedAccountingGuidancePolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NonControllingInterestsPolicyPolicyTextBlock" xlink:label="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="NonControllingInterestsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for non-controlling interests.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1">Non controlling Interests Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2">Non-Controlling Interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonControllingInterestsPolicyPolicyTextBlock" xlink:to="usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" xlink:title="label: NonControllingInterestsPolicyPolicyTextBlock to usph_NonControllingInterestsPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_SelfInsuranceProgramPolicyPolicyTextBlock" xlink:label="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="SelfInsuranceProgramPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl">Disclosure of accounting policy for self-insurance program.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1">Self Insurance Program Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2">Self-Insurance Program</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:to="usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" xlink:title="label: SelfInsuranceProgramPolicyPolicyTextBlock to usph_SelfInsuranceProgramPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl">Tabular disclosure of clinic acquisition during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl" xlink:title="label: ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock to usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl1" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl1">Schedule of Business Acquisitions, Clinic Acquisition [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl1" xlink:title="label: ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock to usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl2" xml:lang="en-US" id="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl2">Schedule of Clinic Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" xlink:to="usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl2" xlink:title="label: ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock to usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MayTwoThousandSeventeenAcquisitionMember" xlink:label="MayTwoThousandSeventeenAcquisitionMember" xlink:title="MayTwoThousandSeventeenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_MayTwoThousandSeventeenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MayTwoThousandSeventeenAcquisitionMember_lbl" xml:lang="en-US" id="usph_MayTwoThousandSeventeenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MayTwoThousandSeventeenAcquisitionMember" xlink:to="usph_MayTwoThousandSeventeenAcquisitionMember_lbl" xlink:title="label: MayTwoThousandSeventeenAcquisitionMember to usph_MayTwoThousandSeventeenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MayTwoThousandSeventeenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MayTwoThousandSeventeenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_MayTwoThousandSeventeenAcquisitionMember_lbl1">May Two Thousand Seventeen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MayTwoThousandSeventeenAcquisitionMember" xlink:to="usph_MayTwoThousandSeventeenAcquisitionMember_lbl1" xlink:title="label: MayTwoThousandSeventeenAcquisitionMember to usph_MayTwoThousandSeventeenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MayTwoThousandSeventeenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MayTwoThousandSeventeenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_MayTwoThousandSeventeenAcquisitionMember_lbl2">May 2017 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MayTwoThousandSeventeenAcquisitionMember" xlink:to="usph_MayTwoThousandSeventeenAcquisitionMember_lbl2" xlink:title="label: MayTwoThousandSeventeenAcquisitionMember to usph_MayTwoThousandSeventeenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JuneTwoThousandSeventeenAcquisitionMember" xlink:label="JuneTwoThousandSeventeenAcquisitionMember" xlink:title="JuneTwoThousandSeventeenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl" xml:lang="en-US" id="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JuneTwoThousandSeventeenAcquisitionMember" xlink:to="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl" xlink:title="label: JuneTwoThousandSeventeenAcquisitionMember to usph_JuneTwoThousandSeventeenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl1">June Two Thousand Seventeen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JuneTwoThousandSeventeenAcquisitionMember" xlink:to="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl1" xlink:title="label: JuneTwoThousandSeventeenAcquisitionMember to usph_JuneTwoThousandSeventeenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl2">June 2017 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JuneTwoThousandSeventeenAcquisitionMember" xlink:to="usph_JuneTwoThousandSeventeenAcquisitionMember_lbl2" xlink:title="label: JuneTwoThousandSeventeenAcquisitionMember to usph_JuneTwoThousandSeventeenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FebruaryTwoThousandSixteenAcquisitionMember" xlink:label="FebruaryTwoThousandSixteenAcquisitionMember" xlink:title="FebruaryTwoThousandSixteenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl" xml:lang="en-US" id="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandSixteenAcquisitionMember" xlink:to="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl" xlink:title="label: FebruaryTwoThousandSixteenAcquisitionMember to usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl1">February Two Thousand Sixteen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandSixteenAcquisitionMember" xlink:to="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl1" xlink:title="label: FebruaryTwoThousandSixteenAcquisitionMember to usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl2">February 2016 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FebruaryTwoThousandSixteenAcquisitionMember" xlink:to="usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl2" xlink:title="label: FebruaryTwoThousandSixteenAcquisitionMember to usph_FebruaryTwoThousandSixteenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JanuaryTwoThousandSeventeenAcquisitionMember" xlink:label="JanuaryTwoThousandSeventeenAcquisitionMember" xlink:title="JanuaryTwoThousandSeventeenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl" xml:lang="en-US" id="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JanuaryTwoThousandSeventeenAcquisitionMember" xlink:to="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl" xlink:title="label: JanuaryTwoThousandSeventeenAcquisitionMember to usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl1">January Two Thousand Seventeen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JanuaryTwoThousandSeventeenAcquisitionMember" xlink:to="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl1" xlink:title="label: JanuaryTwoThousandSeventeenAcquisitionMember to usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl2">January 2017 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="JanuaryTwoThousandSeventeenAcquisitionMember" xlink:to="usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl2" xlink:title="label: JanuaryTwoThousandSeventeenAcquisitionMember to usph_JanuaryTwoThousandSeventeenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NovemberTwoThousandSixteenAcquisitionMember" xlink:label="NovemberTwoThousandSixteenAcquisitionMember" xlink:title="NovemberTwoThousandSixteenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl" xml:lang="en-US" id="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandSixteenAcquisitionMember" xlink:to="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl" xlink:title="label: NovemberTwoThousandSixteenAcquisitionMember to usph_NovemberTwoThousandSixteenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl1">November Two Thousand Sixteen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandSixteenAcquisitionMember" xlink:to="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl1" xlink:title="label: NovemberTwoThousandSixteenAcquisitionMember to usph_NovemberTwoThousandSixteenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl2">November 2016 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NovemberTwoThousandSixteenAcquisitionMember" xlink:to="usph_NovemberTwoThousandSixteenAcquisitionMember_lbl2" xlink:title="label: NovemberTwoThousandSixteenAcquisitionMember to usph_NovemberTwoThousandSixteenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl">Refers to the commencement period of redemption rights for redeemable non controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1">Redeemable Non-controlling Interest, Redemption Rights, Commencement Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xml:lang="en-US" id="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2">Redeemable non-controlling interest, redemption rights, commencement period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xlink:title="label: RedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DepreciationAmortizationImpairmentTable" xlink:label="DepreciationAmortizationImpairmentTable" xlink:title="DepreciationAmortizationImpairmentTable" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DepreciationAmortizationImpairmentTable_lbl" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentTable_lbl">A table or schedule providing information pertaining to depreciation amortization impairment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="usph_DepreciationAmortizationImpairmentTable_lbl" xlink:title="label: DepreciationAmortizationImpairmentTable to usph_DepreciationAmortizationImpairmentTable_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DepreciationAmortizationImpairmentTable_lbl1" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentTable_lbl1">Depreciation Amortization Impairment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="usph_DepreciationAmortizationImpairmentTable_lbl1" xlink:title="label: DepreciationAmortizationImpairmentTable to usph_DepreciationAmortizationImpairmentTable_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentTable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DepreciationAmortizationImpairmentTable_lbl2" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentTable_lbl2">Depreciation Amortization Impairment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="usph_DepreciationAmortizationImpairmentTable_lbl2" xlink:title="label: DepreciationAmortizationImpairmentTable to usph_DepreciationAmortizationImpairmentTable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MarchTwoThousandSeventeenAcquisitionMember" xlink:label="MarchTwoThousandSeventeenAcquisitionMember" xlink:title="MarchTwoThousandSeventeenAcquisitionMember" />
    <link:label xlink:type="resource" xlink:label="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl" xml:lang="en-US" id="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl">Date of business acquisition.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarchTwoThousandSeventeenAcquisitionMember" xlink:to="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl" xlink:title="label: MarchTwoThousandSeventeenAcquisitionMember to usph_MarchTwoThousandSeventeenAcquisitionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl1" xml:lang="en-US" id="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl1">March Two Thousand Seventeen Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarchTwoThousandSeventeenAcquisitionMember" xlink:to="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl1" xlink:title="label: MarchTwoThousandSeventeenAcquisitionMember to usph_MarchTwoThousandSeventeenAcquisitionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl2" xml:lang="en-US" id="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl2">March 2017 Acquisition [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarchTwoThousandSeventeenAcquisitionMember" xlink:to="usph_MarchTwoThousandSeventeenAcquisitionMember_lbl2" xlink:title="label: MarchTwoThousandSeventeenAcquisitionMember to usph_MarchTwoThousandSeventeenAcquisitionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AnnualLimitOccupationalTherapyServices" xlink:label="AnnualLimitOccupationalTherapyServices" xlink:title="AnnualLimitOccupationalTherapyServices" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOccupationalTherapyServices_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AnnualLimitOccupationalTherapyServices_lbl" xml:lang="en-US" id="usph_AnnualLimitOccupationalTherapyServices_lbl">Annual Limit occupational therapy services during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOccupationalTherapyServices" xlink:to="usph_AnnualLimitOccupationalTherapyServices_lbl" xlink:title="label: AnnualLimitOccupationalTherapyServices to usph_AnnualLimitOccupationalTherapyServices_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOccupationalTherapyServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AnnualLimitOccupationalTherapyServices_lbl1" xml:lang="en-US" id="usph_AnnualLimitOccupationalTherapyServices_lbl1">Annual Limit Occupational Therapy Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOccupationalTherapyServices" xlink:to="usph_AnnualLimitOccupationalTherapyServices_lbl1" xlink:title="label: AnnualLimitOccupationalTherapyServices to usph_AnnualLimitOccupationalTherapyServices_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOccupationalTherapyServices_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AnnualLimitOccupationalTherapyServices_lbl2" xml:lang="en-US" id="usph_AnnualLimitOccupationalTherapyServices_lbl2">Annual limit occupational therapy services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOccupationalTherapyServices" xlink:to="usph_AnnualLimitOccupationalTherapyServices_lbl2" xlink:title="label: AnnualLimitOccupationalTherapyServices to usph_AnnualLimitOccupationalTherapyServices_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl">Reduction in Medicare spending percentage during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl1" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl1">Reduction In Medicare Spending Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl1" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ReductionInMedicareSpendingPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ReductionInMedicareSpendingPercentage_lbl2" xml:lang="en-US" id="usph_ReductionInMedicareSpendingPercentage_lbl2">Medicare spending cut percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ReductionInMedicareSpendingPercentage" xlink:to="usph_ReductionInMedicareSpendingPercentage_lbl2" xlink:title="label: ReductionInMedicareSpendingPercentage to usph_ReductionInMedicareSpendingPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NetRevenueFromMedicare_lbl" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl">Net revenue from Medicare.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NetRevenueFromMedicare_lbl1" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl1">Net revenue from Medicare</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl1" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NetRevenueFromMedicare_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NetRevenueFromMedicare_lbl2" xml:lang="en-US" id="usph_NetRevenueFromMedicare_lbl2">Net revenue from Medicare accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetRevenueFromMedicare" xlink:to="usph_NetRevenueFromMedicare_lbl2" xlink:title="label: NetRevenueFromMedicare to usph_NetRevenueFromMedicare_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfClinicsOperated" xlink:label="NumberOfClinicsOperated" xlink:title="NumberOfClinicsOperated" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClinicsOperated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfClinicsOperated_lbl" xml:lang="en-US" id="usph_NumberOfClinicsOperated_lbl">Number of clinics operated during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClinicsOperated" xlink:to="usph_NumberOfClinicsOperated_lbl" xlink:title="label: NumberOfClinicsOperated to usph_NumberOfClinicsOperated_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClinicsOperated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfClinicsOperated_lbl1" xml:lang="en-US" id="usph_NumberOfClinicsOperated_lbl1">Number Of Clinics Operated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClinicsOperated" xlink:to="usph_NumberOfClinicsOperated_lbl1" xlink:title="label: NumberOfClinicsOperated to usph_NumberOfClinicsOperated_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfClinicsOperated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfClinicsOperated_lbl2" xml:lang="en-US" id="usph_NumberOfClinicsOperated_lbl2">Number of clinics operated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfClinicsOperated" xlink:to="usph_NumberOfClinicsOperated_lbl2" xlink:title="label: NumberOfClinicsOperated to usph_NumberOfClinicsOperated_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl">Percentage reduction for service in office or other non institutional settings during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1">Percentage Reduction For Service In Office Or Other Non Institutional Settings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xml:lang="en-US" id="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2">Percentage reduction for service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:to="usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" xlink:title="label: PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings to usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl">Percentage of practice expense component of relative value unit during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1">Percentage Of Practice Expense Component Of Relative Value Unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xml:lang="en-US" id="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2">Percentage of practice expense component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:to="usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" xlink:title="label: PercentageOfPracticeExpenseComponentOfRelativeValueUnit to usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl">This element represents the period of federal debt ceiling in connection with deficit reductions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1">Period Of Federal Debt Ceiling In Connection With Deficit Reductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xml:lang="en-US" id="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2">Federal debt ceiling in connection with deficit reductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:to="usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" xlink:title="label: PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions to usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl">Amount of reductions in federal spending during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl1" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl1">Amount Of Reductions In Federal Spending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl1" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AmountOfReductionsInFederalSpending_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AmountOfReductionsInFederalSpending_lbl2" xml:lang="en-US" id="usph_AmountOfReductionsInFederalSpending_lbl2">Reductions in federal spending</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmountOfReductionsInFederalSpending" xlink:to="usph_AmountOfReductionsInFederalSpending_lbl2" xlink:title="label: AmountOfReductionsInFederalSpending to usph_AmountOfReductionsInFederalSpending_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl">Expected reduction in Medicare spending percentage during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1">Expected Reduction In Medicare Spending Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xml:lang="en-US" id="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2">Expected reduction in Medicare spending percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ExpectedReductionInMedicareSpendingPercentage" xlink:to="usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" xlink:title="label: ExpectedReductionInMedicareSpendingPercentage to usph_ExpectedReductionInMedicareSpendingPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl">Combined physical therapy/speech language pathology expenses during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1">Combined Physical Therapy Speech Language Pathology Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xml:lang="en-US" id="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2">Combined physical therapy/speech language pathology expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:to="usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" xlink:title="label: CombinedPhysicalTherapySpeechLanguagePathologyExpenses to usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl">Percentage of general partnership interest owned during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1">Percentage Of General Partnership Interest Owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xml:lang="en-US" id="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2">Percentage of general partnership interest owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfGeneralPartnershipInterestOwned" xlink:to="usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" xlink:title="label: PercentageOfGeneralPartnershipInterestOwned to usph_PercentageOfGeneralPartnershipInterestOwned_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl">Maximum difference between actual aggregate contractual reserve percentage as compared to estimated contractual allowance reserve percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1">Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xml:lang="en-US" id="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2">Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:to="usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" xlink:title="label: DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage to usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfMedicarePayment" xlink:label="PercentageOfMedicarePayment" xlink:title="PercentageOfMedicarePayment" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfMedicarePayment_lbl" xml:lang="en-US" id="usph_PercentageOfMedicarePayment_lbl">Percentage of medicare payment during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePayment" xlink:to="usph_PercentageOfMedicarePayment_lbl" xlink:title="label: PercentageOfMedicarePayment to usph_PercentageOfMedicarePayment_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePayment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfMedicarePayment_lbl1" xml:lang="en-US" id="usph_PercentageOfMedicarePayment_lbl1">Percentage Of Medicare Payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePayment" xlink:to="usph_PercentageOfMedicarePayment_lbl1" xlink:title="label: PercentageOfMedicarePayment to usph_PercentageOfMedicarePayment_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfMedicarePayment_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfMedicarePayment_lbl2" xml:lang="en-US" id="usph_PercentageOfMedicarePayment_lbl2">Percentage of increase in medicare payment rates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfMedicarePayment" xlink:to="usph_PercentageOfMedicarePayment_lbl2" xlink:title="label: PercentageOfMedicarePayment to usph_PercentageOfMedicarePayment_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfThirdPartyFacilities" xlink:label="NumberOfThirdPartyFacilities" xlink:title="NumberOfThirdPartyFacilities" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfThirdPartyFacilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfThirdPartyFacilities_lbl" xml:lang="en-US" id="usph_NumberOfThirdPartyFacilities_lbl">Number of third party facilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfThirdPartyFacilities" xlink:to="usph_NumberOfThirdPartyFacilities_lbl" xlink:title="label: NumberOfThirdPartyFacilities to usph_NumberOfThirdPartyFacilities_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfThirdPartyFacilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfThirdPartyFacilities_lbl1" xml:lang="en-US" id="usph_NumberOfThirdPartyFacilities_lbl1">Number Of Third Party Facilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfThirdPartyFacilities" xlink:to="usph_NumberOfThirdPartyFacilities_lbl1" xlink:title="label: NumberOfThirdPartyFacilities to usph_NumberOfThirdPartyFacilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfThirdPartyFacilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_NumberOfThirdPartyFacilities_lbl2" xml:lang="en-US" id="usph_NumberOfThirdPartyFacilities_lbl2">Number of third party facilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfThirdPartyFacilities" xlink:to="usph_NumberOfThirdPartyFacilities_lbl2" xlink:title="label: NumberOfThirdPartyFacilities to usph_NumberOfThirdPartyFacilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:label xlink:type="resource" xlink:label="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xml:lang="en-US" id="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl">Refers to the commencement period of redemption rights for mandatorily redeemable non controlling interest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" xlink:title="label: MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xml:lang="en-US" id="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1">Mandatorily Redeemable Non-controlling Interest, Redemption Rights, Commencement Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" xlink:title="label: MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xml:lang="en-US" id="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2">Mandatorily redeemable non-controlling interest, redemption rights, commencement period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:to="usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" xlink:title="label: MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod to usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:label="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:title="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl" xml:lang="en-US" id="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl">Annual Limit on physical therapy and speech language pathology services during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:to="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl" xlink:title="label: AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices to usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl1" xml:lang="en-US" id="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl1">Annual Limit On Physical Therapy And Speech Language Pathology Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:to="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl1" xlink:title="label: AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices to usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl2" xml:lang="en-US" id="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl2">Annual limit on physical therapy and speech language pathology services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:to="usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl2" xlink:title="label: AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices to usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfRegions" xlink:label="NumberOfRegions" xlink:title="NumberOfRegions" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfRegions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_NumberOfRegions_lbl" xml:lang="en-US" id="usph_NumberOfRegions_lbl">Number of regions of the entity operates.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRegions" xlink:to="usph_NumberOfRegions_lbl" xlink:title="label: NumberOfRegions to usph_NumberOfRegions_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_NumberOfRegions_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_NumberOfRegions_lbl1" xml:lang="en-US" id="usph_NumberOfRegions_lbl1">Number of regions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfRegions" xlink:to="usph_NumberOfRegions_lbl1" xlink:title="label: NumberOfRegions to usph_NumberOfRegions_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl">Percentage of limited partnership interest owned during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1">Percentage Of Limited Partnership Interest Owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xml:lang="en-US" id="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2">Percentage of limited partnership interest owned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PercentageOfLimitedPartnershipInterestOwned" xlink:to="usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" xlink:title="label: PercentageOfLimitedPartnershipInterestOwned to usph_PercentageOfLimitedPartnershipInterestOwned_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl">Difference between net revenues and corresponding cash collections reflected percentage of net revenues.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1">Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xml:lang="en-US" id="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2">Difference between net revenues and corresponding cash collections, approximately of net revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:to="usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" xlink:title="label: DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues to usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl">Maximum contractual allowance reserve estimate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl1">Maximum Contractual Allowance Reserve Estimate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl1" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xml:lang="en-US" id="usph_MaximumContractualAllowanceReserveEstimate_lbl2">Maximum contractual allowance reserve estimate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumContractualAllowanceReserveEstimate" xlink:to="usph_MaximumContractualAllowanceReserveEstimate_lbl2" xlink:title="label: MaximumContractualAllowanceReserveEstimate to usph_MaximumContractualAllowanceReserveEstimate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AccountingStandardsUpdate201609Member" xlink:label="AccountingStandardsUpdate201609Member" xlink:title="AccountingStandardsUpdate201609Member" />
    <link:label xlink:type="resource" xlink:label="usph_AccountingStandardsUpdate201609Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_AccountingStandardsUpdate201609Member_lbl" xml:lang="en-US" id="usph_AccountingStandardsUpdate201609Member_lbl">Accounting Standards Update 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingStandardsUpdate201609Member" xlink:to="usph_AccountingStandardsUpdate201609Member_lbl" xlink:title="label: AccountingStandardsUpdate201609Member to usph_AccountingStandardsUpdate201609Member_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_AccountingStandardsUpdate201609Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_AccountingStandardsUpdate201609Member_lbl1" xml:lang="en-US" id="usph_AccountingStandardsUpdate201609Member_lbl1">Accounting Standards Update 2016-09 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingStandardsUpdate201609Member" xlink:to="usph_AccountingStandardsUpdate201609Member_lbl1" xlink:title="label: AccountingStandardsUpdate201609Member to usph_AccountingStandardsUpdate201609Member_lbl1" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_Year2017Member" xlink:label="Year2017Member" xlink:title="Year2017Member" />
    <link:label xlink:type="resource" xlink:label="usph_Year2017Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_Year2017Member_lbl" xml:lang="en-US" id="usph_Year2017Member_lbl">Medicare payment year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2017Member" xlink:to="usph_Year2017Member_lbl" xlink:title="label: Year2017Member to usph_Year2017Member_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_Year2017Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_Year2017Member_lbl1" xml:lang="en-US" id="usph_Year2017Member_lbl1">Year 2017 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2017Member" xlink:to="usph_Year2017Member_lbl1" xlink:title="label: Year2017Member to usph_Year2017Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_Year2017Member_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_Year2017Member_lbl2" xml:lang="en-US" id="usph_Year2017Member_lbl2">Year 2017 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2017Member" xlink:to="usph_Year2017Member_lbl2" xlink:title="label: Year2017Member to usph_Year2017Member_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_Year2018Member" xlink:label="Year2018Member" xlink:title="Year2018Member" />
    <link:label xlink:type="resource" xlink:label="usph_Year2018Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_Year2018Member_lbl" xml:lang="en-US" id="usph_Year2018Member_lbl">Medicare payment year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2018Member" xlink:to="usph_Year2018Member_lbl" xlink:title="label: Year2018Member to usph_Year2018Member_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_Year2018Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_Year2018Member_lbl1" xml:lang="en-US" id="usph_Year2018Member_lbl1">Year2018 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2018Member" xlink:to="usph_Year2018Member_lbl1" xlink:title="label: Year2018Member to usph_Year2018Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_Year2018Member_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_Year2018Member_lbl2" xml:lang="en-US" id="usph_Year2018Member_lbl2">Year 2018 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2018Member" xlink:to="usph_Year2018Member_lbl2" xlink:title="label: Year2018Member to usph_Year2018Member_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_Year2019Member" xlink:label="Year2019Member" xlink:title="Year2019Member" />
    <link:label xlink:type="resource" xlink:label="usph_Year2019Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_Year2019Member_lbl" xml:lang="en-US" id="usph_Year2019Member_lbl">Medicare payment year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2019Member" xlink:to="usph_Year2019Member_lbl" xlink:title="label: Year2019Member to usph_Year2019Member_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_Year2019Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_Year2019Member_lbl1" xml:lang="en-US" id="usph_Year2019Member_lbl1">Year2019 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2019Member" xlink:to="usph_Year2019Member_lbl1" xlink:title="label: Year2019Member to usph_Year2019Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_Year2019Member_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_Year2019Member_lbl2" xml:lang="en-US" id="usph_Year2019Member_lbl2">Year 2019 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Year2019Member" xlink:to="usph_Year2019Member_lbl2" xlink:title="label: Year2019Member to usph_Year2019Member_lbl2" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DepreciationAmortizationImpairmentLineItems" xlink:label="DepreciationAmortizationImpairmentLineItems" xlink:title="DepreciationAmortizationImpairmentLineItems" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="usph_DepreciationAmortizationImpairmentLineItems_lbl" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentLineItems_lbl">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="usph_DepreciationAmortizationImpairmentLineItems_lbl" xlink:title="label: DepreciationAmortizationImpairmentLineItems to usph_DepreciationAmortizationImpairmentLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="usph_DepreciationAmortizationImpairmentLineItems_lbl1" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentLineItems_lbl1">Depreciation Amortization Impairment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="usph_DepreciationAmortizationImpairmentLineItems_lbl1" xlink:title="label: DepreciationAmortizationImpairmentLineItems to usph_DepreciationAmortizationImpairmentLineItems_lbl1" />
    <link:label xlink:type="resource" xlink:label="usph_DepreciationAmortizationImpairmentLineItems_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="usph_DepreciationAmortizationImpairmentLineItems_lbl2" xml:lang="en-US" id="usph_DepreciationAmortizationImpairmentLineItems_lbl2">Depreciation Amortization Impairment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="usph_DepreciationAmortizationImpairmentLineItems_lbl2" xlink:title="label: DepreciationAmortizationImpairmentLineItems to usph_DepreciationAmortizationImpairmentLineItems_lbl2" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>usph-20170630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 4.3.0.0 Summit Financial Printing, LLC. All rights reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://usph.com/role/CommonStockDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#CommonStockDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#NotesPayableAndAmendedCreditAgreementDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#AccruedExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationOfTradenameReferralRelationshipsAndNoncompetitionAgreementsDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#IntangibleAssetsNetAmortizationOfTradenameReferralRelationshipsAndNoncompetitionAgreementsDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#IntangibleAssetsNetAmortizationExpensesDetails" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#IntangibleAssetsNetIntangibleAssetsNetDetails" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#GoodwillDetails" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#RedeemableNoncontrollingInterestsDetails" />
  <link:roleRef roleURI="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#MandatorilyRedeemableNoncontrollingInterestsDetails" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#AcquisitionsOfBusinessesDetails" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesScheduleOfClinicAcquisitionDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#BasisOfPresentationAndSignificantAccountingPoliciesScheduleOfClinicAcquisitionDetails" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="usph-20170630.xsd#BasisOfPresentationAndSignificantAccountingPoliciesDetails" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables" xlink:type="simple" xlink:href="usph-20170630.xsd#NotesPayableAndAmendedCreditAgreementTables" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="usph-20170630.xsd#AccruedExpensesTables" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="usph-20170630.xsd#IntangibleAssetsNetTables" />
  <link:roleRef roleURI="http://usph.com/role/GoodwillTables" xlink:type="simple" xlink:href="usph-20170630.xsd#GoodwillTables" />
  <link:roleRef roleURI="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsTables" xlink:type="simple" xlink:href="usph-20170630.xsd#MandatorilyRedeemableNoncontrollingInterestsTables" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinessesTables" xlink:type="simple" xlink:href="usph-20170630.xsd#AcquisitionsOfBusinessesTables" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="usph-20170630.xsd#BasisOfPresentationAndSignificantAccountingPoliciesTables" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="usph-20170630.xsd#BasisOfPresentationAndSignificantAccountingPoliciesPolicies" />
  <link:roleRef roleURI="http://usph.com/role/CommonStock" xlink:type="simple" xlink:href="usph-20170630.xsd#CommonStock" />
  <link:roleRef roleURI="http://usph.com/role/NotesPayableAndAmendedCreditAgreement" xlink:type="simple" xlink:href="usph-20170630.xsd#NotesPayableAndAmendedCreditAgreement" />
  <link:roleRef roleURI="http://usph.com/role/AccruedExpenses" xlink:type="simple" xlink:href="usph-20170630.xsd#AccruedExpenses" />
  <link:roleRef roleURI="http://usph.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="usph-20170630.xsd#IntangibleAssetsNet" />
  <link:roleRef roleURI="http://usph.com/role/Goodwill" xlink:type="simple" xlink:href="usph-20170630.xsd#Goodwill" />
  <link:roleRef roleURI="http://usph.com/role/RedeemableNoncontrollingInterests" xlink:type="simple" xlink:href="usph-20170630.xsd#RedeemableNoncontrollingInterests" />
  <link:roleRef roleURI="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterests" xlink:type="simple" xlink:href="usph-20170630.xsd#MandatorilyRedeemableNoncontrollingInterests" />
  <link:roleRef roleURI="http://usph.com/role/AcquisitionsOfBusinesses" xlink:type="simple" xlink:href="usph-20170630.xsd#AcquisitionsOfBusinesses" />
  <link:roleRef roleURI="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:type="simple" xlink:href="usph-20170630.xsd#BasisOfPresentationAndSignificantAccountingPolicies" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementOfShareholdersEquityUnaudited" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedStatementOfShareholdersEquityUnaudited" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedStatementsOfCashFlowsUnaudited" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedStatementsOfNetIncomeUnaudited" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedStatementsOfNetIncomeUnaudited" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedBalanceSheetsUnauditedParenthetical" />
  <link:roleRef roleURI="http://usph.com/role/ConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="usph-20170630.xsd#ConsolidatedBalanceSheetsUnaudited" />
  <link:roleRef roleURI="http://usph.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="usph-20170630.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DocumentAndEntityInformationAbstract" xlink:label="DocumentAndEntityInformationAbstract" xlink:title="DocumentAndEntityInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityCentralIndexKey" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: DocumentAndEntityInformationAbstract to CurrentFiscalYearEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityWellKnownSeasonedIssuer" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityWellKnownSeasonedIssuer" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityVoluntaryFilers" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityVoluntaryFilers" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityCurrentReportingStatus" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityCurrentReportingStatus" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityFilerCategory" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityFilerCategory" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityPublicFloat" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityPublicFloat" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="EntityCommonStockSharesOutstanding" xlink:title="presentation: DocumentAndEntityInformationAbstract to EntityCommonStockSharesOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: DocumentAndEntityInformationAbstract to DocumentFiscalYearFocus" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: DocumentAndEntityInformationAbstract to DocumentFiscalPeriodFocus" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="DocumentType" xlink:title="presentation: DocumentAndEntityInformationAbstract to DocumentType" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: DocumentAndEntityInformationAbstract to AmendmentFlag" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: DocumentAndEntityInformationAbstract to DocumentPeriodEndDate" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheetsUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: AssetsCurrentAbstract to CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AccountsReceivableNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to AccountsReceivableNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="AccountsAndOtherReceivablesNetCurrent" xlink:title="AccountsAndOtherReceivablesNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AccountsAndOtherReceivablesNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to AccountsAndOtherReceivablesNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="OtherAssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to OtherAssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to AssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="PropertyPlantAndEquipmentNetAbstract" xlink:title="PropertyPlantAndEquipmentNetAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="FurnitureAndFixturesGross" xlink:title="FurnitureAndFixturesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="FurnitureAndFixturesGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to FurnitureAndFixturesGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="LeaseholdImprovementsGross" xlink:title="LeaseholdImprovementsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="LeaseholdImprovementsGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to LeaseholdImprovementsGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to PropertyPlantAndEquipmentGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentNetAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: PropertyPlantAndEquipmentNetAbstract to PropertyPlantAndEquipmentNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="PropertyPlantAndEquipmentNetAbstract" xlink:title="presentation: AssetsAbstract to PropertyPlantAndEquipmentNetAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Goodwill" xlink:title="presentation: AssetsAbstract to Goodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="presentation: AssetsAbstract to IntangibleAssetsNetExcludingGoodwill" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OtherAssetsNoncurrent" xlink:title="presentation: AssetsAbstract to OtherAssetsNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Assets" xlink:title="presentation: AssetsAbstract to Assets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="AccountsPayableTradeCurrent" xlink:title="AccountsPayableTradeCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableTradeCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableTradeCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LongTermDebtCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LongTermDebtCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesCurrentAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="LongTermNotesPayable" xlink:title="LongTermNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LongTermNotesPayable" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LongTermNotesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermLineOfCredit" xlink:label="LongTermLineOfCredit" xlink:title="LongTermLineOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LongTermLineOfCredit" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LongTermLineOfCredit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:label="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:title="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="DeferredTaxLiabilitiesNoncurrent" xlink:title="DeferredTaxLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DeferredTaxLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DeferredTaxLiabilitiesNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="DeferredRentCreditNoncurrent" xlink:title="DeferredRentCreditNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DeferredRentCreditNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DeferredRentCreditNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OtherLiabilitiesNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="Liabilities" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to Liabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="CommitmentsAndContingencies" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to CommitmentsAndContingencies" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockValue" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockValue" xlink:title="presentation: StockholdersEquityAbstract to CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: StockholdersEquityAbstract to AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: StockholdersEquityAbstract to RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="TreasuryStockValue" xlink:title="presentation: StockholdersEquityAbstract to TreasuryStockValue" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="StockholdersEquity" xlink:title="presentation: StockholdersEquityAbstract to StockholdersEquity" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="MinorityInterest" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to MinorityInterest" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AllowanceForDoubtfulAccountsReceivableCurrent" xlink:title="presentation: AssetsCurrentAbstract to AllowanceForDoubtfulAccountsReceivableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityAbstract to CommonStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesAuthorized" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: StockholdersEquityAbstract to CommonStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="TreasuryStockShares" xlink:title="presentation: StockholdersEquityAbstract to TreasuryStockShares" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfNetIncomeUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="HealthCareOrganizationPatientServiceRevenue" xlink:title="HealthCareOrganizationPatientServiceRevenue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="HealthCareOrganizationPatientServiceRevenue" xlink:title="presentation: IncomeStatementAbstract to HealthCareOrganizationPatientServiceRevenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSalesRevenueNet" xlink:label="OtherSalesRevenueNet" xlink:title="OtherSalesRevenueNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OtherSalesRevenueNet" xlink:title="presentation: IncomeStatementAbstract to OtherSalesRevenueNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="SalesRevenueNet" xlink:title="SalesRevenueNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="SalesRevenueNet" xlink:title="presentation: IncomeStatementAbstract to SalesRevenueNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="CostsAndExpensesAbstract" xlink:title="CostsAndExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="LaborAndRelatedExpense" xlink:title="LaborAndRelatedExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="LaborAndRelatedExpense" xlink:title="presentation: CostsAndExpensesAbstract to LaborAndRelatedExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RentClinicSuppliesContractLaborAndOther" xlink:label="RentClinicSuppliesContractLaborAndOther" xlink:title="RentClinicSuppliesContractLaborAndOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="RentClinicSuppliesContractLaborAndOther" xlink:title="presentation: CostsAndExpensesAbstract to RentClinicSuppliesContractLaborAndOther" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="presentation: CostsAndExpensesAbstract to ProvisionForDoubtfulAccounts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="RestructuringCharges" xlink:title="RestructuringCharges" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="RestructuringCharges" xlink:title="presentation: CostsAndExpensesAbstract to RestructuringCharges" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="CostsAndExpenses" xlink:title="CostsAndExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostsAndExpensesAbstract" xlink:to="CostsAndExpenses" xlink:title="presentation: CostsAndExpensesAbstract to CostsAndExpenses" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="CostsAndExpensesAbstract" xlink:title="presentation: IncomeStatementAbstract to CostsAndExpensesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="GrossProfit" xlink:title="presentation: IncomeStatementAbstract to GrossProfit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="presentation: IncomeStatementAbstract to SellingGeneralAndAdministrativeExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to OperatingIncomeLoss" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="InterestAndOtherIncome" xlink:title="InterestAndOtherIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="InterestAndOtherIncome" xlink:title="presentation: IncomeStatementAbstract to InterestAndOtherIncome" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseAbstract" xlink:label="InterestExpenseAbstract" xlink:title="InterestExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" xlink:label="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" xlink:title="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestExpenseAbstract" xlink:to="InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" xlink:title="presentation: InterestExpenseAbstract to InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" xlink:label="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" xlink:title="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestExpenseAbstract" xlink:to="InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" xlink:title="presentation: InterestExpenseAbstract to InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_InterestExpenseDebtAndOther" xlink:label="InterestExpenseDebtAndOther" xlink:title="InterestExpenseDebtAndOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestExpenseAbstract" xlink:to="InterestExpenseDebtAndOther" xlink:title="presentation: InterestExpenseAbstract to InterestExpenseDebtAndOther" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InterestExpenseAbstract" xlink:to="InterestExpense" xlink:title="presentation: InterestExpenseAbstract to InterestExpense" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="InterestExpenseAbstract" xlink:title="presentation: IncomeStatementAbstract to InterestExpenseAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: IncomeStatementAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeStatementAbstract to IncomeTaxExpenseBenefit" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ProfitLoss" xlink:title="presentation: IncomeStatementAbstract to ProfitLoss" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLossAttributableToNoncontrollingInterest" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLossAttributableToNoncontrollingInterest" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLoss" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="EarningsPerShareBasicAndDiluted" xlink:title="EarningsPerShareBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareBasicAndDiluted" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareBasicAndDiluted" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfSharesOutstandingBasic" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfDilutedSharesOutstanding" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="CommonStockDividendsPerShareDeclared" xlink:title="CommonStockDividendsPerShareDeclared" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="CommonStockDividendsPerShareDeclared" xlink:title="presentation: IncomeStatementAbstract to CommonStockDividendsPerShareDeclared" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementsOfCashFlowsUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProfitLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="DepreciationDepletionAndAmortization" xlink:title="DepreciationDepletionAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DepreciationDepletionAndAmortization" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="ProvisionForDoubtfulAccounts" xlink:title="ProvisionForDoubtfulAccounts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProvisionForDoubtfulAccounts" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ProvisionForDoubtfulAccounts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="GainLossOnSaleOfPropertyPlantEquipment" xlink:title="GainLossOnSaleOfPropertyPlantEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossOnSaleOfPropertyPlantEquipment" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainLossOnSaleOfPropertyPlantEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ShareBasedCompensation" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ShareBasedCompensation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DeferredIncomeTaxExpenseBenefit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsReceivable" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:label="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" xlink:label="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" xlink:title="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="PaymentsToAcquireProductiveAssets" xlink:title="PaymentsToAcquireProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireProductiveAssets" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireProductiveAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:label="PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:title="PaymentsForProceedsFromBusinessesAndInterestInAffiliates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsForProceedsFromBusinessesAndInterestInAffiliates" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsForProceedsFromBusinessesAndInterestInAffiliates" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="ProceedsFromSaleOfProductiveAssets" xlink:title="ProceedsFromSaleOfProductiveAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSaleOfProductiveAssets" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSaleOfProductiveAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="PaymentsOfDividendsMinorityInterest" xlink:title="PaymentsOfDividendsMinorityInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsMinorityInterest" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsMinorityInterest" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="ProceedsFromLinesOfCredit" xlink:title="ProceedsFromLinesOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromLinesOfCredit" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromLinesOfCredit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="RepaymentsOfLinesOfCredit" xlink:title="RepaymentsOfLinesOfCredit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfLinesOfCredit" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfLinesOfCredit" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:label="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:title="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="RepaymentsOfNotesPayable" xlink:title="RepaymentsOfNotesPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfNotesPayable" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfNotesPayable" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:label="DeferredTaxExpenseFromStockOptionsExercised" xlink:title="DeferredTaxExpenseFromStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="DeferredTaxExpenseFromStockOptionsExercised" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to DeferredTaxExpenseFromStockOptionsExercised" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="ProceedsFromPaymentsForOtherFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromPaymentsForOtherFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromPaymentsForOtherFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to NetCashProvidedByUsedInFinancingActivities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="presentation: StatementOfCashFlowsAbstract to CashAndCashEquivalentsPeriodIncreaseDecrease" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: StatementOfCashFlowsAbstract to CashAndCashEquivalentsAtCarryingValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue_2" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue_2" xlink:title="presentation: StatementOfCashFlowsAbstract to CashAndCashEquivalentsAtCarryingValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CashPaidDuringPeriodForAbstract" xlink:label="CashPaidDuringPeriodForAbstract" xlink:title="CashPaidDuringPeriodForAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="IncomeTaxesPaidNet" xlink:title="IncomeTaxesPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="IncomeTaxesPaidNet" xlink:title="presentation: CashPaidDuringPeriodForAbstract to IncomeTaxesPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashPaidDuringPeriodForAbstract" xlink:to="InterestPaidNet" xlink:title="presentation: CashPaidDuringPeriodForAbstract to InterestPaidNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="CashPaidDuringPeriodForAbstract" xlink:title="presentation: SupplementalCashFlowInformationAbstract to CashPaidDuringPeriodForAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PurchaseOfBusinessSellerFinancingPortion" xlink:label="PurchaseOfBusinessSellerFinancingPortion" xlink:title="PurchaseOfBusinessSellerFinancingPortion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="PurchaseOfBusinessSellerFinancingPortion" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PurchaseOfBusinessSellerFinancingPortion" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion" xlink:label="AcquisitionOfNoncontrollingInterestSellerFinancingPortion" xlink:title="AcquisitionOfNoncontrollingInterestSellerFinancingPortion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="AcquisitionOfNoncontrollingInterestSellerFinancingPortion" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to AcquisitionOfNoncontrollingInterestSellerFinancingPortion" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion" xlink:label="PaymentToSettleRedeemableNonControllingInterestFinancingPortion" xlink:title="PaymentToSettleRedeemableNonControllingInterestFinancingPortion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="PaymentToSettleRedeemableNonControllingInterestFinancingPortion" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to PaymentToSettleRedeemableNonControllingInterestFinancingPortion" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_SaleOfNoncontrollingInterest" xlink:label="SaleOfNoncontrollingInterest" xlink:title="SaleOfNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="SaleOfNoncontrollingInterest" xlink:title="presentation: CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract to SaleOfNoncontrollingInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:title="presentation: SupplementalCashFlowInformationAbstract to CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="SupplementalCashFlowInformationAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to SupplementalCashFlowInformationAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/ConsolidatedStatementOfShareholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="CommonStockMember" xlink:title="presentation: StatementEquityComponentsAxis to CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="AdditionalPaidInCapitalMember" xlink:title="presentation: StatementEquityComponentsAxis to AdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="RetainedEarningsMember" xlink:title="presentation: StatementEquityComponentsAxis to RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="TreasuryStockMember" xlink:title="presentation: StatementEquityComponentsAxis to TreasuryStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="ParentMember" xlink:title="presentation: StatementEquityComponentsAxis to ParentMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="NoncontrollingInterestMember" xlink:title="presentation: StatementEquityComponentsAxis to NoncontrollingInterestMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: StatementTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:label="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:label="NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:title="NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="DividendsCommonStockCash" xlink:title="DividendsCommonStockCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="DividendsCommonStockCash" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to DividendsCommonStockCash" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="ProfitLoss" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to ProfitLoss" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding_2" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="presentation: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfStockholdersEquityAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinesses">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="BusinessCombinationDisclosureTextBlock" xlink:title="BusinessCombinationDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="BusinessCombinationDisclosureTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to BusinessCombinationDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterests">
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:label="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:title="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="MinorityInterestDisclosureTextBlock" xlink:title="MinorityInterestDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:to="MinorityInterestDisclosureTextBlock" xlink:title="presentation: MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract to MinorityInterestDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterests">
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:label="REDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:title="REDEEMABLENONCONTROLLINGINTERESTSAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock" xlink:label="REDEEMABLENONCONTROLLINGINTERESTSTextBlock" xlink:title="REDEEMABLENONCONTROLLINGINTERESTSTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:to="REDEEMABLENONCONTROLLINGINTERESTSTextBlock" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTSAbstract to REDEEMABLENONCONTROLLINGINTERESTSTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/Goodwill">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="GoodwillDisclosureTextBlock" xlink:title="GoodwillDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillDisclosureTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNet">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="IntangibleAssetsDisclosureTextBlock" xlink:title="IntangibleAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="IntangibleAssetsDisclosureTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to IntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpenses">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreement">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="DebtDisclosureTextBlock" xlink:title="DebtDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtDisclosureTextBlock" xlink:title="presentation: DebtDisclosureAbstract to DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStock">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="StockholdersEquityNoteDisclosureTextBlock" xlink:title="presentation: EquityAbstract to StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="CashAndCashEquivalentsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to CashAndCashEquivalentsPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:label="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="GoodwillAndIntangibleAssetsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to GoodwillAndIntangibleAssetsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" xlink:label="MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" xlink:title="MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to MandatorilyRedeemableNonControllingInterestsPolicyTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RedeemableNonControllingInterestsPolicyTextBlock" xlink:label="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="RedeemableNonControllingInterestsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RedeemableNonControllingInterestsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RedeemableNonControllingInterestsPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NonControllingInterestsPolicyPolicyTextBlock" xlink:label="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="NonControllingInterestsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NonControllingInterestsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NonControllingInterestsPolicyPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="RevenueRecognitionPolicyTextBlock" xlink:title="RevenueRecognitionPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RevenueRecognitionPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RevenueRecognitionPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:label="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:title="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="IncomeTaxPolicyTextBlock" xlink:title="IncomeTaxPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="IncomeTaxPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to IncomeTaxPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="FairValueOfFinancialInstrumentsPolicy" xlink:title="FairValueOfFinancialInstrumentsPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="FairValueOfFinancialInstrumentsPolicy" xlink:title="presentation: AccountingPoliciesAbstract to FairValueOfFinancialInstrumentsPolicy" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="SegmentReportingPolicyPolicyTextBlock" xlink:title="SegmentReportingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SegmentReportingPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SegmentReportingPolicyPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="UseOfEstimates" xlink:title="presentation: AccountingPoliciesAbstract to UseOfEstimates" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_SelfInsuranceProgramPolicyPolicyTextBlock" xlink:label="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="SelfInsuranceProgramPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SelfInsuranceProgramPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SelfInsuranceProgramPolicyPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RestrictedStockPolicyPolicyTextBlock" xlink:label="RestrictedStockPolicyPolicyTextBlock" xlink:title="RestrictedStockPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RestrictedStockPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RestrictedStockPolicyPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NewAccountingPronouncementsPolicyPolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RecentlyIssuedAccountingGuidancePolicyTextBlock" xlink:label="RecentlyIssuedAccountingGuidancePolicyTextBlock" xlink:title="RecentlyIssuedAccountingGuidancePolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="RecentlyIssuedAccountingGuidancePolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to RecentlyIssuedAccountingGuidancePolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="SubsequentEventsPolicyPolicyTextBlock" xlink:title="SubsequentEventsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SubsequentEventsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SubsequentEventsPolicyPolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsTables">
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:label="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:title="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="RedeemableNoncontrollingInterestTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:to="RedeemableNoncontrollingInterestTableTextBlock" xlink:title="presentation: MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract to RedeemableNoncontrollingInterestTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:label="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:to="CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" xlink:title="presentation: MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract to CarryingAmountOfRedeemableNonControllingInterestTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="ScheduleOfGoodwillTextBlock" xlink:title="ScheduleOfGoodwillTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="ScheduleOfGoodwillTextBlock" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to ScheduleOfGoodwillTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="presentation: PayablesAndAccrualsAbstract to ScheduleOfAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="ScheduleOfDebtInstrumentsTextBlock" xlink:title="ScheduleOfDebtInstrumentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="ScheduleOfDebtInstrumentsTextBlock" xlink:title="presentation: DebtDisclosureAbstract to ScheduleOfDebtInstrumentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:title="presentation: DebtDisclosureAbstract to ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DepreciationAmortizationImpairmentTable" xlink:label="DepreciationAmortizationImpairmentTable" xlink:title="DepreciationAmortizationImpairmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="RangeAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MarchTwoThousandSeventeenAcquisitionMember" xlink:label="MarchTwoThousandSeventeenAcquisitionMember" xlink:title="MarchTwoThousandSeventeenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="MarchTwoThousandSeventeenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to MarchTwoThousandSeventeenAcquisitionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to BusinessAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:label="ComputerSoftwareIntangibleAssetMember" xlink:title="ComputerSoftwareIntangibleAssetMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerSoftwareIntangibleAssetMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ComputerSoftwareIntangibleAssetMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="presentation: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to PropertyPlantAndEquipmentByTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis" xlink:label="UnusualOrInfrequentItemAxis" xlink:title="UnusualOrInfrequentItemAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain" xlink:label="UnusualOrInfrequentItemDomain" xlink:title="UnusualOrInfrequentItemDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_Year2017Member" xlink:label="Year2017Member" xlink:title="Year2017Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2017Member" xlink:title="presentation: UnusualOrInfrequentItemDomain to Year2017Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_Year2018Member" xlink:label="Year2018Member" xlink:title="Year2018Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2018Member" xlink:title="presentation: UnusualOrInfrequentItemDomain to Year2018Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_Year2019Member" xlink:label="Year2019Member" xlink:title="Year2019Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemDomain" xlink:to="Year2019Member" xlink:title="presentation: UnusualOrInfrequentItemDomain to Year2019Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="UnusualOrInfrequentItemAxis" xlink:to="UnusualOrInfrequentItemDomain" xlink:title="presentation: UnusualOrInfrequentItemAxis to UnusualOrInfrequentItemDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="UnusualOrInfrequentItemAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to UnusualOrInfrequentItemAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="TypeOfAdoptionMember" xlink:title="TypeOfAdoptionMember" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AccountingStandardsUpdate201609Member" xlink:label="AccountingStandardsUpdate201609Member" xlink:title="AccountingStandardsUpdate201609Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TypeOfAdoptionMember" xlink:to="AccountingStandardsUpdate201609Member" xlink:title="presentation: TypeOfAdoptionMember to AccountingStandardsUpdate201609Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="TypeOfAdoptionMember" xlink:title="presentation: AdjustmentsForNewAccountingPronouncementsAxis to TypeOfAdoptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="AdjustmentsForNewAccountingPronouncementsAxis" xlink:title="presentation: DepreciationAmortizationImpairmentTable to AdjustmentsForNewAccountingPronouncementsAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DepreciationAmortizationImpairmentLineItems" xlink:label="DepreciationAmortizationImpairmentLineItems" xlink:title="DepreciationAmortizationImpairmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfGeneralPartnershipInterestOwned" xlink:label="PercentageOfGeneralPartnershipInterestOwned" xlink:title="PercentageOfGeneralPartnershipInterestOwned" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfGeneralPartnershipInterestOwned" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to PercentageOfGeneralPartnershipInterestOwned" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfLimitedPartnershipInterestOwned" xlink:label="PercentageOfLimitedPartnershipInterestOwned" xlink:title="PercentageOfLimitedPartnershipInterestOwned" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfLimitedPartnershipInterestOwned" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to PercentageOfLimitedPartnershipInterestOwned" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfClinicsOperated" xlink:label="NumberOfClinicsOperated" xlink:title="NumberOfClinicsOperated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfClinicsOperated" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to NumberOfClinicsOperated" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="NumberOfStatesInWhichEntityOperates" xlink:title="NumberOfStatesInWhichEntityOperates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfStatesInWhichEntityOperates" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to NumberOfStatesInWhichEntityOperates" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfThirdPartyFacilities" xlink:label="NumberOfThirdPartyFacilities" xlink:title="NumberOfThirdPartyFacilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfThirdPartyFacilities" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to NumberOfThirdPartyFacilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to PropertyPlantAndEquipmentUsefulLife" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfRegions" xlink:label="NumberOfRegions" xlink:title="NumberOfRegions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NumberOfRegions" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to NumberOfRegions" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:label="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to RedeemableNonControllingInterestRedemptionRightsCommencementPeriod" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfMedicarePayment" xlink:label="PercentageOfMedicarePayment" xlink:title="PercentageOfMedicarePayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfMedicarePayment" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to PercentageOfMedicarePayment" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:label="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AmountOfReductionsInFederalSpending" xlink:label="AmountOfReductionsInFederalSpending" xlink:title="AmountOfReductionsInFederalSpending" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="AmountOfReductionsInFederalSpending" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to AmountOfReductionsInFederalSpending" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReductionInMedicareSpendingPercentage" xlink:label="ReductionInMedicareSpendingPercentage" xlink:title="ReductionInMedicareSpendingPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="ReductionInMedicareSpendingPercentage" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to ReductionInMedicareSpendingPercentage" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ExpectedReductionInMedicareSpendingPercentage" xlink:label="ExpectedReductionInMedicareSpendingPercentage" xlink:title="ExpectedReductionInMedicareSpendingPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="ExpectedReductionInMedicareSpendingPercentage" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to ExpectedReductionInMedicareSpendingPercentage" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:label="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:title="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AnnualLimitOccupationalTherapyServices" xlink:label="AnnualLimitOccupationalTherapyServices" xlink:title="AnnualLimitOccupationalTherapyServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="AnnualLimitOccupationalTherapyServices" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to AnnualLimitOccupationalTherapyServices" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:label="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="CombinedPhysicalTherapySpeechLanguagePathologyExpenses" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to CombinedPhysicalTherapySpeechLanguagePathologyExpenses" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:label="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageOfPracticeExpenseComponentOfRelativeValueUnit" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to PercentageOfPracticeExpenseComponentOfRelativeValueUnit" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:label="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NetRevenueFromMedicare" xlink:label="NetRevenueFromMedicare" xlink:title="NetRevenueFromMedicare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="NetRevenueFromMedicare" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to NetRevenueFromMedicare" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:label="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:label="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MaximumContractualAllowanceReserveEstimate" xlink:label="MaximumContractualAllowanceReserveEstimate" xlink:title="MaximumContractualAllowanceReserveEstimate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="MaximumContractualAllowanceReserveEstimate" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to MaximumContractualAllowanceReserveEstimate" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:label="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentLineItems" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: DepreciationAmortizationImpairmentLineItems to IncomeTaxExpenseBenefit" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DepreciationAmortizationImpairmentTable" xlink:to="DepreciationAmortizationImpairmentLineItems" xlink:title="presentation: DepreciationAmortizationImpairmentTable to DepreciationAmortizationImpairmentLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="DepreciationAmortizationImpairmentTable" xlink:title="presentation: AccountingPoliciesAbstract to DepreciationAmortizationImpairmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesScheduleOfClinicAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JuneTwoThousandSeventeenAcquisitionMember" xlink:label="JuneTwoThousandSeventeenAcquisitionMember" xlink:title="JuneTwoThousandSeventeenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="JuneTwoThousandSeventeenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to JuneTwoThousandSeventeenAcquisitionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MayTwoThousandSeventeenAcquisitionMember" xlink:label="MayTwoThousandSeventeenAcquisitionMember" xlink:title="MayTwoThousandSeventeenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="MayTwoThousandSeventeenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to MayTwoThousandSeventeenAcquisitionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JanuaryTwoThousandSeventeenAcquisitionMember" xlink:label="JanuaryTwoThousandSeventeenAcquisitionMember" xlink:title="JanuaryTwoThousandSeventeenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="JanuaryTwoThousandSeventeenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to JanuaryTwoThousandSeventeenAcquisitionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FebruaryTwoThousandSixteenAcquisitionMember" xlink:label="FebruaryTwoThousandSixteenAcquisitionMember" xlink:title="FebruaryTwoThousandSixteenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="FebruaryTwoThousandSixteenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to FebruaryTwoThousandSixteenAcquisitionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NovemberTwoThousandSixteenAcquisitionMember" xlink:label="NovemberTwoThousandSixteenAcquisitionMember" xlink:title="NovemberTwoThousandSixteenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="NovemberTwoThousandSixteenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to NovemberTwoThousandSixteenAcquisitionMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:label="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="BusinessAcquisitionDateOfAcquisitionAgreement1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionDateOfAcquisitionAgreement1" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessAcquisitionDateOfAcquisitionAgreement1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: AccountingPoliciesAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AcquisitionsOfBusinessesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="BusinessCombinationsAbstract" xlink:title="BusinessCombinationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfSeventeenClinicPracticesMember" xlink:label="AcquisitionOfSeventeenClinicPracticesMember" xlink:title="AcquisitionOfSeventeenClinicPracticesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfSeventeenClinicPracticesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AcquisitionOfSeventeenClinicPracticesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_WorkforcePerformanceSolutionsMember" xlink:label="WorkforcePerformanceSolutionsMember" xlink:title="WorkforcePerformanceSolutionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="WorkforcePerformanceSolutionsMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to WorkforcePerformanceSolutionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfFourClinicPracticesMember" xlink:label="AcquisitionOfFourClinicPracticesMember" xlink:title="AcquisitionOfFourClinicPracticesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfFourClinicPracticesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AcquisitionOfFourClinicPracticesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfNineClinicPracticesMember" xlink:label="AcquisitionOfNineClinicPracticesMember" xlink:title="AcquisitionOfNineClinicPracticesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfNineClinicPracticesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AcquisitionOfNineClinicPracticesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfTwelveClinicPracticesMember" xlink:label="AcquisitionOfTwelveClinicPracticesMember" xlink:title="AcquisitionOfTwelveClinicPracticesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfTwelveClinicPracticesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AcquisitionOfTwelveClinicPracticesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfEightClinicPracticesMember" xlink:label="AcquisitionOfEightClinicPracticesMember" xlink:title="AcquisitionOfEightClinicPracticesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfEightClinicPracticesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AcquisitionOfEightClinicPracticesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AcquisitionOfSingleClinicPracticesMember" xlink:label="AcquisitionOfSingleClinicPracticesMember" xlink:title="AcquisitionOfSingleClinicPracticesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AcquisitionOfSingleClinicPracticesMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AcquisitionOfSingleClinicPracticesMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="StatementScenarioAxis" xlink:title="StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="ScenarioUnspecifiedDomain" xlink:title="ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JanuaryTwoThousandEighteenMember" xlink:label="JanuaryTwoThousandEighteenMember" xlink:title="JanuaryTwoThousandEighteenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="JanuaryTwoThousandEighteenMember" xlink:title="presentation: ScenarioUnspecifiedDomain to JanuaryTwoThousandEighteenMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JanuaryTwoThousandNineteenMember" xlink:label="JanuaryTwoThousandNineteenMember" xlink:title="JanuaryTwoThousandNineteenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="JanuaryTwoThousandNineteenMember" xlink:title="presentation: ScenarioUnspecifiedDomain to JanuaryTwoThousandNineteenMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MayTwoThousandEighteenMember" xlink:label="MayTwoThousandEighteenMember" xlink:title="MayTwoThousandEighteenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="MayTwoThousandEighteenMember" xlink:title="presentation: ScenarioUnspecifiedDomain to MayTwoThousandEighteenMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MayTwoThousandNineteenMember" xlink:label="MayTwoThousandNineteenMember" xlink:title="MayTwoThousandNineteenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="MayTwoThousandNineteenMember" xlink:title="presentation: ScenarioUnspecifiedDomain to MayTwoThousandNineteenMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JuneTwoThousandEighteenMember" xlink:label="JuneTwoThousandEighteenMember" xlink:title="JuneTwoThousandEighteenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="JuneTwoThousandEighteenMember" xlink:title="presentation: ScenarioUnspecifiedDomain to JuneTwoThousandEighteenMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_JuneTwoThousandNineteenMember" xlink:label="JuneTwoThousandNineteenMember" xlink:title="JuneTwoThousandNineteenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="JuneTwoThousandNineteenMember" xlink:title="presentation: ScenarioUnspecifiedDomain to JuneTwoThousandNineteenMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NovemberTwoThousandSeventeenMember" xlink:label="NovemberTwoThousandSeventeenMember" xlink:title="NovemberTwoThousandSeventeenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="NovemberTwoThousandSeventeenMember" xlink:title="presentation: ScenarioUnspecifiedDomain to NovemberTwoThousandSeventeenMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NovemberTwoThousandEighteenMember" xlink:label="NovemberTwoThousandEighteenMember" xlink:title="NovemberTwoThousandEighteenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="NovemberTwoThousandEighteenMember" xlink:title="presentation: ScenarioUnspecifiedDomain to NovemberTwoThousandEighteenMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FebruaryTwoThousandSeventeenMember" xlink:label="FebruaryTwoThousandSeventeenMember" xlink:title="FebruaryTwoThousandSeventeenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="FebruaryTwoThousandSeventeenMember" xlink:title="presentation: ScenarioUnspecifiedDomain to FebruaryTwoThousandSeventeenMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FebruaryTwoThousandEighteenMember" xlink:label="FebruaryTwoThousandEighteenMember" xlink:title="FebruaryTwoThousandEighteenMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScenarioUnspecifiedDomain" xlink:to="FebruaryTwoThousandEighteenMember" xlink:title="presentation: ScenarioUnspecifiedDomain to FebruaryTwoThousandEighteenMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementScenarioAxis" xlink:to="ScenarioUnspecifiedDomain" xlink:title="presentation: StatementScenarioAxis to ScenarioUnspecifiedDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="StatementScenarioAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to StatementScenarioAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfBusinessesAcquired" xlink:label="NumberOfBusinessesAcquired" xlink:title="NumberOfBusinessesAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfBusinessesAcquired" xlink:title="presentation: BusinessAcquisitionLineItems to NumberOfBusinessesAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="PaymentsToAcquireBusinessesGross" xlink:title="PaymentsToAcquireBusinessesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="PaymentsToAcquireBusinessesGross" xlink:title="presentation: BusinessAcquisitionLineItems to PaymentsToAcquireBusinessesGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:label="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" xlink:label="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" xlink:title="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" xlink:label="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" xlink:title="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NumberOfSubsidiariesAcquiredClinicPractices" xlink:label="NumberOfSubsidiariesAcquiredClinicPractices" xlink:title="NumberOfSubsidiariesAcquiredClinicPractices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="NumberOfSubsidiariesAcquiredClinicPractices" xlink:title="presentation: BusinessAcquisitionLineItems to NumberOfSubsidiariesAcquiredClinicPractices" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="BusinessCombinationConsiderationTransferred1" xlink:title="BusinessCombinationConsiderationTransferred1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationConsiderationTransferred1" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationConsiderationTransferred1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:label="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: BusinessCombinationsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: BusinessCombinationsAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="BusinessAcquisitionCostOfAcquiredEntityDebtIssued" xlink:title="presentation: BusinessCombinationsAbstract to BusinessAcquisitionCostOfAcquiredEntityDebtIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PaymentsToAcquireBusinessesConsideration" xlink:label="PaymentsToAcquireBusinessesConsideration" xlink:title="PaymentsToAcquireBusinessesConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: BusinessCombinationsAbstract to PaymentsToAcquireBusinessesConsideration" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:label="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:label="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:label="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:label="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:label="BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:title="BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:to="PaymentsToAcquireBusinessesConsideration" xlink:title="presentation: EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract to PaymentsToAcquireBusinessesConsideration" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationsAbstract" xlink:to="EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" xlink:title="presentation: BusinessCombinationsAbstract to EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:label="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:title="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TherapyPracticeMember" xlink:label="TherapyPracticeMember" xlink:title="TherapyPracticeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TherapyPracticeMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to TherapyPracticeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsidiariesMember" xlink:label="SubsidiariesMember" xlink:title="SubsidiariesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityDomain" xlink:to="SubsidiariesMember" xlink:title="presentation: EntityDomain to SubsidiariesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="presentation: LegalEntityAxis to EntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="LegalEntityAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to LegalEntityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="BusinessAcquisitionLineItems" xlink:title="BusinessAcquisitionLineItems" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:label="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:label="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BusinessAcquisitionConsiderationPayableTermOfNote" xlink:label="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="BusinessAcquisitionConsiderationPayableTermOfNote" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="BusinessAcquisitionConsiderationPayableTermOfNote" xlink:title="presentation: BusinessAcquisitionLineItems to BusinessAcquisitionConsiderationPayableTermOfNote" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TermOfEmploymentAgreement" xlink:label="TermOfEmploymentAgreement" xlink:title="TermOfEmploymentAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="TermOfEmploymentAgreement" xlink:title="presentation: BusinessAcquisitionLineItems to TermOfEmploymentAgreement" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_EmploymentAgreementRenewalTerm" xlink:label="EmploymentAgreementRenewalTerm" xlink:title="EmploymentAgreementRenewalTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="EmploymentAgreementRenewalTerm" xlink:title="presentation: BusinessAcquisitionLineItems to EmploymentAgreementRenewalTerm" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:label="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" xlink:title="presentation: BusinessAcquisitionLineItems to NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NonCompeteAgreementBasicTerm" xlink:label="NonCompeteAgreementBasicTerm" xlink:title="NonCompeteAgreementBasicTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="NonCompeteAgreementBasicTerm" xlink:title="presentation: BusinessAcquisitionLineItems to NonCompeteAgreementBasicTerm" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" xlink:label="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" xlink:title="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionLineItems" xlink:to="RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" xlink:title="presentation: BusinessAcquisitionLineItems to RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="BusinessAcquisitionLineItems" xlink:title="presentation: ScheduleOfBusinessAcquisitionsByAcquisitionTable to BusinessAcquisitionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:title="presentation: MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:label="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:title="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:label="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:title="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:to="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:title="presentation: ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward to SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:label="NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:title="NetIncomeLossAttributableToRedeemableNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:to="NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:title="presentation: ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward to NetIncomeLossAttributableToRedeemableNoncontrollingInterest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" xlink:label="DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:to="DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" xlink:title="presentation: ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward to DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:label="NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:title="NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:to="NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:title="presentation: ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward to NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" xlink:label="IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" xlink:title="IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:to="IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" xlink:title="presentation: ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward to IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="PaymentsToMinorityShareholders" xlink:title="PaymentsToMinorityShareholders" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:to="PaymentsToMinorityShareholders" xlink:title="presentation: ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward to PaymentsToMinorityShareholders" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:label="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_2" xlink:title="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:to="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_2" xlink:title="presentation: ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward to SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:to="ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" xlink:title="presentation: MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract to ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:label="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="CarryingAmountOfRedeemableNonControllingInterestAbstract" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:label="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:label="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:label="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:label="RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:title="RedeemableNoncontrollingInterestEquityRedemptionValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="RedeemableNoncontrollingInterestEquityRedemptionValue" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to RedeemableNoncontrollingInterestEquityRedemptionValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ExcessDistributionsOverEarningsAndLosses" xlink:label="ExcessDistributionsOverEarningsAndLosses" xlink:title="ExcessDistributionsOverEarningsAndLosses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="ExcessDistributionsOverEarningsAndLosses" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to ExcessDistributionsOverEarningsAndLosses" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:to="SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:title="presentation: CarryingAmountOfRedeemableNonControllingInterestAbstract to SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:to="CarryingAmountOfRedeemableNonControllingInterestAbstract" xlink:title="presentation: MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract to CarryingAmountOfRedeemableNonControllingInterestAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/RedeemableNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:label="REDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:title="REDEEMABLENONCONTROLLINGINTERESTSAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="RedeemableNoncontrollingInterestEquityCarryingAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="REDEEMABLENONCONTROLLINGINTERESTSAbstract" xlink:to="RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:title="presentation: REDEEMABLENONCONTROLLINGINTERESTSAbstract to RedeemableNoncontrollingInterestEquityCarryingAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/GoodwillDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:title="GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="GoodwillRollForward" xlink:title="GoodwillRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="Goodwill" xlink:title="presentation: GoodwillRollForward to Goodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="GoodwillAcquiredDuringPeriod" xlink:title="GoodwillAcquiredDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillAcquiredDuringPeriod" xlink:title="presentation: GoodwillRollForward to GoodwillAcquiredDuringPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="GoodwillPurchaseAccountingAdjustments" xlink:title="GoodwillPurchaseAccountingAdjustments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="GoodwillPurchaseAccountingAdjustments" xlink:title="presentation: GoodwillRollForward to GoodwillPurchaseAccountingAdjustments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill_2" xlink:title="Goodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillRollForward" xlink:to="Goodwill_2" xlink:title="presentation: GoodwillRollForward to Goodwill" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillRollForward" xlink:title="presentation: GoodwillAndIntangibleAssetsDisclosureAbstract to GoodwillRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to IntangibleAssetsNetExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="FiniteLivedIntangibleAssetUsefulLife" xlink:title="FiniteLivedIntangibleAssetUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetUsefulLife" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetUsefulLife" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="TrademarksMember" xlink:title="TrademarksMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="TrademarksMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to TrademarksMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="AmortizationOfIntangibleAssets" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to AmortizationOfIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/IntangibleAssetsNetAmortizationOfTradenameReferralRelationshipsAndNoncompetitionAgreementsDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:title="IntangibleAssetsNetExcludingGoodwillAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_ReferralRelationshipMember" xlink:label="ReferralRelationshipMember" xlink:title="ReferralRelationshipMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="ReferralRelationshipMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to ReferralRelationshipMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="NoncompeteAgreementsMember" xlink:title="NoncompeteAgreementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="NoncompeteAgreementsMember" xlink:title="presentation: FiniteLivedIntangibleAssetsMajorClassNameDomain to NoncompeteAgreementsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:title="presentation: FiniteLivedIntangibleAssetsByMajorClassAxis to FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsByMajorClassAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="FiniteLivedIntangibleAssetsLineItems" xlink:title="FiniteLivedIntangibleAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearSix" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearEight" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearNine" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearTen" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" xlink:label="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" xlink:title="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" xlink:title="presentation: FiniteLivedIntangibleAssetsLineItems to FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="FiniteLivedIntangibleAssetsLineItems" xlink:title="presentation: ScheduleOfFiniteLivedIntangibleAssetsTable to FiniteLivedIntangibleAssetsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:title="presentation: IntangibleAssetsNetExcludingGoodwillAbstract to ScheduleOfFiniteLivedIntangibleAssetsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/AccruedExpensesDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="PayablesAndAccrualsAbstract" xlink:title="PayablesAndAccrualsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PatientsAndPayorsRelatedLiability" xlink:label="PatientsAndPayorsRelatedLiability" xlink:title="PatientsAndPayorsRelatedLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="PatientsAndPayorsRelatedLiability" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to PatientsAndPayorsRelatedLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedInsuranceCurrent" xlink:label="AccruedInsuranceCurrent" xlink:title="AccruedInsuranceCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="AccruedInsuranceCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to AccruedInsuranceCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="DividendsPayableCurrent" xlink:title="DividendsPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="DividendsPayableCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to DividendsPayableCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to OtherAccruedLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: AccountsPayableAndAccruedLiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayablesAndAccrualsAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:title="presentation: PayablesAndAccrualsAbstract to AccountsPayableAndAccruedLiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="DebtInstrumentAxis" xlink:title="DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="DebtInstrumentNameDomain" xlink:title="DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_PromissoryNotesMember" xlink:label="PromissoryNotesMember" xlink:title="PromissoryNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentNameDomain" xlink:to="PromissoryNotesMember" xlink:title="presentation: DebtInstrumentNameDomain to PromissoryNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentAxis" xlink:to="DebtInstrumentNameDomain" xlink:title="presentation: DebtInstrumentAxis to DebtInstrumentNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentAxis" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="presentation: CreditFacilityDomain to RevolvingCreditFacilityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="presentation: CreditFacilityAxis to CreditFacilityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="presentation: DebtInstrumentTable to CreditFacilityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="presentation: DebtInstrumentTable to RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebt" xlink:title="presentation: DebtInstrumentLineItems to LongTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtCurrent" xlink:title="presentation: DebtInstrumentLineItems to LongTermDebtCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtNoncurrent" xlink:title="presentation: DebtInstrumentLineItems to LongTermDebtNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="presentation: DebtInstrumentLineItems to LineOfCreditFacilityInterestRateDuringPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="DebtInstrumentAnnualPrincipalPayment" xlink:title="DebtInstrumentAnnualPrincipalPayment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentAnnualPrincipalPayment" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentAnnualPrincipalPayment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="DebtInstrumentInterestRateStatedPercentage" xlink:title="DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentInterestRateStatedPercentage" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentInterestRateStatedPercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="DebtInstrumentTable" xlink:title="DebtInstrumentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="CreditFacilityAxis" xlink:title="CreditFacilityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="CreditFacilityDomain" xlink:title="CreditFacilityDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="RevolvingCreditFacilityMember" xlink:title="RevolvingCreditFacilityMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="RevolvingCreditFacilityMember" xlink:title="presentation: CreditFacilityDomain to RevolvingCreditFacilityMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CreditAgreementMember" xlink:label="CreditAgreementMember" xlink:title="CreditAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityDomain" xlink:to="CreditAgreementMember" xlink:title="presentation: CreditFacilityDomain to CreditAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CreditFacilityAxis" xlink:to="CreditFacilityDomain" xlink:title="presentation: CreditFacilityAxis to CreditFacilityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="CreditFacilityAxis" xlink:title="presentation: DebtInstrumentTable to CreditFacilityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="RangeAxis" xlink:title="presentation: DebtInstrumentTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="VariableRateAxis" xlink:title="VariableRateAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="VariableRateDomain" xlink:title="VariableRateDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="LondonInterbankOfferedRateLIBORMember" xlink:title="LondonInterbankOfferedRateLIBORMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VariableRateDomain" xlink:to="LondonInterbankOfferedRateLIBORMember" xlink:title="presentation: VariableRateDomain to LondonInterbankOfferedRateLIBORMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BaseRateMember" xlink:label="BaseRateMember" xlink:title="BaseRateMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VariableRateDomain" xlink:to="BaseRateMember" xlink:title="presentation: VariableRateDomain to BaseRateMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VariableRateAxis" xlink:to="VariableRateDomain" xlink:title="presentation: VariableRateAxis to VariableRateDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="VariableRateAxis" xlink:title="presentation: DebtInstrumentTable to VariableRateAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="ShortTermDebtTypeAxis" xlink:title="ShortTermDebtTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="ShortTermDebtTypeDomain" xlink:title="ShortTermDebtTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_NotesPayableMember" xlink:label="NotesPayableMember" xlink:title="NotesPayableMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeDomain" xlink:to="NotesPayableMember" xlink:title="presentation: ShortTermDebtTypeDomain to NotesPayableMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermDebtTypeAxis" xlink:to="ShortTermDebtTypeDomain" xlink:title="presentation: ShortTermDebtTypeAxis to ShortTermDebtTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="ShortTermDebtTypeAxis" xlink:title="presentation: DebtInstrumentTable to ShortTermDebtTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TwoThousandFifteenAcquisitionMember" xlink:label="TwoThousandFifteenAcquisitionMember" xlink:title="TwoThousandFifteenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TwoThousandFifteenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to TwoThousandFifteenAcquisitionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TwoThousandSixteenAcquisitionMember" xlink:label="TwoThousandSixteenAcquisitionMember" xlink:title="TwoThousandSixteenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TwoThousandSixteenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to TwoThousandSixteenAcquisitionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_TwoThousandSeventeenAcquisitionMember" xlink:label="TwoThousandSeventeenAcquisitionMember" xlink:title="TwoThousandSeventeenAcquisitionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="TwoThousandSeventeenAcquisitionMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to TwoThousandSeventeenAcquisitionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: DebtInstrumentTable to BusinessAcquisitionAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="DebtInstrumentLineItems" xlink:title="DebtInstrumentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="LineOfCreditFacilityMaximumBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityMaximumBorrowingCapacity" xlink:title="presentation: DebtInstrumentLineItems to LineOfCreditFacilityMaximumBorrowingCapacity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="DebtInstrumentMaturityDate" xlink:title="DebtInstrumentMaturityDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentMaturityDate" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentMaturityDate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="DebtInstrumentBasisSpreadOnVariableRate1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentBasisSpreadOnVariableRate1" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentBasisSpreadOnVariableRate1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:title="presentation: DebtInstrumentLineItems to LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:label="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" xlink:title="presentation: DebtInstrumentLineItems to CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_DividendsCashAfterAmendment" xlink:label="DividendsCashAfterAmendment" xlink:title="DividendsCashAfterAmendment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DividendsCashAfterAmendment" xlink:title="presentation: DebtInstrumentLineItems to DividendsCashAfterAmendment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="LineOfCreditFacilityRemainingBorrowingCapacity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityRemainingBorrowingCapacity" xlink:title="presentation: DebtInstrumentLineItems to LineOfCreditFacilityRemainingBorrowingCapacity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="DebtInstrumentFaceAmount" xlink:title="DebtInstrumentFaceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="DebtInstrumentFaceAmount" xlink:title="presentation: DebtInstrumentLineItems to DebtInstrumentFaceAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="presentation: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="presentation: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:title="presentation: DebtInstrumentLineItems to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="LineOfCreditFacilityInterestRateDuringPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="LineOfCreditFacilityInterestRateDuringPeriod" xlink:title="presentation: DebtInstrumentLineItems to LineOfCreditFacilityInterestRateDuringPeriod" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="RepaymentsOfDebt" xlink:title="RepaymentsOfDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentLineItems" xlink:to="RepaymentsOfDebt" xlink:title="presentation: DebtInstrumentLineItems to RepaymentsOfDebt" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtInstrumentTable" xlink:to="DebtInstrumentLineItems" xlink:title="presentation: DebtInstrumentTable to DebtInstrumentLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="DebtInstrumentTable" xlink:title="presentation: DebtDisclosureAbstract to DebtInstrumentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="DebtDisclosureAbstract" xlink:title="DebtDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="LongTermDebtByMaturityAbstract" xlink:title="LongTermDebtByMaturityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:title="presentation: LongTermDebtByMaturityAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:title="presentation: LongTermDebtByMaturityAbstract to LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="LongTermDebt" xlink:title="LongTermDebt" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LongTermDebtByMaturityAbstract" xlink:to="LongTermDebt" xlink:title="presentation: LongTermDebtByMaturityAbstract to LongTermDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtDisclosureAbstract" xlink:to="LongTermDebtByMaturityAbstract" xlink:title="presentation: DebtDisclosureAbstract to LongTermDebtByMaturityAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://usph.com/role/CommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="ClassOfTreasuryStockTable" xlink:title="ClassOfTreasuryStockTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfTreasuryStockTable" xlink:to="RangeAxis" xlink:title="presentation: ClassOfTreasuryStockTable to RangeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="EquityClassOfTreasuryStockLineItems" xlink:title="EquityClassOfTreasuryStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:title="presentation: EquityClassOfTreasuryStockLineItems to StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_MaximumPercentageOfRepurchaseOfCommonStock" xlink:label="MaximumPercentageOfRepurchaseOfCommonStock" xlink:title="MaximumPercentageOfRepurchaseOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="MaximumPercentageOfRepurchaseOfCommonStock" xlink:title="presentation: EquityClassOfTreasuryStockLineItems to MaximumPercentageOfRepurchaseOfCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:label="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="BankCreditAgreementToPermitShareRepurchasesOfCommonStock" xlink:title="presentation: EquityClassOfTreasuryStockLineItems to BankCreditAgreementToPermitShareRepurchasesOfCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="StockRepurchasedDuringPeriodShares" xlink:title="StockRepurchasedDuringPeriodShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="StockRepurchasedDuringPeriodShares" xlink:title="presentation: EquityClassOfTreasuryStockLineItems to StockRepurchasedDuringPeriodShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="usph-20170630.xsd#usph_AdditionalEstimatedRepurchaseOfCommonStock" xlink:label="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="AdditionalEstimatedRepurchaseOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="AdditionalEstimatedRepurchaseOfCommonStock" xlink:title="presentation: EquityClassOfTreasuryStockLineItems to AdditionalEstimatedRepurchaseOfCommonStock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="SharesIssuedPricePerShare" xlink:title="SharesIssuedPricePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityClassOfTreasuryStockLineItems" xlink:to="SharesIssuedPricePerShare" xlink:title="presentation: EquityClassOfTreasuryStockLineItems to SharesIssuedPricePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfTreasuryStockTable" xlink:to="EquityClassOfTreasuryStockLineItems" xlink:title="presentation: ClassOfTreasuryStockTable to EquityClassOfTreasuryStockLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ClassOfTreasuryStockTable" xlink:title="presentation: EquityAbstract to ClassOfTreasuryStockTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6822555968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Aug. 07, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">U S PHYSICAL THERAPY INC /NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,581,237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823277504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 20,242<span></span>
</td>
<td class="nump">$ 20,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Patient accounts receivable, less allowance for doubtful accounts of $1,859 and $1,792, respectively</a></td>
<td class="nump">46,770<span></span>
</td>
<td class="nump">38,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts receivable - other</a></td>
<td class="nump">5,662<span></span>
</td>
<td class="nump">2,649<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">6,932<span></span>
</td>
<td class="nump">4,428<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">79,606<span></span>
</td>
<td class="nump">65,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Fixed assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and equipment</a></td>
<td class="nump">50,644<span></span>
</td>
<td class="nump">48,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">27,729<span></span>
</td>
<td class="nump">26,765<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Fixed assets, gross</a></td>
<td class="nump">78,373<span></span>
</td>
<td class="nump">75,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="nump">58,200<span></span>
</td>
<td class="nump">56,018<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">20,173<span></span>
</td>
<td class="nump">19,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">267,957<span></span>
</td>
<td class="nump">226,806<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other identifiable intangible assets, net</a></td>
<td class="nump">48,321<span></span>
</td>
<td class="nump">38,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,268<span></span>
</td>
<td class="nump">1,228<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">417,325<span></span>
</td>
<td class="nump">351,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable - trade</a></td>
<td class="nump">1,613<span></span>
</td>
<td class="nump">1,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">31,235<span></span>
</td>
<td class="nump">21,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">2,345<span></span>
</td>
<td class="nump">1,227<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">35,193<span></span>
</td>
<td class="nump">24,617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">4,351<span></span>
</td>
<td class="nump">4,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Revolving line of credit</a></td>
<td class="nump">69,000<span></span>
</td>
<td class="nump">46,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent', window );">Mandatorily redeemable non-controlling interests</a></td>
<td class="nump">83,643<span></span>
</td>
<td class="nump">69,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Deferred taxes</a></td>
<td class="nump">15,443<span></span>
</td>
<td class="nump">15,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent</a></td>
<td class="nump">1,789<span></span>
</td>
<td class="nump">1,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">829<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">209,419<span></span>
</td>
<td class="nump">162,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable non-controlling interests</a></td>
<td class="nump">11,940<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.01 par value, 20,000,000 shares authorized, 14,792,744 and 14,732,699 shares issued, respectively</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">71,197<span></span>
</td>
<td class="nump">68,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">155,068<span></span>
</td>
<td class="nump">150,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock at cost, 2,214,737 shares</a></td>
<td class="num">(31,628)<span></span>
</td>
<td class="num">(31,628)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total USPH shareholders' equity</a></td>
<td class="nump">194,784<span></span>
</td>
<td class="nump">187,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests</a></td>
<td class="nump">1,182<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total USPH shareholders' equity and non-controlling interests</a></td>
<td class="nump">195,966<span></span>
</td>
<td class="nump">188,688<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable non-controlling interests, USPH shareholders' equity and non-controlling interests</a></td>
<td class="nump">$ 417,325<span></span>
</td>
<td class="nump">$ 351,231<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.26(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31958-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=28361426&amp;loc=d3e1314-112600<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=28361426&amp;loc=d3e1336-112600<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Line-of-Credit Arrangement<br> -URI http://asc.fasb.org/extlink&amp;oid=6517033<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that is required to be paid, determined under the conditions specified in the contract, if as of the reporting date, the holder of the share has exercised the right to or the shares are mandatorily redeemable after one year from the reporting date or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6940734&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4590271-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4568740-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823343440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts, patient accounts receivable</a></td>
<td class="nump">$ 1,859<span></span>
</td>
<td class="nump">$ 1,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>U.S. Physical Therapy, Inc. ("USPH") shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">14,792,744<span></span>
</td>
<td class="nump">14,732,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">2,214,737<span></span>
</td>
<td class="nump">2,214,737<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6822935680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF NET INCOME (unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>CONSOLIDATED STATEMENTS OF NET INCOME (unaudited) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Net patient revenues</a></td>
<td class="nump">$ 97,657<span></span>
</td>
<td class="nump">$ 88,433<span></span>
</td>
<td class="nump">$ 191,311<span></span>
</td>
<td class="nump">$ 173,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSalesRevenueNet', window );">Other revenues</a></td>
<td class="nump">6,594<span></span>
</td>
<td class="nump">1,997<span></span>
</td>
<td class="nump">10,505<span></span>
</td>
<td class="nump">3,856<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net revenues</a></td>
<td class="nump">104,251<span></span>
</td>
<td class="nump">90,430<span></span>
</td>
<td class="nump">201,816<span></span>
</td>
<td class="nump">177,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Clinic operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries and related costs</a></td>
<td class="nump">58,779<span></span>
</td>
<td class="nump">48,837<span></span>
</td>
<td class="nump">114,606<span></span>
</td>
<td class="nump">96,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RentClinicSuppliesContractLaborAndOther', window );">Rent, clinic supplies, contract labor and other</a></td>
<td class="nump">20,033<span></span>
</td>
<td class="nump">17,546<span></span>
</td>
<td class="nump">40,120<span></span>
</td>
<td class="nump">35,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">888<span></span>
</td>
<td class="nump">956<span></span>
</td>
<td class="nump">1,786<span></span>
</td>
<td class="nump">2,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Closure costs</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total clinic operating costs</a></td>
<td class="nump">79,717<span></span>
</td>
<td class="nump">67,371<span></span>
</td>
<td class="nump">156,535<span></span>
</td>
<td class="nump">133,784<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">24,534<span></span>
</td>
<td class="nump">23,059<span></span>
</td>
<td class="nump">45,281<span></span>
</td>
<td class="nump">43,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Corporate office costs</a></td>
<td class="nump">8,856<span></span>
</td>
<td class="nump">8,026<span></span>
</td>
<td class="nump">17,403<span></span>
</td>
<td class="nump">17,030<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">15,678<span></span>
</td>
<td class="nump">15,033<span></span>
</td>
<td class="nump">27,878<span></span>
</td>
<td class="nump">26,524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income, net</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseAbstract', window );"><strong>Interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue', window );">Mandatorily redeemable non-controlling interests - change in redemption value</a></td>
<td class="num">(3,923)<span></span>
</td>
<td class="num">(1,931)<span></span>
</td>
<td class="num">(6,592)<span></span>
</td>
<td class="num">(4,122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable', window );">Mandatorily redeemable non-controlling interests - earnings allocable</a></td>
<td class="num">(1,787)<span></span>
</td>
<td class="num">(1,330)<span></span>
</td>
<td class="num">(3,081)<span></span>
</td>
<td class="num">(2,217)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_InterestExpenseDebtAndOther', window );">Debt and other</a></td>
<td class="num">(516)<span></span>
</td>
<td class="num">(320)<span></span>
</td>
<td class="num">(931)<span></span>
</td>
<td class="num">(628)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Total interest expense</a></td>
<td class="num">(6,226)<span></span>
</td>
<td class="num">(3,581)<span></span>
</td>
<td class="num">(10,604)<span></span>
</td>
<td class="num">(6,967)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before taxes</a></td>
<td class="nump">9,475<span></span>
</td>
<td class="nump">11,473<span></span>
</td>
<td class="nump">17,321<span></span>
</td>
<td class="nump">19,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">3,085<span></span>
</td>
<td class="nump">3,802<span></span>
</td>
<td class="nump">4,897<span></span>
</td>
<td class="nump">5,974<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">6,390<span></span>
</td>
<td class="nump">7,671<span></span>
</td>
<td class="nump">12,424<span></span>
</td>
<td class="nump">13,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: net income attributable to non-controlling interests</a></td>
<td class="num">(1,449)<span></span>
</td>
<td class="num">(1,659)<span></span>
</td>
<td class="num">(2,667)<span></span>
</td>
<td class="num">(3,124)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to USPH shareholders</a></td>
<td class="nump">$ 4,941<span></span>
</td>
<td class="nump">$ 6,012<span></span>
</td>
<td class="nump">$ 9,757<span></span>
</td>
<td class="nump">$ 10,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted earnings per share attributable to USPH shareholders (in dollars per share)</a></td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="nump">$ 0.78<span></span>
</td>
<td class="nump">$ 0.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in computation - basic (in shares)</a></td>
<td class="nump">12,579<span></span>
</td>
<td class="nump">12,511<span></span>
</td>
<td class="nump">12,553<span></span>
</td>
<td class="nump">12,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in computation - diluted (in shares)</a></td>
<td class="nump">12,579<span></span>
</td>
<td class="nump">12,511<span></span>
</td>
<td class="nump">12,553<span></span>
</td>
<td class="nump">12,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationPatientServiceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=d3e8184-115640<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=d3e8195-115640<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052803&amp;loc=SL9156464-115641<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationPatientServiceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of expenditures for salaries, wages, profit sharing and incentive compensation, and other employee benefits, including equity-based compensation, and pension and other postretirement benefit expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after sales adjustments, returns, allowances, and discounts, of revenue classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_InterestExpenseDebtAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt related expenses and other expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_InterestExpenseDebtAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to expenses related to earnings from mandatorily redeemable non-controlling interests. This expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsEarningsAllocable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to expenses related to increase (decrease) in redemption value from mandatorily redeemable non-controlling interests. This expenses associated with non-operating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_InterestExpenseMandatorilyRedeemableNonControllingInterestsIncreaseDecreaseInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RentClinicSuppliesContractLaborAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to rent, clinic supplies, contract labor and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RentClinicSuppliesContractLaborAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823141200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income including non-controlling interests</a></td>
<td class="nump">$ 12,424<span></span>
</td>
<td class="nump">$ 13,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,789<span></span>
</td>
<td class="nump">4,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">1,786<span></span>
</td>
<td class="nump">2,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on sale of fixed assets</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Equity-based awards compensation expense</a></td>
<td class="nump">2,345<span></span>
</td>
<td class="nump">2,484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax</a></td>
<td class="num">(985)<span></span>
</td>
<td class="nump">2,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in patient accounts receivable</a></td>
<td class="num">(4,006)<span></span>
</td>
<td class="num">(2,449)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets', window );">(Increase) decrease in accounts receivable - other</a></td>
<td class="num">(3,406)<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Increase in other assets</a></td>
<td class="num">(2,342)<span></span>
</td>
<td class="num">(2,443)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase in accounts payable and accrued expenses</a></td>
<td class="nump">5,043<span></span>
</td>
<td class="nump">6,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests', window );">Increase in mandatorily redeemable non-controlling interests</a></td>
<td class="nump">6,401<span></span>
</td>
<td class="nump">4,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Increase in other liabilities</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">447<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">22,191<span></span>
</td>
<td class="nump">31,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase of fixed assets</a></td>
<td class="num">(3,245)<span></span>
</td>
<td class="num">(3,453)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Purchase of businesses, net of cash acquired</a></td>
<td class="num">(33,665)<span></span>
</td>
<td class="num">(12,958)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates', window );">Acquisitions of non-controlling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(250)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds on sale of fixed assets, net</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(36,848)<span></span>
</td>
<td class="num">(16,619)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to non-controlling interests</a></td>
<td class="num">(2,665)<span></span>
</td>
<td class="num">(2,893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid to shareholders</a></td>
<td class="num">(2,516)<span></span>
</td>
<td class="num">(4,254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving line of credit</a></td>
<td class="nump">49,000<span></span>
</td>
<td class="nump">93,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving line of credit</a></td>
<td class="num">(26,000)<span></span>
</td>
<td class="num">(94,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments to settle mandatorily redeemable non-controlling interests</a></td>
<td class="num">(2,230)<span></span>
</td>
<td class="num">(1,136)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Principal payments on notes payable</a></td>
<td class="num">(777)<span></span>
</td>
<td class="num">(533)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxExpenseFromStockOptionsExercised', window );">Tax benefit from equity-based awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="nump">14,852<span></span>
</td>
<td class="num">(9,759)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">4,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents - beginning of period</a></td>
<td class="nump">20,047<span></span>
</td>
<td class="nump">15,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents - end of period</a></td>
<td class="nump">20,242<span></span>
</td>
<td class="nump">20,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashPaidDuringPeriodForAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">7,516<span></span>
</td>
<td class="nump">5,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing transactions during the period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PurchaseOfBusinessSellerFinancingPortion', window );">Purchase of business - seller financing portion</a></td>
<td class="nump">1,650<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion', window );">Acquisition of non-controlling interest - seller financing portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion', window );">Payment to settle redeemable non-controlling interest - financing portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SaleOfNoncontrollingInterest', window );">Sale of non-controlling interests</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (148)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxExpenseFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=65896087&amp;loc=d3e11283-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxExpenseFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables, and operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period net of cash paid for interest that is capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow associated with the acquisition or sale of a business segment during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3095-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition of non-controlling interest - seller financing portion in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AcquisitionOfNoncontrollingInterestSellerFinancingPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashPaidDuringPeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashPaidDuringPeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in mandatorily redeemable non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_IncreaseDecreaseInMandatorilyRedeemableNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payment to settle redeemable non-controlling interest related to financing portion during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PaymentToSettleRedeemableNonControllingInterestFinancingPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PurchaseOfBusinessSellerFinancingPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of business - seller financing portion in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PurchaseOfBusinessSellerFinancingPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SaleOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to amount of noncontrolling interest sold by an entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SaleOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811359280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited) - 6 months ended Jun. 30, 2017 - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Total Shareholders' Equity [Member]</div></th>
<th class="th"><div>Non-controlling Interests [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2016</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 68,687<span></span>
</td>
<td class="nump">$ 150,342<span></span>
</td>
<td class="num">$ (31,628)<span></span>
</td>
<td class="nump">$ 187,548<span></span>
</td>
<td class="nump">$ 1,140<span></span>
</td>
<td class="nump">$ 188,688<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2016</a></td>
<td class="nump">14,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock (in shares)</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Compensation expense - equity-based awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,345<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,345<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans', window );">Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distribution to non-controlling interest partners</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,665)<span></span>
</td>
<td class="num">(2,665)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Contributions of non-controlling interest partners</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared to USPT shareholders</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,031)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,031)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,031)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,757<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,757<span></span>
</td>
<td class="nump">2,667<span></span>
</td>
<td class="nump">12,424<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2017</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 71,197<span></span>
</td>
<td class="nump">$ 155,068<span></span>
</td>
<td class="num">$ (31,628)<span></span>
</td>
<td class="nump">$ 194,784<span></span>
</td>
<td class="nump">$ 1,182<span></span>
</td>
<td class="nump">$ 195,966<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2017</a></td>
<td class="nump">14,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66904339&amp;loc=d3e4534-113899<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65896087&amp;loc=d3e11149-113907<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65896087&amp;loc=d3e11178-113907<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4590271-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4568740-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813404336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The consolidated financial statements include the accounts of U.S. Physical Therapy, Inc. and its subsidiaries (the &#8220;Company&#8221;). All significant intercompany transactions and balances have been eliminated. The Company primarily operates through subsidiary clinic partnerships, in which the Company generally owns a 1% general partnership interest in all the Clinic Partnerships. Our limited partnership interests range from 49% to 99% in the Clinic Partnerships.&#160; The managing therapist of each clinic owns, directly or indirectly, the remaining limited partnership interest in the majority of the clinics (hereinafter referred to as &#8220;Clinic Partnerships&#8221;). To a lesser extent, the Company operates some clinics, through wholly-owned subsidiaries, under profit sharing arrangements with therapists (hereinafter referred to as &#8220;Wholly-Owned Facilities&#8221;).</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company continues to seek to attract for employment physical therapists who have established relationships with physicians and other referral sources by offering these therapists a competitive salary and incentives based on the profitability of the clinic that they manage. The Company also looks for therapists with whom to establish new, de novo clinics to be owned jointly by the Company and such therapists&#894; in these situations, the therapist is offered the opportunity to co-invest in the new clinic and also receives a competitive salary for managing the clinic. For multi-site clinic practices in which a controlling interest is acquired by the Company, the prior owners typically continue on as employees to manage the clinic operations, retaining a non-controlling ownership interest in the clinics and receiving a competitive salary for managing the clinic operations. In addition, we have developed satellite clinic facilities as part of existing Clinic Partnerships and Wholly-Owned facilities, with the result that a substantial number of Clinic Partnerships and Wholly-Owned facilities operate more than one clinic location. In 2017, we intend to continue to acquire clinic practices and continue to focus on developing new clinics and on opening satellite clinics where appropriate along with increasing our patient volume through marketing and new programs.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">During the first six months of 2017 and the year ended 2016, the Company acquired an interest in the following clinic groups:</div><div style="color: #000000;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%;"></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">&#160;Date</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">% Interest Acquired</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">Number of Clinics</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%;"></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">&#160;2017</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">June 2017 Acquisition</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">June 30</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">60</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">9</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">May 2017 Acquisition</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">May 31</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">70</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">January 2017 Acquisition</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">January 1</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">70</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">17</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%; background-color: #cceeff;"></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">&#160;2016</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">February 2016 Acquisition</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">February 29</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">55</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">8</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">November 2016 Acquisition</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">November 30</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">60</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">12</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;">In addition to the above clinic groups, in March 2017, the Company acquired a 55% interest in a company which is a leading provider of workforce performance solutions. Services provided include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers including a number of Fortune 500 companies. Other clients include large insurers and their contractors. Also, during the second quarter, the Company purchased the assets and business of a physical therapy clinic and consolidated its business with an existing clinic.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">As of June 30, 2017, the Company operated 566 clinics in 41 states.&#160; The Company also manages physical therapy facilities for third parties, primarily physicians, with 27 third-party facilities under management as of June 30, 2017.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The results of operations of the acquired clinics have been included in the Company&#8217;s consolidated financial statements since the date of their respective acquisition.&#160; The Company intends to continue to pursue additional acquisition opportunities, develop new clinics and open satellite clinics.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-right: 0.1pt;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-right: 0.1pt;">The accompanying unaudited consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the instructions for Form 10-Q. However, the statements do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. Management believes this report contains all necessary adjustments (consisting only of normal recurring adjustments) to present fairly, in all material respects, the Company&#8217;s financial position, results of operations and cash flows for the interim periods presented. For further information regarding the Company&#8217;s accounting policies, please read the audited financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company believes, and the Chief Executive Officer, Chief Financial Officer and Corporate Controller have certified, that the financial statements included in this report present fairly, in all material respects, the Company&#8217;s financial position, results of operations and cash flows for the interim periods presented.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Operating results for the six months ended June 30, 2017 are not necessarily indicative of the results the Company expects for the entire year.&#160; Please also review the Risk Factors section included in our Annual Report on Form 10-K for the year ended December 31, 2016.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: italic; text-align: left;">Clinic Partnerships</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">For non-acquired Clinic Partnerships, the earnings and liabilities attributable to the non-controlling interests, typically owned by the managing therapist, directly or indirectly, are recorded within the balance sheets and income statements as non-controlling interests.&#160; For acquired Clinic Partnerships with mandatorily redeemable non-controlling interests, the earnings and liabilities attributable to the non-controlling interest are recorded within the statements of net income line items: Interest expense &#8211; mandatorily redeemable non-controlling interests &#8211; earnings allocable and in the balance sheet line item: Mandatorily redeemable non-controlling interests.&#160; For acquired Clinic Partnerships with redeemable non-controlling interests, the earnings attributable to the redeemable non-controlling interest are recorded within the statements of net income line item &#8211; net income attributable to non-controlling interest and the equity interests are recorded on the balance sheet as redeemable non-controlling interests.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; font-style: italic; text-align: left;">Wholly-Owned Facilities</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">For Wholly-Owned Facilities with profit sharing arrangements, an appropriate accrual is recorded for the amount of profit sharing due to the profit sharing therapists. The amount is expensed as compensation and included in clinic operating costs &#8211; salaries and related costs. The respective liability is included in current liabilities &#8211; accrued expenses on the balance sheets.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Restatement of Prior Financial Statements</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">As disclosed in our Current Report on Form 8-K filed March 16, 2017, and further described in our Annual Report on Form 10-K for the year ended December 31, 2016 filed on June 7, 2017, prior to issuing the 2016 annual financial statements, the Company determined it had previously incorrectly accounted for the non-controlling interests in the Company&#8217;s subsidiary clinic partnerships that were mandatorily redeemable. Management and the Company&#8217;s board of directors concluded this error was material to previously issued annual and quarterly consolidated financial statements.&#160; Additional information regarding the restatement is available in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016. Financial information in this Form 10-Q related to all periods prior to the quarter ended December 31, 2016 has been amended where necessary to reflect the restatement. Therefore, this Form 10-Q should be read in conjunction with the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016.</div><div style="color: #000000;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Significant Accounting Policies</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Cash Equivalents</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company maintains its cash and cash equivalents at financial institutions.&#160; The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a concentration of credit risk related on deposits in excess of FDIC insurance coverage. Management believes that the risk is not significant.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Long-Lived Assets</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the assets. Estimated useful lives for furniture and equipment range from three to eight years and for software purchased from three to seven years. Leasehold improvements are amortized over the shorter of the lease term or estimated useful lives of the assets, which is generally three to five years.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances which indicate that the amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Goodwill</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009, from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective January 1, 2009, if the purchase price of a non-controlling interest related to non-acquired Clinic Partnerships by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The carrying value of goodwill and other identifiable intangible assets with indefinite lives are tested for impairment annually and upon the occurrence of certain events, and are written down to fair value if considered impaired. The Company evaluates goodwill for impairment on at least an annual basis (in its third quarter) by comparing the fair value of its reporting units to the carrying value of each reporting unit including related goodwill. The Company&#8217;s business is primarily made up of various clinics within partnerships. The partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test. In the second quarter of 2017, there were six regions.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The estimated fair value of a reporting unit is determined using two factors: (i) earnings prior to taxes, depreciation and amortization for the reporting unit multiplied by a price/earnings ratio used in the industry and (ii) a discounted cash flow analysis. A weight is assigned to each factor and the sum of each weight times the factor is considered the estimated fair value. For 2016, the factors (i.e., price/earnings ratio, discount rate and residual capitalization rate) were updated to reflect current market conditions. The evaluation of goodwill in 2016 did not result in any goodwill amounts that were deemed impaired.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company has not identified any triggering events occurring after the testing date that would impact the impairment testing results obtained. Factors which could result in future impairment charges include but are not limited to:</div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">cost, risks and uncertainties associated with the Company&#8217;s recent restatement of its prior financial statements due to the correction of its accounting methodology for redeemable noncontrolling partnership interests, and including any pending and future claims or proceedings relating to such matters&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">changes as the result of government enacted national healthcare reform&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification or enrollment status&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">business and regulatory conditions including federal and state regulation&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">governmental and other third party payor inspections, reviews, investigations and audits&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information and associated fines and penalties for failure to comply&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">legal actions, which could subject us to increased operating costs and uninsured liabilities&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">revenue and earnings expectations&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">general economic conditions&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">availability and cost of qualified physical and occupational therapists&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">personnel productivity and retaining key personnel&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain operations and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">acquisitions, purchases of non-controlling interests (minority interests) and the successful integration of the operations of the acquired business&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">maintaining necessary insurance coverage&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">availability, terms, and use of capital&#894; and</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">weather and other seasonal factors.</div></td></tr></table></div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Mandatorily Redeemable Non-Controlling Interests</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;">The non-controlling interests that are reflected as mandatorily redeemable non-controlling interests in the consolidated financial statements consist of those owners who have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase the non-controlling interest of those owners at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&#160; The redemption rights are triggered at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically three to five years, as defined in the limited partnership agreement.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;">On the date the Company acquires a controlling interest in a partnership and the limited partnership agreement contains mandatory redemption rights, the fair value of the non-controlling interest is recorded in the long-term liabilities section of the consolidated balance sheet under the caption &#8211; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Mandatorily redeemable non-controlling interests</font>.&#160; Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to its then current redemption value, based on the predetermined formula defined in the respective limited partnership agreement.&#160; The Company reflects any adjustment in the redemption value and any earnings attributable to the mandatorily redeemable non-controlling interest in its consolidated statements of net income by recording the adjustments and earnings to other income and expense in the captions - <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Interest expense &#8211; mandatorily redeemable non-controlling interests &#8211; change in redemption value and Interest expense &#8211; mandatorily redeemable non-controlling interests &#8211; earnings allocable</font>.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Redeemable Non-Controlling Interests</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;">The non-controlling interests that are reflected as redeemable non-controlling interests in the consolidated financial statements consist of those owners who have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase the non-controlling interest of those owners, if certain conditions are met and the owners request the purchase.&#160; The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&#160; The redemption rights can be triggered by the owner at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically three to five years, as defined in the limited partnership agreement.&#160; The redemption rights are not automatic (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;">On the date the Company acquires a controlling interest in a partnership and the limited partnership agreement contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#8211; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Redeemable non-controlling interests</font>.&#160; Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial value, based on the predetermined formula defined in the respective limited partnership agreement.&#160; Hence, the value of the non-controlling interest is not adjusted below its initial value.&#160; The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the statements of net income.&#160; Although the adjustments are not reflected in the statements of net income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation.&#160; The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the income statement.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Non-Controlling Interests</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company recognizes non-controlling interests as equity in the consolidated financial statements separate from the parent entity&#8217;s equity. Changes in a parent entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling interest on the deconsolidation date.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">When the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall, as applicable, is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Revenue Recognition</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Revenues are recognized in the period in which services are rendered. Net patient revenues (patient revenues less estimated contractual adjustments) are reported at the estimated net realizable amounts from third-party payors, patients and others for services rendered. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off experience.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company determines allowances for doubtful accounts based on the specific agings and payor classifications at each clinic. The provision for doubtful accounts is included in clinic operating costs in the statement of net income. Net accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for doubtful accounts, includes only those amounts the Company estimates to be collectible.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Medicare Reimbursement</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&#8216;&#8216;MPFS&#8217;&#8217;). The MPFS rates have historically been subject to an automatic annual update based on a formula, called the sustainable growth rate (&#8216;&#8216;SGR&#8217;&#8217;) formula. The use of the SGR formula would have resulted in calculated automatic reductions in rates in every year since 2002&#894; however, for each year through September 30, 2015, Centers for Medicare &amp; Medicaid Services (&#8216;&#8216;CMS&#8217;&#8217;) or Congress has taken action to prevent the implementation of SGR formula reductions. On April 16, 2015, the Medicare Access and CHIP Reauthorization Act of 2015 (&#8216;&#8216;MACRA&#8217;&#8217;) was signed into law, eliminating the SGR formula and the associated annual automatic rate reductions.&#160; The MACRA promotes the development of new payment models that focus on quality and outcomes.&#160; As a result of MACRA and CMS&#8217; adjustment to the applicable conversion factor, the net fee schedule payment rates were increased for 2017 by 0.24%.&#160; For 2018 and 2019, a 0.5% increase will be applied each year to the fee schedule payment rates, unless further adjusted by CMS.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years, and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extends the 2% reductions to Medicare payments through fiscal year 2025.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-left: 0.2pt; margin-right: 0.2pt;">As a result of the Balanced Budget Act of 1997, the formula for determining the total amount paid by Medicare in any one year for outpatient physical therapy, occupational therapy, and/or speech/language pathology services provided to any Medicare beneficiary (i.e., the &#8216;&#8216;Therapy Cap&#8217;&#8217; or &#8216;&#8216;Limit&#8217;&#8217;) was established. Based on the statutory definitions which constrained how the Therapy Cap would be applied, there is one Limit for Physical Therapy and Speech Language Pathology Services combined, and one Limit for Occupational Therapy. For 2017, the annual Limit on outpatient therapy services is $1,980 for Physical and Speech Language Pathology Services combined and $1,980 for Occupational Therapy Services. Historically, these Therapy Caps applied to outpatient therapy services provided in all settings, except for services provided in departments of hospitals. However, the Protecting Access to Medicare Act of 2014, and prior legislation, extended the Therapy Caps to services furnished in hospital outpatient department settings. The application of these annual limits to hospital outpatient department settings will sunset on December 31, 2017 unless Congress extends it.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In the Deficit Reduction Act of 2005, Congress implemented an exceptions process to the annual Limit for therapy expenses for therapy services above the annual Limit. Therapy services above the annual Limit that are medically necessary satisfy an exception to the annual Limit and such claims are payable by the Medicare program. The MACRA extended the exceptions process for outpatient therapy caps through December 31, 2017. Unless Congress extends the exceptions process further, the exceptions no longer will be available in those outpatient therapy setting where the annual Limits are applicable. For any claim above the annual Limit, the claim must contain a modifier indicating that the services are medically necessary and justified by appropriate documentation in the medical record.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Furthermore, under the Middle Class Tax Relief and Job Creation Act of 2012 (&#8216;&#8216;MCTRA&#8217;&#8217;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services&#894; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">CMS adopted a multiple procedure payment reduction (&#8216;&#8216;MPPR&#8217;&#8217;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value Unit (&#8216;&#8216;RVU&#8217;&#8217;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by 50%. In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&#8217;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge, CMS has rejected claims if the required data is not included in the claim.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Physician Quality Reporting System, or &#8216;&#8216;PQRS,&#8217;&#8217; is a CMS reporting program that uses a combination of incentive payments and payment reductions to promote reporting of quality information by &#8216;&#8216;eligible professionals.&#8217;&#8217; Although physical therapists, occupational therapists and qualified speech-language therapists were generally able to participate in the PQRS program, therapy professionals for whose services we bill through our certified rehabilitation agencies cannot participate because the Medicare claims processing systems currently cannot accommodate institutional providers such as certified rehabilitation agencies. Eligible professionals, such as those of our therapy professionals for whose services we bill using their individual Medicare provider numbers, who do not satisfactorily report data on quality measures will be subject to a 2% reduction in their Medicare payment in 2016 and 2017. As required under the MACRA, the PQRS program has been replaced with the Merit-Based Incentive Payment System (MIPS) on January 1, 2017. Physical therapists and occupational therapists are not required to participate in the MIPS program until January 1, 2019 or later, as determined by CMS.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. The Company believes that it is in compliance in all material respects with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the Company&#8217;s financial statements as of June 30, 2017. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the six months ended June 30, 2017, net revenue from Medicare accounts for approximately $45.8 million.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Management Contract Revenues</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Management contract revenues are derived from contractual arrangements whereby the Company manages a clinic for third party owners. The Company does not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized when services are performed. Costs, typically salaries for the Company&#8217;s employees, are recorded when incurred. Management contract revenues are included in &#8220;other revenues&#8221; in the accompanying Consolidated Statements of Net Income.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Contractual Allowances</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#8217;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&#8217;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#8217;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, the historical difference between net revenues and corresponding cash collections has generally reflected a difference within approximately 1% of net revenues. Additionally, analysis of subsequent period&#8217;s contractual write-offs on a payor basis reflects a difference within approximately 1% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% at June 30, 2017.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Income Taxes</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company did not have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the six months ended June 30, 2017. The Company will book any interest or penalties, if required, in interest and/or other income/expense as appropriate.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Fair Value of Financial Instruments</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement approximates its fair value. The interest rate on the Amended Credit Agreement, which is tied to the Eurodollar Rate, is set at various short-term intervals, as detailed in the Amended Credit Agreement.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Segment Reporting</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by chief operating decision makers in deciding how to allocate resources and in assessing performance. The Company identifies operating segments based on management responsibility and believes it meets the criteria for aggregating its operating segments into a single reporting segment.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Use of Estimates</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, purchase accounting, goodwill impairment, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Self-Insurance Program</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company utilizes a self-insurance plan for its employee group health insurance coverage administered by a third party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through June 30, 2017.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Restricted Stock</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock granted to employees, other than officers, lapse in equal annual installments on the following four anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the first year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The restricted stock issued is included in basic and diluted shares for the earnings per share computation.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Recently Adopted Accounting Guidance</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In March 2016, the FASB issued guidance to simplify some provisions in stock compensation accounting.&#160; The guidance amends how excess tax benefits and a company&#8217;s payments to cover tax bills for the recipients&#8217; shares should be classified.&#160; Prior to this guidance, excess tax benefits were recorded in additional paid-in capital, but will now become a component of the income tax provision/benefit in the period in which they occur.&#160; This guidance allows companies to estimate the number of stock awards expected to vest and revises the withholding requirements for classifying stock awards as equity.&#160; For public business entities, this guidance is effective for fiscal years starting after December 15, 2016, including interim periods within those fiscal years but early adoption is allowed.&#160; The Company adopted this accounting treatment in the fourth quarter of 2016 and retrospectively adjusted each quarter period in 2016.&#160; The adoption increased earnings, by decreasing the tax provision, by $0.5 million for the three months ended March 31, 2016.&#160;&#160; The election to record forfeitures in the period they occur is consistent with the Company&#8217;s past approach, due to the immateriality of past forfeitures, and the Company believes the effect to be immaterial on the consolidated financial statements.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Recently Issued Accounting Guidance</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In January 2017, the FASB issued ASU 2017-04, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Simplifying the Test for Goodwill Impairment (Topic 350),</font> which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment change. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods within those years, beginning after December 15, 2019. The Company is currently evaluating the impact of adopting this ASU on our consolidated financial statements and do not expect adoption to have a material impact.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In February 2016, the FASB issued amended accounting guidance (ASU 2016-02 - <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Leases</font>) which replaced most existing lease accounting guidance under U. S. generally accepted accounting principles. Among other changes, the amended guidance requires that a right-to-use asset, which is an asset that represents the lessee&#8217;s right to use, and a lease liability, which is a lessee&#8217;s obligation to make lease payments arising for a lease measured on a discounted basis, be recognized on the balance sheet by lessees for those leases with a term of greater than 12 months. The amended guidance is effective for reporting periods beginning after December 15, 2018&#894; however, early adoption is permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Since the Company leases all but one of its clinic facilities, it has been evaluating various lease management systems to capture the necessary information and the impact that this amended accounting guidance will have on its consolidated financial statements. The Company believes the adoption of this guidance will significantly affect total assets and liabilities in the consolidated balance sheet.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In May 2014, March 2016, April 2016, and December 2016, the FASB issued ASU 2014-09, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Revenue from Contracts with Customers</font>, ASU 2016-08, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Revenue from Contracts with Customers, Principal versus Agent Considerations</font>, ASU 2016-10, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing</font>, ASU 2016-12, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients</font>, and ASU 2016-20, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customer</font> (collectively &#8220;the standards&#8221;), respectively, which supersede most of the current revenue recognition requirements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. New disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers are also required. The original standards were effective for fiscal years beginning after December 15, 2016; however, in July 2015, the FASB approved a one-year deferral of these standards, with a new effective date for fiscal years beginning after December 15, 2017. The standards require the selection of a retrospective or cumulative effect transition method. The Company does not anticipate a material adjustment upon adoption of these standards.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Subsequent Event</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company has evaluated events occurring after the balance sheet date for possible disclosure as a subsequent event through the date that these consolidated financial statements were issued. No disclosure was required.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35735333&amp;loc=d3e288-107754<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811485424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS OF BUSINESSES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>ACQUISITIONS OF BUSINESSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS OF BUSINESSES</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">2. ACQUISITIONS OF BUSINESSES</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">On January 1, 2017, the Company acquired a 70% interest in a seventeen-clinic physical therapy practice.&#160; The purchase price for the 70% interest was $10.7 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, in January 2018 and 2019.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">On March 23, 2017, (effective March 1, 2017 for accounting purposes) the Company acquired a 55% interest in a company </font>which is a leading provider of workforce performance solutions. Services provided include onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers including a number of Fortune 500 companies. Other clients include large insurers and their contractors.<font style="font-size: 10pt; font-family: 'Times New Roman';"> The purchase price for the 55% interest was $6.2 million in cash and $0.4 million in a seller note that is payable, principal plus accrued interest, in September 2018.</font></div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">On May 31, 2017 the Company acquired 70% interest in a four-clinic physical therapy practice. The purchase price for the 70% interest was $2.3 million in cash and $250,000 in a seller note that is payable in two principal installments totaling $125,000 each, plus accrued interest, in May 2018 and 2019.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">On June 30, 2017, the Company acquired a 60% interest in a nine-clinic physical therapy practice.&#160; The purchase price for the 60% interest was $15.8 million in cash and $0.5 million in a seller note that is payable in two principal installments totaling $250,000 each, plus accrued interest, in June 2018 and 2019.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;">Also, in 2017, we purchased the assets and business of a physical therapy clinic for $100,000 and consolidated its business with an existing clinic.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The purchase price for the 2017 acquisitions has been preliminarily allocated as follows (in thousands):</div><div style="color: #000000;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash paid, net of cash acquired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">33,665</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Seller notes</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,650</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total consideration</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35,315</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Estimated fair value of net tangible assets acquired:</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total current assets</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,868</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total non-current assets</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,790</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total liabilities</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,919</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 27pt; text-indent: -9pt;">Net tangible assets acquired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,739</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Referral relationships</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,693</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Non-compete</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,790</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Tradename</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,118</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Goodwill</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">40,197</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(11,940</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(10,282</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #cceeff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35,315</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">On November 30, 2016, the Company acquired a 60% interest in a 12 clinic physical therapy practice. The purchase price for the 60% interest was $11.0 million in cash and $0.5 million in a seller note that is payable in two principal installments of $250,000 each, plus accrued interest, in November 2017 and 2018. On February 29, 2016, the Company acquired a 55% interest in an eight-clinic physical therapy practice. The purchase price for the 55% interest was $13.2 million in cash and $0.5 million in a seller note that is payable in two principal installments of $250,000 each, plus accrued interest, one of which was paid in February 2017 and one of which is due in February 2018. During 2016, two subsidiaries of the Company each acquired a single clinic therapy practice for an aggregate purchase price of $75,000.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The purchase prices for the 2016 acquisitions have been preliminarily allocated as follows (in thousands):</div><div style="color: #000000;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash paid, net of cash acquired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">23,623</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Seller notes</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total consideration</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24,623</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Estimated fair value of net tangible assets acquired:</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total current assets</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,763</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total non-current assets</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">839</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total liabilities</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,039</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 27pt; text-indent: -9pt;">Net tangible assets acquired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,563</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Referral relationships</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,919</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Non-compete</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">847</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Tradename</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,802</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Goodwill</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32,371</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(18,879</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #ffffff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24,623</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">For the acquisition that occurred in the first quarter of 2016, the purchase price plus the fair value of the non-controlling interests was allocated to the fair value of certain assets acquired (patient accounts receivable, equipment, prepaid expenses and deposits, tradename, non-compete agreements and referral relationships) and liabilities assumed (accounts payable and accrued employee salary and benefits) based on the fair values at the acquisition date, with the amount exceeding the fair values being recorded as goodwill. For the acquisition that occurred after June 30, 2016, the purchase price plus the fair value of the non-controlling interests was allocated to the fair value of certain assets acquired (patient accounts receivable, equipment, prepaid expenses and deposits, tradename, non-compete agreements and referral relationships) and liabilities assumed (accounts payable and accrued employee salary and benefits) based on the preliminary estimates of the fair values at the acquisition date, with the amount exceeding the estimated fair values being recorded as goodwill. The Company is in the process of completing its formal valuation analysis. Thus, the final allocation of the purchase price will differ from the preliminary estimates used based on additional information obtained. Changes in the estimated valuation of the tangible and intangible assets acquired and the completion by the Company of the identification of any unrecorded pre-acquisition contingencies, where the liability is probable and the amount can be reasonably estimated, will likely result in adjustments to goodwill.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">For the above acquisitions, total current assets primarily represent patient accounts receivable.&#160; Total non-current assets are fixed assets, primarily equipment, used in the practices.&#160; The estimated values assigned to the referral relationships and non-compete agreements are being amortized to expense equally over the respective estimated lives.&#160; For referral relationships, the range of the estimated lives was 12 to 13 years, and for non-compete agreements the estimated lives was six years. The values assigned to tradenames and goodwill is tested annually for impairment.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The consideration for each transaction was agreed upon through arm&#8217;s length negotiations. Funding for the cash portion of the purchase price for the 2017 and 2016 acquisitions was derived from proceeds under the Amended Credit Agreement.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-left: 0.2pt; margin-right: 0.2pt;">The results of operations of these acquisitions have been included in the Company&#8217;s consolidated financial statements since acquired.&#160; Unaudited proforma consolidated financial information for acquisitions occurring in 2017 and 2016 have not been included as the results were not material to current operations.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1497-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1490-128463<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1486-128463<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1524-128463<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7000-128479<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4922-128472<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4934-128472<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4926-128472<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=SL65897772-128472<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1383-128463<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6996-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6604032784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract', window );"><strong>MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">3. MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Prior to the second quarter of 2017, when the Company acquired a majority interest (the &#8220;Acquisition&#8221;) in a physical therapy clinic business (referred to as &#8220;Therapy Practice&#8221;), these Acquisitions occurred in a series of steps which are described below.</div><div style="color: #000000;"><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">1.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Prior to the Acquisition, the Therapy Practice exists as a separate legal entity (the &#8220;Seller Entity&#8221;). The Seller Entity is owned by one or more individuals (the &#8220;Selling Shareholders&#8221;) most of whom are physical therapists that work in the Therapy Practice and provide physical therapy services to patients.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">2.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">In conjunction with the Acquisition, the Seller Entity contributes the Therapy Practice into a newly-formed limited partnership (&#8220;NewCo&#8221;), in exchange for one hundred percent (100%) of the limited and general partnership interests in NewCo. Therefore, in this step, NewCo becomes a wholly-owned subsidiary of the Seller Entity.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">3.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The Company enters into an agreement (the &#8220;Purchase Agreement&#8221;) to acquire from the Seller Entity a majority (ranges from 50% to 90%) of the limited partnership interest and, in all cases, 100% of the general partnership interest in NewCo. The Company does not purchase 100% of the limited partnership interest because the Selling Shareholders, through the Seller Entity, want to maintain an ownership percentage. The consideration for the Acquisition is primarily payable in the form of cash at closing and a small two-year note in lieu of an escrow (the &#8220;Purchase Price&#8221;). The Purchase Agreement does not contain any future earn-out or other contingent consideration that is payable to the Seller Entity or the Selling Shareholders.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">4.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The Company and the Seller Entity also execute a partnership agreement (the &#8220;Partnership Agreement&#8221;) for NewCo that sets forth the rights and obligations of the limited and general partners of NewCo. After the Acquisition, the Company is the general partner of NewCo.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">5.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">As noted above, the Company does not purchase 100% of the limited partnership interests in NewCo and the Seller Entity retains a portion of the limited partnership interest in NewCo (&#8220;Seller Entity Interest&#8221;).</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">6.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">In most cases, some or all of the Selling Shareholders enter into an employment agreement (the&#160; &#8220;Employment Agreement&#8221;) with NewCo with an initial term that ranges from three to five years (the &#8220;Employment Term&#8221;), with automatic one-year renewals, unless employment is terminated prior to the end of the Employment Term. As a result, a Selling Shareholder becomes an employee (&#8220;Employed Selling Shareholder&#8221;) of NewCo. The employment of an Employed Selling Shareholder can be terminated by the Employed Selling Shareholder or NewCo, with or without cause, at any time. In a few situations, a Selling Shareholder does not become employed by NewCo and is not involved with NewCo following the closing&#894; in those situations, such Selling Shareholders sell their entire ownership interest in the Seller Entity as of the closing of the Acquisition.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">7.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The compensation of each Employed Selling Shareholder is specified in the Employment Agreement and is customary and commensurate with his or her responsibilities based on other employees in similar capacities within NewCo, the Company and the industry.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">8.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The Company and the Selling Shareholder (including both Employed Selling Shareholders and Selling Shareholders not employed by NewCo) execute a non-compete agreement (the &#8220;Non- Compete Agreement&#8221;) which restricts the Selling Shareholder from engaging in competing business activities for a specified period of time (the &#8220;Non-Compete Term&#8221;). A Non-Compete Agreement is executed with the Selling Shareholders in all cases. That is, even if the Selling Shareholder does not become an Employed Selling Shareholder, the Selling Shareholder is restricted from engaging in a competing business during the Non-Compete Term.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">9.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The Non-Compete Term commences as of the date of the Acquisition and expires on the later of:</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 54pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">a.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Two years after the date an Employed Selling Shareholders&#8217; employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder) or</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 54pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">b.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Five to six years from the date of the Acquisition, as defined in the Non-Compete Agreement, regardless of whether the Selling Shareholder is employed by NewCo.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">10.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The Non-Compete Agreement applies to a restricted region which is defined as a 15-mile radius from the Therapy Practice. That is, an Employed Selling Shareholder is permitted to engage in competing businesses or activities outside the 15-mile radius (after such Employed Selling Shareholder no longer is employed by NewCo) and a Selling Shareholder who is not employed by NewCo immediately is permitted to engage in the competing business or activities outside the 15-mile radius.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">11.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The Partnership Agreement contains provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &#8220;Call Option&#8221;) or on a required basis (the &#8220;Required Redemption&#8221;):</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 54pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">a.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Required Redemption</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 72pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">i.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Once the Required Redemption is triggered, the Company is obligated to purchase from the Seller Entity and the Seller Entity is obligated to sell to the Company, the allocable portion of the Seller Entity Interest based on the terminated Selling Shareholder&#8217;s pro rata ownership interest in the Seller Entity (the &#8220;Allocable Portion&#8221;). Required Redemption is</div></td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-left: 90pt;">triggered when both of the following events have occurred:</div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 108pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">1.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Termination of an Employed Selling Shareholder&#8217;s employment with NewCo, regardless of the reason for such termination, and</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 108pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">2.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The expiration of an agreed upon period of time, typically three to five years, as set forth in the relevant Partnership Agreement (the &#8220;Holding Period&#8221;).</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 72pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">ii.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">In the event an Employed Selling Shareholder&#8217;s employment terminates prior to the expiration of the Holding Period, the Required Redemption would occur only upon expiration of the Holding Period.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 54pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">b.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Call Option</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 108pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">I</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">In the event that an Employed Selling Shareholder&#8217;s employment terminates prior to expiration of the Holding Period, the Company has the contractual right, but not the obligation, to acquire the Employed Selling Shareholder&#8217;s Allocable Portion of the Seller Entity Interest from the Seller Entity through exercise of the Call Option.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 54pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">c.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">For the Required Redemption and the Call Option, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Portion of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed monthly based on available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 54pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">d.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings that is used in the Required Redemption noted above.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 54pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">e.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Although, the Required Redemption and the Call Option do not have an expiration date, the Seller Entity Interest eventually will be purchased by the Company.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 54pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">f.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The Required Redemption and the Call Option never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">12.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.</div></td></tr></table></div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">For the six months ended June 30, 2017, the following table details the changes in the carrying amount of mandatorily redeemable non-controlling interest:</div><div>&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: center;">Six Months Ended</div><font style="color: #000000;">June 30, 2017</font></div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Beginning balance</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69,190</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Operating results allocated to mandatorily redeemable non-controlling interest partners</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,081</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Distributions to mandatorily redeemable non-controlling interest partners</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,272</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Changes in the redemption value of mandatorily redeemable non-controlling interest</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,592</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Payments for settlement of mandatorily redeemable non-controlling&#160; interest</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,230</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: middle; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Purchases of businesses - initial liability related to mandatorily redeemable non-controlling interest</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,282</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Ending balance</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">83,643</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table></div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The following table details the carrying amount of the mandatorily redeemable non-controlling interest (in thousands) as of June 30, 2017:</div><div style="color: #000000;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Contractual time period has lapsed but holder's employment has not been terminated</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">30,838</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Contractual time period has not lapsed and holder's employment has not been terminated</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">55,454</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Holder's employment has terminated and contractual time period has expired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Holder's employment has terminated and contractual time period has not expired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Redemption value prior to excess distributed earnings</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">86,292</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Excess distributions over earnings and losses</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,649</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #cceeff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">83,643</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794840192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REDEEMABLE NON-CONTROLLING INTERESTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract', window );"><strong>REDEEMABLE NON-CONTROLLING INTERESTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock', window );">REDEEMABLE NON-CONTROLLING INTERESTS</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">4. REDEEMABLE NON-CONTROLLING INTERESTS</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">When the Company acquires a majority interest in a Therapy Practice, those Acquisitions occur in a series of steps as described in numbers 1 through 10 of footnote 3 &#8211; Mandatorily Redeemable Non-Controlling Interests.&#160; For the Acquisitions that occurred after the first quarter of 2017, the Partnership Agreement contained provisions for the redemption of the Seller Entity Interest, either at the option of the Company (the &#8220;Call Right&#8221;) or at the option of the Seller Entity (the &#8220;Put Right&#8221;) as follows:</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">&#160;</div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 72pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;">1.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Put Right</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 108pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">a.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">In the event that any Selling Shareholder&#8217;s employment is terminated involuntarily by the Company without &#8220;Cause&#8221; pursuant to Section 7(d) of such Selling Shareholder&#8217;s Employment Agreement prior to the fifth anniversary of the Closing Date, the Seller Entity thereafter shall have an irrevocable right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 108pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">b.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">In the event that any Selling Shareholder is not employed by NewCo as of the fifth anniversary of the Closing Date and the Company has not exercised its Call Right with respect to the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, Seller Entity thereafter shall have the Put Right to cause the Company to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest at the purchase price described in &#8220;3&#8221; below.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 108pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">c.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Seller Entity shall have the Put Right, and upon the exercise of the Put Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 72pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;">2.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">Call Right</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 108pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">a.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">If any Selling Shareholder&#8217;s employment by NewCo is terminated (i) pursuant to a voluntary termination by the Selling Shareholder or (ii) by NewCo with &#8220;Cause&#8221; (as defined in the Selling Shareholder&#8217;s Employment Agreement), prior to the fifth anniversary of the Closing Date, the Company thereafter shall have an irrevocable right to purchase from Seller Entity the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest, in each case at the purchase price described in &#8220;3&#8221; below.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 108pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 18pt; align: right;">b.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">In the event that any Selling Shareholder&#8217;s employment with NewCo is terminated for any reason on or after the fifth anniversary of the Closing Date, the Company shall have the Call Right, and upon the exercise of the Call Right, the Terminated Selling Shareholder&#8217;s Allocable Percentage of Seller Entity&#8217;s Interest shall be redeemed by the Company at the purchase price described in &#8220;3&#8221; below.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 72pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;">3.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">For the Put Right and the Call Right, the purchase price is derived from a formula based on a specified multiple of NewCo&#8217;s trailing twelve months of earnings before interest, taxes, depreciation, amortization, and the Company&#8217;s internal management fee, plus an Allocable Percentage of any undistributed earnings of NewCo (the &#8220;Redemption Amount&#8221;). NewCo&#8217;s earnings are distributed monthly based on available cash within NewCo&#894; therefore, the undistributed earnings amount is small, if any.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 72pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;">4.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The Purchase Price for the initial equity interest purchased by the Company is also based on the same specified multiple of the trailing twelve-month earnings that is used in the Put Right and the Call Right noted above.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 72pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;">5.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The Put Right and the Call Right do not have an expiration date, but the Seller Entity Interest is not required to be purchased by the Company or sold by the Seller Entity.</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 72pt;"></td><td style="font-size: 10pt; font-family: 'Times New Roman'; vertical-align: top; color: #000000; width: 22.5pt; align: right;">6.</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">The Put Right and the Call Right never apply to Selling Shareholders who do not become employed by NewCo, since the Company requires that such Selling Shareholders sell their entire ownership interest in the Seller Entity at the closing of the Acquisition.</div></td></tr></table></div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">An Employed Selling Shareholder&#8217;s ownership of his or her equity interest in the Seller Entity predates the Acquisition and the Company&#8217;s purchase of its partnership interest in NewCo. The Employment Agreement and the Non-Compete Agreement do not contain any provision to escrow or &#8220;claw back&#8221; the equity interest in the Seller Entity held by such Employed Selling Shareholder, nor the Seller Entity Interest in NewCo, in the event of a breach of the employment or non-compete terms. More specifically, even if the Employed Selling Shareholder is terminated for &#8220;cause&#8221; by NewCo, such Employed Selling Shareholder does not forfeit his or her right to his or her full equity interest in the Seller Entity and the Seller Entity does not forfeit its right to any portion of the Seller Entity Interest. The Company&#8217;s only recourse against the Employed Selling Shareholder for breach of either the Employment Agreement or the Non-Compete Agreement is to seek damages and other legal remedies under such agreements. There are no conditions in any of the arrangements with an Employed Selling Shareholder that would result in a forfeiture of the equity interest held in the Seller Entity or of the Seller Entity Interest.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">At June 30, 2017, the recorded initial value of $11.9 million approximates the Redemption Amount.&#160; Any allocation of earnings during the three months ended June 30, 2017 was immaterial.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a redeemable non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_REDEEMABLENONCONTROLLINGINTERESTSTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813393968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>GOODWILL [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">GOODWILL</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">5. GOODWILL</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The changes in the carrying amount of goodwill consisted of the following (in thousands):</div><div style="color: #000000;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; width: 78%; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: center;">Six Months Ended</div><font style="color: #000000;">June 30, 2017</font></div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; width: 78%; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 78%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Beginning balance</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">226,806</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 78%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Goodwill acquired during the period</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">40,197</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 78%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Goodwill adjustments for purchase price allocation of business acquired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">954</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 78%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Ending balance</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">267,957</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6795651216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>INTANGIBLE ASSETS, NET [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS, NET</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">6. INTANGIBLE ASSETS, NET</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Intangible assets, net as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):</div><div style="color: #000000; text-align: left;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Tradenames</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">26,352</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">21,234</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Referral relationships, net of accumulated amortization of $6,214 and $5,275, respectively</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">18,613</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,859</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Non-compete agreements, net of accumulated amortization of $3,781 and $3,380, respectively</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,356</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,967</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 76%; background-color: #ffffff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">48,321</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">38,060</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Tradenames, referral relationships and non-compete agreements are related to the businesses acquired. Typically, the value assigned to tradenames has an indefinite life and is tested at least annually for impairment using the relief from royalty method in conjunction with the Company&#8217;s annual goodwill impairment test. The value assigned to referral relationships is being amortized over their respective estimated useful lives which range from six to 16 years. Non-compete agreements are amortized over the respective term of the agreements which range from five to six years.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The following table details the amount of amortization expense recorded for intangible assets for the three and six months ended June 30, 2017 and 2016 (in thousands):</div><div style="color: #000000;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 52%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Tradenames</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">21</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">42</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 52%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Referral relationships</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">481</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">352</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">939</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">675</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 52%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Non-compete agreements</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">206</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">147</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">401</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">281</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 52%; background-color: #ffffff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">687</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">520</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,340</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">998</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Based on the balance of referral relationships and non-compete agreements as of June 30, 2017, the expected amount to be amortized in 2017 and thereafter by year is as follows (in thousands):</div><div style="color: #000000; text-align: left;"><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; border-collapse: collapse; width: 90%;"><tr><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">Referral Relationships</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">Non-Compete Agreements</div></td></tr><tr><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">Years</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">Annual Amount</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">Years</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">Annual Amount</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2017</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,993</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2017</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;860</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2018</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;2,063</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2018</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;883</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2019</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,973</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2019</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;810</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2020</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,973</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2020</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;597</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2021</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,973</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2021</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;519</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2022</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,924</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2022</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;88</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2023</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,817</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2024</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,698</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2025</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,592</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2026</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,131</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2027</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;971</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2028</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;401</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2029</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;43</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813375776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCRUED EXPENSES</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">7. ACCRUED EXPENSES</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Accrued expenses as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):</div><div style="color: #000000;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Salaries and related costs</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15,692</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,569</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Credit balances due to patients and payors</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,368</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,880</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Group health insurance claims</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,772</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,499</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Dividends payable to USPH shareholders</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,516</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,887</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,808</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">31,235</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">21,756</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804695808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">8. NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Amounts outstanding under the Amended Credit Agreement and notes payable as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Summary of Credit Agreement and Notes Payable</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Credit Agreement average effective interest rate of 2.7% inclusive of unused fee</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">46,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Various notes payable with $2,345 plus accrued interest due in the next year,&#160;interest accrues in the range of 3.25% through 4.0% per annum</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,696</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,823</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 76%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">75,696</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">51,823</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Less current portion</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,345</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,227</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Long term portion</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">73,351</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">50,596</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table></div><div style="color: #000000;">&#160;</div></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Effective December 5, 2013,&#160;the Company&#160;entered into an Amended Credit Agreement, as defined below, with a commitment for a $125.0 million revolving credit facility with a maturity date of November 30, 2018. This agreement was amended in August 2015, January 2016 and March 2017 (hereafter referred to as &#8220;Amended Credit Agreement&#8221;). The Amended Credit Agreement is unsecured and has loan covenants, including requirements that the Company comply with a consolidated fixed charge coverage ratio and consolidated leverage ratio. Proceeds from the Amended Credit Agreement may be used for working capital, acquisitions, purchases of the Company&#8217;s common stock, dividend payments to the Company&#8217;s common shareholders, capital expenditures and other corporate purposes. The pricing grid is based on the Company&#8217;s consolidated leverage ratio with the applicable spread over LIBOR ranging from 1.5% to 2.5% or the applicable spread over the Base Rate ranging from 0.1% to 1%. Fees under the Amended Credit Agreement include an unused commitment fee ranging from 0.1% to 0.25% depending on the Company&#8217;s consolidated leverage ratio and the amount of funds outstanding under the Amended Credit Agreement.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-left: 0.1pt; margin-right: 0.1pt;">The January 2016 amendment to the Amended Credit Agreement increased the cash and noncash consideration that the Company could pay with respect to acquisitions permitted under the Amended Credit Agreement to $50,000,000 for any fiscal year, and increased the amount the Company may pay in cash dividends to its shareholders in an aggregate amount not to exceed $10,000,000 in any fiscal year. Further, the March 2017 amendment, among other items, increased the amount the Company may pay in cash dividends to its shareholders in an aggregate amount not to exceed $15,000,000 in any fiscal year.</div><div style="color: #000000; text-align: left; margin-left: 0.1pt; margin-right: 0.1pt;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">On June 30, 2017, $69.0 million was outstanding on the Amended Credit Agreement resulting in $56.0 million of availability. As of June 30, 2017 and the date of this report, the Company was in compliance with all of the covenants thereunder.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company generally enters into various notes payable as a means of financing a portion of its acquisitions and purchases of non-controlling interests. In conjunction with the acquisitions in the first six months of 2017, the Company entered into notes payable in the aggregate amount of $1.7 million, of which an aggregate principal payment of $625,000 is due in 2018 and an aggregate principal payment of $1,025,000 is due in 2019. Interest accrues at the rate of 4.0% per annum and is payable with each principal installment.&#160; In conjunction with the acquisitions in 2016 and the purchases of non-controlling interests, the Company entered into notes payable in the aggregate amount of $1.5 million of which an aggregate principal payment of $444,000 was paid in 2017, $250,000 is due in November 2017 and $819,000 is payable in 2018. Interest accrues 3.5% per annum and is payable with each principal installment.&#160; In conjunction with the acquisitions in 2015 and the purchases of non-controlling interests, the Company entered into notes payable in the aggregate amount of $4.9 million, of which an aggregate principal payment of $575,000 was paid in 2016, $525,000 due in 2017 (of which $250,000 was paid in the first quarter of 2017), $1.9 million is due in 2018 and $1.9 million in 2019. Interest accrues in the range of 3.25% to 4.0% per annum and is payable with each principal installment.</div><div style="color: #000000; text-align: left;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Aggregate annual payments of principal required pursuant to the Amended Credit Agreement and the above notes payable subsequent to June 30, 2017 are as follows (in thousands):</div><div style="color: #000000;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 58%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">During the twelve months ended June 30, 2018</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,345</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 58%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">During the twelve months ended June 30, 2019</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">73,351</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 58%; background-color: #cceeff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">75,696</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table></div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The revolving credit facility (balance at June 30, 2017 of $69.0 million) matures on November 30, 2018.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6645974304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>COMMON STOCK [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">COMMON STOCK</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">9. COMMON STOCK</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">From September 2001 through December 31, 2008, the Board authorized the Company to purchase, in the open market or in privately negotiated transactions, up to 2,250,000 shares of the Company&#8217;s common stock. In March 2009, the Board authorized the repurchase of up to 10% or approximately 1,200,000 shares of its common stock (&#8220;March 2009 Authorization&#8221;). The Amended Credit Agreement permits share repurchases of up to $15,000,000, subject to compliance with covenants. The Company is required to retire shares purchased under the March 2009 Authorization.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Under the March 2009 Authorization, the Company has purchased a total of 859,499 shares. There is no expiration date for the share repurchase program. There are currently an additional estimated 248,344 shares (based on the closing price of $60.40 on June 30, 2017) that may be purchased from time to time in the open market or private transactions depending on price, availability and the Company&#8217;s cash position. The Company did not purchase any shares of its common stock during the six months ended June 30, 2017.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74567-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811501536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Cash Equivalents</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company maintains its cash and cash equivalents at financial institutions.&#160; The combined account balances at several institutions typically exceed Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance coverage and, as a result, there is a concentration of credit risk related on deposits in excess of FDIC insurance coverage. Management believes that the risk is not significant.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Long-Lived Assets</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Fixed assets are stated at cost. Depreciation is computed on the straight-line method over the estimated useful lives of the assets. Estimated useful lives for furniture and equipment range from three to eight years and for software purchased from three to seven years. Leasehold improvements are amortized over the shorter of the lease term or estimated useful lives of the assets, which is generally three to five years.</div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Impairment of Long-Lived Assets and Long-Lived Assets to Be Disposed Of</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company reviews property and equipment and intangible assets with finite lives for impairment upon the occurrence of certain events or circumstances which indicate that the amounts may be impaired. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Goodwill</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Goodwill represents the excess of the amount paid and fair value of the non-controlling interests over the fair value of the acquired business assets, which include certain identifiable intangible assets. Historically, goodwill has been derived from acquisitions and, prior to 2009, from the purchase of some or all of a particular local management&#8217;s equity interest in an existing clinic. Effective January 1, 2009, if the purchase price of a non-controlling interest related to non-acquired Clinic Partnerships by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall is recognized as an adjustment to additional paid-in capital.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The carrying value of goodwill and other identifiable intangible assets with indefinite lives are tested for impairment annually and upon the occurrence of certain events, and are written down to fair value if considered impaired. The Company evaluates goodwill for impairment on at least an annual basis (in its third quarter) by comparing the fair value of its reporting units to the carrying value of each reporting unit including related goodwill. The Company&#8217;s business is primarily made up of various clinics within partnerships. The partnerships are components of regions and are aggregated to the operating segment level for the purpose of determining the Company&#8217;s reporting units when performing its annual goodwill impairment test. In the second quarter of 2017, there were six regions.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">An impairment loss generally would be recognized when the carrying amount of the net assets of a reporting unit, inclusive of goodwill and other identifiable intangible assets, exceeds the estimated fair value of the reporting unit. The estimated fair value of a reporting unit is determined using two factors: (i) earnings prior to taxes, depreciation and amortization for the reporting unit multiplied by a price/earnings ratio used in the industry and (ii) a discounted cash flow analysis. A weight is assigned to each factor and the sum of each weight times the factor is considered the estimated fair value. For 2016, the factors (i.e., price/earnings ratio, discount rate and residual capitalization rate) were updated to reflect current market conditions. The evaluation of goodwill in 2016 did not result in any goodwill amounts that were deemed impaired.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company has not identified any triggering events occurring after the testing date that would impact the impairment testing results obtained. Factors which could result in future impairment charges include but are not limited to:</div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">cost, risks and uncertainties associated with the Company&#8217;s recent restatement of its prior financial statements due to the correction of its accounting methodology for redeemable noncontrolling partnership interests, and including any pending and future claims or proceedings relating to such matters&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">changes as the result of government enacted national healthcare reform&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification or enrollment status&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">revenue we receive from Medicare and Medicaid being subject to potential retroactive reduction&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">business and regulatory conditions including federal and state regulation&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">governmental and other third party payor inspections, reviews, investigations and audits&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information and associated fines and penalties for failure to comply&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">legal actions, which could subject us to increased operating costs and uninsured liabilities&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">revenue and earnings expectations&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">general economic conditions&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">availability and cost of qualified physical and occupational therapists&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">personnel productivity and retaining key personnel&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain operations and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">acquisitions, purchases of non-controlling interests (minority interests) and the successful integration of the operations of the acquired business&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">maintaining necessary insurance coverage&#894;</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">availability, terms, and use of capital&#894; and</div></td></tr></table></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td style="color: #000000; width: 18pt;"></td><td style="font-size: 10pt; font-family: Symbol, serif; vertical-align: top; color: #000000; width: 18pt; align: right;">&#183;</td><td style="vertical-align: top; color: #000000; text-align: left; width: auto;"><div style="font-size: 10pt; font-family: 'Times New Roman';">weather and other seasonal factors.</div></td></tr></table></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock', window );">Mandatorily Redeemable Non-Controlling Interests</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Mandatorily Redeemable Non-Controlling Interests</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;">The non-controlling interests that are reflected as mandatorily redeemable non-controlling interests in the consolidated financial statements consist of those owners who have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase the non-controlling interest of those owners at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&#160; The redemption rights are triggered at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically three to five years, as defined in the limited partnership agreement.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;">On the date the Company acquires a controlling interest in a partnership and the limited partnership agreement contains mandatory redemption rights, the fair value of the non-controlling interest is recorded in the long-term liabilities section of the consolidated balance sheet under the caption &#8211; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Mandatorily redeemable non-controlling interests</font>.&#160; Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to its then current redemption value, based on the predetermined formula defined in the respective limited partnership agreement.&#160; The Company reflects any adjustment in the redemption value and any earnings attributable to the mandatorily redeemable non-controlling interest in its consolidated statements of net income by recording the adjustments and earnings to other income and expense in the captions - <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Interest expense &#8211; mandatorily redeemable non-controlling interests &#8211; change in redemption value and Interest expense &#8211; mandatorily redeemable non-controlling interests &#8211; earnings allocable</font>.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestsPolicyTextBlock', window );">Redeemable Non-Controlling Interests</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Redeemable Non-Controlling Interests</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;">The non-controlling interests that are reflected as redeemable non-controlling interests in the consolidated financial statements consist of those owners who have certain redemption rights, whether currently exercisable or not, and which currently, or in the future, require that the Company purchase the non-controlling interest of those owners, if certain conditions are met and the owners request the purchase.&#160; The purchase price is derived at a predetermined formula based on a multiple of trailing twelve months earnings performance as defined in the respective limited partnership agreements.&#160; The redemption rights can be triggered by the owner at such time as both of the following events have occurred: 1) termination of the owner&#8217;s employment, regardless of the reason for such termination, and 2) the passage of specified number of years after the closing of the transaction, typically three to five years, as defined in the limited partnership agreement.&#160; The redemption rights are not automatic (even upon death) and require either the owner or the Company to exercise its rights when the conditions triggering the redemption rights have been satisfied.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: justify;">On the date the Company acquires a controlling interest in a partnership and the limited partnership agreement contains redemption rights not under the control of the Company, the fair value of the non-controlling interest is recorded in the consolidated balance sheet under the caption &#8211; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Redeemable non-controlling interests</font>.&#160; Then, in each reporting period thereafter until it is purchased by the Company, the redeemable non-controlling interest is adjusted to the greater of its then current redemption value or initial value, based on the predetermined formula defined in the respective limited partnership agreement.&#160; Hence, the value of the non-controlling interest is not adjusted below its initial value.&#160; The Company records any adjustment in the redemption value, net of tax, directly to retained earnings and are not reflected in the statements of net income.&#160; Although the adjustments are not reflected in the statements of net income, current accounting rules require that the Company reflects the adjustments, net of tax, in the earnings per share calculation.&#160; The amount of net income attributable to redeemable non-controlling interest owners is included in consolidated net income on the face of the income statement.</div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonControllingInterestsPolicyPolicyTextBlock', window );">Non-Controlling Interests</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Non-Controlling Interests</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company recognizes non-controlling interests as equity in the consolidated financial statements separate from the parent entity&#8217;s equity. Changes in a parent entity&#8217;s ownership interest in a subsidiary that do not result in deconsolidation are treated as equity transactions if the parent entity retains its controlling financial interest. The Company recognizes a gain or loss in net income when a subsidiary is deconsolidated. Such gain or loss is measured using the fair value of the non-controlling interest on the deconsolidation date.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">When the purchase price of a non-controlling interest by the Company exceeds or is less than the book value at the time of purchase, any excess or shortfall, as applicable, is recognized as an adjustment to additional paid-in capital. Additionally, operating losses are allocated to non-controlling interests even when such allocation creates a deficit balance for the non-controlling interest partner.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Revenue Recognition</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Revenues are recognized in the period in which services are rendered. Net patient revenues (patient revenues less estimated contractual adjustments) are reported at the estimated net realizable amounts from third-party payors, patients and others for services rendered. The Company has agreements with third-party payors that provide for payments to the Company at amounts different from its established rates. The allowance for estimated contractual adjustments is based on terms of payor contracts and historical collection and write-off experience.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company determines allowances for doubtful accounts based on the specific agings and payor classifications at each clinic. The provision for doubtful accounts is included in clinic operating costs in the statement of net income. Net accounts receivable, which are stated at the historical carrying amount net of contractual allowances, write-offs and allowance for doubtful accounts, includes only those amounts the Company estimates to be collectible.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Medicare Reimbursement</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (&#8216;&#8216;MPFS&#8217;&#8217;). The MPFS rates have historically been subject to an automatic annual update based on a formula, called the sustainable growth rate (&#8216;&#8216;SGR&#8217;&#8217;) formula. The use of the SGR formula would have resulted in calculated automatic reductions in rates in every year since 2002&#894; however, for each year through September 30, 2015, Centers for Medicare &amp; Medicaid Services (&#8216;&#8216;CMS&#8217;&#8217;) or Congress has taken action to prevent the implementation of SGR formula reductions. On April 16, 2015, the Medicare Access and CHIP Reauthorization Act of 2015 (&#8216;&#8216;MACRA&#8217;&#8217;) was signed into law, eliminating the SGR formula and the associated annual automatic rate reductions.&#160; The MACRA promotes the development of new payment models that focus on quality and outcomes.&#160; As a result of MACRA and CMS&#8217; adjustment to the applicable conversion factor, the net fee schedule payment rates were increased for 2017 by 0.24%.&#160; For 2018 and 2019, a 0.5% increase will be applied each year to the fee schedule payment rates, unless further adjusted by CMS.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Budget Control Act of 2011 increased the federal debt ceiling in connection with deficit reductions over the next ten years, and requires automatic reductions in federal spending by approximately $1.2 trillion. Payments to Medicare providers are subject to these automatic spending reductions, subject to a 2% cap. On April 1, 2013, a 2% reduction to Medicare payments was implemented. The Bipartisan Budget Act of 2015, enacted on November 2, 2015, extends the 2% reductions to Medicare payments through fiscal year 2025.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left; margin-left: 0.2pt; margin-right: 0.2pt;">As a result of the Balanced Budget Act of 1997, the formula for determining the total amount paid by Medicare in any one year for outpatient physical therapy, occupational therapy, and/or speech/language pathology services provided to any Medicare beneficiary (i.e., the &#8216;&#8216;Therapy Cap&#8217;&#8217; or &#8216;&#8216;Limit&#8217;&#8217;) was established. Based on the statutory definitions which constrained how the Therapy Cap would be applied, there is one Limit for Physical Therapy and Speech Language Pathology Services combined, and one Limit for Occupational Therapy. For 2017, the annual Limit on outpatient therapy services is $1,980 for Physical and Speech Language Pathology Services combined and $1,980 for Occupational Therapy Services. Historically, these Therapy Caps applied to outpatient therapy services provided in all settings, except for services provided in departments of hospitals. However, the Protecting Access to Medicare Act of 2014, and prior legislation, extended the Therapy Caps to services furnished in hospital outpatient department settings. The application of these annual limits to hospital outpatient department settings will sunset on December 31, 2017 unless Congress extends it.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In the Deficit Reduction Act of 2005, Congress implemented an exceptions process to the annual Limit for therapy expenses for therapy services above the annual Limit. Therapy services above the annual Limit that are medically necessary satisfy an exception to the annual Limit and such claims are payable by the Medicare program. The MACRA extended the exceptions process for outpatient therapy caps through December 31, 2017. Unless Congress extends the exceptions process further, the exceptions no longer will be available in those outpatient therapy setting where the annual Limits are applicable. For any claim above the annual Limit, the claim must contain a modifier indicating that the services are medically necessary and justified by appropriate documentation in the medical record.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Furthermore, under the Middle Class Tax Relief and Job Creation Act of 2012 (&#8216;&#8216;MCTRA&#8217;&#8217;), since October 1, 2012, patients who met or exceeded $3,700 in therapy expenditures during a calendar year have been subject to a manual medical review to determine whether applicable payment criteria are satisfied. The $3,700 threshold is applied to Physical Therapy and Speech Language Pathology Services&#894; a separate $3,700 threshold is applied to the Occupational Therapy. The MACRA directed CMS to modify the manual medical review process such that those reviews will no longer apply to all claims exceeding the $3,700 threshold and instead will be determined on a targeted basis based on a variety of factors that CMS considers appropriate.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">CMS adopted a multiple procedure payment reduction (&#8216;&#8216;MPPR&#8217;&#8217;) for therapy services in the final update to the MPFS for calendar year 2011. The MPPR applied to all outpatient therapy services paid under Medicare Part B &#8212; occupational therapy, physical therapy and speech-language pathology. Under the policy, the Medicare program pays 100% of the practice expense component of the Relative Value Unit (&#8216;&#8216;RVU&#8217;&#8217;) for the therapy procedure with the highest practice expense RVU, then reduces the payment for the practice expense component for the second and subsequent therapy procedures or units of service furnished during the same day for the same patient, regardless of whether those therapy services are furnished in separate sessions. Since 2013, the practice expense component for the second and subsequent therapy service furnished during the same day for the same patient was reduced by 50%. In addition, the MCTRA directed CMS to implement a claims-based data collection program to gather additional data on patient function during the course of therapy in order to better understand patient conditions and outcomes. All practice settings that provide outpatient therapy services are required to include this data on the claim form. Since 2013, therapists have been required to report new codes and modifiers on the claim form that reflect a patient&#8217;s functional limitations and goals at initial evaluation, periodically throughout care, and at discharge, CMS has rejected claims if the required data is not included in the claim.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Physician Quality Reporting System, or &#8216;&#8216;PQRS,&#8217;&#8217; is a CMS reporting program that uses a combination of incentive payments and payment reductions to promote reporting of quality information by &#8216;&#8216;eligible professionals.&#8217;&#8217; Although physical therapists, occupational therapists and qualified speech-language therapists were generally able to participate in the PQRS program, therapy professionals for whose services we bill through our certified rehabilitation agencies cannot participate because the Medicare claims processing systems currently cannot accommodate institutional providers such as certified rehabilitation agencies. Eligible professionals, such as those of our therapy professionals for whose services we bill using their individual Medicare provider numbers, who do not satisfactorily report data on quality measures will be subject to a 2% reduction in their Medicare payment in 2016 and 2017. As required under the MACRA, the PQRS program has been replaced with the Merit-Based Incentive Payment System (MIPS) on January 1, 2017. Physical therapists and occupational therapists are not required to participate in the MIPS program until January 1, 2019 or later, as determined by CMS.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Statutes, regulations, and payment rules governing the delivery of therapy services to Medicare beneficiaries are complex and subject to interpretation. The Company believes that it is in compliance in all material respects with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on the Company&#8217;s financial statements as of June 30, 2017. Compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action including fines, penalties, and exclusion from the Medicare program. For the six months ended June 30, 2017, net revenue from Medicare accounts for approximately $45.8 million.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Management Contract Revenues</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Management contract revenues are derived from contractual arrangements whereby the Company manages a clinic for third party owners. The Company does not have any ownership interest in these clinics. Typically, revenues are determined based on the number of visits conducted at the clinic and recognized when services are performed. Costs, typically salaries for the Company&#8217;s employees, are recorded when incurred. Management contract revenues are included in &#8220;other revenues&#8221; in the accompanying Consolidated Statements of Net Income.</div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock', window );">Contractual Allowances</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Contractual Allowances</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Contractual allowances result from the differences between the rates charged for services performed and expected reimbursements by both insurance companies and government sponsored healthcare programs for such services. Medicare regulations and the various third party payors and managed care contracts are often complex and may include multiple reimbursement mechanisms payable for the services provided in Company clinics. The Company estimates contractual allowances based on its interpretation of the applicable regulations, payor contracts and historical calculations. Each month the Company estimates its contractual allowance for each clinic based on payor contracts and the historical collection experience of the clinic and applies an appropriate contractual allowance reserve percentage to the gross accounts receivable balances for each payor of the clinic. Based on the Company&#8217;s historical experience, calculating the contractual allowance reserve percentage at the payor level is sufficient to allow the Company to provide the necessary detail and accuracy with its collectability estimates. However, the services authorized and provided and related reimbursement are subject to interpretation that could result in payments that differ from the Company&#8217;s estimates. Payor terms are periodically revised necessitating continual review and assessment of the estimates made by management. The Company&#8217;s billing system does not capture the exact change in its contractual allowance reserve estimate from period to period in order to assess the accuracy of its revenues and hence its contractual allowance reserves. Management regularly compares its cash collections to corresponding net revenues measured both in the aggregate and on a clinic-by-clinic basis. In the aggregate, the historical difference between net revenues and corresponding cash collections has generally reflected a difference within approximately 1% of net revenues. Additionally, analysis of subsequent period&#8217;s contractual write-offs on a payor basis reflects a difference within approximately 1% between the actual aggregate contractual reserve percentage as compared to the estimated contractual allowance reserve percentage associated with the same period end balance. As a result, the Company believes that a change in the contractual allowance reserve estimate would not likely be more than 1% at June 30, 2017.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Income Taxes</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount to be recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company did not have any accrued interest or penalties associated with any unrecognized tax benefits nor was any interest expense recognized during the six months ended June 30, 2017. The Company will book any interest or penalties, if required, in interest and/or other income/expense as appropriate.</div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Fair Value of Financial Instruments</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The carrying amounts reported in the balance sheets for cash and cash equivalents, accounts receivable, accounts payable and notes payable approximate their fair values due to the short-term maturity of these financial instruments. The carrying amount under the Amended Credit Agreement approximates its fair value. The interest rate on the Amended Credit Agreement, which is tied to the Eurodollar Rate, is set at various short-term intervals, as detailed in the Amended Credit Agreement.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Segment Reporting</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Operating segments are components of an enterprise for which separate financial information is available that is evaluated regularly by chief operating decision makers in deciding how to allocate resources and in assessing performance. The Company identifies operating segments based on management responsibility and believes it meets the criteria for aggregating its operating segments into a single reporting segment.</div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Use of Estimates</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In preparing the Company&#8217;s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, purchase accounting, goodwill impairment, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_SelfInsuranceProgramPolicyPolicyTextBlock', window );">Self-Insurance Program</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Self-Insurance Program</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company utilizes a self-insurance plan for its employee group health insurance coverage administered by a third party. Predetermined loss limits have been arranged with the insurance company to minimize the Company&#8217;s maximum liability and cash outlay. Accrued expenses include the estimated incurred but unreported costs to settle unpaid claims and estimated future claims. Management believes that the current accrued amounts are sufficient to pay claims arising from self-insurance claims incurred through June 30, 2017.</div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RestrictedStockPolicyPolicyTextBlock', window );">Restricted Stock</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Restricted Stock</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Restricted stock issued to employees and directors is subject to continued employment or continued service on the board, respectively. Generally, restrictions on the stock granted to employees, other than officers, lapse in equal annual installments on the following four anniversaries of the date of grant. For those shares granted to directors, the restrictions will lapse in equal quarterly installments during the first year after the date of grant. For those granted to officers, the restriction will lapse in equal quarterly installments during the four years following the date of grant. Compensation expense for grants of restricted stock is recognized based on the fair value per share on the date of grant amortized over the vesting period. The restricted stock issued is included in basic and diluted shares for the earnings per share computation.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Guidance</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Recently Adopted Accounting Guidance</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In March 2016, the FASB issued guidance to simplify some provisions in stock compensation accounting.&#160; The guidance amends how excess tax benefits and a company&#8217;s payments to cover tax bills for the recipients&#8217; shares should be classified.&#160; Prior to this guidance, excess tax benefits were recorded in additional paid-in capital, but will now become a component of the income tax provision/benefit in the period in which they occur.&#160; This guidance allows companies to estimate the number of stock awards expected to vest and revises the withholding requirements for classifying stock awards as equity.&#160; For public business entities, this guidance is effective for fiscal years starting after December 15, 2016, including interim periods within those fiscal years but early adoption is allowed.&#160; The Company adopted this accounting treatment in the fourth quarter of 2016 and retrospectively adjusted each quarter period in 2016.&#160; The adoption increased earnings, by decreasing the tax provision, by $0.5 million for the three months ended March 31, 2016.&#160;&#160; The election to record forfeitures in the period they occur is consistent with the Company&#8217;s past approach, due to the immateriality of past forfeitures, and the Company believes the effect to be immaterial on the consolidated financial statements.</div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RecentlyIssuedAccountingGuidancePolicyTextBlock', window );">Recently Issued Accounting Guidance</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Recently Issued Accounting Guidance</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In January 2017, the FASB issued ASU 2017-04, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Simplifying the Test for Goodwill Impairment (Topic 350),</font> which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment change. ASU 2017-04 is effective prospectively for fiscal years, and the interim periods within those years, beginning after December 15, 2019. The Company is currently evaluating the impact of adopting this ASU on our consolidated financial statements and do not expect adoption to have a material impact.</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In February 2016, the FASB issued amended accounting guidance (ASU 2016-02 - <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Leases</font>) which replaced most existing lease accounting guidance under U. S. generally accepted accounting principles. Among other changes, the amended guidance requires that a right-to-use asset, which is an asset that represents the lessee&#8217;s right to use, and a lease liability, which is a lessee&#8217;s obligation to make lease payments arising for a lease measured on a discounted basis, be recognized on the balance sheet by lessees for those leases with a term of greater than 12 months. The amended guidance is effective for reporting periods beginning after December 15, 2018&#894; however, early adoption is permitted. Entities are required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. Since the Company leases all but one of its clinic facilities, it has been evaluating various lease management systems to capture the necessary information and the impact that this amended accounting guidance will have on its consolidated financial statements. The Company believes the adoption of this guidance will significantly affect total assets and liabilities in the consolidated balance sheet.</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">In May 2014, March 2016, April 2016, and December 2016, the FASB issued ASU 2014-09, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Revenue from Contracts with Customers</font>, ASU 2016-08, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Revenue from Contracts with Customers, Principal versus Agent Considerations</font>, ASU 2016-10, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing</font>, ASU 2016-12, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Revenue from Contracts with Customers, Narrow Scope Improvements and Practical Expedients</font>, and ASU 2016-20, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customer</font> (collectively &#8220;the standards&#8221;), respectively, which supersede most of the current revenue recognition requirements. The core principle of the new guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. New disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers are also required. The original standards were effective for fiscal years beginning after December 15, 2016; however, in July 2015, the FASB approved a one-year deferral of these standards, with a new effective date for fiscal years beginning after December 15, 2017. The standards require the selection of a retrospective or cumulative effect transition method. The Company does not anticipate a material adjustment upon adoption of these standards.</div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Event</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: left;">Subsequent Event</div><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The Company has evaluated events occurring after the balance sheet date for possible disclosure as a subsequent event through the date that these consolidated financial statements were issued. No disclosure was required.</div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contractual adjustments and third-party settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 405<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491204&amp;loc=d3e4869-115612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualAdjustmentsAndThirdPartySettlementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13279-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64802544&amp;loc=d3e202-110218<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for mandatorily non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MandatorilyRedeemableNonControllingInterestsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonControllingInterestsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonControllingInterestsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RecentlyIssuedAccountingGuidancePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for new accounting pronouncements that have been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RecentlyIssuedAccountingGuidancePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for redeemable non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RestrictedStockPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RestrictedStockPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_SelfInsuranceProgramPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for self-insurance program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_SelfInsuranceProgramPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813542016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock', window );">Schedule of Clinic Acquisition</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">During the first six months of 2017 and the year ended 2016, the Company acquired an interest in the following clinic groups:</div><div style="color: #000000;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%;"></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">&#160;Date</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">% Interest Acquired</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">Number of Clinics</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%;"></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">&#160;2017</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">June 2017 Acquisition</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">June 30</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">60</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">9</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">May 2017 Acquisition</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">May 31</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">70</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">January 2017 Acquisition</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">January 1</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">70</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">17</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 54%; background-color: #cceeff;"></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; width: 12%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">&#160;2016</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">February 2016 Acquisition</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">February 29</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">55</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">8</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 54%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">November 2016 Acquisition</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 12%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">November 30</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">60</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">%</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">12</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of clinic acquisition during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ScheduleOfBusinessAcquisitionsClinicAcquisitionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786487392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS OF BUSINESSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>ACQUISITIONS OF BUSINESSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Preliminary Purchase Prices Allocation</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The purchase price for the 2017 acquisitions has been preliminarily allocated as follows (in thousands):</div><div style="color: #000000;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash paid, net of cash acquired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">33,665</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Seller notes</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,650</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total consideration</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35,315</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Estimated fair value of net tangible assets acquired:</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total current assets</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,868</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total non-current assets</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,790</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total liabilities</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,919</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 27pt; text-indent: -9pt;">Net tangible assets acquired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,739</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Referral relationships</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,693</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Non-compete</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,790</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Tradename</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,118</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Goodwill</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">40,197</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(11,940</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(10,282</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #cceeff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">35,315</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table><div style="color: #000000;"><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The purchase prices for the 2016 acquisitions have been preliminarily allocated as follows (in thousands):</div><div style="color: #000000;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Cash paid, net of cash acquired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">23,623</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Seller notes</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total consideration</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24,623</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Estimated fair value of net tangible assets acquired:</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total current assets</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,763</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total non-current assets</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">839</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Total liabilities</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,039</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 27pt; text-indent: -9pt;">Net tangible assets acquired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,563</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Referral relationships</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,919</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Non-compete</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">847</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Tradename</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,802</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Goodwill</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">32,371</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(18,879</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #ffffff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">24,623</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1486-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6622297424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract', window );"><strong>MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Changes in Carrying Amount of Redeemable Non-Controlling Interest</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">For the six months ended June 30, 2017, the following table details the changes in the carrying amount of mandatorily redeemable non-controlling interest:</div><div>&#160;</div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: center;">Six Months Ended</div><font style="color: #000000;">June 30, 2017</font></div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Beginning balance</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69,190</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Operating results allocated to mandatorily redeemable non-controlling interest partners</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,081</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Distributions to mandatorily redeemable non-controlling interest partners</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(3,272</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Changes in the redemption value of mandatorily redeemable non-controlling interest</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,592</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: middle; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Payments for settlement of mandatorily redeemable non-controlling&#160; interest</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,230</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: middle; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 18pt; text-indent: -9pt;">Purchases of businesses - initial liability related to mandatorily redeemable non-controlling interest</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,282</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Ending balance</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">83,643</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock', window );">Carrying Amount of Redeemable Non-Controlling Interest</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The following table details the carrying amount of the mandatorily redeemable non-controlling interest (in thousands) as of June 30, 2017:</div><div style="color: #000000;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Contractual time period has lapsed but holder's employment has not been terminated</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">30,838</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Contractual time period has not lapsed and holder's employment has not been terminated</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">55,454</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Holder's employment has terminated and contractual time period has expired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Holder's employment has terminated and contractual time period has not expired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Redemption value prior to excess distributed earnings</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">86,292</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Excess distributions over earnings and losses</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,649</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 88%; background-color: #cceeff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">83,643</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of carrying amount of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CarryingAmountOfRedeemableNonControllingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MANDATORILYREDEEMABLENONCONTROLLINGINTERESTSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6629967696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>GOODWILL [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Summary of Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The changes in the carrying amount of goodwill consisted of the following (in thousands):</div><div style="color: #000000;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 90%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; width: 78%; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000; text-align: center;">Six Months Ended</div><font style="color: #000000;">June 30, 2017</font></div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; margin-left: 9pt; width: 78%; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 78%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Beginning balance</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">226,806</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 78%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Goodwill acquired during the period</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">40,197</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 78%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Goodwill adjustments for purchase price allocation of business acquired</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">954</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 78%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Ending balance</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">267,957</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813454784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>INTANGIBLE ASSETS, NET [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Intangible assets, net as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):</div><div style="color: #000000; text-align: left;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Tradenames</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">26,352</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">21,234</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Referral relationships, net of accumulated amortization of $6,214 and $5,275, respectively</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">18,613</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">14,859</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Non-compete agreements, net of accumulated amortization of $3,781 and $3,380, respectively</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,356</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,967</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 76%; background-color: #ffffff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">48,321</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">38,060</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Amortization Expenses</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">The following table details the amount of amortization expense recorded for intangible assets for the three and six months ended June 30, 2017 and 2016 (in thousands):</div><div style="color: #000000;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Three Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="6" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Six Months Ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 52%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Tradenames</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">21</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">42</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 52%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Referral relationships</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">481</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">352</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">939</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">675</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 52%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Non-compete agreements</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">206</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">147</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">401</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">281</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 52%; background-color: #ffffff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">687</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">520</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">1,340</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">998</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Amortization of Tradename, Referral Relationships and Non-Competition Agreements</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Based on the balance of referral relationships and non-compete agreements as of June 30, 2017, the expected amount to be amortized in 2017 and thereafter by year is as follows (in thousands):</div><div style="color: #000000; text-align: left;"><br /></div><div><table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; border-collapse: collapse; width: 90%;"><tr><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">Referral Relationships</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">Non-Compete Agreements</div></td></tr><tr><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">Years</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">Annual Amount</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">Years</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">Annual Amount</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2017</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,993</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2017</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;860</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2018</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;2,063</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2018</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;883</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2019</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,973</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2019</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;810</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2020</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,973</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2020</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;597</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2021</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,973</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2021</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;519</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2022</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,924</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2022</div></td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;88</div></td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2023</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,817</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2024</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,698</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2025</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,592</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2026</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;1,131</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2027</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;971</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2028</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;401</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #ffffff;">&#160;</td></tr><tr><td style="vertical-align: top; color: #000000; width: 20%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: center;">2029</div></td><td style="vertical-align: bottom; color: #000000; width: 25%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: right;">&#160;43</div></td><td style="vertical-align: bottom; color: #000000; width: 4.83%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td><td style="vertical-align: bottom; color: #000000; width: 20%; background-color: #cceeff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804700880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>ACCRUED EXPENSES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Summary of Accrued Expenses</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Accrued expenses as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):</div><div style="color: #000000;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Salaries and related costs</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">15,692</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">10,569</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Credit balances due to patients and payors</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,368</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">3,880</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Group health insurance claims</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,772</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,499</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Dividends payable to USPH shareholders</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,516</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,887</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">4,808</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">31,235</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">21,756</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813418464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Summary of Credit Agreement and Notes Payable</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Amounts outstanding under the Amended Credit Agreement and notes payable as of June 30, 2017 and December 31, 2016 consisted of the following (in thousands):</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 100%;"><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">Summary of Credit Agreement and Notes Payable</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">June 30, 2017</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" nowrap="nowrap" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; text-align: center;">December 31, 2016</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Credit Agreement average effective interest rate of 2.7% inclusive of unused fee</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">69,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">46,000</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">Various notes payable with $2,345 plus accrued interest due in the next year,&#160;interest accrues in the range of 3.25% through 4.0% per annum</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">6,696</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">5,823</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 76%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">75,696</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">51,823</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 76%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Less current portion</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(2,345</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">(1,227</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 4px; width: 76%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left;">Long term portion</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">73,351</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">50,596</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility</a></td>
<td class="text"><div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000; text-align: left;">Aggregate annual payments of principal required pursuant to the Amended Credit Agreement and the above notes payable subsequent to June 30, 2017 are as follows (in thousands):</div><div style="color: #000000;"><br /></div><div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman'; width: 70%;"><tr><td valign="bottom" style="vertical-align: top; color: #000000; width: 58%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">During the twelve months ended June 30, 2018</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">2,345</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 2px; width: 58%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman'; text-align: left; margin-left: 9pt; text-indent: -9pt;">During the twelve months ended June 30, 2019</div></td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; color: #000000; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">73,351</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; color: #000000; padding-bottom: 4px; margin-left: 9pt; width: 58%; background-color: #cceeff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; color: #000000; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman';">75,696</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; color: #000000; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6479336&amp;loc=d3e64711-112823<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6826434896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>State</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>State </div>
<div>Facility </div>
<div>Region</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Nov. 02, 2015</div></th>
<th class="th"><div>Apr. 01, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfGeneralPartnershipInterestOwned', window );">Percentage of general partnership interest owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfClinicsOperated', window );">Number of clinics operated | Clinic</a></td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states where clinics are operated | State</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfThirdPartyFacilities', window );">Number of third party facilities | Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfRegions', window );">Number of regions | Region</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions', window );">Federal debt ceiling in connection with deficit reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AmountOfReductionsInFederalSpending', window );">Reductions in federal spending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ReductionInMedicareSpendingPercentage', window );">Medicare spending cut percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ExpectedReductionInMedicareSpendingPercentage', window );">Expected reduction in Medicare spending percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses', window );">Combined physical therapy/speech language pathology expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit', window );">Percentage of practice expense component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings', window );">Percentage reduction for service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NetRevenueFromMedicare', window );">Net revenue from Medicare accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues', window );">Difference between net revenues and corresponding cash collections, approximately of net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage', window );">Difference between actual aggregate contractual reserve and estimated contractual allowance reserve percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MaximumContractualAllowanceReserveEstimate', window );">Maximum contractual allowance reserve estimate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties associated with any unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations', window );">Interest expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Increase in earnings by decreasing the tax provision due to adoption of new accounting treatment</a></td>
<td class="nump">$ 3,085,000<span></span>
</td>
<td class="nump">$ 3,802,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,897,000<span></span>
</td>
<td class="nump">$ 5,974,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=usph_AccountingStandardsUpdate201609Member', window );">Accounting Standards Update 2016-09 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Increase in earnings by decreasing the tax provision due to adoption of new accounting treatment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_Year2017Member', window );">Year 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfMedicarePayment', window );">Percentage of increase in medicare payment rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.24%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_Year2018Member', window );">Year 2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfMedicarePayment', window );">Percentage of increase in medicare payment rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=usph_Year2019Member', window );">Year 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfMedicarePayment', window );">Percentage of increase in medicare payment rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_MarchTwoThousandSeventeenAcquisitionMember', window );">March 2017 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfLimitedPartnershipInterestOwned', window );">Percentage of limited partnership interest owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod', window );">Mandatorily redeemable non-controlling interest, redemption rights, commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod', window );">Redeemable non-controlling interest, redemption rights, commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member] | Furniture &amp; Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PercentageOfLimitedPartnershipInterestOwned', window );">Percentage of limited partnership interest owned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod', window );">Mandatorily redeemable non-controlling interest, redemption rights, commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod', window );">Redeemable non-controlling interest, redemption rights, commencement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member] | Year 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices', window );">Annual limit on physical therapy and speech language pathology services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AnnualLimitOccupationalTherapyServices', window );">Annual limit occupational therapy services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member] | Furniture &amp; Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DepreciationAmortizationImpairmentLineItems', window );"><strong>Depreciation Amortization Impairment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on prepetition obligations included in the statement of operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=64805424&amp;loc=d3e55733-112764<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Prepetition Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6521744<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AmountOfReductionsInFederalSpending">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reductions in federal spending during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AmountOfReductionsInFederalSpending</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AnnualLimitOccupationalTherapyServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Limit occupational therapy services during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AnnualLimitOccupationalTherapyServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Limit on physical therapy and speech language pathology services during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AnnualLimitOnPhysicalTherapyAndSpeechLanguagePathologyServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Combined physical therapy/speech language pathology expenses during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CombinedPhysicalTherapySpeechLanguagePathologyExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DepreciationAmortizationImpairmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DepreciationAmortizationImpairmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum difference between actual aggregate contractual reserve percentage as compared to estimated contractual allowance reserve percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between net revenues and corresponding cash collections reflected percentage of net revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ExpectedReductionInMedicareSpendingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected reduction in Medicare spending percentage during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ExpectedReductionInMedicareSpendingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the commencement period of redemption rights for mandatorily redeemable non controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MandatorilyRedeemableNonControllingInterestRedemptionRightsCommencementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MaximumContractualAllowanceReserveEstimate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum contractual allowance reserve estimate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MaximumContractualAllowanceReserveEstimate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NetRevenueFromMedicare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net revenue from Medicare.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NetRevenueFromMedicare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfClinicsOperated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of clinics operated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfClinicsOperated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfRegions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of regions of the entity operates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfRegions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfThirdPartyFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of third party facilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfThirdPartyFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfGeneralPartnershipInterestOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of general partnership interest owned during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfGeneralPartnershipInterestOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfLimitedPartnershipInterestOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of limited partnership interest owned during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfLimitedPartnershipInterestOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfMedicarePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of medicare payment during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfMedicarePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of practice expense component of relative value unit during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageOfPracticeExpenseComponentOfRelativeValueUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage reduction for service in office or other non institutional settings during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the period of federal debt ceiling in connection with deficit reductions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the commencement period of redemption rights for redeemable non controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RedeemableNonControllingInterestRedemptionRightsCommencementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ReductionInMedicareSpendingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in Medicare spending percentage during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ReductionInMedicareSpendingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=usph_AccountingStandardsUpdate201609Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=usph_AccountingStandardsUpdate201609Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_Year2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_Year2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_Year2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_Year2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=usph_Year2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=usph_Year2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_MarchTwoThousandSeventeenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_MarchTwoThousandSeventeenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823461376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Clinic Acquisition (Details) - Clinic<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_JuneTwoThousandSeventeenAcquisitionMember', window );">June 2017 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="text">Jun. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_MayTwoThousandSeventeenAcquisitionMember', window );">May 2017 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="text">May 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_JanuaryTwoThousandSeventeenAcquisitionMember', window );">January 2017 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="text">Jan.  01,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_FebruaryTwoThousandSixteenAcquisitionMember', window );">February 2016 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 29,  2016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_NovemberTwoThousandSixteenAcquisitionMember', window );">November 2016 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1', window );">Acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the business acquisition agreement was executed, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_JuneTwoThousandSeventeenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_JuneTwoThousandSeventeenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_MayTwoThousandSeventeenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_MayTwoThousandSeventeenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_JanuaryTwoThousandSeventeenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_JanuaryTwoThousandSeventeenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_FebruaryTwoThousandSixteenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_FebruaryTwoThousandSixteenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_NovemberTwoThousandSixteenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_NovemberTwoThousandSixteenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6829079632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS OF BUSINESSES (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th">
<div>Mar. 23, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2017 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th">
<div>Nov. 30, 2016 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th">
<div>Feb. 29, 2016 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($) </div>
<div>Clinic </div>
<div>Installment</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($) </div>
<div>Subsidiary</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes issued for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NumberOfSubsidiariesAcquiredClinicPractices', window );">Number of subsidiaries acquired clinic practices | Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price for the acquired clinic practices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,665,000<span></span>
</td>
<td class="nump">$ 12,958,000<span></span>
</td>
<td class="nump">23,623,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,623,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract', window );"><strong>Estimated fair value of net tangible assets acquired [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,868,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,763,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets', window );">Total non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,919,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,039,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset', window );">Net tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,739,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,563,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships', window );">Referral relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,693,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,919,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements', window );">Non-compete</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">847,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename', window );">Tradename</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,118,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,802,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,197,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,371,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests', window );">Fair value of non-controlling interest (classified as redeemable non-controlling interests)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,940,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Fair value of non-controlling interest (classified as mandatorily redeemable non-controlling interests)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,282,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,879,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PaymentsToAcquireBusinessesConsideration', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,623,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfSeventeenClinicPracticesMember', window );">Acquisition of Seventeen Clinic Practices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinic practices acquired | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes issued for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration', window );">Business acquisition number of installments to payment of purchase consideration | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfSeventeenClinicPracticesMember', window );">Acquisition of Seventeen Clinic Practices [Member] | January 2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest', window );">Acquisition cost payable in two principal installments including accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfSeventeenClinicPracticesMember', window );">Acquisition of Seventeen Clinic Practices [Member] | January 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest', window );">Acquisition cost payable in two principal installments including accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_WorkforcePerformanceSolutionsMember', window );">Workforce Performance Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes issued for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfFourClinicPracticesMember', window );">Acquisition Of Four Clinic Practices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinic practices acquired | Clinic</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes issued for acquisition of interest in clinic</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration', window );">Business acquisition number of installments to payment of purchase consideration | Installment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfFourClinicPracticesMember', window );">Acquisition Of Four Clinic Practices [Member] | May 2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest', window );">Acquisition cost payable in two principal installments including accrued interest</a></td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfFourClinicPracticesMember', window );">Acquisition Of Four Clinic Practices [Member] | May 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest', window );">Acquisition cost payable in two principal installments including accrued interest</a></td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfNineClinicPracticesMember', window );">Acquisition Of Nine Clinic Practices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinic practices acquired | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes issued for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration', window );">Business acquisition number of installments to payment of purchase consideration | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfNineClinicPracticesMember', window );">Acquisition Of Nine Clinic Practices [Member] | June 2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest', window );">Acquisition cost payable in two principal installments including accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfNineClinicPracticesMember', window );">Acquisition Of Nine Clinic Practices [Member] | June 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest', window );">Acquisition cost payable in two principal installments including accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfTwelveClinicPracticesMember', window );">Acquisition Of Twelve Clinic Practices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinic practices acquired | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes issued for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration', window );">Business acquisition number of installments to payment of purchase consideration | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfTwelveClinicPracticesMember', window );">Acquisition Of Twelve Clinic Practices [Member] | November 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest', window );">Acquisition cost payable in two principal installments including accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfTwelveClinicPracticesMember', window );">Acquisition Of Twelve Clinic Practices [Member] | November 2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest', window );">Acquisition cost payable in two principal installments including accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfEightClinicPracticesMember', window );">Acquisition Of Eight Clinic Practices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of clinic practices acquired | Clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes issued for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration', window );">Business acquisition number of installments to payment of purchase consideration | Installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued', window );">Seller notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfEightClinicPracticesMember', window );">Acquisition Of Eight Clinic Practices [Member] | February 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest', window );">Acquisition cost payable in two principal installments including accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfEightClinicPracticesMember', window );">Acquisition Of Eight Clinic Practices [Member] | February 2018 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest', window );">Acquisition cost payable in two principal installments including accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfSingleClinicPracticesMember', window );">Acquisition Of Single Clinic Practice [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for acquisition of interest in clinic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business acquisition cost of acquired entity debt issued on the date of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionCostOfAcquiredEntityDebtIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisition number of installments to payment of purchase consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of business acquisition principal installments payable at cost of acquired by entity at accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net tangible asset acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of acquired finite-lived intangible assets in business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationAcquiredFiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the redeemable noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationAcquisitionFairValueOfRedeemableNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-competition agreements recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompetitionAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of referral relationships at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedReferralRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tradename recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTradename</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EstimatedFairValueOfNetTangibleAssetsAcquiredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NumberOfSubsidiariesAcquiredClinicPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents number of subsidiaries of the entity acquired clinic practices during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NumberOfSubsidiariesAcquiredClinicPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PaymentsToAcquireBusinessesConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to acquire businesses total consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PaymentsToAcquireBusinessesConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfSeventeenClinicPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfSeventeenClinicPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=usph_JanuaryTwoThousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=usph_JanuaryTwoThousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=usph_JanuaryTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=usph_JanuaryTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_WorkforcePerformanceSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_WorkforcePerformanceSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfFourClinicPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfFourClinicPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=usph_MayTwoThousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=usph_MayTwoThousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=usph_MayTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=usph_MayTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfNineClinicPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfNineClinicPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=usph_JuneTwoThousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=usph_JuneTwoThousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=usph_JuneTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=usph_JuneTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfTwelveClinicPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfTwelveClinicPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=usph_NovemberTwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=usph_NovemberTwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=usph_NovemberTwoThousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=usph_NovemberTwoThousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfEightClinicPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfEightClinicPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=usph_FebruaryTwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=usph_FebruaryTwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=usph_FebruaryTwoThousandEighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=usph_FebruaryTwoThousandEighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfSingleClinicPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_AcquisitionOfSingleClinicPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811862224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward', window );"><strong>Changes in Carrying Amount of Redeemable Non-Controlling Interest [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent', window );">Beginning balance</a></td>
<td class="nump">$ 69,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Operating results allocated to mandatorily redeemable non-controlling interest partners</a></td>
<td class="nump">3,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests', window );">Distributions to mandatorily redeemable non-controlling interest partners</a></td>
<td class="num">(3,272)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Changes in the redemption value of mandatorily redeemable non-controlling interest</a></td>
<td class="nump">6,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest', window );">Payments for settlement of mandatorily redeemable non-controlling interest</a></td>
<td class="num">(2,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Purchases of businesses - initial liability related to mandatorily redeemable non-controlling interests</a></td>
<td class="nump">10,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent', window );">Ending balance</a></td>
<td class="nump">83,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CarryingAmountOfRedeemableNonControllingInterestAbstract', window );"><strong>Carrying Amount of Redeemable Non-Controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated', window );">Contractual time period has lapsed but holder's employment has not been terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated', window );">Contractual time period has not lapsed and holder's employment has not been terminated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,454<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired', window );">Holder's employment has terminated and contractual time period has expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired', window );">Holder's employment has terminated and contractual time period has not expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue', window );">Redemption value prior to excess distributed earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_ExcessDistributionsOverEarningsAndLosses', window );">Excess distributions over earnings and losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,649)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent', window );">Redeemable non-controlling interests</a></td>
<td class="nump">$ 69,190<span></span>
</td>
<td class="nump">$ 83,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired', window );">Business acquisition, percentage of limited partnership acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired', window );">Business acquisition, percentage of limited partnership acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed', window );">Percentage of equity interest of subsidiary contributed for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired', window );">Business acquisition, percentage of general partnership interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BusinessAcquisitionConsiderationPayableTermOfNote', window );">Business acquisition, consideration payable, term of note</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_EmploymentAgreementRenewalTerm', window );">Employment agreement renewal term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder', window );">Non-Compete agreement term under condition of termination of employment of employed selling shareholder</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TermOfEmploymentAgreement', window );">Employment agreement term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementBasicTerm', window );">Non-Compete agreement term regardless of whether the selling shareholder is employed</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders', window );">Required redemption term, under condition of termination of employment of employed selling shareholders</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember', window );">Therapy Practice [Member] | NewCo. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_TermOfEmploymentAgreement', window );">Employment agreement term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_NonCompeteAgreementBasicTerm', window );">Non-Compete agreement term regardless of whether the selling shareholder is employed</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders', window );">Required redemption term, under condition of termination of employment of employed selling shareholders</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redemption value, as if currently redeemable, of redeemable noncontrolling interest classified as temporary equity and the election has been made to accrete changes in redemption value to the earliest redemption date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 24(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that is required to be paid, determined under the conditions specified in the contract, if as of the reporting date, the holder of the share has exercised the right to or the shares are mandatorily redeemable after one year from the reporting date or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6940734&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionConsiderationPayableTermOfNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the term of the note issued for consideration payable for the acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionConsiderationPayableTermOfNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of equity interest in subsidiary contributed for acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfEquityInterestInSubsidiaryContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of general partnership interest acquired in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfGeneralPartnershipInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the percentage of limited partnership interest acquired in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BusinessAcquisitionPercentageOfLimitedPartnershipInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CarryingAmountOfRedeemableNonControllingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CarryingAmountOfRedeemableNonControllingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ChangesInCarryingAmountOfMandatorilyRedeemableNonControllingInterestsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to amount of contractual time period had not lapsed and holder's employment had not been terminated as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ContractualTimePeriodHadNotLapsedAndHoldersEmploymentHadNotBeenTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to amount of contractual time period had lapsed but holder's employment had not been terminated as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ContractualTimePeriodHasLapsedButHoldersEmploymentHasNotBeenTerminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The distributions during the period for redemption of mandatorily redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DistributionsToLmitedPartnersAndRedeemableNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_EmploymentAgreementRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the renewal term of the employment agreement with the subsidiary entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_EmploymentAgreementRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_ExcessDistributionsOverEarningsAndLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to distributions in excess of earnings and undistributed (loss) earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_ExcessDistributionsOverEarningsAndLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to holder's employment has terminated and contractual time period has expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to holder's employment has terminated and contractual time period has not expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_HoldersEmploymentHasTerminatedAndContractualTimePeriodHasNotExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the amount of increase due to revaluation fair value of redeemable non-controlling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_IncreaseDueToRevaluationFairValueOfRedeemableNonControllingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonCompeteAgreementBasicTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the term of non-compete agreement regardless of whether the Selling Shareholder is employed by the subsidiary entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonCompeteAgreementBasicTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the term of non-compete agreement under the condition if an Employed Selling Shareholders' employment is terminated (if the Selling Shareholder becomes an Employed Selling Shareholder).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_NonCompeteAgreementTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the required redemption term under condition of termination of an Employed Selling Shareholder's employment with subsidiary , regardless of the reason for such termination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_RequiredRedemptionTermUnderConditionOfTerminationOfEmploymentOfEmployedSellingShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_TermOfEmploymentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refers to the term of employment agreement with the subsidiary entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_TermOfEmploymentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_TherapyPracticeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=us-gaap_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=us-gaap_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6813405680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REDEEMABLE NON-CONTROLLING INTERESTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract', window );"><strong>REDEEMABLE NON-CONTROLLING INTERESTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Initial value of redeemable non-controlling interests</a></td>
<td class="nump">$ 11,940<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_REDEEMABLENONCONTROLLINGINTERESTSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823320016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 226,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the period</a></td>
<td class="nump">40,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill adjustments for purchase price allocation of business acquired</a></td>
<td class="nump">954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 267,957<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=73531572&amp;loc=d3e961-128460<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6809232368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET - Intangible Assets, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 48,321<span></span>
</td>
<td class="nump">$ 38,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Tradenames [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">26,352<span></span>
</td>
<td class="nump">21,234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">18,613<span></span>
</td>
<td class="nump">14,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 6,214<span></span>
</td>
<td class="nump">5,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total</a></td>
<td class="nump">$ 3,356<span></span>
</td>
<td class="nump">1,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 3,781<span></span>
</td>
<td class="nump">$ 3,380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6811819024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET - Amortization Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">$ 687<span></span>
</td>
<td class="nump">$ 520<span></span>
</td>
<td class="nump">$ 1,340<span></span>
</td>
<td class="nump">$ 998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Tradenames [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">481<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="nump">939<span></span>
</td>
<td class="nump">675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Total amortization expenses</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 401<span></span>
</td>
<td class="nump">$ 281<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6827618752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTANGIBLE ASSETS, NET - Amortization of Tradename, Referral Relationships and Non-Competition Agreements (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember', window );">Referral Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2017</a></td>
<td class="nump">$ 1,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2018</a></td>
<td class="nump">2,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2019</a></td>
<td class="nump">1,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2020</a></td>
<td class="nump">1,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2021</a></td>
<td class="nump">1,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix', window );">2022</a></td>
<td class="nump">1,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven', window );">2023</a></td>
<td class="nump">1,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight', window );">2024</a></td>
<td class="nump">1,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine', window );">2025</a></td>
<td class="nump">1,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen', window );">2026</a></td>
<td class="nump">1,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven', window );">2027</a></td>
<td class="nump">971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve', window );">2028</a></td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen', window );">2029</a></td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2017</a></td>
<td class="nump">860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2018</a></td>
<td class="nump">883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2019</a></td>
<td class="nump">810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2020</a></td>
<td class="nump">597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2021</a></td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix', window );">2022</a></td>
<td class="nump">$ 88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense expected to be recognized during the eighth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense expected to be recognized during the eleventh fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearEleven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense expected to be recognized during the ninth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearNine</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense expected to be recognized during the seventh fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense expected to be recognized during the sixth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearSix</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense expected to be recognized during the tenth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTen</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense expected to be recognized during the thirteenth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearThirteen</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense expected to be recognized during the twelfth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwelve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=usph_ReferralRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6632322032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Salaries and related costs</a></td>
<td class="nump">$ 15,692<span></span>
</td>
<td class="nump">$ 10,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_PatientsAndPayorsRelatedLiability', window );">Credit balances due to patients and payors</a></td>
<td class="nump">4,368<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedInsuranceCurrent', window );">Group health insurance claims</a></td>
<td class="nump">2,772<span></span>
</td>
<td class="nump">2,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable to USPH shareholders</a></td>
<td class="nump">2,516<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">5,887<span></span>
</td>
<td class="nump">4,808<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 31,235<span></span>
</td>
<td class="nump">$ 21,756<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_PatientsAndPayorsRelatedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred due to patients and payors . Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_PatientsAndPayorsRelatedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6826644864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT - Summary of Notes Payable and Credit Agreement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt, Total</a></td>
<td class="nump">$ 75,696<span></span>
</td>
<td class="nump">$ 51,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="num">(2,345)<span></span>
</td>
<td class="num">(1,227)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long term portion</a></td>
<td class="nump">73,351<span></span>
</td>
<td class="nump">50,596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt, Total</a></td>
<td class="nump">$ 69,000<span></span>
</td>
<td class="nump">46,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 4.0% notes payable due in next year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt, Total</a></td>
<td class="nump">$ 6,696<span></span>
</td>
<td class="nump">$ 5,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Annual installments</a></td>
<td class="nump">$ 2,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 4.0% notes payable due in next year [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember', window );">3.25% through 4.0% notes payable due in next year [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest accrued</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=usph_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6826368144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 05, 2013</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Aggregate principal payment due in 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Aggregate principal payment due in 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,351,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember', window );">Notes Payable [Member] | 2015 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Aggregate principal payment due in 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Aggregate principal payment due in 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Aggregate principal payment due in 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 575,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember', window );">Notes Payable [Member] | 2016 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Aggregate principal payment due in 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Aggregate principal payment due in 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 819,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">444,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember', window );">Notes Payable [Member] | 2017 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate amount of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Aggregate principal payment due in 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Aggregate principal payment due in 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,025,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Percentage of unused commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member] | Notes Payable [Member] | 2015 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member] | LIBOR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum [Member] | Base Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Percentage of unused commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member] | Notes Payable [Member] | 2015 Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member] | LIBOR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member] | Base Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Revolving credit facility maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 30,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining revolving credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=usph_CreditAgreementMember', window );">Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement', window );">Cash and noncash consideration with respect to acquisition after amendment</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=usph_CreditAgreementMember', window );">Credit Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_DividendsCashAfterAmendment', window );">Cash dividends after amendment</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and noncash consideration that could pay with respect to acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_CashAndNoncashConsiderationWithRespectToAcquisitionAfterAmendement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_DividendsCashAfterAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_DividendsCashAfterAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=usph_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_TwoThousandFifteenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_TwoThousandFifteenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_TwoThousandSixteenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_TwoThousandSixteenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=usph_TwoThousandSeventeenAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=usph_TwoThousandSeventeenAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=usph_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=usph_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823174048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long Term Debt By Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">During the twelve months ended June 30, 2018</a></td>
<td class="nump">$ 2,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">During the twelve months ended June 30, 2019</a></td>
<td class="nump">73,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Payments/Long term debt, Total</a></td>
<td class="nump">$ 75,696<span></span>
</td>
<td class="nump">$ 51,823<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6812489840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2009</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2008</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Common stock authorized by the Board of Directors (in shares)</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Total purchased shares (in shares)</a></td>
<td class="nump">859,499<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_AdditionalEstimatedRepurchaseOfCommonStock', window );">Additional estimated shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Closing price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_MaximumPercentageOfRepurchaseOfCommonStock', window );">Maximum percentage of repurchase of common stock</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock', window );">Bank credit agreement to permit share repurchases of common stock</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_AdditionalEstimatedRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional estimated repurchase of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_AdditionalEstimatedRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bank credit agreement to permit share repurchases of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_BankCreditAgreementToPermitShareRepurchasesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_usph_MaximumPercentageOfRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of repurchase of common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">usph_MaximumPercentageOfRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>usph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>49
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MUQ]^5V'KM=F9?VQ\$>Q:^'47W1=02P,$%     @ I70'2YE<G",0!@  G"<
M !,   !X;"]T:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T
M$W-I=MNTF83M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY
M\^XN8NB&B)3R>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2
MP]R"BPA+>!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?
M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA
M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M
M&N#C\7@XMLO2BW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_K
MFVB<"HU;3]-K=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K
M>A(5M>5 TR  6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T
M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)
MI#-ZG7TZSFN4?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R
M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M[\4P<X>%XOWX/1%-'S75'U!+ P04    " "E= =+CEL/G<<$   6&   &
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MQ&,G.722@T%1O2QSTTNJQFUE)0EV44 7!7"1*1>%S95%^P BR2.SQ"7XUD^
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M+W-H965T,3,N>&UL?5-AC]0@$/TKA!]P[+)5UTW;Y/:,T423S1GU,]M.6W+
M5*#;\]\+M%>K-GX!9ICWYLTPY"/:)]<!>/*LE7$%[;SO3XRYJ@,MW!WV8,)-
M@U8+'TS;,M=;$'4":<7X;O>::2$-+?/DN]@RQ\$K:>!BB1NT%O;G&12.!=W3
M%\>C;#L?':S,>]'"%_!?^XL-%EM8:JG!.(F&6&@*>K\_G;,8GP*^21C=ZDQB
M)5?$IVA\K NZBX) 0>4C@PC;#1Y J4@49/R8.>F2,@+7YQ?V]ZGV4,M5.'A
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MV7A\V=C_VA@/*&5SA2/4X@>;#0FU#\<;/-MQS$;#FV[Z06S^QL4O4$L#!!0
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MLK'_E3$>4,KF"D>HP0\V&PHJ'XZ?\6S',1L-;[KI!['Y&^=_ 5!+ P04
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M_T9K!UY*<N5'J/,?;#$$-"X<;_W93&,V&4[W\P\BRS<NWP%02P,$%     @
MI70'2^;B=OK& 0  -P0  !D   !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
M=53;;MLP#/T501]0)8J=!H%MH&E1;, &!!VV/2LV?4%U\20Y[OY^DNRZ7J:]
M6")U> XIBLY&I5]-"V#1F^#2Y+BUMC\28LH6!#-WJ@?I3FJE!;/.U TQO096
MA2#!"=UL]D2P3N(B"[ZS+C(U6-Y).&MD!B&8_GT"KL8<;_&[XZ5K6NL=I,AZ
MUL WL-_[LW8665BJ3H TG9)(0YWCA^WQE'I\ /SH8#2K/?*57)1Z]<;G*L<;
MGQ!P**UG8&ZYPB-P[HE<&K]F3KQ(^L#U_IW].=3N:KDP X^*_^PJV^;X@%$%
M-1NX?5'C)YCK23&:B_\"5^ .[C-Q&J7B)GQ1.1BKQ,SB4A'L;5H[&=9Q.MGO
MY[!X )T#Z!)P"#ID$@J9/S'+BDRK$>GI[GOF6[P]4G<WI7>&JPAG+GGCO->"
M)KN,7#W1C#E-&+K";!<$<>R+!(U)G.@_X30>OHMFN OAN[7ZX3_Z290@"03)
M7R4F-R7&,&E<)(V*I!&"_8U(#'-_(T)6C1.@F_!D#2K5(,.XK+S+5#S0T/@/
M^#127YEN.FG015GW?$*3:Z4LN%0V=RZ7UDWQ8G"HK=_>N[V>WO)D6-7/8TJ6
M?T7Q!U!+ P04    " "E= =+(A39\K<!  #2 P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970R,"YX;6QM4^UNVR 4?17$ Q2'.&T6V9::3E4GK5+4:=MO8E_;
MJ'RX@./V[0?8\;S.?X![.>?<#R[9H,VK;0$<>I="V1RWSG4'0FS9@F3V1G>@
M_$VMC63.FZ8AMC/ JDB2@M DN262<86++/I.ILAT[P17<#+(]E(R\W$$H8<<
M;_#5\<*;U@4'*;*.-? #W,_N9+Q%9I6*2U"6:X4,U#F^WQR.:<!'P"\.@UV<
M4:CDK/5K,+Y5.4Y"0B"@=$&!^>T"#R!$$/)IO$V:> X9B,OS5?TQUNYK.3,+
M#UK\YI5K<[S'J(*:]<*]Z.$)IGIV&$W%?X<+" \/F?@8I18VKJCLK=-R4O&I
M2/8^[ES%?1AO=E?:.H%.!#H3]I% QD Q\Z_,L2(S>D!F['W'PA-O#M3WI@S.
MV(IXYY.WWGLI:+K/R"4(39CCB*$+S&9&$*\^AZ!K(8[T/SI=IV]7,]Q&^G89
M?7^W+I"N"J11(/VGQ"^?2ES![))/0<BBIQ),$Z?)HE+W*D[RPCL/[#V-;_(7
M/D[[,S,-5Q:=M?,O&_M?:^W IY+<^!%J_0>;#0&U"\<[?S;CF(V&T]WT@\C\
MC8L_4$L#!!0    ( *5T!TOJZGE*S0$  )P$   9    >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;&U4;6_;(!#^*X@?4!P2NUMD6VHZ59NT25&G=9^)?7Y1
MP;B X^[?#[#C>AY? G=^7NX(1SI*]:H; (/>!>]TAAMC^B,ANFA ,'TG>^CL
METHJP8P-54UTKX"5GB0XH5&4$,':#N>ISYU5GLK!\+:#LT)Z$(*I/R?@<LSP
M#M\2SVW=&)<@>=JS&GZ"^=6?E8W(HE*V CK=R@XIJ#+\L#N>$H?W@)<61KW:
M(]?)1<I7%WPK,QRY@H!#89P"L\L5'H%S)V3+>)LU\6+IB.O]3?W)]VY[N3 -
MCY+_;DO39/@31B54;.#F68Y?8>XGQFAN_CM<@5NXJ\1Z%))K_XN*01LI9A5;
MBF#OT]IV?AUG_1LM3* S@6X(9#+RE7]AAN6IDB-2T]GWS/W%NR.U9U.XI#\*
M_\T6KVWVFM-XEY*K$YHQIPE#5Y@/!+'JBP4-69SH?W0:IN^#%>X]?;]V_QR%
M!0Y!@8,7./S3(MVT&,+LPR9QT"0."!PV)B%,'#9)@B9)0"#9F(0P]QL3LKH=
M E3MYT*C0@Z=G\E5=AF]!^IOUP=\FML?3-5MI]%%&GM'_4VJI#1@2XGN;,.-
M?2J6@$-EW/;>[M4T,%-@9#^_!61YD/*_4$L#!!0    ( *5T!TL7T"WVN0$
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M-9>@+-<*&6@*_+@]GK* CX"?'$:[VJ/0R47KEQ!\J0N\"89 0.4" _/+%9Y
MB$#D;?R>.?$B&0K7^QO[I]B[[^7"+#QI\8O7KBOP>XQJ:-@@W+,>/\/<3X;1
MW/Q7N(+P\.#$:U1:V/B+JL$Z+6<6;T6RUVGE*J[CS'\K2Q?0N8#>%9!)*#K_
MR!PK<Z-'9*:S[UFXXNV1^K.I0C(>1?SFS5N?O9;TL,W)-1#-F-.$H2O,&X)X
M]D6"IB1.]+]RFB[?)1WN8OENK?[AD";8)PGVD6#_3XOTKL449I<6R9(B68)@
M?R>2PF1W(F1U<1),&Y^L194>5!R757:9BD<:+_X-/HW4-V9:KBRZ:.>?3[SD
M1FL'WLKFP7OI_!0O@8#&A>T[OS?36YX"I_MY3,GR7U'^!5!+ P04    " "E
M= =+7XV%H2D%   9'@  &0   'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6R5
M6>MNHT88?16+!UB8*Q#9EN+$:2JU4K2KMK^)/;YHN;B X^W;%S!A[9GS>4U^
MQ :?[S;,.=\,,ST5Y?=J9TP]^9&E>37S=G5]>/#]:K4S65)]*0XF;W[9%&66
MU,UEN?6K0VF2=6>4I3X/ NUGR3[WYM/NWELYGQ;'.MWGYJV<5,<L2\K_%B8M
M3C./>9\WONZWN[J]X<^GAV1KOIGZK\-;V5SY@Y?U/C-YM2_R26DV,^^1/;R&
M06O0(?[>FU-U\7W2EO)>%-_;B]_7,R]H,S*I6=6MBZ3Y^#!/)DU;3TT>__9.
MO2%F:WCY_=/[2U=\4\Q[4IFG(OUGOZYW,R_R)FNS28YI_;4XO9J^(.5-^NK_
M,!\F;>!M)DV,59%6W?_)ZEC51=9[:5+)DA_GSWW>?9YZ_Y]FV(#W!GPP$/RF
M@>@-Q&# V4T#V1O(>PU4;Z & ZEO&NC>0-\;(>P-PL& R9L&46\060;^^7%T
MS_<YJ9/YM"Q.D_(\10])RP3V$#4S:-7>["9,]UOSB*OF[L><:SWU/UI'/69Q
MQO +3,2N(4L7\A/A-PD,67"4Q8([YER'UR&>$":ZQCPC3&RE"C!A<(UYN2/6
M;\B/-2RO",/QP CX>$3G0%PY$-B!A YDYT!>.9#6B"",PD$4#**  WL2G3&J
MP^0=1MD3;7D;<Y6(AHEHD(@UCQ;:"2+MV7P3<I5&"-,(01K6]%F&3@P>XA@1
MC!&!&/94CYP8Q&C&,$3LAH@LIBP1AA@K%F %"H +;NO+&11>E,*:!CW\$1$)
MS6,@HK C(I DXD!5>V0<N%"6C$"0Q=#77X"ND\%*P@1P81.P!UT.LPC)T<6*
MPX"<1*$="($B(@X6'094)[(9@$ Q50_6% 9$)7;ZGW8&3JKHUM3$RL& =,0.
M&9"^$(+-L'HP(!^Q0P&D,50<+"$,Z$-L]Q\$HN)P+"(<B$AL46W)71$AG@['
MPL&!)L1VH^M!.$J?"'.$F4H$*PL'>A#;'.M!]T3!DL&!9,2172Z0C"!2EQ._
M7[\!8!1P![@$0!G%H0-\ 4 5AY+D',>"Q8$6Q3'A FL15_>OTSB6&8YDQEG?
MNC*C;H@,QR+#7?T0I NL'SP:43"6!NZR7@2VKD(0M8+&TB!<:1 !D:K O!?L
M_FH%9JQP&>M6"T%$FQ?$AL'EK @(+168#T*.J!;S0;AM%U2+0%2UF#3")8T(
MB#6NP&00X8AJ,1F$VR=%8&\[(,C>%/P"=)T,II5 C"'43&+&R&#$KA,S1KJ=
M4C!;Z"&(V#Q(3"L)&,/L]1($4?5@6DE *^;LHQ&(BD-LU]U>)!A!7XFY)T?T
M(HEI)0&MF+U7@" J#N:>!(V($;M@B;DG1S0BB1DC 6/<:A&(B*,PK11H1(P@
MM\*T4B,:D<*,48@,SHN8$8Q1F#$*D8'0(87)H$8T(D6\F0(]QM$A!.+$>DAA
MQBA$!EN'$(@3>J<P8Q1BC*U#"$3&P;12H!%Q8MVE,*U4?/_3TY@Q&C"&V[M4
M#5X-Q1'Q^#3FE0:=B-O#JMV-W8U F'T:$(L3^JXQL?2(=\(:$TNC+F-K  )Q
MZFTL9I]&Q"+T71-O=/6(:C%G-.*,4RWB#"'.&G-&(\X0BJ<Q9_0(SH28,R'J
M,G:U".0HA']QAI29<MN=,5:357',ZS;'B[O#.>9C=U)GW5^PAV<&[B_9P\OY
ME/*G^_.AZ9])N=WGU>2]J.LBZ\ZG-D51FR;WX$LSJ78F60\7J=G4[=>P^5Z>
M#RO/%W5QZ ]B_>$T>/X_4$L#!!0    ( *5T!TME96E_P0(  $$,   9
M>&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;)67W8Z;,!"%7P7Q  L>DU\ED394
M52NU4K15VVMOXB1H 5/;2;9O7]L0EDW&E?<F8'/FS!CSP61Q$?)%'3G7T6M5
MUFH9'[5NYDFBMD=>,?4@&EZ;*WLA*Z;-4!X2U4C.=BZH*A-(TW%2L:*.5PLW
MMY&KA3CILJCY1D;J5%5,_EWS4ER6,8FO$T_%X:CM1+):-.S ?W#]L]E(,TIZ
MEUU1\5H5HHXDWR_C1S+/86(#G.)7P2]J<![9I3P+\6('7W?+.+45\9)OM;5@
MYG#F.2]+ZV3J^-.9QGU.&S@\O[I_=HLWBWEFBN>B_%WL]'$93^-HQ_?L5.HG
M<?G"NP6-XJA;_3=^YJ61VTI,CJTHE?N-MB>E1=6YF%(J]MH>B]H=+YW_-0P/
M@"X ^@ R_F\ [0+H34#25N:6^HEIMEI(<8EDNUL-LP\%F5-S,[=VTMT[=\VL
M5IG9\XK2=)&<K5&G6;<:&&C(>T5^KZ#T39.8"OHR "MC#7<&<),"44SQ#!1=
M*'7QV;L2 3?(4(/,&=!W!A0W&*$&(Z2"[.96WVM@C.<8HSG&]SG2R4T.1$-'
M>)()FF2"&(QODK2:D=/43C/#4TS1%%,DQ00WF*$&L_#=(BE.1AJP7ZC(\UP2
M#X$D8,\P$?7<48(B]D@@8-LZT7#?,D\6'#."<):E'@L<-/(!T@B.&@EA#1-E
MGK<6P7$C(;QA(N_>X<21$.3(/7/$PPS!J2,(=IGG)4EP[L@'P ,</ @ +\=$
MF2\/#AX$@)>C(@_@@(,' >#E< ^>+PL.'F#@>=@%'#SX 'B @P<!X.68*/-\
M@0 '#P+ RS&1[TL'.'@0 %X."'BWU"2#AJSB\N!Z5Q5MQ:EVC?-@MN^/'\$U
M=&_RMKG^SN2AJ%7T++1I"UWSMA="<U-*^F"*.)I^OA^4?*_MZ<2<R[:I;0=:
M-%W#GO3_&E;_ %!+ P04    " "E= =+V(\UFP<'  !G+0  &0   'AL+W=O
M<FMS:&5E=',O<VAE970R-BYX;6R5FMMNVT80AE]%T'VB/1\,VT#EHX 6"%*T
MO:9MVA8BB2I%V^G;EZ1H1=KYAR!S$4GT[,X,N=\_N\L]_RC*'[O7/*\F/]>K
MS>YB^EI5V[/9;/?XFJ^SW==BFV_JOSP7Y3JKZI_ERVRW+?/LJ6VT7LV4$&ZV
MSI:;Z>5Y>^U;>7E>O%6KY2;_5DYV;^MU5OXWSU?%Q\543C\O?%^^O%;-A=GE
M^39[R?_,J[^VW\KZU^S0R]-RG6]VRV(S*?/GB^EO\FPA16A:M"9_+_./W='W
M29/+0U'\:'XLGBZFH@DI7^6/5=-'5G^\YU?Y:M5T50?R;]?K]."T:7C\_;/W
MVS;[.IN';)=?%:M_ED_5Z\4T3"=/^7/VMJJ^%Q_W>9>1G4ZZ]'_/W_-5;=Y$
M4OMX+%:[]O_)X]NN*M9=+W4HZ^SG_G.Y:3\_NOX_F^$&JFN@#@VT[VV@NP;Z
MT$#)W@:F:V!^>0B]#6S7P YMX+H&;F@#WS7P0QN$KD$8FG3L&L1?'O9#9/_\
MV@%QG579Y7E9?$S*_:#>9@T[\BS60^ZQN=B.L/9O]9C8U5??+[5QY[/WIJ/.
M9KZW42<V_M3F"MF$4YMK9!-/;6Z C16G-K?(1I[:W"$;=6IS3VV42V)>H'[T
MP696W]O##5;P!JNV WW<@68ZT+ #W79@3B(P2;9[&]_:;%H;Z:RH_R79 #LA
M3NQ. C(P( ,"LHFCO8T]<J2P"PM=6. B&94+2W+QELW$03<.N$D&]ITCF6CM
MG"7W]M[1>ZNB#?0AT!Z5=DJSL7L8NP>Q)X/WSA-/>%@ N[YA$6!  024T'T7
MZ,VT6M*;N:"&RO3=HPA#BI0]QW0@!99'0;-*X>MLCH.UP8$'#PRE=WQ2DI%L
M26-R1/\D\!7!LP>&04<^)JQR4I&84F#O.IMC3U]DE!'$A"Q%7U18.B703J?2
ML#1]?%ZCJ*BAM'V/#\NG!/KI=!H4%5#CH@9! </DGIX&A057 L5U9*#;H6.*
M&@;C^9BP.DL@S\ZF,5$UM5(B^("0!Z'XH+#L2JJ[AK!']=0(&3T(BEIJI;WD
MH\+:*X'X.L(?%=4O4D;#"[W$LBHC\);6S<XH85@%!>X",@W!\Z-88;560*U)
M#>J,C@LU4X2 97\54EBP%1+LP'3!S")'3",5%D.%Q)#<'&#DN6RQOBF@;UXR
M76 U4G9$ME@\%!(/DBTP\LQ$56$]4& >YKE0,;PJC,@6$ZD0D21;8.0-]J,Q
M8!H YBW3!89!RQ$+(@R#II,-[1.UN]9T#B$]XX99> $61")S"V2D(^,' Z,1
M,#Y-QX"EF^^9I&N,ED9+*Y,F1==6ML\51E CNM(] 0U60XP7#* >L!!:=$:#
M$\*@:E!E/?>L,:@:+$FXT6\P@P8P&)+2=6U Z;)\P@:S:D#A"HR4&\RJ&5&X
M#.;0 ,1HPG1KHS=A9FL#H!B8\6@P8&9$[3(8' / 287G"AHQDPJ#T3&H=A$_
M%!VG^O:,,#L&;0^8U!>=H9H^5Y@Q ^I<J@A7G9$?Z,IB%BUBD7G8%C-F1]1#
MBQFS ^KAW-)ZR-1^BS&T \KA'!EQY=!B!NV <CBWM!RV\W+V^3'[C .JX=S2
M:M@G+19#;0=4P[D=7 TM1MH.J(9S2Y'N30@3;0'1@1M2F%0[HAHZ3* ;4 WG
M#FR\J9[-8DRJ0]60F?PZ3*H;40T=QM -J(9S!S;Z^Q+&)#I4#1W3!0;,C:B&
MCMFD1^"D>QN.@L.HCL/@. !.JFYWR$AS(P!3X] <DO@)]/&U;Q+8!XCY<J@2
MIKMZCE;"OKFQQQQZM#(D[R,HAXR\>8R@!PC2MQYR7$(850^*:F 6D!ZCZO7P
MP>\Q@AXA*-*$P=NV'CWW&%4/:F%@)I0>H^K=B(29UUH ,9HPW3;M31BCZ%$!
M8U3#8\#\B (6,#@!@9/(VTU !8QQ@\D)@)Q4WVZ0$:=O 6,3T%R4^%%4W_K?
M.&+ PH!WXS>!UL(^.0@8Q(!FI2%U-?BU=\ ,!C0?)5[&[<X$S&H 935R76!6
M@Q\Q^IF7QHA!D28,W@;WX!XPJP$4P\AL9D3,:A3#$XZ8PX@FD6G"D5:POH0C
M1C$"%",S'B,&+(ZH8!&#$Q$XB;[=1@H.4WDB!B<"<%)YNX5&G!],34234>('
M' 71?7LF$?,5T6+.I,[&;6U&S&%$T]*0N@(<,EZ8\Q@#=F9NX[CY:%TWH*_]
M]73X,V-7"N:HA1BQ.R,%<S9"H*DD.=0FZ 9-'_12,&<>!"B*D5F72\&<41!F
M3-[,F0*!9I0T[W';*U(PIP4$*FC,Y$4*YNV^&%'2FD.^N),A:[Q/*WH8+_$V
M.SK*V1Q!_B,K7Y:;W>2AJ*IBW9[=?"Z**J\[%5_K>_F:9T^''ZO\N6J^-I/[
M<G_R=_^C*K87^V/-L\/9ZLO_ 5!+ P04    " "E= =+W"9>A:T#  # $0
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M30=@HS<I!E.0SMKQ0*FI.Y#<W*D1!EQIE9;<8JG/U(P:>.-)4E 6QQ^HY/U
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MM-9-=SC7X9*%PJIQ?C]T><3E'U!+ P04    " "E= =+Y\'@9_@!   +!0
M&0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6QM5-N.VR 0_17+'[ X^)9$
MMJ7-5JM6:J5HJ[;/Q!E?M&"\0.+MWY>+U^LFO!AF.'/.' P4$Q>OL@-0P3NC
M@RS#3JEQCY"L.V!$/O 1!KW2<,&(TJ%HD1P%D+,M8A3A*,H0(_T05H7-'455
M\(NB_0!'$<@+8T3\/0#E4QENPH_$2]]VRB1058RDA9^@?HU'H2.TL)Q[!H/L
M^1 (:,KP<;,_Y 9O ;][F.1J'A@G)\Y?3?#M7(:1:0@HU,HP$#U<X0DH-42Z
MC;>9,UPD3>%Z_L'^;+UK+R<BX8G3/_U9=66X#8,S-.1"U0N?OL+L)PV#V?QW
MN +5<-.)UJ@YE?8;U!>I.)M9="N,O+NQ'^PXN94<SV7^ CP7X*4 .R].R';^
MA2A2%8)/@7![/Q+SBS=[K/>F-DF[%79--R]U]EHE\:9 5T,T8PX.@U>83P32
M[(L$]DD<\%UY$F,_0>SM,;8$\7\$L9\@\1(DEB!9$<2[[8U)A\DM9K 8C+-M
ME/EU4J].>J>3Q,F-CL.D*YTDVNQROTSFE<D\,NF-3'8GLTL3OTCN%<GO1:);
M+_G]GF7Y+KTU@U:'D8%H[3640<TO@WT"5MGEIC_:TX\^X>Z9^$%$VP\R.'&E
MKX0]N WG"G0WT8-VV^F7:0DH-,I,<ST7[GZZ0/%Q?GK0\OY5_P!02P,$%
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MD@NBR<3[2'!_$M>@-)GX(A+<H>0&BQ+<H\0U*5(M!H*)/+C]B.L_FM )"MR
MY 8' NY F./ #G3U\:51/#YL$ ,NXBDYN/]@CO_ ]1]-TO&!@:',D3$A!_<?
MN/YC;.(9 >X_N,%_@/L/YO@/ 0T/T>L\N/\ .2#9A(4!]Q_<X#_ _0=S_(>
MW*]-,)C52BX/=JQ5WE:<*CM3#W;[T?D![*SW 6_G[N^9/.25\EZ$-A.CG>OV
M0FANM(1WIFU',^KWBX+O=7.;F'O9SKOM0HNZF^6#_A^*]3]02P,$%     @
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M,G.!.,HFE)P=VJZ'!LEE!\:1^+LV,JC^'?5.^,E$])2%833Q3E*HP\Q;3##
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M7]8QQ->)Y_9P5&8BV:Q&>F _F?HU/@D]2A:77=NS0;9\B 3;K^-/</] <K/
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MM4^<*Z:U^$_ZDEST(-=M<G929AGKM6BFF6:C>-5.:EXW+J[_ E!+ P04
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MJ7FR-1&[E,QMB:%XMA5"?&C\)I%3-AQE,^-V2\/ :"G2F$VU-=QH*E 8W;9
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M<3"& F 8.?99PK%[O6/[*C U E 3F<4 BB)''$R, #!$CIDL, Q"W9$MAD&
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M@$BX<B(U"DJX_G>**Q>T[EFDE1J_F6?5Z&=GWB1)'V8/"/N < B0VO\+B/J
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M"C^Z<F39G5,?A3[]U-!DSFG &R,TI""YTBFO 3C[\HZ//M/7_NBM U0ZK#Y
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MTQ@4WV&ZU5%ZAIJG8,8G&6TRK/60S5)-8=-"-!6PA832W5LKTO@NT[@^;)]
MFFF1/R9SUVR)TS%:"B?4&21/TE:>G]9C"NH$F^HXSZQLU!;20D)ARR1?Q0>D
M%) @M)@/IY9Q707<%<9>8(6@ ZWOTPY-W)*J,6?0I"GE-'ABE?[#QHRS>I90
M[TE_NB?) 0#;OC'$V^@>&]6X5.]DAH2PL#G@Q->MJ=.#&QHA(.]/T/N@9M[&
M9P$MV24R(G_L#SOK3P+N(LTYWCN.#@Y'77<W!.8RV#\$YC&(AD<X[,$1XO-H
MV*<*EWO[^-_CXZ.P2Z5RA'SV-=C=I,>Q6,&DVU70.,F#EBT>9 R?(&!3=G56
M;BI8ZL[I*EAGJ^!81K]0CMJ8$92%F];?:#U !(_W^,\CH'U4 WP(9'"/_SPZ
MVN,NY_#>H?QY-,#WX)#U-_AS!-P;_ACXWP;1"-Z%/X;XVW"?_SPZPO\"C8^/
M!O3%/M;,/J9?1UB5]'B(?R)Q'NP-\,_#Z/B0_CCBB^X/CZ.6V('QR<G5Q].W
MT>G_OCP];VWV$#Y_+N?&7O?U(1H=*?XNW/I:>SG;-B03[/B,6#""TT7N/>C'
MHX-C+=GENKM*BR2MG</5=KA7\'Z\=W"$M5Z/^M&/'5U$YDFV $2,#P_AVN+]
MX^/H+18* NH3E-OX>'WY$UIJO4UD&(]@Z;O1!:DS(Y@$\!C$12UF_@+W-]P;
ML=QQ"-RZ?J'G%S=P!9?C7RAR8WS^-AI_.#U_"_=S<G7Z]NPF&O]X=7H*/S5$
MN>V_W! X<@0L9?MQQMHI<%V50,=),MVFE52SX=7O 6'7Z\5"7 *M2SBG)5S*
M$IZ"Q^80TFK&-_&H=<":1</>X4LNH%;B<_AEO20;YBR5&$2LO0P\XX#^^%E:
M7(5G0[+*BR'0_5%[]6RM@(VGL4R_5$1Z8U,GB-[W(8-:A7"O-QR]C#3J9K_7
M?XEZ"XE B^@ $.P (1BHVN&(_S&@?[U'G40+O:DM8H?7AV6,XR$0MU?1^QR%
M Y0R])T7T2%*J,C11H"V,.*I.SIWWB,Z[KW09Y/25J:NZ$AW5S'C 21WAQ;^
MH/3NC/LA<F8]=M\P]>/1-3?_C& DG2EGR80#$V4 UU]-DZ/KQ?"IMD%6FB("
M5 -1E@J'/U[?@?:'K\(F39>8 X)&:0Z#P+?C&6E[_;:N_8>EASKQ#RWI0-@G
M:RUZ2@&'>;*D_DG+A/017WY!#,):<U*LMZ[?.19+??3'')0BQ&*?W&O>MV8B
MN[I&]/F7L?&U?XZEXZ1 HTL@Z]P/-J "J80Q"PN3Y,4GNLEDE0'5C6ME3E<V
M*K5-"4!8 9 HJWSR*8ZF0OI-F^I\XV=!U2M9 S/3*9F1K,4+1&'L,\HUY*G)
MCY2,+[();N&NR$@9"IPI&XM(AN=H:@G[]O$E\/]$U(+W9V\NKH@FX'1TUH/>
MB J1#?&_6BZV_6M\A%(H=>L+1^GW!C3*X&4O>I>FVQ3:U%J3B.)"*"W:IATS
M](F.35,Z8/0G//^4:@5W,?QPC<S^>8R-KR[$;'R5U<?\R;VCDSN5$L3:C0$$
M=FE1W:C]%6(AFBT!0AO!3D'53Y_%O\5MP,<ON'<#<2=UQ<^R$FL5,I/ABLIV
MY:HHF,4A?N+2M,O$U E3V" >:YS6*X[8Y@HR(.6OYE(+&QONN(5I!36_+JPB
M6R!^,1LQI-7=!WF.$5@(#;,J73#-^SOL9+1Q)\U.3R\.C@WC0B9CP33?W/U2
M3-M2/N7%Z, ,A1H[.YN)\U$EJU:Q#"?P-4(R;2X8,FTR&',5C'F6:&MR6U[,
M<1M6'0DDPP)!OA%[:LHR?FZ5DZC QR)-N%Z<E,%%VXMUF&1:[ULQ@C0#RQ Z
M2]]W5]\,!@Q:,AC311!/W"K8A-O):KWN#6UZ,?"-[V*NKT)%6(.6)+X)6^(J
M@[TXD(YCOFV*ZXZUQ=>#N-_V_7'/Q N*K*F]H 5(:L*E6/@""9>\2ZUM9+8_
M>"=,V="5S;?ZC>YC9)%HZ^O8W]^GX[0-;P3'7;,Y=]+-[D(OC@;'^I)9)LNB
MC2O90W;^-[F#T=_C#O:]6^QY.#'B5CWU2SB 2Q@)N'M8!^'<C>WNR'[I<;^6
M2/ J1CCQKKL6% R?=^)6AQZ7_U8L&_MC98.:$WAA$O^-"W*Q<9U/ZOMT;]1S
M(+Q2+,\+ XJ\46,U1;K)?/C6>"^#*+*FE?@(#2ZDH3[CHV.OKXH&?$,V]"Y%
M<4=-L$G-I\NDUS#M5ZQ-<O6PIAY9-\J<7'SX<'$>7=]<G/S'IF<;[#H 1\&;
M[SC:U#?A[/O\FYKMHW_$^/DF3XJIMJ'_:QK&X)M(5A<!DH- #ALM/J44$Y!A
M4ZOL,U>4TIK_.(SO&H!5.%>D>L2*6R10;:6I$8E24:]_O&'1(*V80!Z><= G
M7<<XU-%S%P_[]66@!&&G=74[_=2@Z?-\25B':*-2SJ*Y2)!FB:5?HQ$5,7+E
M]E<1\>LBEI.K&JU?;(!:D5+0ENS,QZIYS:!K1]B$X*EWFK5I_ R)=!J!C1V-
MCLF^RJO0V X*IZL'X3G/4/V$,#H*&TK;R!"Q3V'KM*"5C'>T#=$_NK^O^]\)
M-&P-3?/]W [ZO?T^/@XP^Q5K8F* \#MDFP4F*2)MQ/^VXX0@1( #H29+*X@#
MN;PS/$U:96@,G;W[:38-ZQ5+*'074)M8ALWNMP:Q>C.^/J/^T9=7I]>GYS=C
M;"A-9N3KLQ_/S]Z=G8S1<GQR<O'Q_ :S$2\OWI^=G)U>1SN7H)YC@YQ7#2*'
M&SL%T/V<S)$A/?4\V+H6%2]YEZI8TQ^I^0;NT?;. $"IUM*3A )0\L4M%Q+D
MIC?>V4!EK#]3(6G[F2FV):K>NW1*;[WE5E:1;XE^(F8@,J4*/7GW]NS$M'MH
MMCC'\N^)K35<*?*0'0ZCF'WU*&%6159^<MX41"SIJA5Q"7^I/X93MTS9PPQ,
M#9^^16?[Y]18!&ELB81%USB%[X%@4;\MM SOOJ<@\C'Y?)]\(7IGV@81?E.#
M% H.0)=0#X_4!853_5NX_'5EXH\QPAB[:(+DF6I0@#-A=;C?U3U.T_9,&\3@
M+21+LW6QY! Q*@VJS8RL(]T57*-NGEH>5!K\E/FL>J!F$C42HA]1$W5UP+]'
M&P4:&3 \H4#Q89/3OP2B+'(H_A.#*=3]7VRU\]@7T_3Z>$O]N,9%G_G@"1BP
M>:NX^^:O,.:;%$LGH#ET&EW,?J=A R(!4EV6/E )0F#$0F/]/;8W#B-FZR)7
M%!9L:(HFDTBVL?CGM4&>U!:$;R99,5DOT(8S<6$?V)UDDFC+56^0*I7=\$08
M=..W>$O)!+Q%-.<PHT0 F*I.#K*TAX9&'%UAF_E1/4+VN4IMR&;<GT;*N#]<
MFS!I4.6HBK&ID;9$P/^,UH,.HIL?N1 Y'S07@JX8EO7DM8&;:)6UB^U%/V4E
MYIE+().+!G*=M\,DF)H]R:20L2#J^]X9L;-6;I\[*V23-5;7QC! FZOBLT::
M<<5M[<2]7TV-T2S)'\<:1-WL6)MTGKR-^\)WW&&?<+<ADQQ?UC,=F/,1C&<E
MPQ. LT2LY/DGC:5BT"1)"95-ITKH&%Q3EDC9+.%&91A'!$SFKRG7]K4][\CN
M[84^A+9=,MF2+T;XN4*^ R1WS=X]LQE.F  $X6M(!!#I)'BM1@]<"%N0:;:)
M.+"%'4=\*-!PCZ7>'B@+P"!!-G/N@71JR((E<"EW14Q]7\CZXC"<V,?:J0U
MRMPBSA!"9X5K;44IF<AH$R<KAIA)D>M$?=A_DGG?6?/TR3(1OAWX(!D$6YM:
M.O1PV!\T@%DD@/EKRA!1RS$CBJM=;_(XU/]F89H4"I@J7ZHUA(M,E^YRG(W)
M!4?FKK!0F=[1^:++:>Z4&''WX6#3E%,6]!#KNZH?(56KA>$Q]8[PM-HB;E'2
M,[N:D['H2#W=4-Z7_5$>CAD*2YX8&8!CY6]3BXJNRUE'51V._B7L(:(3;BX.
MHR6>C9&Q(SBA6-?D&.&\]?:2X?OU57(:)%\:24Z<N88X.0&V4;ZFM&<79>\3
MBIL)C Q!-DS2UP\)II2,N8R3MQ*FV]^[.=B-:?/CM.D"S4 )U F*!J2[I*+^
MS$ 6B'QSUS$   FG6=@MDE"3]^9TSW*]<%@K7R'UUH;"]&Y66KK4=2.<CNJ[
M%,LAPII[:2]NW6CL=L(>!@X1*ZF5FU)Y/4]\X15#]GHU510MTMD<K2<:QR(J
MN<\F$8@(>LEZ[!)7@VK5)ET$G58.:D5>X\22E'KD42YO.XG6.A8*XA2<\:AE
MJC-?C-KW;O29T(CE^,O428R,G3C5A+EKC2;8HF>^J^X[.7V6FR:U;!CI4F5&
MXNB.TDE8F"B92&=([5A4Y:^C?_GGP='>#R1,QJ0I,O%<+X7?:2_F?,)6P<X(
M;6PURVY,[9'ILO$(SUJ;:$H\(#L=X<8GH3^00 G/@Q7#?)[?<9AY6/?+"D>M
MO9V</URX%F5KB2V'I%T^/HDO)/M/+JV=2PG614J2<\X3($K%/2$PR5</4/)@
M@FZ<#)P@'B_I/-)E0C&[7%L!3H(C'">L#2#;:!\3+OA#BDH'OK>>:W/8-0 D
MJLT:BIDM;C%]3'.] )/GDAR5KPO'6FT[MXKBW=W8>.6F>S+FC^*QTH!X:>O:
MG@N$^S6R)VDT+"JU&Y#BI^@?V50B[HUY=)57B%#DNH#[2U@RAJM=3\0^:^;R
M"@3M]0Y3,?+B,<PST_N=B4&'HM0K"H'A+QK#^MM)+#=C>0IAZ9'C4]'JLDK5
M&"Y:*7+%SXBQV@^-F 9V@:T#1\T0W%S?/'D(MD;#6<BK./CH<S*AP$G?(A/;
M0%C>JSV@;9=96I?'X9D#&D "@$!M:Z,0HZ;KQW 7G 7H/ *6$NFMKCG@PH5K
M>&F+M54F+63!2H-V[YV 'X)UP3W;"^<H9,+@@M%JMV9APN!A(@V_:3E3AK=;
M1:M)O@O?8@8SLW2-56X'?3)'* _DH'R^O!J824,[E/+R!>AF'FS#%QOVY(FT
M-<5^U])P2+N2$K@"RUDI.:E<H]-P4+B$,E\N0<H%ND:[_:S#<U<[/)]/Z:-_
ML0F^:94A>L9^"T2&[>6$*9](<YA[*]-"\X@X.@10BC0O[A(44,G8,D?!6_4L
MT\S9)3'<HHJ-%>RDQA\\^%X^)/J=<Q\_O7+"&7B3!%'4T])=TM(P%)'^E<]F
M7>)L78*M75-WX&*WG60'Q-*P<E_YRLAM$]2FT=2'3^_"_@*-SM9-RTJX0"7Q
MN()EBB.CM:%I.NZ&OIC3OJ7Z"FM$(L+)1_A /GQ($SHV?X E%88!H!2QL=EO
M^IE% W_K]R32=5\.5\9A1CR7U)KRN;5&?1KLD^W#)5Z>KY,43JJ80,4AJ-J%
MXH&I5\A=.&/7MLD[TZ0H#BV.DO>E:H[0:'TO%G\OB?,D\\0.(QNAB\X4M<GZ
MUU@_GB(5</!Z6$LIFJ#.2'O)&:^FL4;-'OQ&(2F3.M?6B+.6G]X\3;8*N8XS
M6EF#+%YH57Q.\YE70>DL15T\EY;:2E_76^85$S6@25((Q]=NX8*=^%N]Q5FM
MH(=Q:F[3>:9VX!M/F<(B712BA293P+05CBBE/QA3"./&^7PC*L74QS:$:3=.
M=\*T&#$ET5^,\\N[77+.&*$%K3;VJ@.LUZ"3\CX%!=8[[X&&TC=MQ5.W(C&^
M0X0D;NI(SR96^J%T" ^)C1B X1:^_82^]I&6=VK4V?T*CO"[<8%_4/XM*#^Y
M,'3I1A3$TURD/MA,=HN3IV58+$U,O)VES?[;\1;MZ.O8BWAAZ S^P6M^*Z_I
M9NAHY?)-I7?(24]^G2D*JJ]$]6'P-V5S^%[$T&M"Z%S-05?SIS0&=0_KQB18
MM:Z-;I$\E=ADN,2S_/NQS.;R\-@,I^)):S%^WX*;?A6CO-J""C=R;[?E'9L9
MAH]&$']*N8$1),8=O"5+*%.X*@JE<Q[II&"+85"&DL?MV6832<>K[37?$HKK
MS:89U7E%NB]%S;PI>9KZ]9+MB.3C-!%>*%L+ N/4=VT7(I8%">XR!V5CN5I*
M8MDS3J([L@2POH^+0R\5Z/?HHB?\"_9#G,(>=B^Z1LH6#E)B+@K;GWR%DF>
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MD\Z>D_BJN#7;CYA2S0R:6T#Q"CYE!- L7# (?AP/#T/,F$J@,EK;PGB.E<!
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M%@7@F;9SQ%:(-[5 BQHLD]A3KVUBHA1(C4?*Y2E9@_#[-5_2D7%XIS 4;R9
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MN0-!)NS <:!%DHO<LR^?-$TN0OW"7SQ^**EO;GDN;UK)2(QR%VA$^+/+CK6
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MYONUC:7C,$A/6UW/6;-9,3=#;I"-T!ZFQM;G7%@X7',H)Y^5=#3QWFB(?PR
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M6Y)']DQZW&0L6[(M2_(GZW.L3#8F?01B!,[.^.:5@GBF).<TTB-><%)XSZN
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M     %]R96QS+RYR96QS4$L! A0#%     @ I70'2V;S"V""    L0   !
M             ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "E
M= =+BV"8>^\    K @  $0              @ &9 0  9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " "E= =+F5R<(Q &  "<)P  $P
M@ &W @  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *5T!TN($QH[
M? (  . (   8              "  ?@(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " "E= =+CEL/G<<$   6&   &
M@ &J"P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ I70'
M2S'&U'UA @  >@@  !@              ( !IQ   'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    ( *5T!TM"):P94 4  *4:   8
M      "  3X3  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M" "E= =+8*7^0/$$  !M&0  &               @ '$&   >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ I70'2[)6S<*0 P  K1$  !@
M             ( !ZQT  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    ( *5T!TL#%>6?M0$  -(#   8              "  ;$A  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "E= =+B/EUJ+0!  #2
M P  &               @ &<(P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ I70'2T8=%%.R 0  T@,  !@              ( !AB4
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( *5T!TN[4L;<
MM $  -(#   9              "  6XG  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ I70'2_\_]>VS 0  T@,  !D
M ( !62D  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "E
M= =+=+*:UK4!  #2 P  &0              @ %#*P  >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( *5T!TMS3ER<LP$  -(#   9
M          "  2\M  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#
M%     @ I70'2Y$"6\.U 0  T@,  !D              ( !&2\  'AL+W=O
M<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "E= =+!+':^+8!  #2
M P  &0              @ $%,0  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM
M;%!+ 0(4 Q0    ( *5T!TMPB"<2F (  *L*   9              "  ?(R
M  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ I70'2Y'9
M: ZX 0  T@,  !D              ( !P34  'AL+W=O<FMS:&5E=',O<VAE
M970Q-RYX;6Q02P$"% ,4    " "E= =+['U 7+<!  #2 P  &0
M    @ &P-P  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M *5T!TOFXG;ZQ@$  #<$   9              "  9XY  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ I70'2R(4V?*W 0  T@,  !D
M             ( !FSL  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    " "E= =+ZNIY2LT!  "<!   &0              @ &)/0  >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( *5T!TL7T"WVN0$
M -(#   9              "  8T_  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ I70'2X$F>QK! 0  -P0  !D              ( !
M?4$  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "E= =+
M7XV%H2D%   9'@  &0              @ %U0P  >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    ( *5T!TME96E_P0(  $$,   9
M      "  =5(  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ I70'2]B/-9L'!P  9RT  !D              ( !S4L  'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "E= =+W"9>A:T#  # $0
M&0              @ $+4P  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    ( *5T!TOG_-(4L@$  - #   9              "  >]6  !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ I70'2^?!X&?X
M 0  "P4  !D              ( !V%@  'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    " "E= =+2JP,Q_ "  !<#   &0
M@ $'6P  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( *5T
M!TL_EDU3GP(  )$)   9              "  2Y>  !X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ I70'2\%UUUN\ @  ?@L  !D
M         ( !!&$  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
M    " "E= =+,C =S2H"  ")!@  &0              @ 'W8P  >&PO=V]R
M:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( *5T!TN5]AL%M (  #H*
M   9              "  5AF  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL
M4$L! A0#%     @ I70'2YA=X,JJ!   IQD  !D              ( !0VD
M 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " "E= =+',U7
M3-<!  "A!   &0              @ $D;@  >&PO=V]R:W-H965T<R]S:&5E
M=#,V+GAM;%!+ 0(4 Q0    ( *5T!TNB"<JR7 (  'P'   9
M  "  3)P  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @
MI70'2R(L5YLH>0  />L! !0              ( !Q7(  'AL+W-H87)E9%-T
M<FEN9W,N>&UL4$L! A0#%     @ I70'2^VAJ6,O @  ? D   T
M     ( !'^P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "E= =+^K.N2"8#
M  !_&   #P              @ %Y[@  >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ I70'2]G7G$23 0  )!<  !H              ( !S/$  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ I70'2Z8<<E^? 0
MDQ<  !,              ( !E_,  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2     "X +@!T#   9_4

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.7.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>134</ContextCount>
  <ElementCount>274</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>52</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>010000 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>010100 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>020000 - Statement - CONSOLIDATED STATEMENTS OF NET INCOME (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementsOfNetIncomeUnaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF NET INCOME (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>030000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>040000 - Statement - CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/ConsolidatedStatementOfShareholdersEquityUnaudited</Role>
      <ShortName>CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>060100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>060200 - Disclosure - ACQUISITIONS OF BUSINESSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinesses</Role>
      <ShortName>ACQUISITIONS OF BUSINESSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>060300 - Disclosure - MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/MandatorilyRedeemableNoncontrollingInterests</Role>
      <ShortName>MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>060400 - Disclosure - REDEEMABLE NON-CONTROLLING INTERESTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RedeemableNoncontrollingInterests</Role>
      <ShortName>REDEEMABLE NON-CONTROLLING INTERESTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>060500 - Disclosure - GOODWILL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/Goodwill</Role>
      <ShortName>GOODWILL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>060600 - Disclosure - INTANGIBLE ASSETS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNet</Role>
      <ShortName>INTANGIBLE ASSETS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>060700 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpenses</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>060800 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableAndAmendedCreditAgreement</Role>
      <ShortName>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>060900 - Disclosure - COMMON STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommonStock</Role>
      <ShortName>COMMON STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>070100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>080100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>080200 - Disclosure - ACQUISITIONS OF BUSINESSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinessesTables</Role>
      <ShortName>ACQUISITIONS OF BUSINESSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/AcquisitionsOfBusinesses</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>080300 - Disclosure - MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsTables</Role>
      <ShortName>MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/MandatorilyRedeemableNoncontrollingInterests</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>080500 - Disclosure - GOODWILL (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/GoodwillTables</Role>
      <ShortName>GOODWILL (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/Goodwill</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>080600 - Disclosure - INTANGIBLE ASSETS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>INTANGIBLE ASSETS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/IntangibleAssetsNet</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>080700 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpensesTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/AccruedExpenses</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>080800 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables</Role>
      <ShortName>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://usph.com/role/NotesPayableAndAmendedCreditAgreement</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>090100 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetails</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>090102 - Disclosure - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Clinic Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/BasisOfPresentationAndSignificantAccountingPoliciesScheduleOfClinicAcquisitionDetails</Role>
      <ShortName>BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Clinic Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>090200 - Disclosure - ACQUISITIONS OF BUSINESSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AcquisitionsOfBusinessesDetails</Role>
      <ShortName>ACQUISITIONS OF BUSINESSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/AcquisitionsOfBusinessesTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>090300 - Disclosure - MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsDetails</Role>
      <ShortName>MANDATORILY REDEEMABLE NON-CONTROLLING INTERESTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/MandatorilyRedeemableNoncontrollingInterestsTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>090400 - Disclosure - REDEEMABLE NON-CONTROLLING INTERESTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/RedeemableNoncontrollingInterestsDetails</Role>
      <ShortName>REDEEMABLE NON-CONTROLLING INTERESTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/RedeemableNoncontrollingInterests</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>090500 - Disclosure - GOODWILL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/GoodwillDetails</Role>
      <ShortName>GOODWILL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/GoodwillTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>090600 - Disclosure - INTANGIBLE ASSETS, NET - Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetIntangibleAssetsNetDetails</Role>
      <ShortName>INTANGIBLE ASSETS, NET - Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>090602 - Disclosure - INTANGIBLE ASSETS, NET - Amortization Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetAmortizationExpensesDetails</Role>
      <ShortName>INTANGIBLE ASSETS, NET - Amortization Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>090604 - Disclosure - INTANGIBLE ASSETS, NET - Amortization of Tradename, Referral Relationships and Non-Competition Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/IntangibleAssetsNetAmortizationOfTradenameReferralRelationshipsAndNoncompetitionAgreementsDetails</Role>
      <ShortName>INTANGIBLE ASSETS, NET - Amortization of Tradename, Referral Relationships and Non-Competition Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>090700 - Disclosure - ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/AccruedExpensesDetails</Role>
      <ShortName>ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/AccruedExpensesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>090800 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT - Summary of Notes Payable and Credit Agreement (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfNotesPayableAndCreditAgreementDetails</Role>
      <ShortName>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT - Summary of Notes Payable and Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>090802 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableAndAmendedCreditAgreementDetails</Role>
      <ShortName>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/NotesPayableAndAmendedCreditAgreementTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>090804 - Disclosure - NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://usph.com/role/NotesPayableAndAmendedCreditAgreementSummaryOfAggregateAnnualPaymentsOfPrincipalRequiredToRevolvingCreditFacilityDetails</Role>
      <ShortName>NOTES PAYABLE AND AMENDED CREDIT AGREEMENT- Summary of Aggregate Annual Payments of Principal Required to Revolving Credit Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="usph-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>090900 - Disclosure - COMMON STOCK (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://usph.com/role/CommonStockDetails</Role>
      <ShortName>COMMON STOCK (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://usph.com/role/CommonStock</ParentRole>
      <Position>37</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>usph-20170630.xml</File>
    <File>usph-20170630.xsd</File>
    <File>usph-20170630_cal.xml</File>
    <File>usph-20170630_def.xml</File>
    <File>usph-20170630_lab.xml</File>
    <File>usph-20170630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>55
<FILENAME>0001140361-17-030329-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-17-030329-xbrl.zip
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MAO[+V8C:J0W5LT/PJ&W8FH'8\>;BM_!70\??QP9S% *,Q583H.?RYK_.?FW
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MC\4#!8JY/ (/G+Y"6+7>(RF#HP<'%IH'#N]9/0U%L(%GM1#'YLJSNLJ+%,M
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MW*LT[.?ZYHV0Q4[7-.72)=7E\2GHDD(9&Y7X*)CXR%6YY!&%<BI^L7UYB=Z
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M?+K6C=@KSZYN+X *L*O[1\@NRFM#A+2;^5 )G#OJ([0*P0J_>'(8XS9] >0
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M+"+>D+-X^@\W-L$2C7+A VN.!&FRT")Z2!-U#A.\#\0"9M>_^&!"="*$P*)
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M?(I@!L)&.'_\F\#.KWBTJZMJO96*!!D :=$B9OI1>PVRM?/H4"K\I=S.>&#
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M(M\-+##H*"]4.UDJ*<V$G2IUDL+;L=#JE#^;8_AL3HF]@XN7\:5X62KR')M
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M]U0EVZN2[6V2<+A?:S75H\J+_'+M5=Q5<==1N:O5KS6ZC1/EKDU+\.44LK,
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MBY2N,% TGHO\@'0\TQR,PC79$S 2Z"%DQT4N? #J 9Z^HJ\RIYSCZ$KLLV(
M6[S@$6 X5VSTL3O*U ;&,"Q8IZ'[H+L2)T =\S !%A*/\6+\/K5=RB?P,@$+
M -EL@?=I1=Y$\Y07V_F./)JX='2NXOM20U\:88X\_0R-R*:8:9Z!2GF)?3=-
MLE?Q[(%YMED.GKVQT/CYT[=&Y-U_,;Q),OO&F8L,,C3DD$R3*!PT*:@ZQ6(O
MYKP^MITI,*)I3 U\0 ^L[EG 69CCZ9W$?0#;I1U7@,! ['4TP1!U6(Y#C#SQ
M+1T5X(P_ME/>(>V\1ZY$2())D,6>&$P#G"5/&*AX%\>F&4EX@(8&X5#C' NB
M ]5IC7\'!8HI25!, =N;L!XN5UQ_Z!JZH3GS8.X8CBJ6+1O+MLK!LH^2$4N9
M?%W!;6 0!@G>EC3;G>\ &Z$Q&32)Z37LSNUA?KA=YGC)2G[G(#^ZO&6G\2/V
M'B2P8!+;(5\2EVF8HPT <FM$2$'?52P;Y]@0![H-L%BVI\R"-<H#K@0&.%OS
MH4.PW$7=CZ+/L?VGR3)"X$2A 9YAZ?CP IUWN $H&?@<L_ I,(<6)"9("Y&<
MAV39@IA%@V7FP)G:@<T'</D]DK @4(+BB@!C8-Y["IY@$5B4<F ]31&;WHM=
MGV-,!^"".IH&\[$3P(6' ?LEG2K =(N?/3C0RU0381M5 %_U7!G['A[#87*K
M;OL>VEHVY97"1@"G" >4$$ V$JY8K%-8C7&:$TA*VIE*NI9-NK;+)UV1NQ(D
MH>G:8)6P$5@_>/J7!,L*^2NU2A;!*!*XO4&\@6DB\3=ACQ$B>=82>PA($$G'
M,A@]V$9(S8LQND02S;M@R8:;)(:C,2JV*QG;=<K!=A>D5)"$A_8SB]/D]@H^
M,O)3>-FA:S<T[6? :JB8LI@-X:#OTIP3H9<ZIE,KYBD9\W3+P3QPB"?'E+"G
M74S2B4GKP"B43J:+)A0_/(1G!S:=F38%<"VHL:BZ@ZS0KJ+FR?J,7 F<3>A/
MF *3+QOHZ<+ 5])R\DG"HY=" ,S8>&8*6K++#CII5@R,BCL+^#2 V2EHQQ'Z
M"K@][( R>P&M75-\RT1_O+14U'<PD&%1:K^9[,%DJ&LY^A:F!4V*(@/XVS>]
M&OR5@-[(:Q"@%A;W;FDI3$_J'$-DI+_1-I%@YZ;]JG& (BP 1%[B<"ZM**57
M8(D(E,(_\;]HV--QJ88G$!3,'E#C.8@ZP, 82!+L"9_;)6DX"24Y1TZ &((J
M$M,&;V-8^!P7/DJ4-+9-D[_RQT6(4Y# UJ#]$S\NV: A9%A<?S1)Y@"7F>1W
M-1QR.<,1)CK R=(^P0@,;:_@*";^*5E6E;POF[SOE4/><W_"%#-_:H'1PC0@
M\I5<C5[-&1L98X/?'BX(MNB(+WAPY+LH2AU^#H+YX*/KTRT-<22Z24$TX#$?
M^&2&Q_LPN^)0PPQQ"!FY 0(!2/:8"Z:5J:%LH@05V!S'"XRJN.T7F&V&I0,X
M3N55+1U/]<O#4TGG_D4N>F=8P<O8(1#W2I;CY_7$#ZC@EK3?>\FM8$FU1-+=
M"EAQA,".E1R)VV$4$H":S#%&GINZ,++!F/6D/>$7P^(2QJ.%!H$,>+GSS%D6
MW16:)%!F/%,1:D' ;R*@ 9R+EAN84XK\/9)$(&$$1O3H:BH1G[)'&0TE\B[6
M%'P=JQBI-O"20;+&GJJE#@20!BB&KDNXU)*PJ4?/0!;14XFYLHFY07G$W"*Q
M"=V.(0>16:NCGE^V:4FBL=<9V,JN8G,C A.1HXOP8T6T*433:1>3:+62$.V+
M+?P!6NC!)OI<(Z[#V!VU]U/ZH?_="OT@'>)7302'=*<B_I(1_[ <Q'^-WC#/
MAF/3JV""\(8^14;74(SK;$P/8,1!+]&^JH'-\J0Y.CG%**J-T7%MA9&S9+-6
MEDK9+!6U40["7S15) ?%;&8:/$!2D\UNH&8*8J,3CQ'Q (68JITZ3,<41],-
M7V*BQ= UZ?2PSKN*\0NH1SR/AW:3Q<^2STZ,G"72 <KV/8R'(!@68'O'U1SY
M+5<"8-F*:5M/*:SY7H2')/5\F=B!GW79"6N .:@;(%S,^8HU>H$7*GZJR;K*
M2G"43G"4) Z=(I>2XBV"F"67!U^[%$(1A&(Y3 =.D.^ DV]T:PHS2$N"D,!6
M=JQ/X$):]']<HG?B=K;T@(1B6DF*B=<H0\TUEN^][H//]R&4\C#5R:MLQF=)
M3EY)=%>16O)6]YK%)#6C'*1V:XVXF9! <W1BAR6!I</TI8 U$1#'[9,P1B@M
MCCDQ#FAQ%'XQ;,LS\6E!C-LC(LZ%@*%D91%=A%&RG\CIL.+27^W]1 H*["1/
MRWPAO?1B,03TC@,:][@G(WF/O+W_MY[*5'.>#*N.__BH#,)WM2%A\#>>="LC
M-B4*%Z TF:XRT> P'3RA7-*:)RN:U$913<IRR*9'P;B"W]><"V.,++D=HSB6
M1<<+MS\U5[P,H(.?%\V))U&]TKME(^Z2/ &DJ#*\T9'IFZZ<=<6?P2_QJUW0
M@_,9PF[.DT+VR/GH,D_$K@M=Y3"3/>-[F>1SV:+RPA001EB,IXJA+;7Y61+[
M\X93*AD*VTKXT,!S%T))8^R%O\0IO)9J^+[8OJESBP6L2& YXLAUXU5<4C9_
M0$DNHV0W5D5B);-';DI!8C$Y3(\$]BB,LPGBP+<PT5QQRV%Y>#OD:R;'9TT9
M^AY=GI '.'R05Y,?4J\+LX_!O71<7^-72/%N!,^5V2MS1H8;W@Y+?%OIAK+I
MAE$Y=,.UN$A),F,"KYM$AYS50G?=S*&T(7AIZQC/00RE1B_??5.+'&ERT"E\
M\8R9R<(W,C&> IXUB.GB2;8I6%YD!1U2VH_0M08P::_XA$IG,P<F"4[?4^3)
M?T5G<5E*Q*:D@3"W):!%>^*'FS&#,]/,]"F**)'/4=;XEAXDQX.%A0 &"TNX
M$0J1>S&U_7C0[WD"-L(A*3N8-!>A!2S+",//@#?.OYAN0 [.EY[:>%'2% 0M
M!7Z-8*.W!YBDH(;!N+#<2@B530CIY1!"L:P5E-4BO. -7A\R2G@9N=,#$12^
MC9.N%NBM?\R'[VI3EB*!R,4?ESEU8JZ('8*T%[X;A68ER4OI+73%*F5C%58.
M5KDP\4WGTR3=^9"@M17=)KN7+E*TF"<"HQ&3<H6%-BN9]#XY#E\,&''(4GFO
M(OJR$?VX'$3_N &I6T"P#@4;SO%<E_CN"./H!$NDO6FN*:X1W&T'JD6$^PB%
MD,L#9:]ZG7QJ\7<EN5"ZV,!?$Y$S4*CTHGC12$ND<3BCZ5J0@G+QD5+:$2T\
M<<*$AN=FR327^DHZ-;(^D ERDK0PYI <43PA&ZQ6.M,!&[R M3GZ+IWEN#,L
M"S8FS"2ALS9LN :@.:L4=?04VY"=<7A2588.O307\D3.1N'$WJRB]\T]5[[B
M\5J8RW1G&'^3N2Z\6HJ8&2_@"C-1R'B2Q.W:N.GPV2<,.F:&%WO+C@R'6R3]
M-O;-Y7-#LMA-#"]:F@\)+YR(B".+UR^6]S#.1G@UY( "\AT7WPMCD*NW'L.(
MTVA#15QK:EX 032I3W4I;HI]!T-PJCTQD:R,AN19G1V&8>7PP;?T(+P]?-KL
MBC2LY)ZPJ*"D+E*>"_X1J-$<2AK#:UH&F656KE+D8\:+-)ZRA;_(%7N!B0L#
M:E[88>*HQ&VVG34[M4?E6KR$^X&G#Y\DI5:NZ]460K"X*:!CQBU3^-4G//U/
M\)@ MG9.62VYTP@P#%"!A+<I)28&:+,I#<(%3503(MBQI(@N^C-,8936(#15
MAK8#-!-:*:NLEOSLDV="^2]G0]OS[.E9FI+GGY=W30!=Y]\_*LW9ZV+T',))
MFVO QEGP2WT0&CUQ9,6LC1P 6SLG# )8ATF;9[#Q+XXV^^6,__=L4WCXYH;3
M"[@0#,6U34/?BPV45*A#YJ,1Y=W*;:I5+"Q/_0#,*ZI"7B'S+G(&#KU*!,5X
MG3ICCR2!%-_.';<P$ZVGG$?2B$R2R/MDPP)PW"&9:].I]TP(Q=AS(=O[_1]_
M(DO^R0%5IM>#9J,18^/Q?GA_78#T"H+[Q*"=1<_V-%.S1FPUR^X')VH&E.2G
M>E+/OEG VL.A^(=<42ROCGL,@N4-#K.\[J"F#AH'E?P[[6A.8F%JZ+K)-A8+
M8_K?0<0"=RZER(7;&>5G![G #TJN>.\B7L5L:(V'KI4C2I<89HLC78X 5B:Q
ML$="I#%:M49?+;14R+03QY$*!S065DJ%I4J7)90#9; R"B0']FT>O&O5FKUF
MH07!OI?\/IL+\ U:&9=QMY^4> '6[[,M_'Z5@5$ L(YB8'1KG4&QY4IE8*P5
M"'?:G%_GT.-7YGDF"Q+<9Q,$$5Z+(!(J6^.XMD:SUFR5R!513ELCT>]>$@,D
M"!"F\'HI05L]C!$V#8URV:/0,;=T?^0J@5:A_[ FP=H[M:+:,KL!?A1K1VW4
MFOW#FCO9[M<*8 -E74 [@Z JR#7-E:4?ZHYF%98.:T^DL"4 I.BV/TS21<=6
MO_N]V]D1 4>QN?JM6K?=.JI@:F\CF#:]$RIIP-;CND"LY<@K_'E3/^\[7G[+
M=Z&?^UX4$XC%B:Q*N;4%VD+JJD*WWGSH5G+\R8[LM4$HUW(\5+%,M"H$J@J!
M.LB>E\.VOI1R>E#%*I'E#'-^F-J,GB3ZGL)#R/\SEE@$F_ '7\R27BA4'L=R
MV=F%,Z)!>?1;_?(X+HLE5P[H7-Q6KJ#0$+(%W\:40[94%YQ'=?EU.K5VIUUH
MH7!,[UXYC(V_I'"Z]+R1U]A-EQV\YEYE9!0!K*-8!_5"RX!C&@8%OXK,63!0
M":<#"(?JQO$MWC@>5NJ4_K*Q'.;(_6+$I90?=425J1-2^5661^7>V.V.L%MK
M%CQ6L[)BMHM36) :]$[$QN1941Y0L&),&Z.L*B.E,E+V;*2\:]:Z[4')+94]
MX"'',-"-HC"6!4<VNZ@ U]I5W%,5]U3%/2V)C/2XI^#OGS_X;OU)TV8?OQJ6
M[1C>/,B%]=EP,0NE[[!'@/*3:8^^__KO_Z8H/_]'O?[@P;]$LLO_5*YX_JT+
MCYL1%-0#AY)OMB6'&P7CUNM\F+1YR6L",]ZS\2]G(XS*:'1;C3/%MPS^V^^-
M1O-,T=G(F&JF^\M9O77VJZKVFX#F]-4<!_2NVFRI:T%O-[*!_HUYRB6F=K_#
ME(0ZSU7Z[G>>D_J]$F4!N @+>2]"#$/@",$ G^;8^\8*NT8]$[9!;:B>G7%#
MFDUUH,:6E7WJ@BRX&RZXFV'!+;71:>6\X!OK&>AAJP6'7?>VX+K:[:J#+"M.
MF+L@*]Z,INNM;K_=W\>*;RS*.?SN"QRMWB])GSO- 4LJ89F\&W9*V+OV!GL'
M.]U<7$<T>,Z@;H;T0:_3.R*H[0U ;0_:2R+O8*!NQKP@K!J-O<!Z'P489]2:
ML9GDX1[M:+#X6"ML@TUHJ=7HK]B@S4#)*L&N#4NS1EM)L+#K_F0V<%,FD9TP
M=4$6O-F.J^U^9TG2;;/@U4RP.^7G0N_-;G>%[,P"0#%QL(E05MOM)8HO/PXV
MM4V;[5/$P28FC]I=EGQ;XN">X0,"$XZ-NCW#N[:+T0C?W^!R?_,-'5_]+2_W
M)6H%PL>"/T<\&_:=;1JC.?__X5%[+>?_FN0'6?<D0O*3'"./;13<G@6%BRZ+
M0C_5NK&4KYHSFN SDBY/H7U]\?!),5S7A^4]B351LG5C.C.-\5QQD8O"\@*4
M6,?U^-Y/9\QR>7T>+<3,N90O Y^&A8-J0$>ZJTSLE^ FV-->E2&SV!@SUN,E
MCD:#+A55"#)X>)BY'6]^J*-AFFY8?PL+ZLT,;"5U55Q,U.["?R@_^Y#Q6B!4
M7$L&\RXJIVRX(<"U1#!?,(T\)L-W=%YE"SUFB +-!$ -O0X_C;29X6DF+^1)
MU8@L6+0HX<+7:%LL>@IG<%&%\X2(_B!F#!(9B: <^-?+Q( =A-_FO'1S'.'2
M BB_XHLK<(IF"M6&\$#>>+QBC.5/AXRRS?,MU5XT1Z=P0#82>0GPB$A[XS
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M0(8N9YP5)M-"##'BCPU!-@2Y+8)\%!ZII49!3827D)-"ICC-I?^\@/P.HGB
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M(YPN_XL@P; N!UL204A'I2(2W=&V>B7J$=EYEE6=NP2C_JV-TR!1Y 7WN<6
M<MY/2\^7;)I&]*886_QDIL O)$D4(]H5-V9F,Z\'QB)O3&@>":ICPD[J&^FE
M1Z_11A;]_-61E<X;0MI&K_4+M?A582>2 E&&SG%HK5*CK".&>L3L#PZD9U\Y
M*[J%=^YE>0 3U4(/XT,2H'$6\EO6$H817D5)6J854^@3'1:\4DPY<!@9:LJ7
MN#R6G31B>[:=\R P6-?&5^Z>?Q%3X. %67^(ZXI3;\UT@L%:<D%&0427TMRN
MRX*-EEY@C\BA$>2X'T8C6:E9:9;)_/ ,NVKPZBD,Y&+G%&:586H5+;N/P/3&
M&V05+&QZP+HR0,3D4Z":#]C!ZV4AVXNGU)N6.HVZ1!X3(JM_,[U(:>NK=!"Y
M3$*4C%NV;\KUR@Y+(*)T,3>>?Y<W*M<ZU/WF"32)J5OM3;OZ^_6-6^&"0WV*
M$&N%SJM3A3N?)3() MU!VAF!%!<2V]<>8!GCD)?,"5^XT062-8.J/DJQGZ89
M!+")\@6 DLZ5Z&"H,7,[].A4+$G'=1>DI$_]-ROJFQ+\IB1J499:#]*]D6G;
MK>*IR=4^]&?(D26M(=X5-EU;D)@U$.]\)(ZOF< C'%M4"I7A2SWHN,$<!OCD
MK\IU!?8A6)%1F@/C3@R]3.;&F59U?&:DDDL-P(A^$BM33XZ%$1E3X V\)# =
MTTQ%#.I[#P[K2Y8#>.Q\+-U%5P\A[6QNNK<VMG1PJA];/4CFKVIDXA=E*$8J
MG)<M'%*F.;V6F*1BN(I692!LHG7VX@6.T4CG6P2JLZ&Z7<N;Q+-CO /5K,LR
M5=%X<>?HB!B@Y.JSP!O:S7"_ C]-C]@;_EF?4'EQ)=F$\^;KYZN;M[BLOZ'U
M$S\YVIUR-7]>%I4$MO(DC'PI.08XH0:?LW#R4P\HVAAS9V0&G;:$#O'^\X8N
M( 0U>=(=<]P\?Z34$.ZCH%01[$A)\1:6,J*)W/9-FSL87VH,U!)'?%=*G"))
MBI>=85PY)8GD A3OT._Q(*1JPDE1=.VJVP%)QSM>AL;<$9"2C60P(_YDN0U*
MFP21E2NSAQX][J=I]SLFK9&B@#FJ(=<("_Z,@@?R=P38AD67:#0]"A]C,,!'
MD7:#61$OGH%;C,>(#ZG8E/6++DTU\&BROV6A4-$K<$ N"MV2B'.5KEVFSEJ[
M(3L[6\TSI+N!G0'V5M$I>!2(8@[ZH(!!>D-WP_,4G]&=\#!.T35]DUQ9/0%^
MY\@(E3(Q[Z?]I/1W_[M.-B9O;6[YK@R>Y9CE0EM)%4B(#+IPC7[2.^X[4WF-
M7I.3_)*:6R#0:/LN9+2CH\*@:[*VM1>BPC9-K#5NJ<I?IXW.17;&,6;4R+@#
M6938.EOH5?/N66ODT%2V#TU'&<ZUR3.D42285?#Y#9\J,G+X&DRVY(4A5#ZV
M6X3>R!#[=MAD?6.(+:?:H,PV8:X29C[0.J2=4QAL,TUFX:-3]"(BS=+DAB=>
MP-Q96<9E;(=SVP6=5!D_3WFZ-!45>::P\J4;95LX:H).ZQT74E%/ZA_:[Y18
M)NT.H4+N<6'G7MWDTAPQ4/BS3)ZLPQ&L6?;>A74TSG70\T'Q GL)5J"[C&_1
M@D-E'N!O=R)]%#(?BL/IV$@?%2[FU2'1I7SHJ.6JIB>HY5'Q"+O8+5*F:BQE
MR<QDAH2*NJ;565X*LL14@DAT0()I_UW03!!R]*1'6(A]OMT5N47HZ(T<MIM,
M"@2I,AAP9BM>6-M=N6NTTSI?'GXJL/Z/GZ#Y)>].C1NN))1!\4;#[4J#W\O#
M[@W?XUQM6\'0I:Z-!I?359<E?9C48S3K,-"1U(:<%##PZ8S&(HPF;E@R70UR
M&0!I(0?!N %-KHFNC6:8.+OD.0'.NO$L!PA('C:"F#N:3V3YJ^1^S(8L29A0
M:6N)60U#GP.E$*14)@^LM9D%N0;9VF6Y(N!2GC$P <;MHC:>9&,T'E02( Z0
MVS;VUY"CDN2EOC\>87XJAP]Y6,<%VWV2$LS;2YNAVLSHO2\$W1@!*F.C)6/0
M1,]2E\/3\V>G$%]9H&?2_[DQH\G,M8(3R8^(W,MPLU*1;."^(K1Q&I04]\97
MB9I[0MEDY$-)5=X-)OYGYB)1-C>%1U2\=&HEHV$5P1%%3TRUB,\=\1QHZ.,P
MSAJC+F&ECDQ&'XCOJ!R8&F/5!T^1BX*%T:)J9D16ZIYVAO-"E.; ^R\K71AU
M!/D$G<.E4R<YS8:Y3XRN)UQ[K+B&ETRL@YYP_]<83=&(;4C+)+$2E:4T86#O
M[_&>)14RY$ZKI4=W3T>&[_@)74_DWG"+/,=(0"T <P!P>R4;OKD5H/O&. ^M
MVEWVX'BN_+!@2+5_42E<:KYBHB[@,WC"RV*\ES*7.;R9.6JRM\;*SHHX1QXI
MGV^=3;'!5<"SE0*U[QK[]I1EW"I16Z\O]BLR%A?R/)/LH+UB?"O%! UFK>+7
MQW;N@9OC@7GGB&>=J.4,6)\H]D;@$0W\/P0E$CD8CN)0OC=@"X;.NQ=JHC,^
M6Q-F(P'#:@Y,_Y6 IPBX8[DSI#9K?++4"(=.N:K+^B3[IAYCO*"(B7J][[)C
M3NY)Y:RSC$JE_$G7$+Z(\1MT;$E*%DJV5"G@)0ZL8HHF\03Q'5@9?5<!'FM9
M?FQ7%D*HF!D0_\S5 N W$&Q8N"\GA54]>O$H61TEA0(3*B\!WV+;0AL.*(=4
MN W\+"/T:/?DZ>1B;CKG7%ZF@ZT=Q:3%6"C$J>V1[WAS'JC4'5DQ:1JHH"?C
M1ARML"JJ"6&Q#;V2?%T&/RQ KZM6>?KF4D8S(DYH8P^O<(9MM5C52JHHE_W;
M*>,0,3>+N!\0IP-S,:]\ H54=4%S% _H)Z6=81433BAS8N*]DA43"Z9['T[)
ME)$Q<AI3O)!R/4<8;4LN4@L65#:$ULEQ[",>^PC'/L*Q=;B7#-WGY Y#9_EB
M":5.:)^Q%*!EG1C,T(*IQ("N.48KZK64+.2%^I,(B GP>"<X]0CK'N QP^*!
M:*)..7P$R9Q0KV5F.28/E^Q&_BCO7 0.'V=B9)6IB8WK?$Z-P#>RT-HT8HJ\
M&ZB&QQ3M@D_YQ0J^UDMVZ,Q"3WO>T.?+1JP-DYO !I@*FJI;.)?9BGQ,)OW8
M997_I&#S:ADE^&S]XQ,6)?J'*DKT21^HSYCT0^'-AZ66(!',B7%=VD3RC5P%
MQT1&*"83-D7P U+% \8LHHNZM."#_E(YI?#=D%)^]3=&U9<:@JD A8')VDU"
M%8FX=#T\G!'_U<DK=BDKO25,[,6*$D;G.I_R";E@%>-<U]*T8&)KT8#$8^HS
M0%%RTO-2-9RJ>X$LUPHN_IC%T0CD@1<[UV01H@L%=<!4.P^M)=.,#Q34P/?8
MGA^8K:J:^N /WHVXIQW1(4DU6=!JT%]JE3;A=9A+=0J59&TN= 2[G+!R+H>A
M<$TC59'.HFT3T81:LTXE8:TN42%P8F2Y/>Z>0%W$3 2C8(_$D*O 3+T_!.NT
M^!6Y%2AY,=)%N%!?C[)X*'5XM,W)6R,+H:IJT7FYXH_P'GU,ZNH\"K0K=FI[
M:<C][EO-I+6I[*>D$;'"HK,'Z#I8N@ HLSLMG8PJ&GB8,W$?V'%B\H'FWJD$
MG-\Y5NJC\B8>U)G[C+&[>'240E3F\EQ:#]*UB1-/2:*KNALGJW3"9EQF%A-(
MJ3H3N=^H<GT@7<B1ZX"M+3TV7$T7O]/5_DQI5]?TR_4!;#]F 9*_US 2%J^&
MT73099W835A>*XE=3FQL&K-A7NXO+Y9I^](QB)9;!*/34#OAP 9(Z.*JX!Q/
M+"_U*Y!.P?CHL[Y:O.++PIJL:GU3)DO]0%;[3'!EYM)T!IH@D1[5A)/1!7AQ
ME<WD;:DSWT[4\49H1B>I*O#OV;>AQX NNQ U.7UD\K&)+Y<1(9;/M7B32PX;
MG&>*G:ZK#OS4 W4NFUK.-:W%1ED:>$](NVRWZ9Q9$R%O.XQ5^ 2=:+3<Y.'A
MTFB4GXU&+_Q$:3@JJ17OJ/48TBO'O^5N*_+^83J-IOPS@:=.+=]:V3=NH%&;
M'%J?)#2=NL)>JLAVM0X5"_RZ/,;7@.W8'W+,233\HR;K61OX!($'U2[)V'+0
MH3U$4IS>$G$A;>L.4]X7(C7K-A>.O/;F[U7Z3:0*Q'KQR+6<LP&<B-_491+]
M0!!QJ*0JAX&@ <<+TP)LKG0*D.LH0AJEJ.C FW&W)?$?DDV<FXP&&TPB@X*D
MRTK[R<88L0U/8@!KPI%/\K*38L>QP3P"H"(-*7Y[0K=\%F :3:H(O[48DK4%
MR.#_X$S'),8MX"POR]B/P?JC/#W3W:,2(@L4@XT"),\%!/'#GFF#M!)@D"D"
M6_-T5$,HC0WZG9 :SU.=[6/*!;M959I-W7A5C]F>&?D5:-PX@*ZJ1-&XNI'"
ML>Q/4D[RA8J4>%TPE*0?9/0T[[:Z\"@K9P]+SV2D<DW8P O8VI#S*,YE&NNY
MZ0KP6P8Z&W#XFJQQ977]JP=J,&4N\*'X='[S7FW_O5P3"59,WL/\Z@2O-;3.
M2^8KT\S0)G*C5!>+S^E!O2G5=$"35U:^SGE?2;]7:D9.G;"+Z0Z9KO%%.,&&
M$N'H^#/*R+<SB"2Y)A-5#TB5;<4.-P;,*RH*0YXB. $*8+<43,H:LGNQ5-??
M9CM$9ID_8A8/]6^8S[WU];VE0?2?U"5!11%F^.Z)&S'E$6XM@.V1Q K"0[&A
M[K7S4;2\I1Y=^.4NTQZD\UG&RK!? /5#O!'AVPAR5_,.C4UI7/("YH;55?2+
M%?EFV5V T1MX;4CE/["2OL]6E+T>]+F0187WF3B55:4L09.)O0TL(W29$:R"
MQO1N@NS)P>>K2)E$14*P ,F-BELHR+5#N>S*&828S1.1K=NKM'<"WVHE0OT$
M[+XI*%! U9:21U:J.)7X3N/(* BFEB"%IJDW#%G@BW,-1#3(NEB?8MDNV@@C
M05_KZF4V =(#/[>.>RKFWTKNQHY9N6L/YBJRH(L-1@$@H4+]*(,5#Q&..A:R
M,D;Q]E21.*)<]K#+76^5&1\S+Y$^9<"3:_NT_:E*)I'>;'K4FM_5\8DE$23Z
MZIAO_LQ@.M=VF27_>N3A9Y87KT <J@0V4YK-%HCG-[_3+T>M$W=[?;-NI*A5
MQ_!6,%DZORGOU&?MG7+>W$8SX)7=7NNM2QA3S;2D7%"E9"7-6MR9Q*>J&BP/
M!%>YR'<!T3XQ-/4YH@,OJ.<]93(PXMA&4YY'SW(<K,BQS7%;R([ELW?BW@_#
M:OX^*'C%[3Q8E:PN$8Q+X+I S"#I:W@!UT'%^.(5W7(RZY3EI>&V:327O<93
MUH4#K'P\/HF[6)V/$H71DS=AEHC3POJ-I(K3HU9GFTU^OZ!<R_>5>RO/@LZL
MG49TDR^CI@*1=P,;F/FV\O=CY^;8S@P?8H6Q_#)G8!,.,34 _; @"N^E$<Y'
M(E&A(HP>/;ZN9BL#$JD@Z5$:'66)#$JSKB^]4,:IR<H-,PQ-5*7SL=B($#G!
M1X,A[66)JKH@EZK]</;H94-$H(?=*S<Z>>+E"*8Z@/)UX860_%&'?5'8*;JH
M9= =A9NYA3B9J.2^&U4-!D=I]'CP:725ITHAW&SH6I$R[8[40V2IQ2+"YS3&
M8F/!9"E?Z9<52I_7"&?H6DVI9.]'J;[.50&A759%.@H:GE99"$RY=-IYHEOT
M)U&<6\@.7KYIT\X0LP@5G X ^H+*SDWI9M-_L&V(JD@E583$UH$D+)@IC,HP
M%CN5\>(J+= ;RG@Y%Z\/=6*[Q775';LD&.."534+2#:9"'B3KF#?PFIQP?Q;
M>FV1F!?P(1):W+:VI-EY.1)NJU1 O>.$9MLVX;J<)L>7(MRDOD@U@<L##)<V
M\_SQBG9^]9YDP5;;5\&UM/DS(E$?TW+))(7/R5%KL$7-[=I.HE;9=Y)C78"U
M!E9]G!=-KF/$8G_?D+GH^4 QALT_X6\XH.?W,B6:JL]Q:EC5 MJM_2_@,P<_
MD.Y\9?73OM22C,_<%Q],ET2%M)0MIK/_Q7SSXCAZ=&Z&T4R@SA]C-7>M;%YQ
M.2K8JX^@;XY\'0=G5H./Z15UMKD]MV(X"0F8"\R3&1I,Y^ &ML[VRFD+#NDJ
M:,C;-&]4R@T9$%96-%^)>%C ;V0G1;_-7ZLHA2?)0/8E E,ZHT3[W4Q37X8K
M-OW;<FXM&=H648JJU/MTOT1 EJUNL&87JFZ0TO6H]1\]%Q7P!,S(!H'85G+,
M'B LLT19:6AR<7M JWS(4)$+5Y/7X<A6=:]$BQ1]AO%-[3=4L+'9HIHNT9<R
MRDU\ES'O1AF; ^:8Z,0*2,!"N!DO)\20051""3@7^Q]R&#86QI&A'>R"4>C0
M%\1C<EGFKE2'>4HQ&.#^A4FDE2S>J @T8:K\J F$O;8+?(?+E,!32_<#_/PM
M"YZLYC$D>$A_>Z ,,%"1CNBVBE,,O,"$3FJ07*77(@$9R.@Z9VWP9*2Q6:_I
M5HQQX<KI1I'X>:T3_;79-).U'Y6'"ZF1CX'*BLD%8:N<15!S5(D@R]2U6KQ0
M@'I>9\HAH2[V\/-C4DQVWD=L1E23]:P?C8)*NXEGI,9*"?M>8T-V\W:;)M=9
ME"14$\PP! I+M_,75;NF6#?KYL*L,O@B6248BIO]D(X'#"BRI^-"E9(1%+&I
M/O_O/V7)T;WGS7Z]C.^]4'9U,E4SX(_S<'3%IC;]>3G6$>BFGL8'/>TMH/9]
M$ W_^,O_^_\XSO_^_XZ.+LD1<$[ZO@MRC63,T1'_KF?'A_@9^02Q.1CL6HR!
M6/!0MTZ[K9^H0BE]]WNKU?F)0D>GP/3^_--1]Z>_G ZZ'=AA:U5SXVX<KM-V
MI]M> M?)2:?_/+B^1>%P*6CFH6=!U^Y40V>&WA* JVQKNW.Z/H!?C%FY%$KK
MV1>"6@2R=.2M0[K*KO<[@WF<K@*N5%M=K*!3"N.-%XA$/H55=N:@:YVTVFE$
MGU;8_,'@;![0PAR;!O%,@[@2V^D-3G8.XFFKO086N_W>Z1ZPV%X#B^U6#_Z[
M)HPJ<#)WAA8R<W[!>OXE J?7[Y<09^4<NP-^):G4;Y6QU:7 ZY9QJ.F\N<**
MJ]C['8V3M\Y[&;4@@P0_6S7.SL=C&!'OXHJ+4R-^BF(UW"<8S8P%2H@:Z7-H
MQGDAQ5E+?RX$AX"4]3A%!\_@UC!S+73B =@_UV(DQ)2RB%#<1-16D>K!J!$7
M(,4,=3DV ^7'T9A^&:%T.MU*I*P#1KUQLAZ=M-O=T^W@)(V ,[+!;JC,=7[#
M4E5'](M*G!\[-V1%X?7*!=^^2+<@'(-_?B6GP/^M0M=M)&<QD] 4"VD%/OU+
M/6^!<O[=3_YE_7TYUH Q7!HL!FH1;GLH"L]:Y017!?0+L'@Y=FX?1? @MHC"
M4Z"6%I,6?EH-A0S5L_#7;NT4?]^P[=!N"/!T5>PA3,_"7:^_4]Q]POB2;>*N
MUU6X@T^KX0YA>@[N6$SL#'4WG%A:,\)CJ-9%7PNYWBZ1]Y'B0[;(\EJ=SD!*
M4_BT&NX(J&>=6G)\;1%[_Q7%?X"R@IF&UKWB311D?->U09KK=KJ2YN!3)=XT
M0!8\&IR5<':Z-92A,0S*R07>X,C?1VL@!EZ_'./+ZMT7JJ_=[NEI;]65SDU>
MGU6OJ:!V!KW^ZUKU"D9]IWM*4FA3JX:E7<8C/\3@HP_8?02S5MQU39/+L7[W
MJQ]2U:4-F2&=_J!\N0NFK,,JUS1 JP[P)E9Y@=UP0DY576%I_/B-3'IZT:IZ
M[7(3LGRV?2QH/6(\Z?1.7K0@X#$5-%?I'KJ-U,;?8'H7YB%A,,!+?;&=?J>"
MBY1-MY!;7L41]0\""Y/O;):R1_,&O_!2^=<Y62+^BA/N>CUK.O-/>DM8?/5Z
M8E7FD2C0=6XX)Y!36.86HIZFA_E1F>RR@L.Y;</]^=NGO,.U<NCMPUI",]N"
M]5Q7!%\%7O/T\_#;*RJT"^?8'? K(7Q3P%]Y,<;Q4'3"2!;. QN!%[5X(?#J
M9<POTGOPVLU$=4E8LAO=>0HZ;K6KEE,UTWZ75;)/VUZ6)+7++*4P*!!YJ]":
M]?A63K<U_BY!WP0370ETVAQW)4[*E/:<^\5*0&G(+0*W[MW?0N"LBSSGC7UO
M\];A6UP9#P7;>8X2EZY,YZ$V-V?6/0D-H-\WK[_4\BWPT;7FKMO2UU/U3HHR
M9!-K_X+F,AGY5.)RT0KI4;"I9>'PEZUE,'>+4373M@%?C_X&W9<"CD$?"/=R
M5=L:&%^Z'&_8=CCM5"ZD?+X]K&A=(_6Y*S(MTYPW7Z(D>>OBG[*&Q!4F$H+5
M?5ZH[K^J#R6.QG[ZI=R3ODZ\V-GIV1S_DR/O?R%K<?'N:>>DIBM9TYO0.:GQ
M2M:*].L.YAC;5A=2\7WU=<O*>_8O';[]D:K07.C"P'2]4AZLL?Q>A9V59SM%
MTFU,*==/K$!N'S=J/IIN)93L$!E@@F% X-:1P/.LM/K!66^W!&$[@+>/"<NC
M6S=BN,9:[5CA]*,J3;=U;*@IU8SUI!#38<RYDF7*+KA,V?8Q9.;&J3^'<N(-
MT Y\-1,Q%K:X"JC^80@[#R#,N)+S[XD89P%8!6-Q]%46I=6KI<(AZ,[/IZPN
MP 9-11.=AR,]#4^"<RQ%4^48[Y]NGV:"D*7!LJ%BF/YUC4F9])1<C43A7ZYZ
M_YW#TS)(GX/ 3QG0-U5HP(<^^=^Y9I?&UQR"]X1 #2?\KJ!<BK_^]O'W%<LF
MV_A9AM!:XX\7H_'7W0'^BO1U0:5&T2,<C=-'#Q..@=T!B)2(2*;<WI&I8%0@
M&@ )OJ5T>;8'NGR5>-T#O1;Q>M@"9S<(+,F\JAR]/ -KA2@,>*Q;5+XJI]@5
MY"LEK@ZV 3G'.ZX*>U6\^W+HSWH _VK0%Z(/MP__*G1SUN^NBOTY^&7'$,Q^
M^1!E=RER"5D^LPQT?OQ3%*N'U;,O=.?T^_WB BJGVA'X:_G5SOJG]8)_/5?M
MH%<[\-<*/6P5PXI6@7]Y?I?KL-GH4BX8-_CA2]'BXI;E5O$X9I3G7Y?V3SN#
M_+W!L^8NPT(8A4<V&E1_N[FM7&W&"]ER[YPK 3VKWD![4+A'?,[4^U_KFI?T
MFUIDI<_ZEG[&$B$.U0B9T_&604 #Z!(C2[GG7\H*QRRM[F4*R_RTN^(SGV0Q
M\<4=5-U"@Q)V<W%#1EGFB@NNZD**A?Z3T1BK38Z\-(H!7B=>3IF_EA3B65H5
M47UD^.ZP.4",*3[.4 3!#%L$A/?Z[V3F#=7?ST7RHS]*)_APZQ>S:VFL/XVP
MGC.@_,\_W45I&DWU3 ^@KV#=-K4C_//\KDF@C_CW7YW.[/L[0&5\[X='N(N_
M.@.$DS;7#[$*WZ_.T6!67D(R'6T7L*5SPB" =9@4V$$8/<;>[,\_\;\_K0L/
M;ZZ>7L*%8#A40V@SAZBD(I5]CK .NXBW-M6B(VQ/?0.']RL?WH]X>(LGPRX]
M6%;_*G?6<Y7_YNHWY;;SA5NX$JVO5!O50/4GZ_!M\!C6X,3M\G"M._6&":$>
M>RYY>[__"W ;;_@'=OX+1T?JL>%0B/%X,V=_;L&K$]Q[79-0EH1;?&0W@Y/V
M"BC9GNB9Q]8:8+ULIVB,G[>*8GMU5$M>+V^PF^6=#MSVH+53SO^B'=T26YCZ
MHU$@UF8+8_K/3MA"N[^ +Y@VW*HQK>IN/>*F FMIX]2^-%15M/?#77*8K0]W
MV0-8*[&%#1(BC=%U6_UVK;G"2CNQ'ZZP0V5A(5?XX"<<IT*U$PZ3#QR"EE$C
M/K!I]>!-U^V<=6K-"#:]Y+<+5OMC:QD7>;=?;.X-=!^S-3E,HV#4 *R]*!BG
M;F]0;[[2*!A+&4*NP&0BTC3@!E,K,P*K4VD-6$*C:^Q7U^BXG>X!N2(.4]<H
M];L?B )R)>N]4K;IG2XPY1P!]_!3[%JANRX"TPF>Z?[8*@=:A/[=J@1+[]3J
MJLN\#/"]:#OMEMOI[U;=6>U^K08ZT*H+.%F!4=7DFN8C%][8Q1W-(BSM5I^H
M.)8 D#.*LKLR6;1O\;O9NYT7(F O.E>_ZYZ>=/?*F$Z>PYC6O1/Z$P4)Z;\6
M-JE:+S[,BDV;614#OT78) $,)'QX/@)MIDOVT8/RN1=&ZIZ=Y=,;JZ;9*LCK
M1;?VNMV7@/Q!W*5'MX^1<SN)LH0SNL94J-^NPZR3/7(KK,P!L6' "9;52JTL
M'@R *;@D6-83,MGC9A+%Z:V(ISB33@^QE[Y*4>O>6:\2C3CPRNB[\;]O'7VK
MUONVT"?!VA;Z3DY.GHV^"J2L3I0O05^W%M17;.:R(OJ6U VR1]EDP:/.*4NB
M<GC+ZP9M"? U"QZ=%(L7K@)XDL;9,,VHH^3%!#38^>)9N8?D,R],NN@6P_CG
M9]@"C.OEY;2+TG)',*Y%K$7QN!,8URSU5)0]"V$LEHIX<SZ4S7 %-I@?^T,_
M?3L/=;[<@_6.?.5YJ7V]5O>D2*G+9MK#6E:BYEZO56A@N=9:N"7TM>G&[3I7
M4> /GYQ_RG\7IE30Z];;_,Z!95$\NR5Q"?J*=D:MNQ)+^+F[M^Z;/E(WO3,1
M^Q'])3N[J][H_'@(9B^U!A88,I+ZPK1WAS,Q]TT RHH#3,*?TCDA"\L#?I%K
M8YV\E8//0$/!!M_<Y-R\%@H<$E;R/Z1X<>J)+(.73OQX=(31*T\ T%,4)ZX"
MC'OC15B:45U;R;68=11[-'OWL5"MD+%_^/SPW$\9,[G]D>S-;)7T3JWQL%&]
M!'7DC\>"RB@1T'Y*6('5^,D$%AAC?SL&!H/Y'JD5"@Z]%'6.GX#-C-WLL0D]
M:'>DK!"D^A7&P\1/T"^.3<^!4%3+<OSE,?93<12-Q]2Q/@;4#45=.H>OWVE[
M)! -I+9I7/+VCU1JIZ?2-0WF,%-J!DP66"70 '%X1(U$9. E"?[D<7@5;*SP
MX&P,J:\.[]LLET4Z/Y6/L1187(B/&K_J1#J8<Q@EJ0ZWT VY<3.1^GTJ4\3'
M3@\)AU?X#W@D7'E8\1@E7,]9'B)[UPNI6R'W&<D1ED:8:ZB",9&GR[GUN6IU
M0']A\ 1S1XDYJ?:I4"1-Q^5.:&*$9=2%Z)XM&[Z"0C[$3;@6_O0NBQ/:Q)JL
M:O6CI)<!1'T?>U.@-+D<V-TL-5Q^PC=P="P42XP+QTH/=C5Y2D 1\4+GDQ#.
MS1 87P;<_ W[]/J=]ND[Z^/7JT\W^L^S=];'MWS@\ %FG,"X'VQ*!_*[0Q,\
MR>[^#92%= :3>ED*B$CQ?(<A$GLV&\';!E@/*1MU)M?!0? ^$8\B<%K0K$CP
MW,?1(\@$G+0*[)O?KBN@5J,S]!GWYL09X!7UF_,89<&(U\/1W9);>,%0JIIF
M&2"_LB$S)'B$,0$?0/3&3\Z3\$#>^7A>0>GM2$ &)^^<2?2(C[@L7Y"-T;/I
M)(ZR^XES(V8I^0%4WEC/=2XH)8V9J-Y.&A+_)[_R1_"NE*\5R+GX6K6E6(C^
M(@I!^"8)R>'4^P-VT&,A!1LX(Y6">9H_G7'PB:>;=EHH-&@Y=BY#YWP6^X'3
M/E5KR9$D:,DX(?*WB[]^OH)CZ\E^ #ST^9!8)+Y92:?G%]?G5:MZA)4D<,!H
M%V$5@??H.B+P03PQUR_N/T*"WX&\B88^;SA3J[7O2'[6*JW &CH7"! >QBEY
MJW"T$> NB&9&H#PJG<691B,12)UF' TS9-_.?V!"O%<G]2E+4?3DICD'E$GZ
MQ/%X1D)B;H,M/46I1MYL!K:"<B8#&;+$A'V.8MX;E$ICX ^)X@\*4B;P1]"B
M4-1@P4Q #E(DVA7.W9/3.NZ<_&*#^8E_[!-H\&'@ MBMX]XO>@#0\8( A1#!
M!>-9YX$!K@;%!1N-U-MQ%E/M<EXM# *P "+J(LQ69_OOL]$]8/^"KT$LXF];
M&&>D )L'FAR1SU+X,J0"MS24>B4ISR-IXUJ<*H(]E_L,%F8*9QRQ#<C$/8H%
M]9I)*IF<FAA4-7GM^H1;%T??2:4 QO]S^[CCI'#D WCGV+&[[=A230HJTI>,
ME "X4&G1D^MI#!1N3JHXG5^ -\]L1D-\INOR;_J]_/P**&0/FIDI:^2]C]:&
MGX#(DAMB<2'@'B$<%A98W["8%'+JCF)N@%/L"$4(MJ=/RN=7/'_L)Z@@$MUW
M6IW>P9!N_IH>&,#,?!>S^L9?$I@%MH5(>L_7]J,"JMN#@2Z-P(R9E%YI62C&
MG498W5-JTS,4@$".&LL^&E=/L$^"$8LC6,K3C+0A>!]YAS=[<IUH.,QFGJPA
MJK^%<_$G-%UG0@PG?P)H[S/O'O<0Y%00W3\9HU:2]8CU'0N2.Q'20<2F9F_\
M8W',2RN79[<\,18O+9=J**K+7_T"<BU=) HMD_<84&_;7B#+X=C%3\0SV*N2
M2*,&N$H"%@JYWT!YH><M**7.9)@XK0XW("'D$U2$_2N%<O4VW8(18ITO"K%7
M&K%:FP'Y=X>S,Y/*CWEI;YH<]UA)'DE#4H+S2ZBP&"J0VVPV$8#^N>T.^JT\
MQ&M"2L];XY1!J=\Z=OYJJ<ZNY((6AA,M'H&R%@&O*1!I'P0KA@FC*8V,:0AZ
M9=X)8S\]$LCT]*T+&(]4P19A4^HJ8O(J!IUFF')_$%+=;+YF^.0);Q5P9)@P
M$/=^$GCLYV0.*>58;HTPD@9MC"4ZR3,#L"E@[*4;>/4BI?N&%1REF$J)P@2
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MH-'V7<AH1T>%0==D;6LO1(5MFEAKW%*00\"/1KS1N<C..,:"7C+N %W?\@)
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M2 S]! >9>G^(F.ZX\"L21Y/H$22M+GD+ R41J,2P?B\<X9.8])<D^"B,1_"
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M*9RW<8U\8,)Y[WKJUF[2VKU>Z_2@CD)-++DMWS"WV_V=6P^ \E0X'_QD&$3
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M.7W^\HIUXUWG@[CC8 R&;JZ>/ F07'%V?&-#J^G:6[5@FEW"OPZK.,UK(S6
M?[W#,NBV:P?_.KRLUSY]*?SK:GG.D6/TQ0^VOFC=VQ=Z2\P#MXX&-J^_F9FJ
M>F>L@\3NH-.MQ.)& ?WAMF$MI3UW]]%LP\:V84T!NX@G-MOPDFU8R]!O=P[R
M-.A&QSJ';E,85R.;Y+R7\9MNJ[\90I\#[/5@=$W60795@]'%&%V'"W0Z]C5>
M@]'R4[^.LM<^ZV\;HQ=>'#\AACAZ%>^L5B@<[OR3DI+*VU<!J&I4'O1RO Q
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M1V0#0%S11Q5$EA+J3KP4;LTJ;[28M!JU!G<9:M4< +A3Y3'XK7*$[8N=PE;
MSK]OH\#WGAR\1\JABZ3R18*2-KL\7E]#5>J-WQ;=';;@;LW\W6*U7-A)OS\*
M/.B-MX4%5:Z4U-?_EK57SE_S91&:0Z+GTH^=7XIN"%MGCHLF])]IDOK#)R8
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M3Q.\T#! 1@ C<3MXB*PF&(T"<2R40;D(4"5AH3CN- 7S ?[;^1DYZDPG\,Q
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M8WWV6%JL]Y!R0DX99UU3PS%N\6+7E#6L'M2XLP<+].H!5V6F=<3<";2:NY^
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M'"F,HC@=ND% YP+ /X+9Y/9\V3-M+M>ZC-O TL: WQ4!Q9JX_N $SP:[$XQ
M3YTK_1L=6)E0C(-U/6Y_R5$!=6OELLO\14[ONY#JT?D)U[2J]6B-H-+B=JKG
MISHK5V?<YO)4[JZ6^;9E7(QV;/<B&.)U0=.8:+F-HX?8'5?U:CA:#Y9C7Z)+
M0SZ<S'#QH):[;6.GJ1]("YO@S'P]LPFH+"DLFFUU,-AYB*/IQ!D)-X  U#SL
MX=%0/";D#B!:]Y-4O9?G8JDKYF,#X+)N,Z<.R S3P0+[K2U(9-&O#3C(Y2T>
M@T>_+X9XQI@5648HX_?&LK."KF";1 %RC< %<M0U6'(+6Y]4Y4PG 2/E\FL6
M?/:*:IC3D.O ].9VPBE0(E)(?^ GM#>.%[C^6)X6T##X1)S\[=3Y8LJ85I%0
M&D?KK8V8MTHP=F7KE$SQ_+$O3=W$?=+H[+0G)TOYB)Y'.HKI#1.Z]>NL*?.
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M7VNC?<P:[6BH.H:Z<UWKF=A1%IG\5Z+VG[)JOYM,>K\.1Z.C:F/5@A,C9TG
MN768-'P&.5>HY;P7)0K_E%4X.+,^OAMR/]=A'ID;/_*TZZC^[=1NT@!;_1</
M.]*,GGY8HO:?\R;R[NP!0NK^OZ;]\7'ZEA0^=GW,IFC#AW.(=G5(1"QL=2F&
MM$)?4BPRD] ,U4!+C/,Y:YSQ9-XWM*G^FQC^>22L0];3 W-U85H80C!\-^N+
M1.AHMFT2NUZ[CN&[YN]Q=KI]4&*"JZP)NI/[>\A"C/FD^\^CDEMDDJTSRMS,
M<K?6VSB'+*G^_GS0A%7[(1;F6)UHXU-S/N V]Z@(_5OXT^<#^U,HRM&;2BLA
MLLN4P!3YQ?[Z1ZGA:U53CI9M55:1K=T K\@#ZA932OWB  6;H[?L+0C(GK#S
MK,C*<1F@U'H%)82C5:K4$F0#[7]=9*O\"D*IY2K7(HYV+"M*I"?7O%?%<VJZ
M%%%JN0KEC*/-FM4U9$O602BR;_5J1JGE6]5*CCYQB-RKAWU$[.;)5XS_+;*O
MJP-G7Y$L1X=JXU#\](,5V'BRZ$)+Q)2RL[:^5H'TMW+##X=SPXX6RZFY"RV4
M5)-$/?II]3)!RN/*@%ZE4'!5MU!P-&Z;2D'*X$T0W[!6<'686L'186IO\TAY
MR4%<XR#NT'#;R-$%]M>+4I;>?7B BM%5<<7H:)@*):.<1RFSU4,Y>&GIJD9I
M"5XDG&DA:_ "^T=/J.0)^MJE/OF/X#JN.)6Y0A'.J_A")M3?ZPLR:UK,V]$5
M:KO"9#&GR,(.6O-SI)A29,]P*!!;$8]!WBBF[K6'?<%N4LZJY3T':.95'.YC
M,X>#Y#&1YT<MEDA+B22.J()0G>Y6*FTKUM%72VOE.QEF[KL#5LNOJE7+CV9K
M5"[G=XT@NIDL=J!WP%(V?PW";U)^OVI9?N]HD51\I!%R:9%@8E0)1=L.)D>G
M;.B4];WMS=TH$Q+56<4YND6[L4I?PJ,E\@'4"9 ->-$Q7'Y1DDD\'L7\$1#
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M7;^_O'QY>;EX>7.!R>+RVZNKZ\M_?WY\]I9P!<Y1&%%6&SP;,/KW4?+C(_8
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M-C_D.E<_..D[KN3MWJI6+?S3]^9&+F>:CLW;_SOZ6-_[RS]VZ:M*@HS<^H=
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M>%(W@@%NI)@5^+"\(EWRO ^+KK+@>>A&F]&4?)U#P"139U@HT3&$6=@CPZY
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M>[EJ:7BX2LN)''4JZ725#7!WWA(&,-[?YT_2S;P8W"08ANLG@"'RZZ[7J%H
M0JFJPS#1-X$L>)0X.)%7?JS-) P3+W@B4B[ACOSA[;?-7D2E"C-PX55Q%SH:
M*DM"1HZR88YW%U"IXGH>T]?&"*Z7Y(.WKN\;J5=DPD9<<2C@45!?"T)B^H89
MW%T B;73*"C!A$8?>X?*GF_;%Y1V\?&>WU^'L^57Z^R:.WO\ NR!I/]].I&+
MFP.'>-^-08LQ1+BSCW8L&'>/HJT8T[5N;($)W-=PKM265I-@T\/.;5$9^KFQ
MH]*[IUF[2WJN%NX6J3F[N]V?)Z(@C"*$]^E2*7,]7U@FUXU3QHG(B[U<+Z,5
MWV/'2_(<6DZTT.,I)V-@Y1?(K< JX/+ VJJ0Q,#*HN'$8MZQ8,S.5E2$Z=+^
M!U.!RQH.;1U(F\2:'G5J$-7T:6. Z=6KK(%3W:W"05/>L<[<%3H#+RAX@>'Z
M6$I.@H5$V3+'0EBVIW%7V%"1FH9\QU=S)H3TG&C<0WU5K&60E7D^C#.V-M\)
M<^#=M_&=L/&=L/&=L/$=*COO4/7\3A@<WW$3O^-V\@0YJ;2U,1_MU!D2>>N]
M0ABC5QI'>COR)=Y+9$BT515D2/"K.K%>UG0I)T-"T@0&&1)\#DYTM,?:?/'B
M!-/YB1>+-RU9!9G-YKB@N^"05D]K3_.8GA,1T+& 5UX$H_D. \^?AO_P,*2]
M/-UDOQ3"H+T:$Q2B:D.!B+3J6H 147=BQLGJZKZ&240B@KR#NT;;+8RI,G<
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MF7A;&_GO]#_/) +^V_\#4$L#!!0    ( *5T!TOG<+(JR*X  ,+R"@ 5
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MAU%X2@Q2<A,#^M]^2.XD3G)?ZD&;B?9%(]#],XK*!B#OV((_CRV= Y$S&H<
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MNO 1B#YHBHR[N<5P]2 -GNOF=I'L];UCQ9;^OV(O7GV-U&DOCR$7 %$,>U+
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M_*#3#0PTRP'+PB1,Q5,+IE73Y-UX&8JK[E9TU5ZD'^@+-R^N#WG%@Z03NP6
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M"@;4;@U9RS1:__X8!1L<)Y=_/_CI\QWW*YD]O;E#E\0;G/O"?,!OR?5(K:<
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M,>MBWT/9RT>C[/F:8S6>"@?4E5@$;BL::U50^ZAG(97+E'#W,:_]_AE=_OU
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ME@&0Y)H0SP[I(YDH_$-)C+O& D&N&UM@3Q5^$&'NI-,E4BL 5Z"]HYW;(LW
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M,J#@:_\);^9A2B#BWP?%AW&O#NDAQK,=_=3?/SPZZEQ^V^,PP<)W46R$+KH
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MYD%Q"[YFIIX6#K2M]:X2MC4?9]>QA@"S9 W*)II=>/@F'T;EPY1V!.V"U,;
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M_V#2<BA+G'H>3<I+->+!9CH&/;3]3="%F#)4:.-#2WUG=Y,SR6-_LTS((4P
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MVU(<X4*>57TH%!3ED@H5Z)GI0#NJQ./<VXRFAU''F#.R.*.EL">T&!@TD_=
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M66I]9"@J+\Y45GC$DU.YSNG$[YJ.^)W^LOH5_<]CD.&K_P-02P,$%     @
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ML[K>-"GR-4KA[X<=$1-P/&(FT/K$00%,(JLYL/J, []VRQ+O-LL*)3"U"05
MHH0!@H@IHRV *-/ HU98HLV*/,NCA/B7%1#$H!; J$4=();XTMH"JL4Y\#"5
M1C"@XLI*HT0_V#+8-96^U(8AF=+55*A)/1LR2I92"I1]9 6WB%*7TA!)W.53
MJ-=1>[(QUTX2*AYR EDUJ4EGA9C.>BG4.Z:M\,%*,E$$9IN"%8))*3Q'B%PJ
MXR!,RLWBOJD/KMEPP^V^%V?X^5R>\<G%N?Q>)]EL=0?RVP13@?WY_&A'\E4[
M]HWCN+$E5/N7(SA4H\U$?P-1G*\O\>B8I<]10E]FPO_%[7L$Z0M<@ ?P I+>
M'0&#DK46M$J.9A=D/8IL5-"V!IRJB '0JB)PGW:95.0QBD%62]1_+4M$TDSC
MTB/Q&48*0BGCA<TK<-^T&!-BS06%!$<@X/5_J"&[ER@KTR1<OVU!D@%>:)B,
M;+^]YI&-%SX0/:$4-^D!E/<,ZY9U@P6$1#0T@$,T&NJEG8(4)6NCG\>V7#1S
MV(TV/9(U+^GZ/WW\^:>/=<=OU[^6>=DP&5P\%MMM3-) DX![+ 65H+3F'1AH
MEMK?^E4LY350S&171XXR_\ GU/L4O< ,JX,1(M@[K).3'MXG%9!Z#2P-*=71
M)&8:^)'O \""%HN\2&'R?+F.TN>>#U-$LC=++!*OH:(@E8[!83$+_MRV+;!D
MF299GGD.!XDTZE#H,PK\I6*%_8[BBEUYX\/G%_B0^I*B+,/SR:J7_X7QA;Y4
MW/SB,PKX(BAW?(O%$./FF-X.4-ZX_0(2D$8Q1O-DN<%+4B)L#E\ >W.H5XCZ
M1A0+^0P>(\'5/2F*W ./7IAM 1&(7/,FJICBP=1UO/(IJ-^51>$S<N0BJ7M=
M6:PL8A1\,$/TQC_=]%:B]8Z]1$2']]*91#Z#0TDP97SPN T1K# "1&HSR#T:
M%5)U0-*C<N=OZU1!'X&!\:Z5__FRG_4BPQU&@DW %:C^O4T.+\>P$J@=HRJV
MXAQ7->(8%:,&'57)W9'.;%MSI _3)@,/MJL4<^['U#[!8DPJ[#\0. 1K^S'#
M8'VB8T2FQ&.,"48;#%SOQQT#Y#E=SMF- B4;H6W*@  G$-$4/VV6!FYTO[)N
M=J03(T:,DJ"0X0@-1JZ]-@+F@7A+U1;2VIN2'COS=TT\V970/?@-UFSUM$:!
M)Y%ZDXZ2[ *L4 HJNGGT!K+K-RPZ%ALF4;J[Q:K*E'(E'J&F5N#H0#7YC?EC
MJ5ACW S8)(NG7_QP&M4RUT;E B2@?V8AH6IAGD'E/UYEHFEBC<$N]!S'U5D-
MP]'<_W"(+ME_\!D!7 &4.[W)P29'L0\&87^1@XACD([8N'RM=(/R/H/+5AW*
M&#2HR"0QL%];L9;0(B"*0!80@)R 8Z#,O$?L=NIDHND,+J(,+B;)\@K&1=Z[
MPZU(7>M42NTS6/1$58:/E"T%5( OG_\#P.<U%F+R@C<#S^"NV#R!=+;J)6<I
M9>X@RZALK7S-LCZCSD8-RAC4K(0B,M0 #XZX]8B3)6PR+"V&)K]T@.!45(4M
M//G54("&FA&CD>GC"K[ )4B6^_GA"BQB_(\@F8JT2#^SBJ"(S_@S$%HC>E:%
M-T6:DZ"5\3,-7$;9^B9&K]GXF08:22'VK9(G_>>2]I/],TC'W&N1YI1W9' /
M7NR^96!YF^PCZ2:+'&.P3'S!5H$Y@\.N39O!V5^F9]$L.DG=E:9?"<?+%JHS
M=;+\5Y%5C\D3YPS617G&,$</8('_'\:@M6.?([N1=ZSJ]H\>#UW=:!UW!3#:
M%K#$,?X[!N603):3#7F1J\KUT5&^3I%:@6I%QGO!X5AP0D;::]N:H1M++)-:
M(P.W6=_5%>1C0MSX*O,QH*UT)3K46_5?(I@0S<P2DH!EML+"8FWDN_LX2G*2
MKVU+E-L!MUXA>K5/L=!W 7@C#1X?^JK-##Z@D?KTP?(2;4C4 FL9(R:B6U<.
MT7<!:R4-'1_&O&:97[ >^\CFJFZL6NR2(O5^Z2VA_BZ@K*>S,1;<DO8%GMZ^
M?[-HKY#+: OS*.9G-=4L>(C=4R[HD5KZSR1*%<(OPE4%J\B89PZZ78R,]- [
MAE"LM@Z#5*ANQ-MQQP,DO?ER,&GE2XH&.)5PTH OE],)HEI-:T.#G=N*$6_'
M#397F<#="-DG"N*CXU4(S7 WMOR!>1_MZE&)?TD+W-1#WGYERZS"1&J4Q4R"
MA[*!KH8QQ>(&C)9MC'M#N2N'SB5L*8)-F'&1K,<L>$1;Z,XMLO4:<GH[XM:<
MI6._I245UQNG9:E5M3+DRH-EDPTB>%] ^H3&?ZCHF!X[8\?/\9UW.DT=(DU?
M,-%41P[;<1&C-7R3 S]R5E>K<?2D<=1DL /%6#<N(*]3^1#/NARQEY2"F+7Z
M0_?MO5ZU>CTP[!N(XYN1V^0%K_8M@K$5&(C-BI#!>+%KT:Z<D^9HLOAW 5.
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MA@B54LDS3B@I#YO>8#>D2HFV*R";UH>GY;^"S1-(.S)RO_<?C:??QS?.POY
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ME:8[@\LUV[KOW;$-<5 -I%3K >6N709'*7[E%V7+1W5:9J4LGC*XA%&ZJSV
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MF"GRMTB,Y 7H'L$SD><!;$DZJ%H5DCE9JPR-6U KXSGH3"37 9TB?XM42EZ
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M[UTU5X:!=U6K,M_.Q?^!TM]6".]S\&8'_[LA%[$>45QF:& #3:-$K5.E$F$
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MR^W$\9X"D8:9.7__P_31#].7/D)XWD-MJ=+&IM&:E<U":\G:93%>ZD@38^-
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MR0;FY=@Y")*)T&?+9I_/TY1-*,ATI"@CG)K7'?BMQ,X<L6Q&@%0SA'@A("C
MGNV9!4*!J+;P+N9M9BUCY)_CV,G)<EE>!XOBZRR'&_*.H]J\K%^PUJI.P5"@
M9:P,(XCIU!;X>[#5B+G-L@(L[U.X(#=PR]^ZADU&MT\3RZ4+!6NJHII9+S[S
M<*.@E-PO^OX##<>,$O-PDY]SSC*0^KD "ZS-LRH!G\%#S.HOY#]/V,#^Q_\'
M4$L! A0#%     @ I70'2^L#U6%>_P  H.8* !$              ( !
M '5S<&@M,C Q-S V,S N>&UL4$L! A0#%     @ I70'2_":;_.3$P  <M<
M !$              ( !C?\  '5S<&@M,C Q-S V,S N>'-D4$L! A0#%
M  @ I70'2R!0\1_6$0  L.T  !4              ( !3Q,! '5S<&@M,C Q
M-S V,S!?8V%L+GAM;%!+ 0(4 Q0    ( *5T!TO)'L+J*24  )]T @ 5
M          "  5@E 0!U<W!H+3(P,3<P-C,P7V1E9BYX;6Q02P$"% ,4
M" "E= =+YW"R*LBN  #"\@H %0              @ &T2@$ =7-P:"TR,#$W
M,#8S,%]L86(N>&UL4$L! A0#%     @ I70'2W*_\1\U1P  \?$$ !4
M         ( !K_D! '5S<&@M,C Q-S V,S!?<')E+GAM;%!+!08     !@ &
+ (H!   700(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
